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The heel is a particularly high risk and problematic area for pressure ulcers (PU) to 
develop. The effectiveness of devices and the factors that lead to their use for the 
prevention of heel PUs is poorly understood. 
Aims 
1. To assess the effectiveness of devices used for the prevention of heel PUs. 
2. Explore what factors influence the implementation, and how heel-specific 
devices are used (or not used) in secondary care. 
Methods 
To address aim 1: Systematic review of the evidence of effectiveness for devices in the 
prevention of heel PU.  
Aim 2: Realist evaluation, including Phase 1 - theory elicitation through stakeholder 
interviews with Tissue Viability Nurse Specialists (TVNS) from across the UK and 
Phase 2 - testing theories using ethnography in three orthopaedic wards in the North of 
England. 
Results 
Systematic review: identified 29 trials with fifteen comparisons and eight meta-analyses 
conducted. Offloading devices were found to be effective in prevention of ≥Category 1 
and ≥Category 2 heel PUs when compared to standard care, but this is based on low 
to moderate quality evidence and intervention compliance was found to be an issue. 
Realist evaluation Phase 1: Interviews with eight TVNS elicited thirteen candidate 
theories into three programme theories, regarding the proactive and reactive use of 
offloading devices, along with patient factors that influenced their use.  
Phase 2: Ethnography found that heel-specific devices are used in practice. 
Leadership, protocols, identification of high-risk patient groups and access to devices 
influenced staff knowledge but did not necessarily increase device use. 
Conclusion 
Exploring the perceptions and realities of how offloading and heel-specific devices are 
used in practice can not only influence their use, but also inform how future device 
trials are designed and conducted to improve protocol compliance and reduce 
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Chapter 1 Background 
1.1 Introduction 
This chapter describes what pressure ulcers are, how they develop, why they are a 
problem and the extent of the problem. It then goes on to describe the anatomy and 
physiology of the heel and why the heel is a particularly high risk and problematic area 
for pressure ulcers to develop. It will finally discuss who is at risk of developing a heel 
pressure ulcer, especially amongst patients being cared for in an acute care 
environment. Methods that can be used to reduce heel pressure ulcer risk will be 
discussed in the following chapter. 
1.2 What are pressure ulcers? 
 is presented in Table 1-1.  In 2009 two additional categories were defined; 
'unstageable/unclassified' and 'suspected deep tissue injury' (EPUAP et al., 2019), 
initially for use in the US, but more recently implemented across England (NHS 
Improvement, 2018). As pressure ulcers are categorised according to depth of the 
wound, these categories are used when the depth of the wound is unknown. 
Unstageable describes wounds in which slough or necrosis (loose or dead tissue) 
obscures the wound bed. 'Suspected deep tissue injury' describes wounds in which it is 
suspected that there is deeper damage, such as when bruising or a blood blister is 
present (Table 1-1). 
1.3 Why are pressure ulcers a problem? 
Pressure ulcers are globally a significant problem that have the potential to affect any 
person with reduced mobility, in a wide range of care settings. Pressure ulcers have 
been found to have a massive impact upon health-related quality of life; their presence 
and treatment have been found to affect people's lives emotionally, mentally, 
physically, and socially (Gorecki et al., 2009, Spilsbury et al., 2007). Health related 
quality of life is a multidimensional concept which describes the physical, role 
functioning, social, and psychological aspects of well-being and functioning related to 
disease and health (de Wit and Hajos, 2013). It is something that differs between 
individuals and is therefore both objective and subjective. Along with affecting quality of 
life, pressure ulcers can be painful (Briggs et al., 2013, McGinnis et al., 2014a) and can 





failure, myocardial infarction, multiple organ failure, amputation and can be fatal (Black, 
2004, Fowler et al., 2008, Gorecki et al., 2009).  
Pressure ulcers also have a massive financial burden, with estimated mean costs of 
treating a pressure ulcer varying from £1,214 (Category 1) to £14,108 (Category 4) 
(Dealey et al., 2012b) and the estimated total cost in the UK is £1.4 to £2.1 billion 
annually (4% of total NHS expenditure) (Bennett et al., 2004). The latter study created 
a costing model based on data from prevalence and incidence studies in acute and 
long-term care. Costs for community nursing following discharge from hospitals were 
not considered which, along with inflation, means the true costs could be higher.  A 
more recent estimate of the annual costs in the United States is USD 9.1 to 11.6 billion 
(Berlowitz et al., 2011). Most costs are due to nursing time, and more severe pressure 
ulcers have higher costs that relate to complication rates (e.g., infections or longer 
hospital stay) and litigation.  
1.3.1 What is the extent of the problem?  
There are several different methods through which pressure ulcer frequency have been 
reported; predominantly through prevalence, incidence and facility acquired rates.  
Prevalence reports the proportion of individuals with a pressure ulcer within a defined 
population (e.g., within a ward, hospital, or geographical region). This can be measured 
as either a point prevalence which is a specific point in time (usually on a specific day), 
or a period prevalence which is over a specified period (usually days or weeks).  
Prevalence data therefore provides an indication of the extent of pressure ulcers within 
a given population (Baharestani et al., 2009, Berlowitz, 2012). 
Incidence relates to the proportion of individuals who develop a new pressure ulcer 
within a population. Cumulative incidence refers to the proportion of a population that 
develops a new pressure ulcer over a specified time period (usually weeks or months) 
(Baharestani et al., 2009, Berlowitz, 2012). One of the problems with incidence 
reporting is that patients with existing pressure ulcers may or may not be excluded.    
Facility acquired pressure ulcer rates measure incidence within that facility (also 
referred to as hospital acquired, nosocomial or healthcare acquired) at a specific point 
in time. However, this requires accurate documentation of skin assessments on 
admission to the facility in order to exclude pre-existing pressure ulcers (EPUAP et al., 
2019). If reported accurately, these provide the best estimate of the adequacy of 






Table 1-1 Pressure ulcer classification system (EPUAP et al., 2019) 
Category Description 
Category I (1): 
Non blanching 
erythema 
Intact skin with non-blanchable redness of a localized area 
usually over a bony prominence. Darkly pigmented skin may not 
have visible blanching; its colour may differ from the surrounding 
area. The area may be painful, firm, soft, warmer, or cooler as 
compared to adjacent tissue. Category I may be difficult to detect 
in individuals with dark skin tones. May indicate “at risk” persons. 
Category II (2): 
Partial thickness 
skin loss 
Partial thickness loss of dermis presenting as a shallow open ulcer 
with a red, pink wound bed, without slough. May also present as 
an intact or open/ruptured serum-filled or serosanguinous filled 
blister. Presents as a shiny or dry shallow ulcer without slough or 
bruising*. This category should not be used to describe skin tears, 
tape burns, incontinence associated dermatitis, maceration, or 
excoriation.  
*Bruising indicates deep tissue injury. 
Category III (3): 
Full thickness 
skin loss 
Full thickness tissue loss. Subcutaneous fat may be visible, but 
bone, tendon or muscle are not exposed. Slough may be present 
but does not obscure the depth of tissue loss. May include 
undermining and tunnelling. The depth varies by anatomical 
location. The bridge of the nose, ear, occiput, and malleolus do 
not have subcutaneous (adipose) tissue and can therefore be 
shallow. In contrast, areas of significant adiposity can develop 
extremely deep Category III pressure ulcers. Bone/tendon is not 
visible or directly palpable 
Category IV (4): 
Full thickness 
tissue loss 
Full thickness tissue loss with exposed bone, tendon, or muscle. 
Slough or eschar may be present. Often includes undermining and 
tunnelling. The depth of a Category IV pressure ulcer varies by 
anatomical location. The bridge of the nose, ear, occiput, and 
malleolus do not have subcutaneous (adipose) tissue and these 
ulcers can be shallow. Category/Stage IV ulcers can extend into 
muscle and/or supporting structures (e.g., fascia, tendon, or joint 
capsule) making osteomyelitis or osteitis likely to occur. Exposed 




skin or tissue loss 
– depth unknown 
Full thickness tissue loss in which actual depth of the ulcer is 
completely obscured by slough (yellow, tan, grey, green, or brown) 
and/or eschar (tan, brown or black) in the wound bed. Until enough 
slough and/or eschar are removed to expose the base of the 
wound, the true depth cannot be determined; but it will be either a 
Category/Stage III or IV. Stable (dry, adherent, intact without 
erythema or fluctuance) eschar on the heels serves as “the body’s 




Purple or maroon localized area of discoloured intact skin or 
blood-filled blister due to damage of underlying soft tissue from 
pressure and/or shear. The area may be preceded by tissue that 
is painful, firm, mushy, boggy, warmer, or cooler as compared to 
adjacent tissue. Deep tissue injury may be difficult to detect in 
individuals with dark skin tones. Evolution may include a thin 
blister over a dark wound bed. The wound may further evolve and 
become covered by thin eschar. Evolution may be rapid exposing 





Reported prevalence rates can differ massively depending on the methodological 
design, settings, and rigor; from 0% to 54%. These two figures come from small 
studies; the 0% prevalence was in a single acute care unit following the implementation 
of a pressure ulcer prevention programme (Hiser et al., 2006), whilst the 54% 
prevalence was in a single urban acute care setting that had no structured risk 
assessment process (Moore et al., 2015b).  
Some prevalence studies have been conducted as a survey or questionnaire which 
allows for a larger sample size (up to 85,838 participants) across a wider geographical 
area (VanGilder et al., 2008), but might not be as accurate as there is a reliance on the 
ability of the person completing the survey (Barrois et al., 2008, VanGilder et al., 2008). 
Other prevalence studies have an inclusion and exclusion criteria or require informed 
consent so do not include the whole patient population. As demonstrated, due to the 
variability in methods used, results of prevalence studies are not always comparable, 
but they can be used to demonstrate the significance of pressure ulcers as a worldwide 
healthcare problem; of the prevalence studies presented in Table 1-2, the median 
prevalence is 13.5% (range 7.8-54%), although this is a subset of the evidence on 
prevalence, based upon studies that reported individual body sites. Most prevalence 
studies concentrate on acute or long-term care (e.g., care homes) populations.
Pressure ulcer prevention is part of the national patient safety agenda, with several 
different monitoring systems being introduced including reporting monthly prevalence 
through the NHS Safety Thermometer, incident reporting systems and the Strategic 
Executive Information System (StEIS) for reporting Serious Incidents. Use of these 
systems is inconsistent between organisations in the UK, along with a variance in 
pressure ulcer classification systems being used, different methods of investigating 
how severe (Category 3, 4 and unstageable) pressure ulcers develop and if they were 
caused by lapses in care, means results are not comparable between organisations 
(Dealey et al., 2012a, Smith et al., 2016), therefore the true extent of the pressure ulcer 
problem between different healthcare settings and organisations remains uncertain. 
1.4 How do pressure ulcers develop? 
Pressure ulcers are primarily caused when sustained pressure (including pressure 
associated with shearing forces) is applied to soft tissue, generally over a bony 
prominence (EPUAP et al., 2019). The most common locations for a pressure ulcer to 
develop are illustrated in Figure 1-1. 
Pressure is a continuous physical force exerted on or against an object by something in 





shear forces cannot exist in the absence of pressure. Shearing forces cause tissue 
damage when the skeleton and deep fascia slide downwards with gravity whilst the 
skin stays in contact with the surface, for example when a patient is in a semi-
recumbent position in bed (Figure 1-1). 
Figure 1-1 Common body sites for pressure ulcers to develop (Wounds UK, 2012) 
 
 
There are several different theories with regards to how pressure and shearing forces 
affect the soft tissues and lead to pressure ulceration. Pressure ulcer conceptual 
frameworks attempt to address this through creating theoretical models of the critical 
determinants of pressure ulcer development (Coleman et al., 2014).  
It is well established that the magnitude and duration of pressure are causal factors for 
pressure ulceration, but the relative contribution of magnitude and duration of pressure 
in the development of pressure ulcers is difficult to determine (Figure 1-2). However 
Defloor (1999) proposes that when sufficient shearing forces are present, half the 
pressure can lead to vascular occlusion. The tolerance of soft tissues to the effects of 
pressure had previously been thought to be an important variable in pressure ulcer 
development (Braden and Bergstrom, 1987, Defloor, 1999). More recently immobility, 
skin and pressure ulcer status, and perfusion have been identified as direct causal 





Table 1-2 Prevalence studies since 2000 that also reported heel pressure ulcer prevalence 
Author Country Setting 
Year(s) prevalence took 
place 
Total number of 
participants 
Overall PU ulcer 
prevalence 
Proportion of PUs on 
the heel (% of total 
PU population) 
Amir et al. (2017) Indonesia Acute Not reported 1,132 91 (8.0%) 16.9% 
Barrois et al. (2008) France Acute October 2004 37,307 3314 (8.9%) 46% 
Davis and Caseby (2001) Canada Long term care Not reported 187 84 (44.9%) 29% 
Gunningberg et al. (2011) Sweden Acute September 2009 1,192 14.9% 37% 
Gunningberg et al. (2013) Sweden Acute March 2011 16,466 2737 (16.6%) 29.7% 
Gunningberg et al. (2013) Sweden Nursing homes March 2011 18,592 2693 (15.5%) 32.4% 
Jenkins and O'Neal (2010) USA Acute  
4 surveys conducted 
quarterly in 2009 
310 49 (15.8%) 26% 
McGinnis and Stubbs (2014) UK Acute 
5 surveys between 2006 and 
2010 
  Range 19-26% 
Mehta et al. (2015) India Acute 31st August 2013 258 28 (7.8%) 21.4% 
Moore et al. (2015a) Norway Acute Not reported 59 32 (54%) 10% 
Moore et al. (2015b) Ireland Acute Not reported 121 14 (12%) 29% 
Stevenson et al. (2013) UK Community 2010 1782 185 (10.4%) 25.9% 
Tubaishat et al. (2011) Jordan Acute Not reported 302 36 (12%) 25% 
Tubaishat and Aljezawi (2013) Jordan Acute Not reported 295 48 (16%) 49% 
VanGilder et al. (2008) 




Using just 2005 survey data 85,838 3176 (15.2%) 23.6% 




There have been multiple laboratory and animal studies investigating the potential 
aetiological mechanisms by which stress and internal strain within the tissues lead to 
pressure ulcer development. These include lack of blood supply (ischaemia), tissue 
deformation, impaired interstitial flow, impaired lymphatic drainage, and reperfusion 
injury (Bouten et al., 2003, Coleman et al., 2014). 
Figure 1-2 Factors that influence the susceptibility of an individual for 
developing pressure ulcers taken from NPUAP and EPUAP (2009), adapted by 
Coleman et al. (2014) 
 
1.4.1 Tissue deformation  
One of the more recent developments in our knowledge about mechanical forces and 
response of the body is in respect of tissue deformation.  It is thought that pressure 
leading to reduced circulation reduces viability of muscle tissue over longer periods, 
whereas shear strains leading to cell deformation had a more immediate effect  
(Gawlitta et al., 2007b, Bader and Hawken, 1986). Without ischaemia, deformation 
causes cell membranes to rupture, damaging muscle tissue. Due to its stiffness, skin 
has been found to deform to a lesser degree than fat and skeletal muscle, with skeletal 
muscle the most susceptible to both deformation and ischaemia (EPUAP et al., 2019, 
Gawlitta et al., 2007a, Gawlitta et al., 2007b). The direct cause of the deformation 
damage remains unclear, but theories include direct rupture of the cytoskeleton, 
stretching of the plasma membrane or other factors leading to cell death (Breuls et al., 
2003, Ceelen et al., 2008, Stekelenburg et al., 2007).  
1.4.2 Ischaemia  
Ischaemia occurs when there is a restriction in blood supply to tissues, causing a 
shortage of oxygen. Ischaemia has traditionally been viewed as the predominant 





pressure to a tissue that is higher than capillary pressure slows down flow in the 
capillaries and lymph nodes, resulting in an insufficient oxygen and nutrient supply, and 
reduced removal of metabolic waste, eventually leading to tissue damage (Defloor, 
1999).   
When there is an acute reduction in the circulating volume of blood, subcutaneous 
tissue is one of the first tissues in which vasoconstriction (muscular narrowing of blood 
vessels) occurs, and the last to regain normal perfusion once the circulating volume 
has been restored (Gottrup et al., 1987). 
It has been theorised that following a period of prolonged ischaemia, once the tissue 
becomes re-perfused harmful oxygen free radicals can be released, causing a 
cytotoxic effect on the tissue, and exacerbating the existing damage (EPUAP et al., 
2019, Jiang et al., 2011, Peirce et al., 2000). A number of different studies have looked 
at the magnitude and duration of pressure in animal models, finding an increase in 
tissue damage with an increasing number of total ischemia‐reperfusion cycles 
(pressure being cyclically being applied and removed), duration of ischemia, and 
frequency of ischemia‐reperfusion cycles (Tsuji et al., 2005, Peirce et al., 2000). 
1.4.3 Impaired interstitial flow  
The interstitial space surrounds tissue cells contain interstitial fluid, which is essential 
for healthy tissue homeostasis through the movement of nutrients and waste products 
across the cell barrier. Mechanical loading of muscle tissue has been found to hinder 
diffusion of nutrients, waste products and hormones that regulate muscle metabolism 
(Gefen et al., 2008), with the plasma membrane becoming more permeable when it is 
highly stretched (Slomka and Gefen, 2012).  
1.4.4 Impaired lymphatic drainage  
Occlusion of lymph vessels in soft tissues caused by external loading is associated 
with an accumulation of waste products, an increase in interstitial fluid, inflammation, 
fibrosis, and localised cell death contributing to pressure ulcer development (Gray et 
al., 2016, Reddy et al., 1981). 
1.4.5 Microclimate 
Microclimate refers to the temperature and humidity of the skin, especially between the 
skin and covering surfaces. As temperature and humidity increases, the skin becomes 
weaker and less stiff, whilst excessively dry skin becomes more brittle and liable to 





role in the development of superficial (Category 1 or 2) pressure ulcers (Gefen, 2011), 
but the characteristics and extent to which microclimate plays a role remains a matter 
of debate and ongoing research (EPUAP et al., 2014).  
1.5 Conceptual framework 
Although there have been a number of different conceptual frameworks for pressure 
ulcer development, Coleman et al. (2014) is the only to link evidence from a systematic 
review of epidemiological evidence and a consensus study including international 
clinical and bioengineering experts group meeting, therefore making it the most 
evidence based and up to date. It was used to explore the causal factors for pressure 
ulcer development and created into a theoretical causal pathway highlighting direct, 
key indirect and other potential indirect causal factors (Figure 1-3).   
Figure 1-3 Theoretical schema of proposed causal pathway for pressure ulcer 
development (Coleman et al., 2014) 
 
1.5.1 Direct causal factors 
The risk factors for pressure ulcer development that were identified during a systematic 
review by Coleman et al. (2013), and which have been subsequently updated as part of 
the international guidelines (EPUAP et al., 2019), will be presented here.   
1.5.1.1 Immobility 
As previously discussed, pressure ulcers develop following sustained pressure, or 
pressure associated with shear.  It is therefore logical to assume that having limited 
mobility will have a direct impact upon an individual’s exposure to pressure and shear. 





immobility in combination with other causal factors leads to a pressure ulcer 
developing.   
1.5.1.2 Skin/pressure ulcer status 
The presence of Category 1 pressure ulcers have been found to increase the 
probability of Category 2 pressure ulcer development by two to three times (Nixon et 
al., 2006a, Reed et al., 2003). General skin status is an important consideration 
because it is likely that the physiology, transport properties and ability of the skin to 
repair can become impaired (Coleman et al., 2013, EPUAP et al., 2014, EPUAP et al., 
2019).  
1.5.1.3 Poor perfusion 
Factors that impair circulation, thus altering the perfusion and oxygenation of tissues 
increase the probability of pressure ulcer development. As can be seen in Figure 1-3 
there are several indirect causal factors that influence perfusion such as diabetes, 
infection, and albumin. Other examples of conditions that can affect perfusion that were 
identified in the systematic review include cardiac disease, peripheral vascular disease 
(PVD), renal disease, cerebral vascular attack, inotropes, cigarette smoking and blood 
pressure (Coleman et al., 2014, EPUAP et al., 2019).  
1.5.2 Indirect causal factors 
As illustrated in Figure 1-3, indirect causal factors change the direct causal factors 
affecting the impact on the outcome or likelihood of pressure ulcer occurrence. These 
include nutritional deficit, skin moisture, temperature, advanced age, sensory 
perception, medication, and general health status including acute illness.  
1.6 Why are heel pressure ulcers important? 
The heel is the second most common site for pressure ulcers to develop, after the 
sacrum, accounting for between 10-49% of all pressure ulcers (Table 1-2). Along with 
being a common site for pressure ulcers to develop, the most severe pressure ulcers 
often develop to the heel (Clark et al., 2004).   
Heel pressure ulcers can lead to pain, reduced mobility, and in extreme cases can 
result in a major amputation (Fowler et al., 2008). A study of heel pressure ulcer 
healing saw that only 42% of Category 2 or more severe heel ulcers healed over an 18 
month period, with a median time to healing of 121 days (range 8–440) (McGinnis et 





high risk for pressure ulcers to develop and why they need to be managed differently to 
other body sites.   
1.6.1 Anatomy and physiology of the heel 
The heel is defined as the posterior aspect of the foot that covers the calcaneal 
tuberosity.  The plantar aspect of the heel has a thickened dermis with the superficial 
fascia bound to the deep fascia, with fat contained in the interstices to create a large, 
tough but elastic fat pad (Figure 1-4), which is well adapted to absorb shock, pressure, 
and shear from the skeletal system during standing and locomotion. 
In contrast the posterior heel has a smaller surface area, thin subcutaneous tissue 
volume, and no muscle (approximately 3.8mm between the skin and bone), providing 
little cushioning over the calcaneal tuberosity. The skin to the posterior heel is tightly 
bound to the underlying deep fascia and fibres of the Achilles tendon.   
The Achilles tendon (also known as the calcaneal tendon) is the largest and strongest 
tendon in the body that connects the gastrocnemius and soleus muscles (calf muscles) 
to the calcaneum. Despite its strength, the Achilles tendon has a poor vascular supply, 
which along with the high tensions placed on it leaves it susceptible to injury.  
Figure 1-4 MRI of the heel, adapted from radiopaedia.org 
 
 
1.6.2 Who is at risk of developing a heel ulcer? 
Due to the anatomy of the heel, there are clinical situations that make the heel an area 
more susceptible than other body sites to the effects of pressure and/or shear. Linking 
to the conceptual framework and causal factors discussed in 1.5, the risk factors and 






The small surface area and lack of muscle to cushion and distribute pressure to the 
posterior heel, leads to higher pressures being exerted directly over the bone when a 
person is in a supine position, semi-recumbent position or seated with the heels in 
direct contact with a foot stool (Tong et al., 2016). A person with reduced mobility might 
spend longer periods in a recumbent position in bed, where the foot tends to externally 
rotate (abduct) so pressure is going through the lateral posterior aspect of the heel 
where the surface of the calcaneus is irregular, and the covering fat pad is thinner 
(Tenenbaum et al., 2013). A computer modelling study has demonstrated that during 
bed rest an abducted foot posture leads to a greater load through the tissues (Sopher 
et al., 2011) along with skin strains (Tenenbaum et al., 2013), although Tong et al. 
(2016) found higher interface pressures in elderly participants when the foot was in an 
upright position.   
Immobility can affect the heel in specific ways as there are conditions that can 
immobilise the lower limb, but not the rest of the body. A large proportion of the surgical 
patient population, where long periods of immobility alongside decreased sensation 
related to analgesia and anaesthesia increases pressure ulcer risk (Lindgren et al., 
2005, Edwards et al., 2006).  
Shear forces are a common problem in the acute and long-term care population due to 
poor positioning in beds or chairs, which can lead to the patient sliding downwards. 
Shear forces are also exerted when patients use their heel as a pivot point to reposition 
themselves. Friction can also cause an increased risk in heel pressure ulceration 
during poorly conducted moving and handling of patients, or when patients are agitated 
or have tremors that can lead to their heels rubbing against bed sheets. Patients that 
spend extended periods in bed can also have higher loads going through the heel due 
to the weight of blankets.  
1.6.2.2 Poor perfusion 
Conditions that reduce the circulation of the lower limb, such as peripheral arterial 
disease (PAD), increases the heels’ susceptibility to ischaemia. In a study of heel 
pressure ulcer healing, 62% of all patients with a heel pressure ulcer had evidence of 
inadequate arterial blood supply to the lower limb (McGinnis et al., 2014b). In a smaller 
study 50% of patients with a heel pressure ulcer had evidence inadequate blood supply 
to the lower limb, of which 45% were considered to have a severe obstruction 





Circulatory conditions that reduce the blood flow to the lower limb such as PAD are 
commonly associated with older age. However, they can be present in younger people 
such as those with diabetes, hypertension, or smokers (Tendera et al., 2011).  
During an acute illness, the sympathetic nervous system, and some medications (e.g., 
inotropes) preserve the body's organs, especially the heart and brain, through increasing 
the central circulating volume available to them, while decreasing the peripheral 
circulating volume. Making the feet and heels of patients in intensive care settings at risk 
of developing heel pressure ulcers (EPUAP et al., 2019, Coleman et al., 2014).  
1.6.2.2.1 Diabetes 
Diabetes is commonly associated with ulceration to the feet, primarily affecting the 
plantar aspect of the foot or the toes and tend to be caused by accidental trauma, 
especially from ill-fitting footwear (Jeffcoate and Harding, 2003, Macfarlane and 
Jeffcoate, 1997). Prolonged periods of hyperglycemia (high levels of glucose in the 
blood) can induce thickening and interlinking of collagen fibers in connective tissues, 
which in turn leads to progressive stiffening of the tissues (Gefen et al., 2001). 
Displacement of the soft tissues and atrophy can potentially lead to tissues that, along 
with being pathologically stiffer, could also be thinner over the calcaneus; thus 
decreasing the ability of the tissues to deform and spread the mechanical load 
transmitted from the bone (Gefen, 2010).  
Peripheral neuropathy (reduced or altered ability to sense, in this case in the feet) is 
one of many complications of diabetes, resulting in significant morbidity and mortality 
(Callaghan et al., 2012). Although neuropathy is most common amongst diabetics, it is 
also associated with other conditions such as alcoholism, stroke, demyelinating 
diseases such as multiple sclerosis, and conditions such as Guillain-Barré syndrome, 
which can have quite a rapid onset (White et al., 2004). Peripheral neuropathy can lead 
to an increased risk of heel pressure ulcers, as individuals are unaware of pain and 
pressure, and so do not respond accordingly through repositioning the foot. 
1.6.2.3 Skin Status 
The presence of a pre-existing pressure ulcer, along with other conditions that affect 
structure and integrity of the skin increases the risk of an individual developing a heel 
pressure ulcer.  
1.6.2.3.1 Oedema 
Alongside reducing the blood flow to the lower limb, circulatory problems such as 





(swelling of the feet due to fluid accumulation), which impairs the delivery of oxygen 
and nutrients to the tissues, and also the disposal of metabolic waste products (Ryan 
and Byrne, 1989) along with a potential stiffening of tissues (Gefen, 2010). Oedema 
also increases the weight of the limb, which in turn, increases normal resting 
pressures.  
1.6.2.3.2 Age related skin changes 
A number of studies have found a significant association between pressure ulcer 
incidence and increasing age (Baumgarten et al., 2006, Nixon et al., 2006a, Perneger 
et al., 2002) and has been identified as an indirect causal factor (Coleman et al., 2013) 
(Figure 1-3).  
With aging, the epidermis (outer layer of the skin) thins, is dry, dehydrated and lacks 
sebum (Tong et al., 2016). The strength and elasticity of connective tissues reduce, 
and blood vessels to the dermis also become more fragile (Defloor, 1999). The 
subcutaneous tissue thins which reduces the padding over bony prominences and can 
also reduce the shock absorbency capacity of the heel pad (Alcántara et al., 2002). 
1.7 Summary 
This chapter has presented what pressure ulcers are and how they develop and why 
they are a significant health care problem.  Due to the unique anatomy of the heel and 
medical conditions such as PVD, PAD and diabetes the heel is an at-risk area for 
pressure ulcers to develop. However, acute illness can lead to a reduction in the 
peripheral circulation or a reduction in mobility levels which in turn increases the risk, 
making the acute care population at high risk.  
There are various models that attempt to determine how the magnitude and duration of 
pressure affect the soft tissues and lead to pressure ulcer development, but factors 
affecting tissue tolerance are multi-factorial. Pressure ulcer prevention strategies 
therefore involve attempting to identify which patients are at risk of developing a 
pressure ulcer and implementing a plan of care that attempts to reduce the magnitude 
of pressure through the use of support surfaces and devices, and the duration of 






Chapter 2 Heel pressure ulcer prevention strategies 
2.1 Introduction 
This chapter provides a general overview of heel pressure ulcer prevention strategies 
including risk assessment, care planning and prevention strategies that address the 
direct and indirect causal factors discussed in Chapter 1. It will go on to demonstrate 
the number of different types of devices available for the prevention of heel pressure 
ulcers, along with the merits of each and recommendations based on international 
consensus. It will finally highlight the need for a systematic review of the evidence due 
to the wide range of device types available with different mechanisms of action along 
with the sparsity of good quality research.  
2.2 How do we prevent pressure ulcers? 
As illustrated in Chapter 1, pressure ulcers rarely occur due to a singular factor, 
therefore prevention strategies require an understanding of the different risk factors 
individual to each patient, and the implementation of a multifaceted plan of care.  
Pressure ulcer prevention strategies in nursing tend to focus on identifying which 
patients will be at risk of developing a pressure ulcer, and for these patients 
implementing a plan of care aimed at modifying the direct and indirect causal factors 
identified in Figure 1-3. The primary focus is on factors that will affect the status of the 
skin along with decreasing the intensity and duration of pressure through increasing 
mobility and repositioning. The third direct causal factor is poor perfusion which nursing 
interventions alone will have little impact upon, but the focus should be on recognising 
this risk and modifying the other risk factors accordingly. 
2.2.1 Recognising risk/risk assessment 
Risk assessment is a central component of nursing practice aimed at identifying 
hazards and risk factors that have the potential to cause harm to vulnerable patients. It 
is a requirement that all patients being admitted to secondary or long term care 
provided by the NHS have a pressure ulcer risk assessment completed, (NICE, 2014b) 
to help identify at risk individuals and thereby target appropriate interventions.  
Pressure ulcer prevention interventions are not appropriate for all patients as they can 
be costly (e.g., medical devices), resource intensive (e.g., nursing time taken to 
reposition patients) and can impact upon quality of life for patients (e.g., frequent 





There are numerous different risk assessment tools available, including Braden 
(Bergstrom et al., 1987), Norton (Norton et al., 1962), Waterlow (Waterlow, 2005) 
scales and more recently PURPOSE T (Coleman et al., 2018). There is insufficient 
evidence to state whether risk assessments have a better predictive capacity than 
clinical judgement alone (Diaz-Valenzuela et al., 2014). There is also very low certainty 
evidence regarding the effectiveness of risk assessment tools at reducing pressure 
ulcer incidence (Moore and Patton, 2019), they can be time consuming and provide 
false assurances of lack of risk. However, they can be advantageous as they can 
provide a structured framework, provide a clinical reminder which is beneficial for 
novice nurses and define relevant risk factors that are useful and measurable, allow for 
monitoring and audit, and should therefore be used in combination with clinical 
judgement (NICE, 2014b, EPUAP et al., 2019).  
Risk assessments tend to assess the patients’ risk, rather than identifying individual 
body sites, such as the heels.  Table 2-1 explores which of the most used risk 
assessment tools identify risk factors specific to the heel explored in Chapter 1.  
 
Table 2-1 Commonly used risk assessment tools and their ability to identify heel 
pressure ulcer risk factors  
Heel ulcer risk 
factors 
Braden Norton Waterlow Purpose T 
Perfusion × × ✓ ✓ 
Skin status × × ✓ ✓ 
Diabetes × × ✓ ✓ 
Neuropathy ✓ × ✓ ✓ 
Age × × ✓ × 
Mobility ✓ ✓ ✓ ✓ 
 
Regardless of which risk assessment is used, to be effective there is a requirement that 
the nurse understands, can interpret the results, and prescribe preventative 







2.2.2 Care Planning  
The concept of caring has long been a prominent aspect of the nursing role. A care 
plan is a written document designed to guide practice specific to each individual 
patients’ needs. The Royal College of Nursing (2016) states the purpose of care 
planning is to: 
• Ensure that the patient/client gets the same care regardless of which 
members of staff are on duty.  
• Ensure that the care given is recorded. 
• Support the patient/client to identify, manage and, hopefully, solve his or her 
problems. 
If a patient has been identified as being at risk of developing a pressure ulcer, then it is 
recommended practice that they should have a preventative care plan initiated. There 
is no universal care plan used, but often each organisation will have their own 
template. A commonly used care plan bundle that is being adopted in a number of NHS 
hospitals is the SSKIN bundle (Gibbons et al., 2006), an acronym used to help nursing 
staff prescribe care: 
Surface: make sure your patients have the right support  
Skin inspection: early inspection means early detection - show patients and 
carers what to look for  
Keep your patients moving 
Incontinence/moisture: your patients need to be clean and dry 
Nutrition/hydration: help patients have the right diet and plenty of fluids 
2.2.3 Skin/pressure ulcer status 
Skin assessment involves a healthcare worker observing at risk skin sites to identify if 
there are signs of early pressure damage or to assess the severity of pressure damage 
if present. Skin assessment is also a useful indication of the effectiveness of a 
preventative intervention (EPUAP et al., 2019).  
The EPUAP et al. (2019) pressure ulcer classification system presented in Chapter 1 
offers a structured tool for the assessment of pressure ulcers, but is reliant on the 
healthcare workers’ skill and experience at undertaking this. 
Skin assessment should also identify skin vulnerability such as moisture (e.g. from 
perspiration, wound exudate and incontinence) which is important as moist skin 





strength and flexibility (Baharestani et al., 2010). An appropriate skin care regime to the 
heels should be implemented that includes keeping the skin clean and hydrated, 
without the use of alkaline soaps (Ananthapadmanabhan et al., 2004). Nutrition and 
hydration is important in pressure ulcer prevention as macro and micronutrients are 
required to grow, develop, maintain and repair body tissues (EPUAP et al., 2019).  
2.2.4 Immobility 
Extended periods in one position would normally result in pain and discomfort which 
would stimulate an individual to change position. However, if the individual is unable to 
reposition themselves, or has impaired sensation or reduced levels of consciousness 
and will not experience the discomfort, then assistance will be required. Theoretically, 
by repositioning, the duration of pressure to the tissues is reduced which in turn 
reduces the levels of deformation and hypoxia (Defloor, 2000, Gillespie et al., 2014). 
2.2.4.1 Repositioning 
Frequent repositioning has long been a recommendation as a means of preventing 
pressure ulcers (EPUAP et al., 2019, NICE, 2014b), although there is still debate in the 
literature about how frequently a patient should be repositioned, and if repositioning 
techniques such as the 30 degree tilt are sufficient to prevent pressure ulcers, 
especially at the heel and will be explored further here.  
Repositioning can be done using a variety of repositioning aids but is mostly done 
using pillows as this is something that is readily available in most clinical areas. For 
repositioning to be effective there is a requirement for the patient to maintain the 
position that they are turned to, along with the ability of the carers to repositioning the 
patient effectively.  From personal experience in clinical practice it is sometimes seen 
that the patient is turned at the torso, relieving the pressure at the sacrum and 
buttocks, but the heels often remain in the same or similar position, or that patients will 
be turned but will return to a position that is comfortable to them, as reported in 34% of 
subjects by Vanderwee et al. (2007b).   
There is a published systematic review looking at repositioning for the prevention of 
pressure ulcers in terms of both the degree of repositioning (30º versus 90º tilt) and the 
frequency (Gillespie et al., 2014). Only three randomised controlled trials (RCTs) were 
included, all of which were underpowered and at high risk of bias, and no evidence of a 
reduction in pressure ulcer incidence was seen with either the frequency or degree of 
repositioning (Defloor et al., 2005, Moore et al., 2011, Young, 2004).  Further research 





Young (2004) compared the 30⁰ tilt with 90⁰ lateral rotation, although they do not state 
how frequently the patient was repositioned, and it was a very short study only lasting 
for one night. No difference was seen between the two groups.  
Defloor et al. (2005) compared four different combinations of repositioning schedules in 
combination with standard or high specification foam mattresses using cluster 
randomisation. Significantly fewer pressure ulcers developed in the four hourly 
repositioning group on a high specification foam mattress.   
A trials by Vanderwee et al. (2007b) and Bergstrom et al. (2013) were not included in 
the systematic review.  Vanderwee et al. (2007b) compared frequencies of 
repositioning (two versus four hourly) for patients with Category 1 pressure ulcers on a 
pressure relieving support surface and saw no significant difference in frequency and 
number of pressure ulcers that developed and both groups had their heels elevated 
using a wedge-shaped cushion. Bergstrom et al. (2013) compared two, three and four 
hourly repositioning and reported no difference between the three groups.  
Moore et al. (2011) compared the 30⁰ tilt three-hourly versus six-hourly repositioning 
using the 90⁰ lateral rotation.  They saw significantly fewer pressure ulcers in the three-
hourly 30⁰ tilt group and was the only study to compare pressure ulcer incidence by 
body site. No heel pressure ulcers were seen, therefore the effect of repositioning on 
heel pressure ulcers remains uncertain.  
2.2.5 Devices 
For the purpose of this thesis, a device is any instrument, apparatus, implement, 
appliance, material or other similar or related article, intended to be used, alone or in 
combination, in human beings, for the purpose of diagnosis, prevention, monitoring, 
treatment or alleviation of disease (World Health Organization, 2020).  
Where effective repositioning is not possible or is insufficient to meet the patients’ 
perceived need, medical devices can help to help minimise the risk. It has been 
identified that there is limited evidence on whether pressure redistributing devices 
reduce pressure ulcer risk at specific body sites, and have therefore been identified as 
a research priority (James Lind Alliance, 2013, NICE, 2014b). 
Support surfaces such as mattresses and overlays, and dressings can be used for the 
prevention of pressure ulcers. In addition, for the prevention of heel pressure ulcers 
there are heel-specific devices. Current recommendations according to EPUAP et al. 






“For individuals at risk of heel pressure ulcers and/or with Category 1 or 2 
pressure ulcers, elevate the heels using a specifically designed heel 
suspension device or a pillow/foam cushion. Offload the heel completely in 
such a way as to distribute the weight of the leg along the calf without 
placing pressure on the Achilles tendon and the popliteal vein”. 
 
This is a strong recommendation meaning this should be carried out in practice, but the 
strength of the evidence that these recommendations were made is mainly based on 
either low to moderate quality RCTs or moderate to high quality quasi-experimental 
trials. Alongside RCTs, the biomechanical properties of a devices can be investigating 
through measuring interface pressures, perfusion of the tissues, usually through 
measuring blood flow or transcutaneous oxygen and carbon dioxide levels or using 
MRIs to measure tissue deformation. There is no consensus on which method is best, 
their comparability, and are often conducted in laboratory settings using healthy 
participants.  Tissue Viability Society (2010) recommend that support surfaces should 
include human subject interface pressure tests as part of a wider investigation into their 
physiological effects, but as they cannot be standardised this should not form part of 
the basic product information. It is also acknowledged that other factors such as 
shearing forces and microclimate need to be considered (Tissue Viability Society, 
2010). 
2.2.5.1 Support surfaces  
Support surfaces are specialist devices designed to redistribute the pressure exerted 
on the individual’s body when in contact with the device.  The term support surface can 
apply to specialist beds, mattresses, and mattress overlays, and to chair and 
wheelchair cushions. Chair and wheelchair cushions will not be explored as these do 
not have any impact upon the heels. 
Support surfaces are not included in the EPUAP et al. (2019) recommendations for the 
prevention of heel pressure ulcers, due to the lack of evidence in their effectiveness. 
There is a Cochrane systematic review that looks at the evidence of effectiveness of 
support surfaces for the prevention of pressure ulcers, but does not look at individual 
body sites (McInnes et al., 2015).  Support surfaces are part of standard care, and 
therefore how they might reduce the risk of heel pressure ulcers needs to be 
understood. 
Mattresses and overlays aim to reduce the risk of pressure ulcer development to all 
parts of the body, and generally fall into one of two categories: constant low pressure 
(CLP) or alternating pressure (AP). CLP devices reduce the magnitude of the applied 





related both to the force applied, and to the area over which it is spread; 
mathematically, Pressure = Force/Area). CLP mattresses (Figure 2-1) include foam 
mattresses and overlays, low air-loss mattresses, air-fluidised-bead beds and air 
overlays (McInnes et al., 2015).  
Tong et al. (2016) saw significantly reduced interface pressures to the heels of elderly 
participants on a pressure relieving foam CLP mattress when compared to a standard 
hospital mattress, although the average pressures were only slightly below 32mmHg 
which is thought to be the average arteriolar flow and the pressure required to close 
capillaries and cause ischaemia (Landis, 1930). 
 
AP devices (Figure 2-2) reduce the duration of pressure by alternately inflating and 
deflating air-filled cells in a mattress over a set cyclical period (usually every 5 
minutes), thereby redistributing the pressure regularly for the whole body. These can 
differ by the depth and size of the cells, and the frequency of the inflation and deflation 
cycles. Some AP mattresses also have special heel zones where the cells can be 
partially deflated to help offload the heel. Despite this there is little evidence about the 
effects of AP mattresses on the prevention of heel pressure ulcers. Numerous studies 
have been identified looking at the properties and interface pressures of AP devices, 
(Vanderwee et al., 2008) only two were identified that reported separate heel interface 
pressures (Sideranko et al., 1992, Rithalia, 2004), however they used different 
methods to record and report the results. Sideranko et al. (1992) reported mean 
interface pressures at the heels of 22-22.8mmHg depending on position on the AP 
Figure 2-1 Examples of CLP mattresses from top left clockwise low air-loss, foam 





mattress, whilst Rithalia (2004) compared four different AP mattresses and reported a 
range of interface pressures from a minimum of 39.4mmHg to a maximum of 
186.9mmHg. The relationship between interface pressure measurements and pressure 
ulcer risk is almost completely unknown, therefore the utility of these proxy measures 
and the significance of these results on the prevention of heel pressure ulcers is 
unclear. 
More recently hybrid mattresses (Figure 2-2) have been introduced which uses 
combines two technologies such as foam and alternating air so the mattress can be 
upgraded through the addition of a pump without the whole mattress needing to be 
replaced.   
Figure 2-2 Examples of AP mattresses, from left to right: heel zone of an AP 
mattress with the heels floating and a hybrid mattress (Arjo) 
 
 
2.2.5.2 Heel-specific devices  
There are numerous heel-specific devices available on the market to prevent heel 
pressure ulcers that tend to fall into one of three categories: 
• Devices that offload or float the heel 
• Heel-specific CLP devices  
• Heel-specific low friction devices  
Recommendations by Huber et al. (2008) state that heel devices should increase the 
tissue blood flow, prevent shear forces, be effective in all positions, allow mobilisation, 
be easy to use, cost-effective and comfortable. They should also prevent 
hyperextension of the knee as this could lead to compression of the popliteal vein, 
which is a possible association with deep venous thrombosis (Leon et al., 1992, Huber 







2.2.5.2.1 Devices that offload or float the heel 
The general consensus for preventing heel pressure ulcers is that the only effective 
method is through alleviating the pressure by elevating (offloading) the lower leg and 
calf from the mattress (Fowler et al., 2008, EPUAP et al., 2019).  Offloading the heels 
so they are completely free of pressure can be achieved using a pillow, cushion, or 
wedge under the lower legs, or by using an offloading device that floats the heel. These 
will aim to distribute the pressure to the lower legs over a larger surface area whilst 
floating the heel, so it is free from pressure.  
Pinzur et al. (1991) reported zero pressure to the heels when effectively elevated using 
a device. Huber et al. (2008) used a laser Doppler to measure flux at the heel 
(concentration and speed of the red blood cells with respect to time) as a method of 
assessing perfusion, although this was a study of non-hospitalised volunteers with and 
without PVD. They found that flux was significantly higher when using an offloading 
device compared with laying the heel on pressure reduction devices; illustrating the 
importance of elevation. Guin et al. (1991) compared the heel interface pressures for six 
different heel devices, including a combination of offloading and cushioning devices. The 
lowest pressures were reported with an offloading splint, although they came in a variety 
of sizes which complicates purchasing and application.  The offloading splint was difficult 
to apply and would take several adjustments to ensure proper positioning, but this could 
be addressed through effective training of the staff and patients/carers. Guin et al. (1991) 
also found that products which were secured by straps to the foot or leg could lead to 
higher pressures at the heel if applied tightly. This could also cause a problem in patients 
with ischaemia if the straps are secured too tightly. 
Pillows 
Pillows can be effective at offloading the heel by being placed lengthways under the full 
length of the calf with a slight flexion to the knee, allowing the heel to be suspended 
above the mattress. Pillows are the most accessible method of elevating the heel as 
they are cheap and available to all clinical areas and are suitable for short term use in 
alert and co-operative individuals who can maintain the leg in the same position 
(EPUAP et al., 2019). Pillows can however be placed incorrectly leading to the heel still 
being in contact with the bed, or patient movement can cause the pillow to move 
(Figure 2-3), making pillows less suitable for more mobile patients, those who are 
agitated or where there is increased movement to the lower limb. The thickness of the 
pillow can differ, with thinner pillows or a heavier lower limb can cause ‘pancaking’ of 





De Keyser et al. (1994) and Smith (1984) looked at the interface pressures of the heel 
when using a variety of different heel protection devices and found the lowest pressures 
in the standard pillow group. Pillows do not protect from footdrop, where extended 
periods of bedrest can lead to weakness and overstretching of the muscles and nerves 
to the lower leg.  




The heels can be elevated in a similar manner to pillows using a wedge (Figure 2-4). 
Wedges are thicker and larger than pillows minimising the chance of the wedge moving 
and the heel being in contact with the bed, but the leg can still move out of the correct 
position illustrate. Wedges such as the one in Figure 2-4 can also lead to an increase in 
pressure to the Achilles tendon. Beeckman et al. (2009) performed a non-randomised 
comparative study looking at pillows versus wedges and reported fewer heel pressure 
ulcers in the wedge-shaped cushion group, although two ankle pressure ulcers were 
reported, but it is unclear if this was attributed to the wedge. 








Heel offloading devices 
Heel offloading, also referred to as heel suspension devices, solve most of the 
problems associated with pillows and wedges as they; float the heel so it is free from 
pressure, are designed to stay in intimate contact with the foot and lower leg, can 
reduce friction & shear and can remain in place for up to 24 hours a day. Some can 
also help to minimise foot drop. 
Heel offloading devices can vary in both design and materials as illustrated in Figure 
2-5; such as foam or air-filled boots and Pressure Relief Ankle Foot Orthosis (PRAFO® 
boots).  Recommendations, based on expert opinion, state that the device should be 
selected taking into consideration mobility, skin integrity, oedema, anatomical 
appearance and/or alignment of the foot and leg (e.g. contractures or deformities), 
manufacturers guidelines along with comfort and the patients’ ability to tolerate the 
device (EPUAP et al., 2019). 
Figure 2-5 Heel offloading devices from top left clockwise Pressure Relief Ankle 
Foot Orthosis (PRAFO by Anatomical Concepts UK Ltd), foam (Heelift 
reproduced by permission of Walgreen Health Solutions, LLC), padded 
(Prevalon™ Heel Protector III, Stryker) and air filled (Repose, Frontier Medical) 
 
2.2.5.2.2 Heel-specific CLP devices 
CLP heel devices are designed either to reduce the magnitude of the applied pressure 
increasing the contact area through padding the heel or reduce the effects of the forces 
of friction or shear, or both. They can include gel, foam or sheepskin materials made into 
either a heel cup, bootie or overlays that only sit under the heels (Figure 2-6).  They are 
useful in certain situations, for example patients where friction or shear is more of an 





be used under prostheses or shoes, or in certain situations such as surgery or vascular 
radiology where the limb cannot be elevated and needs to be kept stable.  
Synthetic sheepskin has been found not to reduce heel pressures compared to no device 
(De Keyser et al., 1994). Pinzur et al. (1991) saw higher relative heel pressures in CLP 
devices when compared to devices that completely offload the heel.  CLP devices might 
not reduce interface pressures but might reduce friction and shear. These studies also 
do not consider confounding factors such as comfort, patient preferences which can 
affect concordance with wearing the devices, whether the devices stay in place as well 
as the influence of friction and shear. 
Figure 2-6 Heel-specific CLP devices, from top clockwise: gel heel pad, 
Sheepskin Heel Protector (by James Thornton, Thorpe Mill Ltd, licensed 
under CC BY-NC-ND 4.0) and egg-crate foam heel protector and sheet (© 2018 
courtesy of Cardinal Health UK Ltd) 
 
2.2.5.2.3 Heel-specific low friction devices 
These can include dressings or booties that are designed to reduce the risk of pressure 
ulcer development through reducing the forces of friction and shear. Although it has 
been identified that complete offloading of the heel is the most preferential method for 
preventing heel pressure ulcers, this will not be suitable for all patients.  Low friction 
devices could be more suitable for the more mobile patient or those with tremors or 
agitation that leads to frequent movement of the lower limb which could make the heels 
more susceptible to the effects of friction and shear rather than pressure. They could 






2.2.5.2.4 Prophylactic dressings 
Dressings, such as polyurethane or silicone foam can help to reduce heel pressure 
ulcer risk by cushioning the heel and reducing friction, and a simple film dressing can 
help reduce friction (Figure 2-7). In a laboratory setting a range of dressings including 
hydrocolloids, silicone and foam dressings have been found to reduce pressure, 
although this was to the sacrum (Matsuzaki and Kishi, 2015). Other laboratory studies 
have shown foam dressings to reduce pressure, shear and friction (Levy et al., 2015, 
Levy and Gefen, 2016) and can improve the microclimate of the skin (Call et al., 2013).  
Film dressings do not reduce interface pressures, but can reduce the effects of 
shearing forces (Nakagami et al., 2006) and allow for the skin to be monitored without 
tampering with the dressing.  
A systematic review has shown that silicone dressings may reduce pressure ulcer 
incidence, however the evidence included was of a low level of certainty, and this 
review was looking at all body sites and not specifically at the heel (Moore and 
Webster, 2018).  Therefore current recommendations are that prophylactic dressings 
should be used only as an adjunct to elevation (EPUAP et al., 2019).  
Figure 2-7 Dressings for heel pressure ulcer prevention. From left to right multi-
layered silicone foam dressing (Mölnlycke Health Care), polyurethane foam 
dressing, film dressing 
 
2.2.5.2.5 Low-friction garments 
Textiles with low friction coefficient can be used as either bed linen or clothing such as 
undergarments and booties (Figure 2-8). The textiles work by reducing the effects of 
friction and shear as well as influencing the microclimate of the skin by absorbing 
moisture away from the skin and reducing heat.  They have non-slip areas to help 
patient positioning and reduce the risk of slips and falls.  
Medical technologies guidance from NICE (2014c), which was based on four multiple 
patient case series reports, shows that low friction booties have the potential to reduce 
the development and progression of skin damage caused by friction and shear in 
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patients at risk of developing a pressure ulcer, although there is insufficient evidence of 
effectiveness to support them being adopted into routine practice.  
Figure 2-8 Low friction booties (APA Parafricta Ltd) 
 
2.2.5.2.6 “Homemade” Devices 
There are a variety of “homemade” devices reported in the literature as being used to 
reduce pressure at the heel, such as water-filled gloves (Figure 2-9) or intravenous 
fluid bags. Water-filled gloves were a more traditional nursing intervention for reducing 
pressure at the heel, however a small study measuring the interface pressures on the 
heels of healthy volunteers saw equivalent pressures between the water-filled gloves 
and a standard mattress, regardless of the size of the glove and amount of water in the 
glove (Lockyer-Stevens, 1993). Williams (1993) saw higher interface pressures when 
the heel rested on a water-filled glove compared to the bed in 40 inpatients. It is also a 
small area for the heel to be resting on so would be difficult to maintain it in the correct 
position. It has therefore been recommended that water-filled gloves should not be 
used as a pressure relieving aid (EPUAP et al., 2014).  
Figure 2-9 Water-filled glove used for heel pressure ulcer prevention 
 
Intravenous bags have been used to lift the heel from the bed by placing the bag under 
the Achilles. Bales (2012) performed a quasi-experimental trial comparing intravenous 
fluid bags and a heel offloading device for the prevention of heel pressure ulcers. 





intravenous fluid bags can cause similar problems as the water-filled glove; the foot or 
bag could move and there is the potential that they could increase interface pressures 
in a similar manner to the water-filled gloves, and therefore increase risk of pressure 
ulcers developing over the Achilles. 
2.3 Knowledge theories  
Nurses knowledge of risk assessments, prevention practice and device use for the 
prevention of heel pressure ulcers could be of potential relevance to this thesis. How 
nursing knowledge is established, understood, transmitted, and used could be 
important when levels of formal knowledge might be limited and differ amongst staff.  
Teaching, learning, and knowledge are interrelated, although learning and knowledge 
are separate and individual processes to teaching. An important component of teaching 
is imparting and sharing knowledge, but this alone is seldom enough to elicit a change 
in thinking or behaviours (Wills and McEwen, 2011). Knowledge is always in a state of 
flux, changing with experiences. Therefore as work changes, so does our knowledge 
(McKenna and Slevin, 2011).  
There are numerous theories about knowledge and practice, how we learn complex 
skills, as well as theories specific to how nurses gain and use their knowledge. There 
are too many theories to consider them all within the remit of this thesis. Therefore, an 
overview will be given of two nursing theories that were deemed to be potentially 
relevant as they explore how knowledge influences practice.   
Kerlinger and Lee (1986) theorise a hierarchy to knowledge with a positivist view that 
empirical evidence is required to provide certainty on whether something is true, but 
knowledge is also gained through tenacity, authority and a priori. Knowing through 
tenacity is knowing something because it has always been believed to be true, for 
example, regardless of the research evidence, nursing staff may consider that 
repositioning is the best way to prevent pressure ulcers. Knowing through authority is 
because an authoritative person, such as the Ward Manager or the TVNS, has said 
you must offload the heels to prevent heel pressure ulcers. Knowing through a priori is 
knowing something because reason tells you it is true, for example it is reasonable to 
assume that floating the heels will reduce the pressure ulcer risk as pressure has been 
removed.  
By way of contrast, as most nurses work amongst teams whether it is on a ward, 
department, or a service, factors that influence nursing knowledge as part of a team, or 
‘community’ also needs to be considered.  A community of practice is a model of 





and the world (Wenger, 2010). In this theory nurses collaborate amongst their peers, 
with individuals working to a common purpose, defined by knowledge rather than the 
task (Andrew et al., 2008). Central to this theory is the belief that individuals are 
motivated to join a community of practice to develop a sense of identity and belonging. 
In an acute setting, through this act of engagement and collaboration, learning occurs 
and evolves over time to gain the knowledge and skills to become a proficient member 
of the nursing team (Ellingson, 2003, Andrew et al., 2008). 
2.4 Discussion 
This chapter has given an overview of the different devices and methods that can be 
used with the aim of preventing heel pressure ulcers, as well as considering how 
nurses knowledge of pressure ulcer prevention might influence practice.  The gaps in 
knowledge illustrated in this chapter led to the aim of this thesis; to explore the use of 
devices in the prevention of heel pressure ulcers, both in terms of their clinical 
effectiveness but also how they are used and perceived in clinical practice.    
When a new product is brought out, evidence for their use tend to be clinical 
evaluations led by the developers, which are often small in scale, underpowered with 
no comparator group or adequate allocation concealment which can lead to misleading 
results. Currently there is a lack of good quality evidence for robust recommendations 
to be made. 
International guidelines state the heel should be free from pressure where possible 
(EPUAP et al., 2019), therefore it could be argued that any device that completely 
offloads the heel should be best practice; especially when experimental studies like 
Pinzur et al. (1991) demonstrate that offloading devices can lead to no pressure at the 
heel. Unfortunately, studies like these do not account for confounding factors such as 
whether the device is applied correctly, that it stays in place, length of time being worn, 
and whether there are any adverse events from their use such as increase in pressure 
to other body sites.  This chapter has also demonstrated that there are numerous 
different types of devices, made of different materials and which will fit differently. A lot 
of the trials are more than 20 years old, and therefore the design of the devices could 
have changed over this period.  They also often use healthy volunteers so there is no 
risk factor analysis, and they only look at one aspect of the products effectiveness over 
a short period. Therefore, clinical trials are necessary to evaluate a product, as this will 






A systematic review is a method of secondary research that aims to identify, appraise 
and synthesise research-based evidence related to a specific research question and 
present it in a systematic manner that allows it to be accessible to all (Green et al., 
2011).  Pawson et al. (2005) criticises systematic reviews stating that they provide little 
evidence on how and why an intervention works in different contexts or circumstances. 
However, it was felt that the most comprehensive and objective way to appraise the 
current evidence base with regards to the relative effects of the different device types 
available for the prevention of heel pressure ulcers is by performing a systematic 
review (Liberati et al., 2009).  
2.5 Summary 
This chapter has presented the different strategies available to help identify whether an 
individual is at risk of developing a pressure ulcer, and the preventative care including 
devices that can be used to prevent heel pressure ulcers. When repositioning is 
insufficient or cannot be achieved, additional interventions are often sought in the form 
of a device, which can vary from a mattress to a dressing.  However, the evidence with 
regards to which device is the most effective is sparse.  
The following chapter will present a systematic review that will present the current 
evidence with regards to the different devices presented in this chapter in their 







Chapter 3 Devices for the prevention of heel pressure ulcers: a 
systematic review 
3.1 Introduction 
Chapter 2 presented the different devices available aimed at preventing heel pressure 
ulcers from developing, however there is a lack of evidence with regards to their 
effectiveness. A systematic review of the evidence of effectiveness of devices used for 
the prevention of heel pressure ulcers will be presented in this chapter. The chapter will 
begin with a rationale for carrying out a systematic review and why this was done 
utilising the Cochrane format. It will then go on to describe the research design, how 
studies were identified and appraised with regards to their quality and risk of bias using 
the GRADE approach. The findings are then summarised and based on these, 
recommendations for clinical practice and future research are presented. 
This chapter is presented using The Preferred Reporting Items for Systematic Reviews 
and Meta-analysis (PRISMA) format, a universally recognised quality standard for 
reporting systematic reviews (Liberati et al., 2009).  
3.1.1 Research Question 
What are the relative effects of different pressure-relieving devices in the prevention of 
heel pressure ulcers? 
3.1.2 Rationale 
It has been established in Chapter 2 that there are numerous approaches to reducing 
heel pressure ulcer risk. When a new device is brought out, the evidence provided 
tends to be clinical evaluations, led, or funded by the developers. These are often 
small, underpowered and with no comparator group or adequate allocation 
concealment, which can lead to misleading results. Therefore, by evaluating the 
existing evidence base for devices that aim to prevent heel pressure ulcers, and where 
possible combine in a meta-analysis to address low power, will answer the research 
question.  
It is also important to consider whether heel-specific devices increase the risk of 
developing pressure ulcers to other body sites, as it has been shown that by elevating 
the leg there pressures to the sacral region increase (Al-Majid et al., 2017). Devices 
applied to the feet could also affect independent movement of the patient which could 





devices both heel and non-heel body sites should be evaluated separately to see if 
harm and effectiveness are related. 
3.1.2.1 Existing evidence base 
As discussed in Chapter 1, there is a small surface area to the posterior heel, along 
with the small volume of subcutaneous tissue, meaning that mechanical loads are 
transmitted directly angular to the bone; making it more challenging for pressure 
redistributing devices to redistribute the load (EPUAP et al., 2019), and therefore 
support surfaces could be less effective at preventing heel pressure ulcers in 
comparison to other body sites.  
A previous Cochrane systematic review was looking at evidence for support surfaces 
(mattresses, mattress overlays, limb protectors and cushions) for the prevention of 
pressure ulcers (McInnes et al., 2015). The data analyses were not specific by body 
site and so it remains unclear if these devices are effective in specifically preventing 
heel pressure ulcers. Mattress trials tend to focus on whether they reduce the 
incidence of all pressure ulcers, but it is also important to know if they are effective at 
preventing heel pressure ulcers, or if additional interventions are also required. It is 
therefore necessary to do a systematic review focusing on devices for the prevention of 
heel pressure ulcers and update the searches following the McInnes et al. (2015) 
review.  
McInnes et al. (2015) identified three studies that looked at heel-specific devices 
(Donnelly et al., 2011, Gilcreast et al., 2005, Tymec et al., 1997) but due to risk of bias 
and unclear reporting a meta-analysis could not be performed. A review by Nicosia et 
al. (2007) looking at pressure relieving surfaces on the prevention of heel pressure 
ulcers did include a robust search strategy and performed a meta-analysis. They found 
14 randomised controlled trials (RCTs); 2 heel protection device trials and 12 mattress 
or overlay trials. Methodological quality of the included RCTs were assessed using 
PEDro (Maher et al., 2003) and Jadad scales (Clark et al., 1999), but these results 
were not considered when performing the meta-analyses.  They found that foam 
mattresses were associated with a lower risk of heel pressure ulcer development 
compared with a standard hospital mattress, but no evidence of a difference was found 
with air mattresses compared with a standard hospital mattress. No meta-analysis was 
performed for the heel protection devices and no explanation is provided, but it is 
assumed that this is because there was no standard comparator. Due to the age of this 





Two reviews described as systematic were also found; the first looking at pressure 
redistributing support surfaces and heel protection devices for the prevention of heel 
pressure ulcers (Junkin and Gray, 2009) and the second looked just at heel elevation 
devices (Clegg and Palfreyman, 2014). Neither of these studies used a robust search 
strategy, performed a meta-analysis, or a quality appraisal of the evidence, therefore all 
recommendations are made based on the results presented by the RCT authors.  
Newer devices also need to be considered, such as Parafricta® Booties which work 
through reducing the development and progression of skin damage caused by friction 
and shear, however there is insufficient evidence of effectiveness (Meads et al., 2016). 
Dressings could also be viewed as a device that can potentially reduce the effects of 
friction and shear at the heel. In a systematic review by Moore and Webster (2018) it 
was found that silicone foam dressings may reduce the incidence of pressure ulcers, 
although there was a low level of evidence certainty due to included trials being 
imprecise or at risk of bias. This review did not report body site of pressure ulcer 
development so the effectiveness of dressings for the prevention of heel pressure 
ulcers remains unknown, therefore further research is required. 
3.1.3 Objectives  
To determine the relative effects of different pressure relieving devices for the 
prevention of heel pressure ulcers. All randomised controlled trials that assessed 
efficacy of devices for the prevention of heel pressure ulcers compared to other 
devices, no intervention, or standard care, in participants of any age in any care setting 
were included.  
3.2 Methods 
3.2.1 Protocol 
The protocol was written using guidance from the Cochrane Handbook (Higgins and 
Green, 2011a) and peer reviewed, approved and published through the Cochrane 
Library (Greenwood et al., 2014). 
A protocol ensures that a systematic review is carefully planned and documented 
before the review starts (Moher et al., 2015). The benefits of publishing a protocol prior 
to the systematic review being performed is that it increases the integrity and 
transparency of the research and there is greater consistency and accountability 






3.2.2 Eligibility Criteria 
3.2.2.1 Types of studies 
Because this review addresses the effectiveness of an intervention, it was decided to 
only include randomised controlled trials (RCTs) that compared the effects of different 
pressure relieving or reducing devices on the incidence of new heel pressure ulcers. 
Provided that trials are of sufficient size, randomisation should ensure that participants 
in each group are similar with respect to both known and unknown prognostic factors. 
Therefore any difference found between the groups can, in principle, be ascribed to the 
causal effect of the intervention (Higgins et al., 2011a).  Non-randomised trials have 
been seen to produce effect estimates that indicate more extreme benefits of an 
intervention compared with randomised trials, although it is difficult to predict the extent 
or direction of the bias (O’Connor et al., 2011).  
RCTs focusing specifically on pressure-relieving or reducing devices in the prevention 
of diabetic foot ulcers were included if heel pressure ulcer data could be identified 
separately. Similarly, RCTs that compared the effects of pressure-relieving or reducing 
devices non-specific to the heel (e.g., mattresses) were included as long as they 
intended to redistribute or reduce pressure at the heel, and heel pressure ulcer data 
could be identified separately. 
Cluster randomised trials were allowed, but in order to minimise the risk of a unit-of-
analysis error (Whiting-O'Keefe et al., 1984) the participant would be adjusted for in the 
cluster as the unit of analysis (Higgins et al., 2011b). Cross-over randomised trials 
were also included.  
3.2.2.2 Types of participants 
People of any age in any care setting without a pre-existing Category 2 (or worse) heel 
pressure ulcer who were at any level of risk for developing a pressure ulcer were 
included.  
3.2.2.3 Types of interventions 
Any device or intervention designed either to offload or reduce pressure, friction and 
shear, or all at the heel were considered. These could be used alone or in combination. 
The following interventions, as described in more detail in Chapter 2, were included 
and could be compared with each other, with no intervention, or with standard care. 






• Total body AP devices 
• Total body CLP devices 
• Heel-specific offloading devices 
• Heel-specific CLP devices 
• Heel-specific low friction devices 
3.2.3 Outcome measures 
There are several different grading systems used to determine the severity of a 
pressure ulcer. For the purpose of this review, all outcomes were converted to the 
EPUAP/NPIAP grading system as this is internationally recognised (EPUAP et al., 
2019) (Table 3-1). 








































































































































0 0 0 0/1 0 0 0 0 0/1 
1 1 1 2a 1 1 1 1 2 
2 2 2 2b/3 2 2 2 2 3 
3 3 3 4 - 3 3 3 4 
4 - 4 /5 5 - 4 4 4 5 
Unstageable 4 - - 3/4 - - - - 
DTI - - - - - - - 4 
Granulating 
wound 
5  - - - - - - - 
3.2.3.1 Primary outcomes  
In pressure ulcer prevention trials, the main outcome of interest is both the presence of 
any pressure ulcer and the severity, identified by the grade/category of the ulcer. 
Ideally, any measurements taken in a clinical trial should be precise and reproducible 
to eliminate observer variation (Pocock, 2013) however, pressure ulcer prevention trials 
 
1 Operational definitions recommended by the Agency for Health Care Policy and 
Research (AHCPR) 






rely on the knowledge and experience of the practitioner to accurately classify the 
wound. Category 1 pressure ulcers (non-blanching erythema) can get confused with 
hyperaemia, be difficult to assess in individuals with dark skin tones or 
hyperpigmentation and can also be difficult to differentiate between moisture 
associated skin damage (Defloor and Grypdonck, 2004, Defloor et al., 2006, 
Vanderwee et al., 2007a). The main methods to diagnose a Category 1 pressure ulcer 
are either through the ‘finger method’; using a finger to press on an area and check if 
the skin blanches, or the ‘disc method’; using a clear plastic disc that can be pressed 
over the area to see if the skin blanches, which has been seen to be a more reliable 
method (Defloor et al., 2006, Vanderwee et al., 2006). Unfortunately, it is rarely 
reported which method was used. 
Category 1 pressure ulcers are the most common and including any Category will 
increase power and therefore impact the sample size required for a trial. Category 1 
pressure ulcers are associated with an increased risk of subsequent pressure ulcer 
development (Nixon et al., 2007); therefore are a clinically relevant outcome.  
The primary outcomes for this review were: 
• Heel pressure ulcer incidence, defined as the number of people who developed 
a new heel pressure ulcer of any category 
• The number of new heel pressure ulcers that developed 
• Category of any new pressure ulcer (grading system should be specified) 
• Deterioration of pre-existing Category 1 pressure ulcer 
3.2.3.2 Secondary outcomes  
It is unknown how long it takes for a pressure ulcer to develop as there are several 
different factors that can influence an individual’s tissue tolerance to the effects of 
pressure (Gefen, 2008, Coleman et al., 2013). Time to the development of a heel 
pressure ulcer (including time-to-development of each grade) is a relevant outcome, as 
if one group has a significantly longer time to pressure ulcer development then this is a 
risk reduction.  
Other relevant outcomes that can influence how the devices are used in practice were 
included: 
• Cost of the intervention  






• Acceptability of the intervention with respect to comfort (from the perspective of 
the participant, or caregiver)  
• Quality of life as measured by a validated scale (e.g. SF-36, PUQoL) (Gorecki 
et al., 2013, Ware, 2000)  
3.2.3.3 Adverse events 
Adverse events were recorded as it is important to know about any potential harms that 
could occur from the devices. For the heel-specific devices, where information was 
provided regarding development of new pressure ulcers at sites adjacent to the device, 
or to the sacrum, this would be reported as a potential adverse event. 
3.2.4 Search 
It is essential when performing a systematic review to develop an explicit and 
meticulous search strategy in order that all relevant papers are identified. The search 
strategy was developed by amalgamating strategies used in other systematic reviews 
of pressure relieving devices alongside terms identified by the researcher, minimising 
the likelihood of leaving out relevant terms. 
For the heel-specific devices, terms used by manufacturers or found in the literature 
were included. Terms used to identify RCTs were those used by the Cochrane Wounds 
Group (Cochrane Work, 2019). The strategy was developed by the researcher in 
collaboration with the supervisory team (JN/EM/EAN) and was approved by Cochrane 
as part of the protocol submission (Appendix A Search Strategy). It was run by a 
member of the Cochrane Wounds Group; the most recent updated search was 
performed on 25th April 2016. No restrictions were placed in terms of language or year 
of publication.  
3.2.4.1 Databases 
The following databases were searched: The Cochrane Wounds Specialised Register; 
The Cochrane Central Register of Controlled Trials (CENTRAL); Ovid MEDLINE (1946 
to 25 April 2016); Ovid MEDLINE (In-Process & Other Non-Indexed Citations); Ovid 
EMBASE (1974 to 25 April 2016); EBSCO CINAHL Plus (1937 to 25 April 2016). The 
following clinical trials registries were also searched to identify ongoing and 
unpublished studies that related to "pressure ulcer " using a full text search: 
• ClinicalTrials.gov (http://www.clinicaltrials.gov/) 






• EU Clinical Trials Register (https://www.clinicaltrialsregister.eu/index.html) 
3.2.4.2 Other resources 
The bibliographies of all retrieved and relevant publications identified by these 
strategies were searched for further studies. Experts in the field were contacted and 
asked if they were involved in or knew of any studies relevant to this review. 
Manufacturers of devices used in the prevention of heel pressure ulcers were 
contacted and asked for information relevant to this review (Frontier Medical Group, 
DM Systems, Posey, Covidien, Sundance Solutions, Smith & Nephew, Spenco). 
3.2.4.3 Study selection 
There is the potential for bias to be introduced during the study selection process. Even 
with a protocol that contains clear and precise inclusion criteria, there is the potential 
for human error and subjectivity; where the reviewers knowledge and understanding (or 
lack of) of the area being reviewed can influence the selection process (McDonagh et 
al., 2013). It is not possible to completely remove this bias, as it is a subjective process, 
but to minimise this it was done independently by the researcher and supervisor (EM) 
in two phases. First the titles and abstracts of studies identified by the search strategy 
were assessed against the eligibility criteria for inclusion in the review. Full versions of 
potentially relevant studies were then screened against the inclusion criteria. Any 
differences in opinion were discussed with JN/EAN until consensus was met.  
3.2.5 Data collection process 
A data extraction form was developed and piloted prior to the screening process. The 
researcher and supervisor (EM) extracted data from eligible studies independently. If 
there was any disagreement during the extraction process, this was resolved by 
consensus during supervision meetings. Where possible study authors were contacted 
to obtain any missing data. 
3.2.5.1 Data Items 
The following information was collected: 
• author, title, date of study and source 
• participant inclusion/exclusion criteria 
• participant characteristics (e.g., age, sex, diagnosis, comorbidity, baseline risk, 
details of existing ulcers) 
• care setting 





• description of interventions 
• description of any co-interventions 
• duration of intervention (e.g., mean length of time on the support surface or 
wearing a heel-specific device over a 24-hour period) and length of time 
intervention took place (e.g., 2 weeks or until discharge) 
• sample size calculation and sample size 
• method of randomisation 
• number of participants randomised into each arm 
• allocation concealment 
• blinding (of the participant/outcome assessor) 
• outcome measures 
• length of follow-up 
• dropout rates and loss to follow-up 
• results 
• length of hospital stay 
• intention-to-treat (ITT) analysis 
• conclusions, as reported by the study authors. 
3.2.6 Risk of bias assessment of individual studies 
Bias is defined as a ‘systematic error or deviation from the truth in results’, meaning 
that multiple replications of the same study, on average, would reach the wrong answer 
(Boutron et al., 2019). Biases can occur in the design, conduct, analysis or reporting of 
a trial and can lead to under-estimation or over-estimation of the true intervention 
effect. The magnitude of the bias can also vary from small and trivial, compared with 
the observed effect, to substantial where an apparent finding may be entirely due to 
bias (Boutron et al., 2019).  
Independently the researcher and supervisor (EM) assessed each included study using 
the Cochrane Collaboration tool for assessing risk of bias (Higgins et al., 2011a) and a 
'Risk of bias' table were completed for each eligible study which addresses seven 
specific domains; sequence generation, allocation concealment, blinding of participants 
and personnel, blinding of outcome assessors, incomplete outcome data, selective 
outcome reporting and other issues (e.g. extreme baseline imbalance) (Appendix B 
Risk of bias tables). Blinding and completeness of outcome data were assessed for 
each outcome separately using the criteria set out in the Cochrane handbook (Higgins 
et al., 2011a). Trials were classified as being at high risk of bias if they were rated ’high’ 





and blinded outcome assessment. Where there was a high risk of bias in any of these 
key domains, an attempt was made to contact the trial authors. Where contact details 
were available, open-ended questions were asked about the design and conduct of the 
study. However, not enough information was gained from any of the authors contacted 
to change the initial assessment of bias. 
3.2.7 Summary measures 
Where possible, all outcomes were reported using 95% confidence intervals (CI). For 
dichotomous outcomes risk ratios were calculated. For continuous outcomes, where 
the outcome measures were measured using the same scale, mean difference was 
calculated. Standardised mean difference (SMD) was used as a summary statistic in 
meta-analysis when studies assessed the same outcome, but measured it in a variety 
of ways (Deeks et al., 2011). Time-to-event outcomes (i.e. time-to-ulceration) were 
measured using the appropriate analytical method, as long as the individual time points 
were known for all participants (Deeks et al., 2011). If hazard ratios were reported, we 
had planned to extract and include in a forest plot or meta-analysis. 
As this review is looking at heel pressure ulcer prevention, the unit of analysis could 
have been at the heel (i.e., the number of heel pressure ulcers that developed) or the 
trial participant (i.e., the number of trial participants who developed a heel pressure 
ulcer). Both are valid outcome measures; however, the unit of analysis needs to be the 
same as the unit of randomisation to avoid unit of analysis error, therefore the unit of 
analysis was the trial participant.  
3.2.8 Synthesis of results 
Studies were combined using a narrative overview and where appropriate a meta-
analysis performed. The method used to synthesise studies depended on the quality, 
design, and degree of heterogeneity of the studies. If there had been high variability in 
the clinical characteristics, methodology, treatment effect or statistical heterogeneity, it 
would be inappropriate to perform a meta-analysis. Where studies were clinically 
similar and the outcome measures comparable, quantitative data, as presented in the 
study, were entered into RevMan 5.3 (Nordic Cochrane Centre, 2014), for analysis. 
Where there was no ITT, a best-case and worst-case scenario was performed to 
assess the impact of the missing data. For dichotomous outcomes, a relative risk (RR) 
plus 95% confidence intervals (CI) would be calculated. For three-armed trials where 
there were two interventions and one control, the members of the control group were 





3.2.8.1 Risk of bias across studies 
If ten or more studies were included for meta-analysis, visual asymmetry of funnel plots 
would have been used to assess for any potential reporting or publication bias (Sterne 
et al., 2011). The study protocols, where available, were consulted in order to identify 
outcome reporting bias.  
3.2.8.2 Additional analyses 
The following subgroup analyses had been planned if sufficient data were available: 
• type of setting (community, inpatient, outpatient, operating room) 
• participants with/without diabetes 
• presence/absence of peripheral vascular disease 
• presence of Category 1 pressure ulcer at baseline 
When I² was greater than 0, the analysis was repeated using random effects model 
and sources of heterogeneity investigated using a sensitivity analysis in order to 
assess whether the findings were robust to the method used to obtain them (Higgins 
and Green, 2011b). 
3.2.9 Assessing certainty using the GRADE approach 
For systematic reviews the Grading of Recommendations Assessment, Development 
and Evaluation (GRADE) approach offers a system for rating quality of evidence and 
grading strength of recommendations (Guyatt et al., 2011). The certainty of a body of 
evidence is ‘the extent to which one can be confident that an estimate of effect or 
association is close to the quantity of specific interest’ (Schünemann et al., 2019). The 
GRADE approach considers:  
• Within and across-study risk of bias (limitations in study design and execution 
or methodological quality) 
• Inconsistency (or heterogeneity) 
• Indirectness of evidence  
• Imprecision of the effect estimates  
• Risk of publication bias  
Following each meta-analysis of primary outcome measures, the GRADE assessment 








3.3.1 Study selection 
A PRISMA flowchart (Figure 3-1) was completed to demonstrate the number of 
citations retrieved through each search method and the number excluded at each 
stage (Liberati et al., 2009, Moher et al., 2009). One hundred and four citations were 
retrieved in full for detailed assessment and thirty-five citations were found that related 
to twenty-nine eligible studies for inclusion in the review. Published protocols were 
found for only three of the included studies (Bååth et al., 2016, Nixon et al., 1998, 
Nixon et al., 2006b). No eligible studies were obtained from the 12 companies that 
were contacted. Thirteen authors were contacted to see if they had further information 
and three responded with sufficient data for inclusion (Nixon et al., 1998, Santamaria et 
al., 2013, Torra i Bou et al., 2002). In total 69 citations relating to 63 studies were 
excluded from the review (Figure 3-1). 
Where there were multiple citations for a single study these were grouped together and 
presented under the reference for the citation that has most of the results.  
3.3.2 Study Characteristics 
Table 3-2 illustrates the characteristics of the 29 studies (8770 participants) that met 
the inclusion criteria. The median sample size was 140 (range 32 to 1971) and only 15 
of the studies included an a priori sample size estimate. The standard of reporting 
varied amongst the studies.  
3.3.2.1 Participants 
All participants were included in the trials because they had been assessed as at risk 
for developing a pressure ulcer.  Twenty four studies had a mean age >60 compared 
with three studies <60 (Table 3-2), two of which had a mean age <41 years, the 
population consisted of people with a chronic neurological disease (Conine et al., 1990, 
Daechsel and Conine, 1985). The mean age for ten studies was >80 years; in keeping 
with age being a known risk factor for pressure ulcer development (Coleman et al., 
2013).  
3.3.2.2 Interventions 
Nineteen studies evaluated total body devices, four heel-specific offloading devices, 
and four heel-specific CLP devices (three of which were dressings trials), one trial that 






Figure 3-1 PRISMA flowchart (adapted from Moher et al. (2009)) 
 
3.3.2.3 Primary outcomes 
Nine different pressure ulcer classification scales were used across the included 
studies (Table 3-1). For the purpose of the meta-analysis, where possible all results 
were converted to the EPUAP/NPIAP/PPPIA classification scale (EPUAP et al., 2019). 
Different outcomes were used with some studies reporting Category 1 or above and 
others reporting Category 2 or above pressure ulcers (Table 3-2).  
3.3.2.4 Secondary outcomes 
None of the trials reported quality of life. Ten studies reported time-to-pressure ulcer 
development, of which two studies reported median days (Berthe et al., 2007, Demarre 
et al., 2012), three studies reported mean days (Cadue et al., 2008, Takala et al., 1996, 
Tymec et al., 1997) and five studies reported Kaplan-Meier survival analysis (Donnelly 
et al., 2011, McGowan et al., 2000, Nixon et al., 2006b, Santamaria et al., 2013, 







Table 3-2 Characteristics of included studies 
Study Care 
setting 
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Figure 3-3 Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included
53 
   
  
3.3.3 Risk of bias within studies 
Risk of bias for each study was considered using the Cochrane tool for assessing risk 
of bias (Higgins et al., 2016) and the tables for the individual studies are presented in 
Appendix B Risk of bias tables with the summary and graph presented in Figure 3-2 
and Figure 3-3. The risk of bias tables were used to help judge the GRADE 
assessments that follows each comparison (Guyatt et al., 2011). 
Where there were high or unclear risk of bias in any of the domains, or missing 
outcome data, the study authors were contacted for clarification about the design and 
conduct of their study. Contact details were found for 18 studies, and 11 authors 
responded providing additional information about the conduct of their studies (Bååth et 
al., 2016, Cadue et al., 2008, Campbell et al., 2010, Cavicchioli and Carella, 2007, 
Nixon et al., 1998, Santamaria et al., 2013, Takala et al., 1996, Torra i Bou et al., 2002, 
Van Leen et al., 2013, Van Leen et al., 2011, Vanderwee et al., 2005). Only one of the 
studies was deemed to be at low risk of bias for all areas (Nixon et al., 1998). 
One study was assessed as high risk of bias as it did not state the method of 
randomisation, and changed the randomisation ratio following an interim analysis which 
found that high risk participants were more often assigned to one arm so modified the 
randomisation in favour of the other arm (Berthe et al., 2007). Seven studies were 
classed as having an unclear risk of bias as they did not describe randomisation 
method (Conine et al., 1990, Daechsel and Conine, 1985, Gray and Smith, 2000, 
Gunningberg et al., 2000, Hofman et al., 1994, Russell and Lichtenstein, 2000, Torra i 
Bou et al., 2002). The remaining 21 studies were assessed as low risk of bias for 
randomisation. Only 12 of the 29 included studies gave information that indicated that 
participants were allocated with concealment. 
3.3.3.1 Incomplete outcome data (attrition bias) 
The completeness of outcome data for each main outcome in each study was 
examined, including whether reasons for attrition or exclusion were reported; whether 
there was re-inclusion of participants; and if the numbers in each intervention group 
were reported compared with total number of randomised participants. Ten studies 
were assessed as high risk of bias as they did not adequately address incomplete 
outcome data or include an ITT analysis, and one study stated that they conducted an 
ITT, however it is not a true ITT (Russell and Lichtenstein, 2000). Three studies were 
assessed as unclear risk of bias as they did not report this or it was unclear if there 





Tymec et al., 1997). The remaining 16 studies were assessed as at low risk of attrition 
bias. 
3.3.3.2 Selective reporting (reporting bias) 
Whilst all studies were assessed as low risk, this was not based upon inspection of 
study protocols for all studies, but on the study reports.  The study protocols were only 
available for three of the studies (Bååth et al., 2016, Nixon et al., 1998, Nixon et al., 
2006b). Judgement for the remaining studies were made based on the reporting of 
outcomes in the results that were described in the methods. Funnel plots could not be 
performed to assess for publication bias as fewer than 10 studies were included in 
each meta-analysis (Higgins et al., 2019). 
3.3.3.3 Other potential sources of bias 
Baseline characteristics of the included studies were assessed for risk of bias. Two 
studies were assessed as unknown risk as minimal baseline demographics were 
provided (Campbell et al., 2010, Gilcreast et al., 2005). Hofman et al. (1994) was 
assessed as unknown risk of bias because although age and length of hospital stay 
were similar, sex and fracture type were not similar at baseline, although sex is not a 
risk factor for pressure ulcer development (Coleman et al., 2013), it is not known if 
patients with different fracture types are more at risk. Torra i Bou et al. (2002) was also 
at unknown risk of bias because the two groups were comparable at baseline "once the 
inclusion of patients with diabetes was rejected", when diabetes is a known risk factor 
(Coleman et al., 2013). 
Due to most of the studies being at unknown or high risk of bias for at least one factor, 
it was not possible to perform a sensitivity analysis. Risk of bias was not used to weight 
the studies in the comparisons; all included studies were used in the analysis 
regardless of methodological flaws. However, methodological quality is discussed in 
relation to the interpretation of the results. 
3.3.4 Results of individual studies 
Details of the individual studies and results are presented in Table 3-2. The main 
outcome of interest for this review was heel pressure ulcer incidence, however some 
trials reported this as the number of participants who developed a heel pressure ulcer, 
and some reported it as the total number of heel pressure ulcers that developed. This 
is problematic for meta-analysis as it cannot be assumed that each participant has two 





(Hirji and Fagerland, 2009) as it is the person that is randomised, but multiple body 
sites are at risk.  
3.3.5 Synthesis of results 
3.3.5.1 Total body AP devices (9 trials) 
There is a wide variety of AP devices available including replacement mattresses and 
mattress overlays. The devices can vary by the number and size of the cells, layers of 
cells and cell cycle time, which is not always reported in RCTs. The control used for 
some of the total body device trials was the "standard hospital mattress". There is no 
international definition of what constitutes a standard hospital mattress, which can 
change between countries, hospitals and over time as technologies change. Therefore, 
in this review a standard hospital mattress is assumed to be a low-tech foam mattress 
that is used as part of standard care practices. 
Comparison 1: AP compared with standard hospital mattress (3 trials; 413 
participants) 
This comparison included three studies (Matsui et al., 2001, Russell and Lichtenstein, 
2000, Sanada et al., 2003) which compared any type of AP mattress, with a variety of 
cell depths and cell-cycle times with a standard hospital mattress for the prevention of 
pressure ulcers in a mixture of acute and extended care settings. 
Primary outcome: heel pressure ulcer incidence, Category 1 (or equivalent) or 
above 
Russell and Lichtenstein (2000) compared a multi-cell pulsating dynamic mattress with 
a standard hospital mattress. No participants in the AP group developed a heel 
pressure ulcer, and one participant in the standard hospital mattress group developed 
a Category 3 heel pressure ulcer. However, this person was randomised to the AP 
group, but due to a change in the operating room schedule was placed on conventional 
treatment, therefore was reassigned to the standard hospital mattress group in the 
original publication’s analysis. Only participants with a minimum of three days 
observation were included in their ITT. The results presented in the meta-analysis are 
as per the results presented in the study, but Two three-armed RCTs compared a 
double layered air-cell overlay, a single layer air-cell overlay and a standard hospital 
mattress (Matsui et al., 2001, Sanada et al., 2003).  It was felt that the air overlays 
were homogenous enough to be pooled into a single AP group.   
Table 3-3 shows that the missing data and reporting as per ITT makes a substantial 





Two three-armed RCTs compared a double layered air-cell overlay, a single layer air-
cell overlay and a standard hospital mattress (Matsui et al., 2001, Sanada et al., 2003).  
It was felt that the air overlays were homogenous enough to be pooled into a single AP 
group.   
Table 3-3 Results for Russell and Lichtenstein (2000) including best-case and 
worst-case scenarios 





RR, Fixed 95% CI 
Presented results 0/89 1/96 RR 0.36, 95% CI 0.01 to 8.71 
Intention to treat 1/98 0/100 RR 3.06, 95% CI 0.13 to 74.23 
Best-case scenario 1/98 4/100 RR 0.26, 95% CI 0.03 to 2.24 
Worst-case scenario 10/98 0/100 RR 21.42, 95% CI 1.27 to 360.68 
 
In the protocol for both trials, it states that if participants on the standard hospital 
mattress developed any pressure ulcer, they would be transferred onto an air mattress. 
There was no ITT analysis in either of these studies, therefore the denominators are 
the numbers presented by the authors after withdrawals and attrition. Best and worst-
case scenarios were conducted to determine the impact of missing data. The use of 
best-case and worst-case scenarios had no effect on the direction of effect for the 
Matsui et al. (2001) study (Table 3-4).  
Table 3-4 Results for (Matsui et al., 2001) including best-case and worst-case 
scenarios 





RR, Fixed 95% CI 
Presented results 4/70 3/35 RR 0.67, 95% CI 0.16 to 2.82 
Best-case scenario 8/72 13/35 RR 0.65, 95% CI 0.15 to 2.74 
Worst-case scenario 10/72 13/35 RR 0.97, 95% CI 0.26 to 3.66 
 
For the Sanada et al. (2003) study the overall pooled analysis was substantially 
altered, with the best-case scenario moving the direction of the pooled estimate to 
favour the AP overlay, and the worst-case scenario moving the pooled estimate to 
favour the standard hospital mattress; demonstrating a potential impact of the missing 
data on the results of this study (Table 3-5).  
For the meta-analysis, the studies were pooled using a fixed-effects model and the 





385 participants were pooled from the three studies. There was no clear difference 
between the two groups in terms of the number of participants who developed a 
Category 1 or above heel pressure ulcer (RR 0.55, 95% CI 0.19 to 1.63; I2 = 0%) 
(Figure 3-4).  
Table 3-5 Results for Sanada et al. (2003) including best-case and worst-case 
scenarios 





RR, Fixed 95% CI 
Presented results 2/55 2/27 RR 0.42, 95% CI 0.06 to 2.80 
Best-case scenario 2/73 10/35 RR 0.10, 95% CI 0.02 to 0.41 
Worst-case scenario 20/73 2/35 RR 4.79, 95% CI 1.19 to 19.38 
 
Figure 3-4 Forest plot for AP versus standard hospital mattress for prevention of 
Category 1 or above heel pressure ulcers 
 
GRADE assessment: Very low certainty evidence; downgraded once for design & 
execution due to high risk of attrition bias for all studies and poor reporting for all 
studies; downgraded once for imprecision due to small sample size and wide 95% CI 
that crossed the line of no effect.  
Primary outcome: heel pressure ulcer incidence, Category 2 (or equivalent) or 
above 
A total of 306 participants were pooled from the two different AP groups (Russell and 
Lichtenstein, 2000, Sanada et al., 2003). No clear difference was seen between AP 
and standard hospital mattresses in the prevention of Category 2 or above heel 
pressure ulcers (RR 0.28, 95% CI 0.04 to 1.87; I2 = 0%) (Figure 3-5).  
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 Figure 3-5 Forest plot for AP versus standard hospital mattress for prevention of 
Category 2 or above heel pressure ulcers 
 
GRADE assessment: Very low certainty evidence; downgraded once for design & 
execution due to high risk of attrition bias for all studies and poor reporting for all 
studies; downgraded once for imprecision due to small sample size and wide 95% CI 
that crossed no effect. 
Secondary outcome: Adverse events 
Russell and Lichtenstein (2000) reported that approximately half of all participants 
experienced adverse events (no difference between groups), but all were related to the 
participant's condition and none were attributable to the surface. 
Comparison 2: AP compared with CLP mattress (4 trials; 806 participants) 
This comparison includes four studies which compared any type of AP mattress, with 
any type of CLP mattress (Cavicchioli and Carella, 2007, Conine et al., 1990, Daechsel 
and Conine, 1985, Vanderwee et al., 2005). These studies took place in a mixture of 
acute and extended care settings. 
Primary outcome: heel pressure ulcer incidence: Category 1 (or equivalent) or 
above  
Two trials compared AP air overlays with CLP static overlays (Conine et al., 1990, 
Daechsel and Conine, 1985). It has not been possible to pool the results as the Conine 
et al. (1990) trial as it gives the total number of heel pressure ulcers: In the AP group 
39/72 participants developed a total of 133 pressure ulcers, 19 of which were on the 
heel, and in the CLP group 45/76 developed a total of 148 pressure ulcers, 18 of which 
were on the heel. It is unclear if participants experienced more than one heel pressure 
ulcer, and if this were the case then a unit of analysis error would occur as the unit of 
randomisation, the person, should be the unit of analysis, unless adjusted analyses are 
prepared to take account of clustering. There was no ITT analysis performed in this 
trial, with the results for the 39 randomised participants who dropped out not included 





Daechsel and Conine (1985) reported no clear difference between the AP and CLP 
groups; RR 3.00, 95% CI 0.13 to 68.57.  
GRADE assessment: Low certainty evidence: downgraded once for design & execution 
due to poor reporting for all studies; downgraded once for imprecision due to small 
sample size and wide 95% CI that crossed the line of no effect.  
Primary outcome: heel pressure ulcer incidence Category 2 (or equivalent) or 
above 
Vanderwee et al. (2005) compared an AP overlay with no turning protocol against a 
visco-elastic foam mattress with a four hourly turning protocol. We are moderately 
certain that there is a difference in the incidence of Category 2 or above heel pressure 
ulcers in favour of AP overlays when compared to visco-elastic foam mattresses, but 
there is a possibility that it is substantially different (RR 0.32, 95% CI 0.12 to 0.85). 
GRADE assessment: Moderate certainty evidence; downgraded once for design and 
execution due to lack of blinding of participants and personnel.  
Cavicchioli and Carella (2007) is a three-armed trial but the high specification foam 
mattress arm was excluded from the analysis as participants were not randomised to 
this intervention. The analysis is therefore only concerned with the two randomised 
arms that compare an air mattress in either AP or low air loss (CLP air) mode. There 
was no ITT analysis in this study, therefore the denominators presented in Table 3-6 
are the numbers presented by the authors after withdrawals and attrition. Best and 
worst-case scenarios were performed to determine the impact of missing data from this 
study and found that the overall pooled analysis results were substantially altered, with 
the best-case scenario moving the direction of the pooled estimate significantly and 
substantially favour the AP intervention, and the worst-case scenario moving the 
pooled estimate to significantly favour the CLP intervention; demonstrating a potential 
impact of the missing data on the results of this trial (Table 3-6). No clear difference 
was seen between AP or CLP mattresses for prevent Category 2 or above heel 
pressure ulcers (RR 3.09, 95% CI 0.13 to 74.47). 
GRADE assessment: Very-low certainty evidence; downgraded once for design & 
execution due to high risk of attrition bias and poor reporting; downgraded once for 






Table 3-6 Results for Cavicchioli and Carella (2007) including best-case and 
worst-case scenarios 




RR, Fixed 95% CI 
Presented results 1/69 0/71 RR 3.09, 95% CI 0.13 to 74.47 
Best-case scenario 1/86 13/84 RR 0.08, 95% CI 0.01 to 0.56 
Worst-case scenario 18/86 0/84 RR 36.15, 95% CI 2.21 to 590.36 
 
These trials were put in the same comparison, but as the CLP groups differ due to 
being a CLP foam and a CLP air mattress, it was decided that they were clinically 
heterogeneous and therefore not pooled.  
Secondary outcome: Acceptability of the intervention 
Daechsel and Conine (1985) reported that participants did not indicate a particular 
preference to either type of mattress that they were assigned, although there is a lack 
of evidence of a systematic approach to this data being collected and is potentially 
subject to reporting bias. Conine et al. (1990) recorded the number of participants who 
dropped out of the trial due to discomfort, with no clear difference between the two 
groups (RR 1.18, 95% CI 0.67 to 2.08). 
GRADE assessment: Low certainty evidence: downgraded once for design & execution 
due to poor reporting for all studies; downgraded once for imprecision due to small 
sample size and wide 95% CI that crossed the line of no effect.  
Comparison 3: AP mattresses with different alternation cycles (1 trial; 610 
participants) 
This comparison includes one study which compared two different AP mattresses with 
single and multi-stage alternation cycles in an acute care setting (Demarre et al., 
2012). 
Primary outcome: heel pressure ulcer incidence Category 2 (or equivalent) or 
above 
No clear difference was found between the two groups: RR with multistage 0.64, 95% 
CI 0.18 to 2.23, versus single stage. 
GRADE assessment: Low-certainty evidence; downgraded once for design & execution 
due to high risk of performance and detection bias and poor reporting; downgraded 





Comparison 4: AP replacement mattress and AP overlay mattress (1 trial; 1972 
participants) 
This comparison includes one study which compared an AP replacement mattress with 
an AP overlay mattress in an acute care setting (Nixon et al., 2006b). 
Primary outcome: heel pressure ulcer incidence, Category 2 (or equivalent) or 
above 
No clear difference was found between the two groups: RR with AP mattress 1.05, 
95% CI 0.55 to 1.98 versus AP overlay. 
GRADE assessment: Moderate certainty evidence; downgraded once for design and 
execution due to lack of blinding of participants and personnel.  
Secondary outcome: Acceptability of the intervention 
The acceptability of the mattresses was assessed by recording the numbers of 
participants who requested to change mattresses due to comfort (Nixon et al., 2006b). 
We are moderately certain that there is a clear difference in favour of the AP 
replacement for the number of patient requested mattress changes (used as a proxy 
measure for comfort). (RR 0.81, 95% CI 0.69 to 0.97). 
Secondary outcome: Adverse events 
Nixon et al. (2006b) reported 399 adverse events for 308 participants: nine adverse 
events in eight participants were attributable to the mattress. This included four falls (all 
on the replacement mattress), four bed rails incidents for three participants (two on 
replacement mattress and one on the overlay), one case of contact dermatitis from the 
replacement mattress. Twelve adverse events were reported unrelated to the 
mattresses. 
Summary: Total body AP devices 
One meta-analysis was performed on two of the nine trials found evaluating total body 
AP devices. No clear difference was found between the AP and standard hospital 
mattresses in the prevention of heel pressure ulcers. GRADE assessment showed very 
low-quality evidence amongst these trials. We are moderately certain that AP overlays 
reduce the incidence of Category 2 or above heel pressure ulcers, but there is a 
possibility that it is substantially different, and this is based on one trial with moderate 
certainty evidence. More evidence is required to strengthen this recommendation. 
None of the trials included time-to-heel pressure ulcer development. In terms of 
acceptability of the intervention Nixon et al. (2006b) found that fewer participants 





overlay group, although the reasons why changes in mattresses were requested is not 
known. Only Nixon et al. (2006b) reported adverse events; attributing nine adverse 
events to the surface that the participant was on. No trials included quality of life as an 
outcome measure. There are not enough studies to show a difference, more trials are 
needed that look at mattresses for the prevention of heel pressure ulcers. 
3.3.5.2 Total body constant low pressure (CLP) devices (11 trials) 
There are several different products which were considered as total body CLP devices 
as described in 3.2.2.3. These were differentiated into CLP air and CLP foam 
mattresses. 
Comparison 5: High specification foam mattress compared with standard 
hospital mattress (3 trials; 1874 participants) 
This comparison includes three studies (Berthe et al., 2007, Gunningberg et al., 2000, 
Hofman et al., 1994) which compared any type of high specification foam mattress with 
a standard hospital mattress in a variety of acute care settings. 
Primary outcome: heel pressure ulcer incidence Category 1 (or equivalent) or 
above 
One trial compared a foam block mattress with a standard hospital mattress (Berthe et 
al., 2007). There was no clear difference in the heel pressure ulcer incidence between 
the mattresses; RR 1.09, 95% CI 0.18 to 6.49. 
GRADE assessment: Low certainty evidence; downgraded once for design & execution 
due to high risk of selection bias and poor reporting; downgraded once for imprecision 
due to wide 95% CI that crossed the line of no effect.  
Primary outcome: heel pressure ulcer incidence Category 2 (or equivalent) or 
above 
There was no ITT analysis for Hofman et al. (1994), therefore the denominators are the 
numbers presented by the authors after withdrawals and attrition. The Hofman et al. 
(1994) trial gives the total number of heel pressure ulcers: In the foam block mattress 
group after 2 weeks 4/17 participants developed a total of 8 pressure ulcers, 3 of which 
were on the heel, and in the standard hospital mattress group 13/19 participants 
developed a total of 18 pressure ulcers, 6 of which were on the heel. It is uncertain 
whether foam block mattresses are more effective at preventing Category 2 or above 
heel pressure ulcers than a standard hospital mattress as the certainty of the evidence 





GRADE assessment: Very low certainty evidence; downgraded twice for design & 
execution due to high risk of attrition and performance bias and poor reporting; 
downgraded once for imprecision due to small sample size.  
Gunningberg et al. (2000) compared a visco-elastic foam trolley mattress and then 
subsequent overlay to a standard trolley and standard hospital mattress. 18/119 
participants were excluded but it was unclear if this was before or after randomisation, 
therefore only complete case data are presented. The total number of heel pressure 
ulcers, rather than total number of participants that developed a heel pressure ulcer 
were presented; in the viscoelastic group they reported three heel pressure ulcers out 
of 48 participants who developed pressure ulcers; one Category 1 and two Category 2. 
In the standard hospital mattress group, they reported five heel pressure ulcers in 53 
participants: two Category 1 and three Category 2 It is uncertain whether viscoelastic 
mattress overlays are more effective at preventing Category 2 or above heel pressure 
ulcers than standard hospital mattresses as the certainty of the evidence has been 
assessed as low. 
GRADE assessment: Low certainty evidence; downgraded twice for design & 
execution due to high risk of performance bias and poor reporting. 
Due to there being a possible unit of analysis error pooling was not performed 
(Gunningberg et al., 2000, Hofman et al., 1994). 
Secondary outcome: Cost 
Only Berthe et al. (2007) reported the cost of the intervention (€70 for the foam block 
mattress), no cost comparison was provided. 
Secondary outcome: Acceptability of the intervention 
Gunningberg et al. (2000) reported no difference between the two groups for 
participants who reported that comfort was "good" or "very good" (RR 1.00, 95% CI 
0.89 to 1.13). 
Comparison 6: New versus old high specification foam mattress (1 trial; 100 
participants) 
This comparison includes one study (Gray and Smith, 2000) which compared a newer 







Primary outcome: heel pressure ulcer incidence Category 2 (or equivalent) or 
above 
No clear difference was seen between the new and old mattresses; (RR 0.33, 95% CI 
0.01 to 7.99). 
GRADE assessment: Very low certainty evidence; downgraded twice for design & 
execution due to high risk of selection bias and poor reporting; downgraded once for 
imprecision due to small sample size and wide 95% CI that crossed the line of no 
effect.  
Secondary outcome: Acceptability of the intervention 
No difference was seen between the two groups for participants who reported the 
mattress as "comfortable" or "very comfortable" (RR 1.00, 95% CI 0.90 to 1.11). 
Comparison 7: Different high specification foam mattresses (1 trial; 105 
participants) 
This comparison includes one study which compared two different types of high 
specification viscoelastic foam mattresses for the prevention of pressure ulcers in an 
acute care setting. 
Primary outcome: heel pressure ulcer incidence, category 1 (or equivalent) or 
above 
Ozyurek and Yavuz (2015) randomised 357 participants, but only participants with a 
length of stay >7days were included in the analysis (n=105). The total number of heel 
pressure ulcers that developed were reported, therefore only complete case data could 
be presented. 22/53 participants on the first high specification visco-elastic foam 
mattress developed a total of 34 ulcers, 3 of which were at the heel compared with 
23/52 participants on the second high-specification viscoelastic foam mattress who 
developed a total of 33 ulcers, 3 of which were at the heel. RR calculations were not 
performed due to a potential unit of analysis error. 
GRADE assessment: Very low-quality evidence; downgraded twice for design & 
execution due to high risk of detection, performance and attrition bias and poor 
reporting; downgraded once for imprecision due to small sample size.  
Comparison 8: Sheepskin overlay compared with standard hospital mattress (1 
trial; 297 participants) 
This comparison includes one study which compared Australian medical sheepskin 





acute care setting (McGowan et al., 2000). Some participants in the sheepskin arm 
would also receive sheepskin heel or elbow protectors depending upon the perceived 
need. 
Primary outcome: heel pressure ulcer incidence Category 1 (or equivalent) or 
above 
The total number of heel pressure ulcers that developed were reported, rather than the 
number of patients with ulcers. For the sheepskin overlay 14/155 participants 
developed a total of 21 ulcers, two of which were at the heel compared with 43/142 
participants in the standard hospital mattress group who developed a total of 72 ulcers, 
28 of which were at the heel. RR calculations were not performed due to a potential 
unit of analysis error. 
GRADE assessment: Low-quality evidence; downgraded twice for design & execution 
due to high risk of performance and detection bias and poor reporting.  
Comparison 9: Static air overlays compared with high specification foam 
mattresses (2 trials; 124 participants) 
Two trials compared static air overlays with a high specification foam mattress for the 
prevention of pressure ulcers in nursing home residents (Van Leen et al., 2013, Van 
Leen et al., 2011). 
Primary outcome: heel pressure ulcer incidence Category 2 (or equivalent) or 
above 
Van Leen et al. (2013) is a crossover trial, so only data up until the point of crossover 
were included (Greenwood et al., 2014). Data from these two studies were pooled 
using a fixed-effects model; Heterogeneity: Chi² = 0.00, df = 1 (P = 0.96); I² = 0%. 
There was no clear difference in the number of heel pressure ulcers that developed in 
the two groups (RR 0.34, 95% CI 0.07 to 1.60) (Figure 3-6). 
GRADE assessment: Low certainty evidence; downgraded once for design & execution 
due to lack blinding, downgraded once for imprecision due to small sample size and 









Figure 3-6 Forest plot comparing static air overlay with high specification foam 
mattress for the prevention of Category 2 or above heel pressure ulcers 
 
Comparison 10: Constant low-pressure air mattress compared with standard 
hospital mattress (1 trial; 40 participants) 
One trial compared a powered CLP air mattress with a standard hospital mattress in an 
acute care setting (Takala et al., 1996). 
Primary outcome: heel pressure ulcer incidence, Category 1 (or equivalent) or 
above 
No clear difference was seen between the two groups: RR 0.18 with CLP air mattress, 
95% CI 0.01 to 3.56 versus a standard hospital mattress. 
GRADE assessment: Low certainty evidence; downgraded once for design & execution 
due to high risk of detection bias and poor reporting; downgraded once for imprecision 
due to small sample size and wide 95% CI that crossed the line of no effect.  
Secondary outcome: Time-to-pressure ulcer development 
The mean number of days to the development of heel pressure ulcers was 9.5 days in 
the standard hospital mattress group. Due to the event rate of 0 in the CLP air mattress 
group a fair comparison of time-to-heel pressure ulcer development cannot be 
performed. 
Comparison 11: Specialist mattress overlay compared with visco-elastic overlay 
(1 trial; 50 participants) 
One study compared a specialist mattress overlay with a visco-elastic overlay for the 
prevention of pressure ulcers in a long-term care setting (Ricci et al., 2013). 
Primary outcome: heel pressure ulcer incidence Category 1 (or equivalent) or 
above 
No difference was seen between the surfaces with 0/25 heel pressure ulcer developing 
in the specialist mattress overlay group and 0/25 in the visco-elastic overlay group. 
GRADE assessment: Low certainty evidence; downgraded once for design & execution 





Secondary outcome: Acceptability of the intervention 
No difference was found between the two arms in terms of acceptability of the 
interventions using Global safety and tolerability scores: with all participants in both 
arms rating the overlays as either "good" or "excellent". 
Summary: Total body CLP devices 
Due to the low numbers if trials that reported heel pressure ulcers, the low quality, and 
clinical heterogeneity of the trials included in this section, only two out of the ten trials 
identified were suitable for meta-analysis (Van Leen et al., 2013, Van Leen et al., 2011) 
and the GRADE assessment showed that this to be low certainty evidence and 
therefore our confidence in the effect estimate is limited. No clear difference was found 
in any of the studies for the prevention of heel pressure ulcers. Takala et al. (1996) 
reported time-to-pressure ulcer development at the heel, but no analysis was possible 
as they had an event rate of zero in the CLP air mattress group. Four trials reported 
acceptability of the intervention; however, these are not comparable as they all use 
different methods to measure this, and none were measured using a validated scale. 
No trials reported adverse events or quality of life. 
3.3.5.3 Heel-specific devices 
A total of nine trials compared heel offloading or CLP devices with other devices or with 
standard care. 
Comparison 12: Heel-specific offloading device compared with standard care (3 
trials; 492 participants) 
Three studies were included which looked at a variety of devices designed to offload 
pressure at the heel compared with standard care in a variety of acute care settings 
(Bååth et al., 2016, Cadue et al., 2008, Donnelly et al., 2011). Standard care often 
includes mattress according to clinical need, a repositioning schedule, and a skin care 
regimen. 
Primary outcome: heel pressure ulcer incidence Category 1 (or equivalent) or 
above 
Bååth et al. (2016) randomised 405 participants in the ambulance prior to consent, but 
only 183 participants were included in the analysis as a large proportion of participants 
were not admitted to hospital or one of the wards involved in the trial. This is unlikely to 
lead to bias as the intended effect of the intervention is dependent on the participant 





The heel pressure ulcer incidence data was pooled for the three studies (Bååth et al., 
2016, Cadue et al., 2008, Donnelly et al., 2011), with a total of 492 participants, using a 
random effects model due to statistical heterogeneity (Chi² = 7.65, df = 2 (P = 0.02); I² 
= 74%) (RR 0.20, 95% CI 0.05 to 0.80 (Figure 3-7). A difference was found in favour of 
the offloading device. 
   
Figure 3-7 Forest plot for the comparison of offloading devices with standard 
care for the prevention of Category 1 or above heel pressure ulcers 
 
 
GRADE assessment: Low certainty evidence; downgraded once for design & execution 
due to lack of blinding, downgraded once for imprecision due to small sample size. The 
confidence in the effect estimate of whether offloading devices prevent Category 1 or 
above heel pressure ulcers is limited due to the quality of the evidence, the true effect 
may be substantially different from the estimate of effect.  
Primary outcome: heel pressure ulcer incidence Category 2 (or equivalent) or 
above 
Two trials included Category 2 or above outcome data (Bååth et al., 2016, Donnelly et 
al., 2011). The heel pressure ulcer incidence data were pooled, with a total of 422 
participants, using a fixed-effect model (Chi² = 0.59, df = 1(p = 0.44); I2 = 0%) (RR 0.08, 
95% CI 0.01 to 0.67) (Figure 3-8). We are moderately confident in the effect estimate of 
offloading devices preventing more Category 2 or above heel pressure ulcers 
compared to standard care. The true effect is likely to be close to the estimate of effect, 









Figure 3-8 Forest plot for the comparison of offloading devices with standard 
care for the prevention of Category 2 or above heel pressure ulcers 
 
 
GRADE assessment: Moderate certainty evidence; downgraded once for design & 
execution due to lack of blinding.  
Secondary outcome: pressure ulcer incidence to other body sites, Category 1 (or 
equivalent) or above 
A meta-analysis was performed for the two studies that reported the number of 
participants that developed a pressure ulcer to body sites other than the heel, (Cadue 
et al., 2008, Donnelly et al., 2011) using fixed effects model. No evidence of a 
difference was seen for heel offloading devices being associated with pressure ulcers 
at other body sites (RR 0.57, 95% CI 0.25 to 1.30; I2 = 0%) (Figure 3-9). 
Figure 3-9 Forest plot for Category 1 or above pressure ulcer development at 
other body sites  
 
 
GRADE assessment: Low certainty evidence; downgraded once for design & execution 
due to lack blinding, downgraded once for imprecision due to small sample size. 
Secondary outcome: Time-to-heel pressure ulcer development 
Cadue et al. (2008) recorded a mean time-to-development of Category 1 or above 
pressure ulcers of 5.6 days in the offloading group versus 2.8 days in the standard care 
group. They also reported an increase in the days that participants remained ulcer free 





Donnelly 2011 plotted Kaplan-Meier survival function and found a significant difference 
in the number of days before the development of HPUs in favour of the offloading 
group. 
GRADE assessment: Low certainty evidence; downgraded once for design & execution 
due to lack blinding, downgraded once for imprecision due to small sample size. The 
confidence in the effect estimate of whether offloading devices effect the time to 
development of Category 1 or above heel pressure ulcers is limited due to the quality of 
the evidence, the true effect may be substantially different from the estimate of effect. 
Secondary outcome: Acceptability of the intervention 
This outcome was reported in two studies (Bååth et al., 2016, Donnelly et al., 2011) but 
no comparison was possible as this was not recorded using comparable, validated 
scales. Donnelly et al. (2011) reported 88 protocol violations which were reported either 
from subjects’ comments or clinical observations as being due to the offloading device 
hindering movement, being too warm, causing pain or discomfort, or issues with the 
application/removal. Baath reported perceptions of the device from the participants, of 
the patients that were questioned, 39% felt that it caused friction and one experienced 
blistering caused by the boot straps, 48% perceived the boot as comfortable when lying 
down and 25% perceived it as comfortable when lying on their side and 63% perceived 
it as ‘okay to have on when I’m sleeping. 
GRADE assessment: Moderate certainty evidence; downgraded once for design & 
execution due to lack of blinding.  
Secondary outcome: Adverse events 
Donnelly et al. (2011) reported 45 adverse events, but only one was potentially 
attributable to the offloading device; bruising was documented to the lower limb, which 
could have been caused by the offloading device, or from when the participants legs 
were bound together by the paramedics to immobilise a fracture.  
Bååth et al. (2016) reported one adverse event in the intervention group where a 
participant "developed blistering due to the bootstraps". 
Comparison 13: Different heel offloading devices (2 trials; 124 participants) 
This comparison includes a three-armed trial comparing three different offloading 
devices; a standard pillow, an offloading boot and a wedge within an orthopaedic acute 
care setting (Campbell et al., 2010) and a two-armed trial comparing an offloading boot 





Primary outcome: heel pressure ulcer incidence Category 1 (or equivalent) or 
above 
Tymec et al. (1997) only specified that there were 52 participants, but not how many 
were in each group. They reported one patient in the pillow group developing a heel 
pressure ulcer and no patients in the offloading device group. 
For Campbell et al. (2010), the trial took place over a 14 day period, participants were 
followed until discharge, but due to the nature of the condition this was over a short 
period (exact data unknown). These trials could not be pooled due to clinical 
heterogeneity of the controls and the number of participants in each group for Tymec et 
al. (1997) was not known.  
Secondary outcome: pressure ulcers to other body sites 
Tymec et al. (1997) reported six Category 1 or above pressure ulcers that developed to 
other body sites in the offloading device group and one in the pillow group. All the 
ulcers that were reported were to the lower limb. 
Secondary outcome: Acceptability of the intervention 
Campbell et al. (2010) collected feedback from both the participants and clinical staff in 
the form of both written and verbal feedback, 18 people gave positive feedback 
regarding the pillow, 19 for the Repose and 28 for the wedge, although denominators 
are not known. 
Secondary outcome: Time to heel pressure ulcer development 
Tymec et al. (1997) reported a mean time-to-development in favour of the pillow group; 
10 days for the offloading device group compared with 13 days in the pillow group, 
although not enough data was provided to do a statistical analysis. 
Secondary outcome: Adverse events 
In the Campbell et al. (2010) trial, four participants had the hospital pillow removed as 
they had all undergone knee replacement surgery and had relatively short legs which 
led to the pillow bunching up beneath the knee which interfered with the newly replaced 
joint. One participant had the wedge removed as they had a fractured hip, and the 
wedge did not keep the leg high enough to keep the hip aligned when in traction. No 
adverse events were reported in the offloading device group.  
Tymec et al. (1997) reported higher mean interface pressures to the Achilles tendon of 
14.2mmHg (SD 15.6mmHg) in the offloading device group compared with 31.2mmHg 





Comparison 14: Heel-specific offloading devices compared with heel-specific 
CLP device (1 trial; 338 participants) 
This comparison includes a single three-armed trial comparing three different heel-
specific devices: a CLP device, an egg-crate offloading boot and an air filled offloading 
boot in an acute care setting (Gilcreast et al., 2005). 
Primary outcome: heel pressure ulcer incidence Category 1 (or equivalent) or 
above 
A total of 338 participants were randomised, but only 240 participants had complete 
data; because the trial did not specify the participant group prior to drop out only 
complete case data were presented. Double counting was avoided by members of the 
control group (CLP device) being divided for the meta-analysis. There was no clear 
difference between the CLP and offloading devices (RR 1.42, 95% CI 0.40 to 5.07) 
(Figure 3-10). 
GRADE assessment: Very low certainty evidence; downgraded twice for design & 
execution due to high risk of selection, detection, performance, and attrition bias; 
downgraded once for imprecision due to wide 95% CI that crossed the line of no effect. 
 
Figure 3-10 Forest plot for the comparison of offloading and heel CLP devices for 
the prevention of Category 1 or above heel pressure ulcers 
 
Secondary outcome: Costs 
Gilcreast et al. (2005) reported that the CLP device was significantly cheaper than the 
other interventions. This was just for the cost of the device, but they did include the 
cost of pillows as they were sometimes used with the CLP device, and the cost of 
replacement devices as they would sometimes be lost in the laundry. 
Comparison 15: Heel-specific CLP devices compared with standard care (4 trials; 
1425 participants) 
This comparison includes four studies looking at CLP heel-specific devices such as 
dressings or gel pads that aim to reduce the peak pressure or friction and shearing 





1998, Santamaria et al., 2013, Torra i Bou et al., 2002). These studies took place in a 
variety of settings including acute care, operating rooms, and home care environments. 
Primary outcome: heel pressure ulcer incidence Category 1 (or equivalent) or 
above 
Nixon et al. (1998) compared a dry visco-elastic polymer pad under the torso and heel 
to a standard operative table foam mattress in the prevention of intra-operative 
pressure ulcers. It was therefore felt that due to the difference in the intervention type, 
and the setting being in an operating theatre this trial could not be included in the meta-
analysis due to clinical heterogeneity. Additional study data were sought and obtained 
from the author as the published article does not include heel pressure ulcer incidence. 
It was therefore possible to report heel pressure ulcer incidence at the participant level 
and at the ulcer level. No clear difference was seen between the two groups (RR 0.45, 
95% CI 0.14 to 1.43).  
GRADE assessment: High certainty evidence 
Three studies compared foam heel dressings to standard care; two compared a 
polyurethane heel dressing with a classic padded bandage (Ferrer Sola et al., 2013, 
Torra i Bou et al., 2002) and one compared a multi-layered silicone foam dressing with 
standard care (Santamaria et al., 2013). The presented data for these three studies 
were pooled with a total of 833 participants; using a random-effects model (Tau² = 
1.84; Chi² = 10.98, df = 2 (P = 0.004); I² = 82%). There was no clear difference in the 
number of Category 1 or above heel pressure ulcers that developed (RR 0.30, 95% CI 
0.05 to 1.63) (Figure 3-11).  
 
Figure 3-11 Forest plot for the comparison of CLP heel devices with standard 
care for the prevention of Category 1 or above heel pressure ulcers 
 
It is likely that the source of heterogeneity is Ferrer Sola et al. (2013) where the 
direction of effect is reverse of the other studies included in this meta-analysis. There 






A best- and worst-case scenario was performed to determine the impact of missing 
data for the Torra i Bou et al. (2002) study and Santamaria et al. (2013). This was 
found to have no effect on the direction of effect for Torra i Bou et al. (2002) (Table 3-7) 
but for Santamaria et al. (2013) the worst case scenario changed the direction of effect 
towards the control group (Table 3-8). 
Table 3-7 Results for Torra i Bou et al. (2002) including best-case and worst-case 
scenarios 
 Polyurethane 
heel group (n) 
Standard 
care (n) 
RR, Fixed 95% CI 
Presented results 2/61 22/50 RR 0.07, 95% CI 0.02 to 0.30 
Best-case scenario 2/65 37/65 RR 0.05, 95% CI 0.01 to 0.22 
Worst-case scenario 6/65 22/65 RR 0.27, 95% CI 0.12 to 0.63 
Table 3-8 Results for Santamaria et al. (2013) including best-case and worst-case 
scenarios 




RR, Fixed 95% CI 
Presented results 3/161 12/152 RR 0.24, 95% CI 0.07 to 0.82 
Best-case scenario 3/219 81/221 RR 0.04, 95% CI 0.01 to 0.12 
Worst-case scenario 61/219 12/221 RR 5.13, 95% CI 2.84 to 9.25 
 
GRADE assessment: Very low certainty evidence; downgraded once for design & 
execution due to lack blinding, downgraded once for inconsistency due to high I² and 
P<0.05, downgraded once for imprecision due to small sample size and wide 95% CI 
that crossed no effect. 
Primary outcome: heel pressure ulcer incidence Category 2 (or equivalent) or 
above 
Ferrer Sola et al. (2013) was the only trial to report Category 2 or above heel pressure 
ulcers, no clear difference was seen, with 5/208 in the polyurethane heel cup group 
and 1/201 in the classic bandage group (RR 4.83, 95% CI 0.57 to 41.0). 
GRADE assessment: Very low certainty evidence; downgraded once for design & 
execution due to high risk of performance bias and poor reporting; downgraded once 







Secondary outcome: pressure ulcer incidence to other body sites, Category 1 (or 
equivalent) or above 
Ferrer Sola et al. (2013) reported no clear difference, with 3/208 in the polyurethane 
heel cup and 0/201 in the classic padded bandage group (RR 0.14, 95% CI 0.01 to 
2.66). 
GRADE assessment: Very low certainty evidence; downgraded once for design & 
execution due to high risk of performance bias and poor reporting; downgraded once 
for imprecision due wide 95% CI that crossed the line of no effect. 
Secondary outcome: Costs 
Torra i Bou et al. (2002) reported a difference between the costs of the device plus 
nursing time over an eight week period in favour of the foam heel dressing when 
compared with the protective padded bandage, although we have very little confidence 
in the effect estimate due to very-poor quality evidence (SMD -0.46, 95% CI -0.81 to -
0.11) (Torra I Bou et al., 2008). 
GRADE assessment: Very low-quality evidence; downgraded once for design & 
execution due to high risk of attrition bias and poor reporting; downgraded once for 
imprecision due small sample size. Santamaria et al. (2013) published a cost benefit 
analysis which included costs for both sacrum and heel. When the costs were 
recalculated for heel pressure ulcers only, we are moderately certain that the average 
costs per group were $55.84 per patient for intervention and $137.94 for control, but no 
adjustment was made for severity of pressure ulcer or potential patient differences.  
GRADE assessment: Moderate quality evidence; downgraded once for design & 
execution due to high risk of performance bias. 
ITT was not considered for either study. 
Secondary outcome: Relative acceptability of the intervention 
Torra i Bou et al. (2002) saw a difference in favour of the foam heel dressing when 
using a five-point scale, where 1 was the lowest value and 5 was the highest value, to 
assess the comfort of the dressing application from the perspective of the patient (SMD 
3.05, 95% CI 2.54 to 3.56) although we have very little confidence in the effect estimate 
due to very-poor quality evidence. 
GRADE assessment: Very low certainty evidence; downgraded once for design & 
execution due to high risk of attrition bias and poor reporting; downgraded once for 







Of the ten heel-specific trials identified, three trials compared heel offloading devices 
with standard care and were included in a meta-analysis, which showed that there is 
limited evidence that offloading devices reduce the risk of developing a Category 1 or 
above heel pressure ulcer due to the low quality of the evidence reducing the certainty 
of these results.  
Two trials compared heel offloading devices with standard care and were included in a 
meta-analysis, which showed that we are moderately confident that offloading devices 
reduce the risk of developing a Category 2 or above heel pressure ulcers. The 
moderate quality of evidence means the true effect is probably close to the estimated 
effect. 
Two of these studies included time-to-heel pressure ulcer development data, but they 
were reported differently hence they could not be pooled. 
Only one trial, of low quality, compared offloading devices to CLP heel-specific devices 
and no clear difference was seen. 
Four trials compared heel-specific CLP devices such as polyurethane foam heel 
dressings and gel pads with standard care; the three foam heel dressings were 
included in a meta-analysis. We are uncertain whether foam heel dressings reduce the 
incidence of Category 1 or above heel pressure ulcers as the certainty of the evidence 
has been assessed as very low due to high risk of bias, imprecision, and inconsistency.  
There is no clear evidence that heel-specific CLP devices increase or decrease the risk 
of developing a pressure ulcer to other body sites. Only Santamaria et al. (2013) 
included time-to-pressure ulcer development as an outcome measure but this was 
combined for heel and sacral ulcers and could not be separated.  
A single high-quality trial looked at the use of visco-elastic polymer pads to the heel in 
theatres, compared with a standard operating table mattress; no clear difference was 
seen in the prevention of heel pressure ulcers. 
3.4 Discussion 
Any device which could potentially be used for the prevention of heel pressure ulcers 
was included in this review, however it was rare that identical devices would be tested 
in different trials, and therefore devices had to be grouped together subjectively into 
comparisons that appeared to be homogenous based on their apparent mechanism of 
action. Since the systematic review was written, standards have been published to test 





Assistive Technology Association of North America (RESNA) (2019), and EPUAP et al. 
(2019) have published terms and definitions associated with support surfaces which 
will aid in assessing comparability for support surfaces. A recent network meta-analysis 
of mattresses, overlays, and integrated bed systems for the prevention of all pressure 
ulcers, used these definitions and identified 65 studies with 14 different intervention 
groups (Shi et al., 2018), whereas this review identified 9 different mattress types, 
which were grouped in a similar manner to Shi et al. (2018).   
There is no recognised definition or standardisation of heel-specific devices, with very 
little published early phase research into the mechanisms of action for individual 
devices. In order to obtain CE (Conformité Européene) marking, wound care products 
and devices are only required to demonstrate safety and performance. Brölmann et al. 
(2012) theorised that this leads to a reluctance from manufacturers to perform high-
quality research in an already profitable and unrestricted market for new wound care 
products. In the absence of evidence this can lead to a reliance on case reports and 
personal opinions. Without knowing the exact mechanisms through which individual 
heel-specific devices work, they were subjectively grouped by reported function: 
offloading the heel by preferentially loading another part of the foot and lower leg better 
able to tolerate the pressure; reduce the intensity of pressure to the heel through 
increasing the contact surface area; or reducing intensity of pressure and friction. 
There are a multitude of characteristics of a device that would potentially impact its 
ability to translate a theoretical beneficial effect on heel interface pressure into a 
reduction in heel pressure ulcers that include:  
• The physical characteristics of the fabric (moisture wicking performance, heat 
capacity, shear and friction, elasticity, density) 
• Different fastenings to the limb to minimise movement of the foot within the 
device, and thereby the length of time the heel remains in the offloaded 
position. However tighter straps can cause trauma when there is poor 
circulation to the limb, and one study reported higher interface pressures to the 
heel in some devices when the straps were tightened (Guin et al., 1991) 
• Positioning of the foot in the device. Some devices are designed to minimise 
foot drop or external rotation of the foot and maintain the foot in an upright 
position. The foot naturally eternally rotates when in a supine or semi-
recumbent position (Sopher et al., 2011, Tong et al., 2016), although these 
studies found differing effects of foot posture on the tissues of the heel. Sopher 





using computer modelling, whilst Tong et al. (2016) reported higher interface 
pressures when the heel foot was upright at a 90° angle to the bed  
• The size of the device in relation to the size of the limb 
• How the pressure is redistributed away from the heel to the rest of the lower 
limb 
Along with the different mechanical properties of the devices, there are numerous 
variables that can influence how offloading devices are utilised in practice that did not 
appear to be considered in the included trials, which in turn will influence the 
effectiveness of the devices along with trial concordance.  These potential confounding 
factors include: 
• Ease of application of the device could influence if it is applied properly and 
whether the heel is offloaded, in the correct position in the device, and free from 
pressure 
• The amount of time that the patient wears the device for, both in terms of hours 
during the day and number of days 
• Frequency of device removal by the patient or healthcare worker 
• If there are bandages, stockings or socks applied to the limb 
• The position of the patient in bed. Most studies that look at interface pressures 
to the heel are done with healthy volunteers in a supine position (Aquila and 
Ferretti, 1997, Flemister, 1991, Sopher et al., 2011, Tenenbaum et al., 2013), 
but in reality patients are rarely nursed in this position as head elevation is 
believed to improve breathing and minimises risk of chest infections (Niël-Weise 
et al., 2011).  Grap et al. (2016) found that backrest elevation and knee angle 
affect the pressures to the heel 
• Masaki et al. (2013) measured heel blood flow during loading and offloading in 
individuals with a normal as well as low ankle brachial pressure index (ABPI)3. 
They found that offloading for longer than 60 minutes in patients with an ABPI 
<0.80 led to a decrease in heel capillary perfusion and excessive elevation of 
the heel may decrease heel capillary perfusion (Roeder et al., 2005).  Devices 
that hyperextend the knee could also lead to an increase in DVT risk (Huber 
and Huber, 2009, Leon et al., 1992) 
 
3 The ratio of the patient's systolic blood pressure at their ankle to the systolic blood 
pressure in their arm. Those with an ABPI <0.80 are considered to have reduced 





• Movement of the patient, Grap et al. (2016) found that pressures at the heel 
increase with patient movement, which could be due to the heel being used as 
a pivot point to lift and move the rest of the body.  This could also have an 
impact of how well the device stays in position 
• Repositioning: does the limb move in the device during repositioning or does 
the device influence how the patient is positioned, the frequency the patient is 
repositioned or the patient’s ability to reposition themselves  
• Impact the device has on the shearing forces exerted on the heel during 
movement 
3.4.1 Strengths of the systematic review 
This is an original piece of research, furthering the knowledge about the use of devices 
for the prevention of heel pressure ulcers. Although there have been previous 
systematic reviews regarding the use of devices for the prevention of heel pressure 
ulcers (Clegg and Palfreyman, 2014, Junkin and Gray, 2009), neither used a robust 
search strategy or performed a meta-analysis, and this is the first to include all potential 
devices from mattresses to heel-specific devices and prophylactic dressings. The 
protocol for the review was written and published prior to being conducted (Greenwood 
et al., 2014) and the PRISMA guidelines (Moher et al., 2009) and GRADE (Guyatt et 
al., 2011) were followed during writing to ensure that the reporting of the systematic 
review was thorough, transparent and robust.  
To thoroughly review the existing evidence-base the review included a broad search 
strategy to include all devices that could be used in the prevention of heel pressure 
ulcers. Twenty-nine RCTs were included with fifteen different comparisons and nine 
meta-analyses were performed.  This was more than expected when compared to 
other systematic reviews in pressure ulcer prevention; Gillespie et al. (2014) looked at 
repositioning and identified three RCTs, two of which were pooled. No RCTs were 
found for the review by Zhang et al. (2015) looking at massage therapy and Moore and 
Webster (2018) identified 18 RCTs for their review on dressings and topical agents for 
the prevention of pressure ulcers and included 6 meta-analyses.  
To minimise publication-bias this review was not restricted by language, however due 
to translation costs alternatives were sought to allow for inclusion. A Spanish paper 
was translated by a colleague (Ferrer Sola et al., 2013) and a Japanese paper was 
translated by a friend who was learning Japanese and took it to her study group 






3.4.2 Limitations of the systematic review 
To be able to answer the review question, it was necessary for trials to include heel-
specific data. Several RCTs were excluded because they displayed their data in terms 
of "how many participants developed a pressure ulcer" but did not provide the body 
sites. It is likely that this information is not included because the aim of these trials is to 
see if there is an overall impact on pressure ulcer incidence. This can be illustrated by 
the systematic review looking at support surfaces for the prevention of pressure ulcers 
which included 59 trials, compared to only 29 in this review (McInnes et al., 2015). 
However, it is necessary to know if support surfaces affect the risk of developing a 
pressure ulcer to all body sites equally because interventions can reduce pressure at 
one site by changing the distribution of pressure, which is why it was felt this 
systematic review was necessary. It would be beneficial for future RCTs to include 
body site data by randomised group. 
Heel pressure ulcer incidence could also be presented in different ways; the total 
number of participants that developed a heel pressure ulcer or the total number of heel 
pressure ulcers that developed. The problem with the latter is that it could lead to a unit 
of analysis error as it is unknown in how many participants these heel pressure ulcers 
occurred, the assumption would have to be made that all participants had both lower 
limbs and only one pressure ulcer developed per heel; meaning that pooling was not 
possible.  
Several trials describe the control as being ‘standard care’, but this is frequently poorly 
described, and as practice moves on, so does standard care.  In the RCT by Tymec et 
al. (1997) pressure ulcers develop significantly sooner in the intervention group, 
leading to the device being redesigned. Therefore, as the devices develop and 
technology moves on, it is difficult to assess the relevance of the existing research, 
which is an ongoing issue in medical device trials (Nixon et al., 2019). This is one of the 
reasons that generic device definitions were used, and similar products pooled rather 
than comparing specific products.   
There is also a potential for publication bias, if studies of pressure relieving devices are 
sponsored by device manufacturers, results may not be published if they show no 
benefit or a negative effect. Product manufacturers and experts in the field were 
contacted to identify unpublished research; but no additional studies were identified.  In 
the absence of widespread trial registration for device related trials, it is not possible to 





Adverse events were rarely reported, this could be because pressure ulcer incidence is 
the outcome of interest, which itself is an adverse event. It is also a possibility that 
adverse event reporting in device trials is poor due to it not being valued or if 
sponsored by the manufacturers then not wanting them to be publicised. 
3.4.2.1 Dated searches 
This review was initially conducted in 2015, with an updated search included in April 
2016. Therefore, between the review being initially conducted and this thesis being 
submitted additional papers have been published, but as the analyses had already 
been conducted it would not be feasible to re-run these. It was therefore decided to re-
run the search strategy in December 2019 to determine if any additional studies had 
been published in the intervening time. Two AP versus CLP mattress trials were 
identified that also reported heel pressure ulcer rates, but the CLP devices differed; a 
static air overlay (Beeckman et al., 2019) and high risk foam (Nixon et al., 2019). These 
would have been added to comparison 2, which might have allowed for a meta-
analysis to be performed, although the comparators for these two trials are 
heterogenous. An additional two dressings trials (Santamaria et al., 2018, Hahnel et al., 
2019) along with two ongoing registered trials that are yet to be published were 
identified (Nct, 2018, Nct, 2017), although these were not found to change the results 
of comparison 15 (Greenwood et al. (2020), article in press).  
Although these would not change the results of this review, it illustrates the importance 
of updating systematic reviews as the evidence base grows.  
3.4.2.2 Quality of evidence 
The overall quality of the included evidence according to GRADE was moderate to very 
low. The majority of the studies were at high risk or unknown risk of bias for one or 
more of the key areas; only one of the trials was at low risk of bias for all assessed 
areas (Nixon et al., 1998). Twenty-eight out of twenty-nine trials were at risk of bias for 
blinding of participants and personnel. In medical device trials the intervention can be 
difficult, but not impossible to blind the participants or personnel to, such as removing 
the device prior to data collection. However, participants are often too ill to be removed 
from a support surface prior to assessment of their pressure areas, and this could be 
inconvenient and time consuming for the patient and nursing staff. Assessment of the 
outcome of a pressure ulcer requires some judgement by the assessor, which could be 
influenced by knowledge of intervention.  Some trials are trying to minimise this bias 
through the use of photography to verify skin assessments, where those who are 





However, it is still unknown how reliable photography is for differentiating between 
blanching and non-blanching erythema, especially on darker skin tones (Baumgarten et 
al., 2009). Nixon et al. (1998) were able to minimise performance bias by blinding 
participants and data collectors because their study was delivered in the operating 
theatre, an area where the data collector would not be involved, and the participant 
would be unaware of the intervention. 
Overall, the included studies were assessed using the GRADE approach as imprecise; 
many of the included trials had a small sample size and were therefore underpowered 
due to the low event rates and had wide 95% CI.  RCTs should be adequately powered 
to detect treatment effects of a specified size, should they exist. Therefore, sample size 
calculations should be used to help estimate the number of people recruited to a trial, 
however only fourteen trials (n = 14/29, 48.3%) include an a priori power calculation.  
It is necessary to use a robust tool to assess the quality and certainty of the evidence in 
a systematic review, however for medical device trials, without exploring more ways to 
blind participants or personnel, they will all be automatically downgraded when using 
the GRADE approach, and therefore will never be ‘high quality evidence’ and a 
definitive conclusion could never be found. More research is needed into better 
methods to overcome the risk of bias due to lack of blinding, along with the GRADE 
approach taking these difficulties into account when assessing trial quality.  If more 
studies followed the CONSORT statement for reporting of clinical trials (Begg et al., 
1996), this would also improve trial reporting and reduce risk of bias. 
3.5 Summary  
Due to the poor quality of the included trials, the certainty of the results reduces.  
Comparisons between heel-specific offloading devices and standard care found a 
significant difference in favour of offloading for all Categories of heel pressure ulcer. 
While the quality of evidence was low according to GRADE, when looking at the 
prevention of Category 2 or above heel pressure ulcers, one of the studies was 
excluded making the evidence moderate quality.  
This review has clearly identified the lack of evidence for both total body and heel-
specific pressure relieving devices for the prevention of heel pressure ulcers. The 
systematic review has also identified some key issues with regards to the trial design of 
both heel-specific devices; as there were issues with trial compliance, withdrawals and 






The mechanical properties of heel-specific devices and numerous variables that can 
influence how devices are utilised in practice do not appear to be considered in the 
included trials and are infrequently published as early phase research trials. The 
subsequent chapters will present a Realist Evaluation that will explore how heel-
specific devices are used in clinical practice for the prevention of heel pressure ulcers, 







Chapter 4 Identification of research question and 
methodological approach 
4.1 Introduction 
Following on from the systematic review presented in Chapter 3, although a significant 
difference was found in favour of offloading devices for all Categories of heel pressure 
ulcer, the quality of the evidence was low according to GRADE.  It therefore remains 
uncertain whether any of the devices presented in Chapter 2 are effective in the 
prevention of heel pressure ulcers. This Chapter will provide a critique of the RCT 
design for the device related trials included in the systematic review. It will then go on 
to discuss how realist evaluation was selected as the methodological approach to 
explore how offloading devices are used in clinical practice, and how knowing this 
could influence and improve future trial design. 
4.2 Research Problem 
In Chapter 3, the systematic review demonstrated that there may be a benefit to 
offloading devices in the prevention of heel pressure ulcers (both Category 1 or above 
and Category 2 or above) in patients at risk of developing a pressure ulcer, but this 
lacked certainty due to the low volume and quality of evidence. Due to insufficient and 
low-quality evidence we do not know if total body support surfaces, heel-specific CLP 
devices or heel-specific low-friction devices have an impact on the rate of development, 
or severity of pressure ulcers; it is possible that they do prevent heel pressure ulcers 
but were evaluated in a way that masks their effectiveness, or they have no significant 
effect.  
RCTs are widely regarded as the gold standard to evaluate the effectiveness of 
interventions, because of their unique study design with comparable groups which 
controls for unknown or unmeasured confounders (Lewin et al., 2009, Moore et al., 
2015a). The next logical step would therefore be to increase the existing knowledge 
base through the addition of a further good quality RCT. However, this could be 
perceived as short-sighted without first considering the learning from the previous trials, 
taking into consideration the issues that some of the existing RCTs experienced. These 
included high rates of withdrawals (Bååth et al., 2016, Donnelly et al., 2011), protocol 
violations and attrition (Donnelly et al., 2011), and low event rates (Campbell et al., 
2010, Gilcreast et al., 2005, Tymec et al., 1997).  Any further RCTs would need to 





Regardless of the evidence, from clinical experience it is known that these devices are 
already widely used in clinical practice (hence the window of opportunity to test them 
versus no device may have been missed due to adoptions prior to an evidence base); 
but we do not know how, when, and why they are implemented and used in the 
absence of a robust evidence base.  
4.2.1 Withdrawals, protocol violations and attrition 
Three of the included RCTs explored participants’ perspectives of the heel devices; 
Donnelly et al. (2011) asked structured questions to gain opinions of the heel devices 
from the perspective of the patient, but reporting of these outcomes was problematic 
due to only presenting percentages, meaning the number of participants interviewed is 
unknown. Feedback included weight and bulk of the boot (36%), heat (particularly at 
night) (31%) and discomfort (24%). These, along with problems with the application 
and removal of the device, were associated with some of the protocol violations.  
Gilcreast et al. (2005) reported that some participants found the heel devices ‘hot and 
bothersome’ without reporting the data in any more detail, hence reporting issues 
precluded further analysis.  Bååth et al. (2016) received feedback from only 28% 
(n=29/103) of participants assigned the offloading. Feedback about the devices 
included that they caused friction (n=9), were itchy (n=14), caused blistering from the 
bootstraps (n = 1), and some evaluated the boot as ugly (n=19). Due to the lack of full 
reporting and different denominators being reported for some of the outcomes, it was 
not possible to clearly determine whether the event rate was appropriately described.  
None of these trials had sufficient evidence to associate the participants’ perspectives 
with the high rates of withdrawals and attrition. No other research has been found 
about patient preferences with regards to the use of heel devices or the experience of 
the prevention of heel pressure ulcers. 
4.2.2 Low event rates 
Recently PRESSURE 2, the largest mattress RCT conducted worldwide with a sample 
size of 2029, reported lower than anticipated event rates of 7.9% of patients developing 
a Category 2 or above pressure ulcer to all body sites, compared to the predicted rate 
of 18%.  Along with lower than anticipated recruitment, this led to the trial being 
underpowered under its original trial design (Nixon et al., 2019). It could therefore be 
anticipated that a trial looking at heel pressure ulcer prevention devices could 
anticipate an even lower event rate because, as demonstrated in Chapter 1, 
prevalence studies consistently report approximately 25% of all pressure ulcers 





would be anticipated that for a trial to have sufficient power to show a difference, a 
sample size similar to or larger than PRESSURE 2 would be required if conducted in 
the general population. This is why some of the trials focused on patient populations 
deemed to be at higher risk of developing a heel pressure ulcer such as orthopaedics 
(Donnelly et al., 2011, Campbell et al., 2010) or critical care (Santamaria et al., 2013, 
Cadue et al., 2008). One option would be to conduct a pilot study amongst high-risk 
populations to attempt to address the issues of attrition and withdrawals along with 
piloting recruitment and data collection.  
4.2.3 Clinical practice 
So far, this thesis has demonstrated that there is insufficient clinical evidence with 
regards to the effectiveness of any device for the prevention of heel pressure ulcers, 
however it is known from clinical practice that they are widely used.  Little is also known 
about how and why nurses decide to use devices when there is little research 
evidence. In these circumstances personal preferences can be formed from the 
experience and influence of champions/leaders (Grebel and Wilfer, 2010, Institute of 
Health Economics, 2015).  
A study by Teo et al. (2019) found that despite the availability of interventions, pressure 
ulcer prevention and management practices were suboptimal due to a poor 
understanding of the mechanisms behind the interventions.  It is therefore important to 
understand how and why devices are used in practice in order to inform trial design, 
before seeking to address the lack of effectiveness evidence.  
4.3 Research Objective and focus 
The objective of this study was to explore how and why heel devices are used (or not 
used) and reasons behind how and why they might (or might not) be used for the 
prevention of heel pressure ulcers. Due to the large range of heel devices, and the 
range of environments in which a patient can be cared for with heel devices, to 
increase the depth of the research, the focus was limited to: 
• Any device that works by offloading/floating the heel, because this is where 
there is limited evidence for heel pressure ulcer prevention  
• Secondary care, because this is where the majority of the RCTs took place, 
where heel pressure ulcers are more likely to occur, and it is also the area of 







The following research questions were developed: 
1. What factors influence the implementation of offloading devices in a clinical 
area? 
2. How are offloading devices used (or not used) in clinical practice? 
3. How could this knowledge influence trial design and reduce attrition rates in 
future clinical trials?  
4.4 Identification of methodology 
To answer the research questions, the perspectives of those who use the heel devices 
in clinical practice need to be sought.  There are numerous approaches that could be 
taken to answer the research question, therefore this chapter will consider how 
qualitative and mixed methods research can be used to inform trial design, before 
going on to justify the choice of realist evaluation as a methodology.  
4.4.1 Qualitative and mixed methods research  
From a philosophical view, positivism is the search for generalizable knowledge based 
on natural phenomena and their properties and relations (Comte, 1908). Empirical 
research such as early phase experiments are viewed as positivist and work by 
attempting to create a closed system by standardising conditions, minimising the 
effects of extraneous factors and reducing bias in order to assess the efficacy of a 
causal agent, based on notions of cause and effect (Maxwell, 2012). However, 
complex healthcare interventions take place in open systems in which many factors 
additional to the intervention itself will affect its effectiveness (Porter and O'Halloran, 
2012).  
When assessing the effectiveness of a device it is more than just whether the device 
works at preventing a heel pressure ulcer that needs addressing, but also factors such 
as the participants’ experience, tolerability of the device, ease of delivery, usability, and 
cost effectiveness. A range of research designs and methods could be used to address 
this.  
The current evidence from the systematic review is positivist, in that it only provides 
descriptions of outcome patterns, telling us about group differences to ascribe cause 
and effect.  The other end of the spectrum from this positivist view point is 
constructivism, which is where qualitative research sits, aimed at understanding the 
lived experience through the individuals’ interactions with the environment (Andrews, 
2012). A qualitative approach could provide explanations of why the intervention works 





these might be replicated by similar interventions in the future (Moore et al., 2015a, 
Pawson and Tilley, 1997f). Qualitative and mixed methods approaches are therefore 
more frequently being undertaken before a clinical trial, as part of a feasibility study, or 
alongside or after an RCT, as part of a process evaluation; to find out not just if an 
intervention works, but how and why it works (or does not work), and for whom in what 
circumstances.  
A process evaluation can be a separate study or conducted as part of an RCT to 
examine the implementation, receipt and setting of an intervention to aid in the 
interpretation of how the intervention brings about an outcome (Oakley et al., 2006). 
The Medical Research Council framework recommends that process evaluations 
should be mixed methods, although existing process evaluations are predominantly 
qualitative (Moore et al., 2015a, Craig et al., 2008). Using a mixed methods approach 
could inform factors that influence how and why these heel devices are used in practice 
in the absence of clinical evidence with the aim of improving compliance with trial 
protocols, but this would need to be done in a methodologically sound way that is 
relevant and informative for future clinical trials.   
One hundred and four citations were reviewed for inclusion in Chapter 3, of which 
fourteen related to heel-specific devices and ten were included. Of the ten trials, only 
one reported a qualitative element; Campbell et al. (2010) used a nominal group 
process to identify seven priority items for a heel-specific device selection to be used in 
their orthopaedic department. Two trials included participants’ opinions of the devices 
in the forms of surveys (Donnelly et al., 2011, Bååth et al., 2016). It is possible that 
more of the included trials addressed multiple aspects alongside the clinical trial but 
were missed as they were published separately to the RCT, although none were 
identified during the literature search or referenced in the studies. 
O'Cathain et al. (2013) performed a systematic mapping review of RCTs in the field of 
health published in peer reviewed journals during 2008-2010 and identified 296 articles 
that reported a total of 356 examples of qualitative research undertaken alongside 
trials.  In their appraisal, they reported that most of the qualitative studies were either 
poorly integrated into the clinical trials and/or methodologically weak. The framework 
described by O'Cathain et al. (2013) that explores qualitative research used alongside 
RCTs in the field of health research was used in Table 4-1, to highlight where there are 







4.4.2 Offloading as a complex intervention 
Table 4-1 highlights that the biggest knowledge gaps are regarding the intervention and 
content delivery.  The use of offloading devices could be argued as being a fairly 
simple intervention; the device floats the heel, and in the absence of pressure a 
pressure ulcer is prevented, but in reality it is more complex than that, with various 
interconnecting components to the intervention, beyond just the offloading device 
itself, that act both independently and inter-dependently (Campbell et al., 2000, Craig 
et al., 2008, Lewin et al., 2009).  
Table 4-1 Framework used by O’Cathain et al. (2013) to describe qualitative 
research performed alongside RCTs, and the extent to which they have been 
addressed in existing heel pressure ulcer studies, highlighting the gaps in 
current knowledge  







Already numerous heel devices available on the 
market 
Intervention components Is it more than just the heel devices that influence 
their use, but also how the patients and staff react 
to and use heel devices? 
Models, mechanisms, 
and underlying theory 
development 
No data 
Perceived value and 
benefits of intervention 
Limited data from the perspective of the 
participants and staff 
Acceptability of 
intervention in principle 
Limited data from the perspective of participants 




intervention in practice 
Some data from the RCTs regarding acceptability 
of heel devices from the perspective of the 
participants, but little information from the 
perspective of nursing staff 
Fidelity, reach and dose 
of intervention 
Little known about how long the heel devices are 
used for or in what clinical areas they are used 
Implementation of the 
intervention in the real 
world 
Little known about how the heel devices are used 






RCTs included in the SR give some data on this, 
but there were some retention issues reported in 
some of the trials (Bååth et al., 2016, Donnelly et 
al., 2011) 
Diversity of participants Incidence studies and risk factors research 
already inform this 
Trial participation Addressed in some existing RCTs (Bååth et al., 
2016, Donnelly et al., 2011) 
Acceptability of the trial 
in principle 






Category Subcategory Existing literature on heel pressure ulcer 
prevention 
Acceptability of the trial 
in practice 
No pilot or feasibility studies reported that address 
this 
Ethical conduct of the 
trial 
Addressed in existing RCTs (Bååth et al., 2016, 
Campbell et al., 2010, Donnelly et al., 2011, 
Gilcreast et al., 2005, Tymec et al., 1997) 
Adaptation of trial 
conduct to local context 
Not reported  
Impact of trial on staff, 
researchers, or 
participants 
Impact of trial on staff or researchers not reported 
Outcomes Breadth of outcomes Outcomes concentrate on pressure ulcer 
incidence, not much data on patient reported 
outcome measures, OUTPUTs study will address 
this (Lechner et al., 2019) and PUQoL as part of 
the PRESSURE 2 trial (Nixon et al., 2019) 
Variation in outcomes Outcomes concentrate on pressure ulcer 
incidence, little variation in outcomes since 
international grading systems started being used 




Accuracy of measures Studies exist that look at grading, reliability and 
validation of pressure ulcer outcomes (McGinnis 
et al., 2017) 
Completion of outcome 
measures 
Studies exist that look at grading, reliability and 
validation of pressure ulcer outcomes (McGinnis 
et al., 2017) 
Development of 
outcome measures 
OUTPUTs study addressing core outcomes for 
pressure ulcer trials (Lechner et al., 2019)  
Target 
condition 
Experience of the 
disease, behaviour, or 
beliefs 
Patient reported health-related quality of life tool 
(PUQoL-P) has been developed to address this 
(Rutherford et al., 2018, Gorecki, 2011)  
 
Complex interventions can be defined as being composed of multiple ‘components’, 
that interact and involve behaviours (either in those delivering or receiving the 
intervention) with the purpose of changing one or more outcomes (Moore et al., 2015a, 
Craig et al., 2008). Not all the components, particularly social and organisational, will 
have a specific purpose but instead influence the extent to which the purpose is 
achieved. For example, in a study of severe pressure ulcer development, it was found 
that prevailing cultural norms impacted on the decisions and actions of clinicians 
(Pinkney et al., 2014). Investigations into the development of severe pressure ulcers 
has found that they usually occur due to a sequence of events, rather than a singular 
causal factor (Greenwood and McGinnis, 2016).     
When examining offloading as a complex intervention, the components and behaviours 





is selected and adopted into clinical practice, patient preferences and values, along 
with how staff use (or do not use) the intervention.  It is not just the offloading device 
that prevents the pressure ulcer, but the patient’s response to it in terms of whether 
they will/are able to wear the device and keep it on, along with the interaction between 
the patient and healthcare worker to ensure that it is implemented. The extent to which 
the device changes the behaviour of the healthcare worker and/or the patient also 
needs to be considered.  
It could also be argued that complexity is not just a characteristic of the intervention, 
but a feature of the dynamic health systems in which they are implemented (Shiell et 
al., 2008, Hawe et al., 2009). Regardless of whether the intervention is simple or 
complex, the healthcare system in which it is implemented will almost invariably need 
to adapt to accommodate it (Greenhalgh and Papoutsi, 2018). Due to the dynamic 
nature of healthcare systems, the conventional empirical quest for predictability, 
certainty, and linear causation can be supplemented and improved upon by addressing 
how we can best deal with unpredictability and uncertainty (Greenhalgh and Papoutsi, 
2018). 
4.5 Realism 
To try and understand not just if offloading devices prevent heel pressure ulcers, but 
also how they might work and the reactions of the patients and staff to the intervention, 
we must acknowledge the complexity and the interplaying factors that could influence 
their use.  Whilst the importance of both positivist and constructivist approaches have 
been acknowledged, a realist approach was taken as, broadly speaking, it sits between 
the two paradigms and acknowledges the importance of both.  Realism asserts that the 
real world is an open system involving social structures and our knowledge of it is 
processed through human behaviour. It acknowledges that our understanding will 
always be partial and imperfect, but can be built on over time with evidence (Wong et 
al., 2013, Pawson and Tilley, 1997f).  
Realism has many philosophical iterations including critical realism, constructive 
realism, philosophic realism, scientific realism, experiential realism, subtle realism and 
emergent realism to name a few, and debate continues regarding the nature of realism 
(Maxwell, 2012). The two most well-known philosophical approaches, critical and 







4.5.1 Critical realism 
Critical realism is widely associated with, but not restricted to, the work of the British 
philosopher Roy Bhaskar (Bhaskar, 1973).  Bhaskar describes three levels of reality, 
the empirical, the actual, and the real. The empirical domain describes the world we 
experience through our senses which are a critical part of the world, but alone cannot 
define the world. The actual domain describes actual events, whether or not we 
experience them, and the real domain describes the underlying mechanisms that 
produces the events.   
Porter et al. (2017) describe critical realism as recognising two distinct sources of 
causation: social structures and human behaviour. As previously described in 4.4.1, 
RCTs are positivist and work by attempting to create closed systems to identify 
causation. From a critical realist perspective, when studying complex social systems, it 
is impossible to conduct the ‘closed system’ investigations available within the 
experimental science paradigm. Critical realist research methods instead focus on 
theoretical inquiry of social systems by exploring the real to establish how it relates to 
the empirical and actual domains.   
In nursing research, critical realism aims to investigate complex phenomena by 
progressing beyond measuring outcomes, superficial causes or examining correlations, 
to identify the deeper and wider causes of outcomes (Clark et al., 2008). For example, 
Clark et al. (2005) explored why cardiac rehabilitation programmes are so variable in 
the longer term, through identifying participants’ perceptions of the contexts and 
mechanisms that influence effectiveness of programmes.  
4.5.2 Scientific realism 
From an ontological point of view, scientific realism considers that the world is 
independent of our mind and science gives us knowledge of this world (Jagosh et al., 
2019).  Reality consists of both observable entities, things that can be seen, and 
unobservable entities. The outcome of interest is triggered by unobservable entities 
(mechanisms) acting in a physical, observable entity (context) through a process 
known as generative causation (Van Belle et al., 2016). A mechanism can be activated 
by a range of contexts and can be detected using a mixture of methods.  
This is in contrast to Hume’s (1739) successionist view that causation is unobservable 
and only through scientific testing can we differentiate between a spurious association 
and a causal relationship. Certain causal forces cannot be observed, for example we 
cannot witness the cognitive leap a person makes to stop smoking, but it is only once 





judgement can be made that a smoking cessation intervention has worked (Pawson 
and Tilley, 1997e). 
In contrast to critical realism that says the closed systems used in experimental science 
cannot be used to explore social systems, scientific realism states that experimental 
investigations can only ever achieve partial closure (Pawson, 2013b).  As science 
develops over time, theories are converging, becoming an approximate truth, but it is 
acknowledged that there can never be complete certainty.   
Scientific realism has been used by social epidemiologists to gain a deeper 
understanding of how, why, and under what contexts macrosocial determinants could 
improve, or harm, population levels of health (Ng and Muntaner, 2014). For example,  
Muntaner (2013) generated theory and data driven statements about immeasurable 
mechanisms and causal powers that link race and health. 
4.5.3 Realist Evaluation 
Realist evaluation is more of a methodology than a philosophy, that uses realist 
principles based on the paradigm of scientific realism (Jagosh et al., 2019).  Realist 
evaluation was developed in the 1990s by Pawson and Tilley, originating in social 
policy, evaluating social interventions, programmes of change for social betterment that 
involve righting wrongs, correcting deficient behaviours or alleviating inequality 
(Pawson and Tilley, 1997f). More recently realist evaluation has been developed and 
adapted as evaluators seek to answer process-orientated questions in order to 
contribute to evidence-based practice in healthcare (Porter and O'Halloran, 2012), and 
is now being widely used in many different areas for the evaluation of programmes, 
policies, services and interventions.  
Realist evaluation is a theory driven approach that allows for an exploration of the 
effectiveness of a programme, policy, service or intervention, but also gives an 
understanding of how the causal mechanisms are influenced by both human decisions 
and actions; simply put what works for whom, in which situations (Pawson and Tilley, 
1997f). This is done by looking beyond the empirical domain, unearthing generative 
causation through a process called retroduction. It has been suggested that 
retroduction overcomes the deficiencies of the logics of induction and deduction to offer 
causal explanations. Merely knowing whether A leads to B is insufficient, instead we 
need to gain an understanding of how A gave rise to B (Bhaskar, 1973). Gaining 
ontological depth through going back from, below or behind observed patterns of 
regularities to discover what produced them can lead to an understanding of the 





Theory-based approaches provide a key to unlock complex processes between the 
intent and outcome of an intervention, by examining implementation, the causal 
processes that generate outcomes and contextual factors that influence them (Chen 
and Rossi, 1980; Weiss, 1998).  There are other theory driven evaluation approaches 
that this research could have taken, such as theories of change (Blamey and 
Mackenzie, 2007). In comparison to realist evaluation, where the focus is on causation, 
theories of change focus on implementation, where the theory is ideally articulated, 
owned and approved by a wide range of stakeholders who are best placed to 
understand the intervention, and are developed through a process of ‘backwards 
mapping’ from the ultimate goals of the intervention towards the inputs and activities 
(Rolfe, 2019).  The stakeholders have ownership of the theory of change generated 
and are involved in the key decisions behind the relative importance of the theory along 
with the actual evaluation research. In realist evaluation the theories are owned more 
by the researcher(s) based on their knowledge, experience, and the existing evidence 
base, and developed through a smaller and more purposive selection of stakeholders.  
It is more concerned in identifying potential causal triggers and the most promising 
theories then go on to be tested (Blamey and Mackenzie, 2007).  
It is important to acknowledge the researcher’s position as a clinician and how this will 
influence the research.  Being a Tissue Viability Nurse Specialist (TVNS) with 
experience of using offloading devices in clinical practice meant that the researcher 
already had several theories about how and why offloading devices are used in 
practice, and it was this interest and experience that led to the topic of this PhD. A 
qualitative methodology such as grounded theory would not be suitable as this requires 
a neutrality in the data collection and analysis in order to assure that as new categories 
emerge they will not be contaminated (Glaser and Strauss, 1967); in contrast a 
methodology such as realist evaluation acknowledges and incorporates this 
knowledge.  
Realists would argue that it is not the intervention that produces the outcome, but how 
people respond to and make use of the resources that the intervention provides that 
determines the outcome, and how people respond is highly dependent upon the 
context (Greenhalgh et al., 2011, Wong et al., 2012).  The researcher has witnessed 
different offloading devices being used in different ways in different contexts, with 
differing responses to them from patients and staff using them. Realist evaluation is 
therefore best placed to answer the research question of ‘how and why different 
offloading devices are used (or not used), and reasons behind how and why they might 





Realist evaluation has been used in nursing and health research as a methodological 
approach that incorporates a mix of methods to allow for an exploration of contextual 
factors that influence the link between the intervention, the outcome, and the 
mechanisms involved; the role of both the human understanding and response to the 
intervention, along with the external reality need to be incorporated in order to fully 
understand the outcome (Greenhalgh et al., 2011). Realist evaluation has been used 
by McGaughey et al. (2017) to explore how early warning systems are used to 
recognise the deteriorating patient in hospitals, using mixed methods including 
interviews, focus groups, observations and case notes review. They found that 
organisational and cultural changes that facilitated staff empowerment, ongoing 
experiential learning and a flexible implementation of protocols led to successful 
implementation of rapid response systems. 
Another example is Randell et al. (2017) who used realist evaluation to explore the 
integration of robotic assisted surgery into routine practice using a combination of 
literature review, interviews, observations, and questionnaires. They found that training 
and skills mix of the team was important, as well as effective team work requiring the 
surgeon to encourage communication within the team. 
4.5.3.1 Programme theories 
Realist evaluation starts with one or more programme theories; a hypothesis about how 
an intervention works and involves eliciting, testing, and refining these theories.  It is 
believed that whenever a programme or intervention is designed and implemented, 
there are one or more underpinning theories regarding what ‘might cause change’, 
regardless of whether the theory(s) are explicit (Pawson and Tilley, 1997f). By 
developing clear hypotheses about how, and for whom, to what extent, and in what 
contexts a programme or intervention might ‘work’, the theories are made explicit. 
The theories are expressed in terms of context, mechanism, and outcome 
configurations (CMOs) where a desired outcome (O) pattern is brought about by the 
mechanisms (M) triggered in certain contexts (C).  It is understood that causal 
associations are rarely universal, but are adaptive ‘demi-regularities’, (frequently 
produced behaviours or patterns),  in which settings and context triggers the 
mechanisms that bring about change (Dalkin et al., 2015).  Summed up this contextual 
dependence of generative mechanisms are expressed as context-mechanism-outcome 
configurations; using the formula C + M = O, the analytical unit on which realist 





In their realist evaluation of the use of early warning systems, McGaughey et al. (2017) 
developed CMOs following a realist review of the literature along with interviews with 
key stakeholders.  Four CMOs were developed about how rapid response systems 
improve outcomes, lead to early recognition, early referral, and early recognition.   
4.5.3.2 Contexts: 
Context is often used synonymously with settings and environments which triggers the 
mechanism (Dalkin et al., 2015). One way of thinking about contexts is that they could 
be static (e.g. aspects of the physical environment) or dynamic (e.g. relationships, 
networks) (Pfadenhauer et al., 2017).  Pawson (2013a) describes the layers that make 
up contexts as the four I’s that are complicated, intertwined and in motion: 
o Individuals – the characteristics and capacities of staff, patients or relatives who 
use the intervention 
o Interpersonal relations – the relationships between the different staff (nurses, 
doctors, allied health professionals) as well as between the staff and patients 
o Institutional settings – the rules, norms, and customs local to the intervention, 
for example differences between the ways different clinical areas or specialities 
work and the pressure ulcer prevention practices or programmes that are in 
place 
o Infrastructure – the wider social, economic, and cultural setting which could 
include procurement processes or the influences of the wider organisation.  
A context can also be described in terms of different levels (Pfadenhauer et al., 2017): 
o Macro level – refers to everything surrounding a community or organisation, for 
example the policies and regulations across a whole health system or country.  
o Meso level – looks at a specific community or organisation, for example the 
introduction of a new intervention or guidelines in a specific hospital or clinical 
area. 
o Micro level – is interested in the direct level of an interaction e.g., where an 
intervention is delivered by a clinician or a team to a specific patient group.  
A contextual factor should not be considered as an on/off switch, but the degree in which 
it ‘fires’ the mechanism (Dalkin et al., 2015). For example, it is not whether nurses are 
educated about offloading devices, or not, that affects how nurses use devices for the 
prevention of heel pressure ulcers; it could be how it is decided what is in an educational 
programme from the policy makers, the setting in which the education is delivered, who 
delivers the education, access to the devices, and the recipients’ response to it. It could 
be argued that due to contextual factors, an intervention is never implemented in the 






The mechanism by which an intervention works (or not) is through particular decisions 
or ‘reasoning’ made by ‘actors’ in response to the resources the intervention provides 
and are only triggered when the right contextual factors are present (Pawson and Tilley, 
1997c, Dalkin et al., 2015). Interventions typically provide multiple resources and 
recipients of an intervention may have different responses to particular resources. 
Mechanisms are not variables, they are usually unobservable attributes that attempt to 
explain why variables are related (Astbury and Leeuw, 2010). By penetrating “beneath 
the surface of observable inputs and outputs the layers of individual reasoning” (Pawson 
and Tilley, 1997d) we can gain ontological depth and attempt to understand how the 
resources made available influence peoples’ choices and capacities.  
Astbury and Leeuw (2010) suggest that there are three interrelated types of mechanisms 
that work in the macro, meso and micro contextual levels: 
o Situational mechanisms - operate at the macro-to-micro level and demonstrate 
how specific social structures, situations or events shape an individual’s beliefs, 
desires, and opportunities. An example of this could be how culture on a ward 
and the influence of the manager can affect staff perceptions with regards to the 
effectiveness of an intervention.    
o Action-formation mechanisms - operate at the micro-to-micro level and look at 
how individual choices and actions are influenced by specific combination of 
desires, beliefs, and opportunities. For example, regardless of the strong 
evidence that smoking reduces life expectancy, smokers rationalise to avoid 
quitting that ‘it won’t happen to them because they are not a heavy smoker’.  
o Transformational mechanisms - operate at the micro-to-macro level, when 
individuals interact with one another, generating macro-level ‘collective’ 
outcomes which could be intended or unintended. One example of this is the 
‘bandwagon phenomena’ such as bloodletting; where up until 200 years ago 
both physicians and patients had a shared belief that bloodletting was an 
effective treatment (Hagemoser, 2009).  
4.5.3.4 Outcomes: 
A programme of intervention is likely to have multiple mechanisms that can have 
different effects on different subjects in different situations, therefore leading to multiple 
outcomes (Pawson and Tilley, 1997d).  
Realist evaluation seeks to understand both the intended and unintended outcomes of 





the conjectured theories, contexts and mechanism are present (Pawson and Tilley, 
1997d), the aim being to identify demi-regularities or patterns of outcomes (Pawson, 
2006b). The term ‘outcome’ could mean different things dependent on the type of 
evaluation. For example, a process evaluation might focus on ‘patterns of 
implementation’ or ‘patterns of efficiency or cost effectiveness’ in economic evaluations 
(Wong et al., 2016).  
4.6 Methodology 
Realist evaluation is seen as cyclical, starting with a set of initial programme theories 
that go on to be refined and tested by collecting data on implementation, impact, 
contextual factors that might affect the outcomes, and how these contexts shape the 
mechanisms that might bring about change (Figure 4-1). As the social world is an open 
system that is continually changing and evolving, the effectiveness of a programme or 
intervention could therefore be subverted or enhanced through the introduction or 
unanticipated new contexts and mechanisms (Pawson and Tilley, 1997d). Realism 
therefore tells us that nothing is absolute, and there is never certainty, the addition of 
further data will build on and lead to further refinement of the theory in different 
contexts and only stops once satisfied that there is sufficient evidence, at least for the 
time being.  
In realist evaluation there is no hierarchy of evidence; to identify mechanisms and 
contextual features and explain how findings fit together, different data types along with 
the expertise of different people involved in the programme are required.  







This chapter has presented the research problem identified following the systematic 
review presented in Chapter 3.  It also provides a rationale for why realist evaluation 
was identified as an appropriate approach to explore how and why different offloading 
devices are used (or not used) and reasons behind how and why they might (or might 
not) be used in clinical practice for the prevention of heel pressure ulcers when there is 
an absence of clinical evidence. It has also presented the philosophical underpinnings 
behind realism and where realist evaluation sits. 
The following chapter will describe the process of undertaking a realist evaluation, 
which will include how the research was designed and the methods used to address 








Chapter 5 Realist evaluation phase 1: Tissue Viability Nurse 
Specialist (TVNS) interview methods  
5.1 Introduction 
The realist evaluation of how and why different offloading devices are used in clinical 
practice for the prevention of heel pressure ulcers consists of two phases: phase 1 
concerns theory elicitation and refinement, and phase 2 theory testing (Figure 5-1 The 
two phases of this realist evaluation.  
This chapter will provide an overview of the methods for both phases, focusing on 
phase 1 of the realist evaluation; TVNS interviews. This will include how the research 
was designed and the methods used. The theories developed from the interviews will 
be presented in Chapters 6-8, and further detail of the methods of phase 2 will be 
provided in Chapter 9, and Chapter 10 will report the results of phase 2. 
The Rameses II reporting standards for realist evaluation (Wong et al., 2016) were 
developed to improve the conduct and reporting of realist evaluation. These were 
developed using a Delphi panel of international experts in realist evaluation who 
identified twenty items that should be included when reporting a realist evaluation. The 
reporting standards have been followed, with adaptation to reflect the linear 
presentation of the two phases, in particular how the results of phase 1 influenced the 
design and methods of phase 2. 
5.2 Methods 
5.2.1 Phase 1: Theory elicitation 
Realist evaluation aims to establish the viability of a using the best available evidence, 
through a process of theory elicitation, testing and refinement. 
Theory elicitation can be carried out in several ways, such as interviewing 
stakeholders, reviewing the existing literature on the topic, identifying relevant theories 
from the literature, or some combination of these approaches.  In this study theory 
elicitation involved presenting candidate theories to a range of stakeholders, to refine, 
develop and add to the theories, based on their direct experience of the intervention, 






5.2.1.1 Initial theory development 
As a Tissue Viability Nurse Specialist (TVNS) working in a large acute trust in the North 
of England, the researcher entered this PhD with substantial clinical experience of 
using offloading devices with the aim of preventing heel pressure ulcers.  Realist 
evaluation makes the assumption that in the ‘real world’ programmes or interventions 
will only work in some contexts for some people, firing different mechanisms in different 
circumstances, generating different outcomes (Wong et al., 2016). Pre-existing or 
newly generated theories will need to be developed and refined by addressing 
contexts, mechanisms and outcomes, in order to become a realist programme theory 
(Pawson and Sridharan, 2010).  
Thirteen initial ‘candidate theories’ were created from personal clinical experience and 
from the literature identified during the systematic review to answer the first two 
research questions presented in Chapter 4: 
1. What factors influence the implementation of offloading devices in a clinical 
area? 
2. How are offloading devices used (or not used) in clinical practice? 



















Whilst developing the theories it became clear that they could be grouped into either 
factors that influence how nursing and healthcare professionals implement and use (or 
do not use) offloading devices in practice (theories 1-10; Table 5-1) or patient factors 
that influence their use (theories 11-13; Table 5-2). The theories are presented in the 
form of CMOs attempting to explicate the resources and reasoning that make up the 
mechanisms, to bring about the outcome in certain contexts. The theories about how 
nurses and healthcare professionals use offloading devices were mainly based on 
personal experiences of practice, due to the paucity of coverage of this aspect in the 
literature.  Theory 12 was based on some of the findings from the RCTs included in 
Chapter 3 regarding patient comfort factors (Bååth et al., 2016, Campbell et al., 2010, 
Donnelly et al., 2011). 
5.2.1.2 Identification of stakeholders and sampling strategy 
Popper philosophises that what we see is our interpretation of the real, not the real 
itself (Popper, 1999).  The realist approach assumes that the accounts of stakeholders 
have a direct relationship with experiences in the ‘real world’, therefore data gathered 
through interviews about how the candidate theories manifest in the ‘real world’ can 
provide evidence that has relevance beyond the interview situation (Manzano, 2016).  
Purposeful sampling allows the researcher to select information rich cases that will 
provide greater insight into the research problem considered by the researcher to be of 
greatest importance (Emmel, 2013). Those sampled are deemed worthy of in-depth 
study due to their detailed insight into the topic, giving a different but potentially greater 
power to this type of research, compared with probability sampling (Emmel, 2013). A 
broad range of stakeholders should be purposively selected based on the researcher’s 
hypotheses (Manzano, 2016).   
Key stakeholders are more likely to have a wide range of experiences with regards to 
the successes and failures of an intervention, and therefore have specific ideas on the 
mechanisms that work or do not work, alongside an awareness of the people and 
places for whom and in which the intervention works (Pawson, 1996, Pawson and 
Tilley, 1997a). Manzano (2016) recommends that for the initial theory development and 
refinement phase, it is better to start interviewing key stakeholders such as 
practitioners who know the intervention well (e.g., nurses), rather than recipients of the 
intervention (e.g., patients).  
It was identified that the key stakeholders should be clinical experts in pressure ulcer 
prevention, such as TVNSs, who will have experience of implementing offloading 





be aware of the processes by which the devices are implemented, utilised, and 
evaluated by nursing teams.  
Within qualitative research there is no simple method for determining what sample size 
is sufficient. Sample size is dependent upon the purpose of the interviews, likelihood of  
data saturation, and the resources of the researcher (Mason, 2010). It has been 
suggested that expertise in the chosen topic can reduce the number of participants 
needed in a study (Jette et al., 2003), and a sample size of 6-8 may be adequate for 
homogenous groups (Holloway and Wheeler, 2010).  The goal of this phase is to have 
enough participants to develop the initial theories and identify those which warrant 
further exploration. Therefore, a purposive sample of eight participants for this stage of 
the study was deemed likely to be sufficient to gain a range of perspectives to develop 
and refine the theories to a sufficient level, within the time and resource constraints of 
the research project. 
5.2.1.3 Recruitment process  
A purposive sample of TVNSs were identified through networks of TVNSs throughout 
the UK (such as the Tissue Viability Society, the North East of England, the Midlands 
and the East of England Tissue Viability groups) and through published literature found 
during the Cochrane systematic review/literature review, where contact details were 
provided or contact details could be identified through electronic sources (such as 
ResearchGate). The only stipulation was participants had to hold a clinical role as a 
TVNS of any band, within an acute care setting. Potential participants were 
approached by email with a participant information sheet (Appendix C Participant 
information sheet and consent form provided as attachments.  The email and 
participant information sheet provided the name and contact details of the researcher 
for potential participants to contact should they wish to discuss the research prior to 
making their decision. Participants were asked to express their interest or to decline 
participation within 3 days.  A reminder email was then sent on days seven and 
fourteen after the first email (timing of reminder emails was taken into consideration if 
an ‘out of office’ notification was received). If no response was received after three 
emails no further contact was made. 
It was found that if a response was received from a potential participant, then their 
preference would be to have the interview within the following weeks as they often had 
busy schedules which could change if booked too far in advance.  Recruitment was 
therefore performed in waves to accommodate for this, with either one network area or 








Table 5-1 Nursing factors that might influence how offloading devices are implemented 
Initial candidate Theory Context Mechanism Outcome Pattern 
1: Healthcare professionals with 
advanced knowledge of PU 
prevention are more likely to 
appropriately implement an 
offloading device as a preventative 
measure 
The specialist has more 
dedicated time to review 
the patient. Also, PU 
prevention is a priority for 
the specialist as it is an 
area of expertise and 
something they do on a 
regular basis.   
Resource: Specialist knowledge 
Reasoning: Specialist knowledge will lead to a 
more thorough and holistic risk assessment and 
will have more knowledge of the available 
resources 
Patients are more likely 
to have a heel offloading 
device implemented 
when there is access to a 
specialist nurse with 
advanced knowledge 
2: Nurses working in clinical areas 
that frequently care for patients at 
high risk of developing PUs are 
more likely to implement an 
offloading device as a preventative 
measure because PU prevention 
becomes more of a clinical priority 
and staff are more experienced at 
managing at risk patients and 
aware of the resources available to 
them 
Culture and ethos of the 
healthcare setting (with 
high risk of PU 
development) makes PU 
prevention more of a focus 
Resource: Staff knowledge 
Reasoning: Patients being cared for in an 
environment where there are high numbers of at-
risk patients means that PU prevention is more of 
a priority and staff are more experienced in 
managing at risk patients and aware of the 
resources available to them / used to 
implementing them (i.e.  – not just awareness). 
Patients are more likely 
to have a heel offloading 
device implemented 
3: Nurses are more likely to 
implement an offloading device if it 
is easily accessed within the care 
environment 
Patients cared for in an 
environment where 
offloading devices are kept 
as ward stock or can be 
easily accessed 
Resource: Offloading devices 
Reasoning: Nurses perceive that an intervention 
is needed immediately for patients at risk, and so 
respond by utilising offloading devices 
immediately following risk assessment 
Increased utilisation of 









Initial candidate Theory Context Mechanism Outcome Pattern 
4: If patients are moved frequently 
between different care 
environments then offloading 
devices are less likely to be utilised 
because of cost factors 
Where it is anticipated that 
patients are going to be 
frequently moved between 
care environments 
Resource: Offloading devices 
Reasoning: Nurses do not see it as a priority and 
something that can be left for the next person to 
deal with. If the offloading device is single patient 
use only, the nurses might see it as too much of a 
hassle to order or feel it should not come out of 
their budget and therefore the next ward can order 
the offloading device.  If the offloading device is 
re-useable there is an ownership issue, and the 
ward are fearful that it will be sent with the patient 
and be lost.   
Patients who frequently 
move between wards or 
who have a short-
anticipated stay are less 
likely to have a heel 
offloading device.  
5: Single patient use offloading 
devices, versus reusable devices, 
will be more desirable dependent 
on the care environment and 
priorities of the ward manager 
Different patient groups in 
different care 
environments  
Resource: Single use vs reusable offloading 
devices 
Reasoning: The financial priorities of the budget 
holder and patient types in their area will 
determine which offloading devices they will have 
available and how readily they will be available in 
that area 
Implementing a plan of 
care appropriate to the 
patient becomes more 
about what is available 
and affordable rather 
than what is best for the 
patient, irrespective of 
cost  
6: Offloading devices are more 
effective in patients with reduced 
consciousness  
Patient with reduced 
consciousness (e.g., brain 
injury or sedated) 
Resource: Offloading devices 
Reasoning: The patients will be unable to remove 
the offloading devices themselves/will not have an 
awareness of the offloading device 
↑ compliance and 
effectiveness in care 









Initial candidate Theory Context Mechanism Outcome Pattern 
7: Nurses are more likely to utilise 
heel offloading devices as a 
response to pressure damage 
rather than as a preventative 
measure 
Patients at risk of 
developing a heel PU 
Resource: Offloading devices 
Reasoning: Nurses are more likely to risk assess 
the patient as a whole and implement a total body 
device such as a mattress, rather than to risk 
assess individual body sites. It is only once 
pressure damage has occurred that they 
implement an offloading device 
Offloading devices 
utilised more in patients 
with heel PUs rather than 
at risk patients. 
8: If a powered air mattress is 
already in use, additional 
preventative methods are less likely 
to be utilised 
Patients at high risk of 
developing a heel PU 
Resource: Powered air mattresses 
Reasoning Nurses knowledge, attitudes and 
opinions of mattresses will mean that they feel 
that this is sufficient to meet the patient’s needs 
↓ utilisation of offloading 
devices in settings or 
people with a powered 
mattress in place  
9: Repositioning is a key 
component of PU prevention but is 
less likely to take place if offloading 
devices are being utilised. 
Care environment where 
nurses lack capacity to 
reposition patients and/or 
knowledge of the need for 
repositioning 
Resource: Pressure relieving equipment including 
mattresses, cushions, and offloading devices 
Reasoning: Nurses are outsourcing to devices to 
replace need for frequent repositioning 
Patients are repositioned 
less frequently and could 
in turn increase risk of 
developing a PU. Care 
becomes focused on the 
device rather than the 
patient 
10: Conversely, the offloading 
device is a physical reminder for 
nurses and the patients of their risk 
and therefore more attention is paid 
to this at-risk body site. 
Patients at high risk of 
developing a heel PU 
Resource: Offloading devices 
Reasoning: The presence of the offloading 
device reminds the patients and nurses that the 
heel is an at-risk area, so more attention is paid to 
the heel 
↓ Heel PU incidence 
because of a reduction in 
pressure, but also raises 
awareness of risk which 
leads to better self-care 
from the patient and more 










Table 5-2 Patient factors that influence how offloading devices are used 
Initial candidate Theory Context Mechanism Outcome Pattern 
11: Offloading devices are not 
suitable for use in patients who 
are at high risk of falls as they 
could become a fall hazard. 
Patients at high risk 
developing a heel pressure 
ulcer and of falls, where 
falls prevention is more of a 
priority 
Resource: Nurses knowledge and prioritisation 
Reasoning: Nurses perceive some offloading 
devices can be a fall hazard and so are reluctant to 
use them with patient at high risk of falls 
↓ use of offloading 
devices in this patient 
group because falls 
prevention takes a 
priority over pressure 
ulcer prevention 
12: Patients are not always 
compliant with the use of the 
offloading devices due to comfort 
factors 
Patients at risk of 
developing a heel pressure 
ulcer with capacity to make 
decisions about their care. 
Resource: Offloading devices 
Reasoning: Patients perceive the offloading 
device as bulky, hot, uncomfortable, or hindering 
self-movement and so are reluctant to use them 
↓ compliance and usage 
of offloading devices 
13: Risk assessments that involve 
the patient and/or carer are more 
likely to highlight specific risk 
factors/ high risk areas leading to 
plan of care that is more patient 
specific and the patient will 
comply with 
Risk assessments that take 
place in the presence of the 
patient and or carer  
Resource: Offloading devices 
Reasoning: When nurses involve the patient 
and/or carers when performing a risk assessment 
and planning the patients care they will have a 
more comprehensive risk assessment and ↑ 
knowledge about the patient’s pressure ulcer risk 
An increased awareness 
of risk leads to an 
increased utilisation of 
interventions specific to 
the patient’s need. 
By involving the patient 
in the care planning 
process, they will be 




5.2.1.4 Data collection methods 
Standard research interviewing techniques tend to sit in one of three domains – 
structured, un-structured or semi-structured.  Structured interviews tend to consist of 
fixed, closed questions and have more of a positivist experimental design with more 
objective outcomes (Pawson and Tilley, 1997a). To the other extreme, unstructured 
interviews involve a more constructivist approach and tend to be more of a 
conversational style of interviewing where the researcher starts with a broad range of 
‘themes’ to be explored until a mutual understanding is achieved.  Realism sits in-
between positivism and constructivism and interviewing in realism uses a combination 
of methods, with elements of the two extremes in the form of semi-structured interviews 
(Pawson and Tilley, 1997a).    
There is not a singular approach to realist research; therefore there is no one 
authoritative account of how a realist interview should be performed (Manzano, 2016).  
The realist interview is qualitative in nature, as it is conducted in a manner that 
explores the participants’ views through conversations and is driven by the theory that 
requires refining. The conventional guidance for qualitative interviews is for an 
interviewer is to take on a neutral position when engaging with the participant so as not 
to influence their responses, thereby minimising bias. However, in realist research the 
researcher’s theory is the subject matter that requires developing and refining, and the 
function of the interviewee is to confirm, falsify, and above all refine the theory (Pawson 
and Tilley, 1997f).  Therefore the “teacher-learner cycle” of realist evaluation (Pawson 
and Tilley, 1997f) was adopted for this stage of the research; a technique whereby the 
theory is taught to the interviewee, having heard the theory the interviewee is then able 
to teach the researcher about their understanding in respect of components of the 
theory in an informed way.  
Interviews were conducted over the telephone at a time convenient to the participant. 
Due to the geographical variation of participants, with TVNSs from across the UK being 
invited to participate, along with time constraints, face-to-face interviews were not 
feasible and telephone interviews were the most accessible method of enquiry. There 
is little evidence to suggest that telephone interviews differ to face-to-face interviews in 
the amount, quality or interpretation of the data (Novick, 2008). 
The topic guide was developed from the 13 candidate theories presented in Table 5-1 
and Table 5-2, and was designed to utilise the clinical expertise and experiences of the 
participants by unpicking the CMO configurations of each of the theories, with the aim 
of developing and refining the theories alongside developing any potential new 





prior to the next interview, as described in 5.2.1.7, and the topic guide was developed 
and amended prior to each interview. An example of the topic guide can be seen in  
Box 1. 
The interviews were digitally audio-recorded and transcribed verbatim to create an 
authentic, accurate and permanent record of dialogue for analysis. The first interview 
was transcribed in full by the researcher as it was felt necessary to have experience of 
the transcription process, and then due to time factors the remaining interviews were 
transcribed by an external transcription agency. 
Box 1 - Sample interview topic guide utilising the teacher-learner method 
 
5.2.1.5 Ethical Considerations 
It is a requirement that research involving patients, service users, care professionals or 
volunteers is reviewed by a research ethics committee to ensure that the dignity, rights, 
safety and well-being of participants has been considered during the design of the 
research (Health Research Authority, 2017).  
Ethical approval 
The ethical implications for this phase of the research mainly related to the recruitment 
of TVNSs and the time taken to participate in a telephone interview.  There was the 
Theory 1: Do you feel that as a TVN, because pressure ulcer prevention is at the 
forefront of your clinical priorities, you are more likely to implement an offloading 
device as a preventative measure than a ward-based nurse? 
Probes: 
o If yes, could you explain more? Could you give any examples? Why do you 
think this is so?  Is it due to your knowledge of the available offloading 
devices, or a more holistic assessment of the patient? 
o If no, could you expand on this? Why do you think our experiences differ? 
Who do you feel is most likely to initiate a device? 
Theory 2: Do you think nurse’s utilisation of the device varies according to care 
environment? For example, clinical areas that care for a population that is at high 
risk of developing pressure ulcers are more likely to implement a preventative 
intervention because it is more of a key priority? 
Probes: 
o If yes, could you explain more? Could you give any examples? Why do you 
think this is so? Is it their knowledge or the resources available to them that 
influences this? Do you think the culture and ethos of the ward influences 
this? 





potential that poor or dangerous practice could have been disclosed due to the nature 
of the research questions, so this was considered during the ethics application, with the 
inclusion of methods that sought to address this.  Ethical approval was gained through 
the School of Healthcare Research Ethics Committee (SHREC) in October 2015 
(HREC15-014, Appendix D School of Healthcare ethics approval (November 2015)). 
NHS ethics was not required because holding an NHS post was not a requirement, 
recruitment was through external groups and the interviews would have no impact on 
their job role. 
Confidentiality and data protection 
All interview transcripts were anonymised and stored in a password protected section 
of the M: drive of the University computer system. As telephone interviews were 
conducted, oral consent was audio-recorded and a consent form signed on the 
participant’s behalf, scanned, and saved on the M: drive, therefore keeping the 
research paperless and secure. A confidentiality agreement was signed by the 
transcriber and a secure file exchange programme was used to send the audio 
recordings.  
5.2.1.6 Grey literature review 
Due to the iterative nature of realist research along with its multi-method nature, 
simultaneous literature searches were performed alongside the interviews to help 
develop and refine the theories.  This included searching a specific grey literature 
database (OpenGrey) and searching manufacturers’ websites identified during Chapter 
3. Secondary and tertiary literature identified in Chapter 3, that did not meet the 
inclusion criteria, were also included. 
5.2.1.7 Data Analysis 
Data analysis should be systematic, robust and comprehensive in order to instil 
confidence in the reader when considering the implementation of research findings 
(Spencer et al., 2014b). In realist evaluation the analysis process is not a defined 
separate stage of the research process; it is an ongoing iterative process seeking out 
nuggets of information that can be used to explain wider CMO configurations (Wong et 
al., 2016, Manzano, 2016, Pawson, 2006a).   
Coding is a way of labelling sections of information compiled during a study, assigning 
it symbolic meaning along with creating a similarity-based ordering of the data (Miles et 
al., 2014b).  The data are segmented into discrete units, labelled, and grouped by 





this the data are decontextualised and contextualised (Tesch, 1990).  However, one 
critique of this method of data analysis is that the relationships developed between 
these categories and the data are based on similarity and not contiguity, which can 
lead to a neglect of context (Maxwell, 2012). Therefore, like a lot of aspects of realist 
methods a middle-ground approach is taken to data analysis, searching for similarities, 
relationships and meaning within the data.  
Due to the methods employed in this stage of the research, time constraints became a 
constant issue.  The iterative nature of the research required transcription and analysis 
between each interview, which was time consuming. Therefore, a simple and straight 
forward primary thematic analysis was required so the time between interviews could 
be shortened. Primary analysis involved an inductive process of listening back to the 
recordings and reading though the transcriptions and allowing themes and ideas to 
emerge.  These would then be noted down and mapped against the candidate 
theories. Once all the interviews had been completed a more in-depth thematic 
analysis took place with open coding against categories and themes derived from the 
candidate theories. 
Presentation of quotations 
The results section (Chapters 6-8) presents quotes from the interview transcripts to 
illustrate and develop arguments about the candidate theories. In order to help the 
quotes make sense for the reader the text has been edited: pauses, repetitions and 
identification of places and people have been excluded, an ellipsis (…) indicates where 
some of the participant dialogue has been excluded or parentheses [ ] are used where 
the text has been altered.  
Maxwell (2012) argues that although manipulation of the data in this manner could be 
seen as affecting the validity of the study through introducing subjectivity by the 
researcher, in realist research the identity and perspective of the researcher is a 
valuable resource in making sense of the data.   
5.2.2 Phase 2: Theory testing and refinement 
It was not possible to take all the theories forward for testing due to time and resource 
constraints, therefore the theories were prioritised, and one overarching programme 
theory was identified for testing (Chapter 9). There is a need for some theories to be 
held for confirmation at a later point, while focusing attention on the testing of other 





One of the key tenets of realism is the basic idea that mechanisms are not always 
observable because they are about peoples’ reasoning. Rather, it is necessary through 
interviewing to explain why the relationships come about; to establish what goes on in 
the system that connects its various inputs and outputs (Dalkin et al., 2015). 
To test the theory, it is necessary to observe what is happening in everyday clinical 
practice. Observations are a powerful way of studying peoples’ actions and accounts in 
everyday contexts, rather than under experimental conditions set up by the researcher 
(Hammersley and Atkinson, 2007). It allows for a detailed investigation of the cultural 
norms, beliefs and behaviours that are characteristic to that setting or environment 
(Morgan-Trimmer and Wood, 2016, Nicholls et al., 2014). There are several different 
methods that the observations could have taken, with consideration given to action 
research and case study design before a multi-site ethnographic approach was 
chosen.  
Action research involves the researcher collaborating with the participants in the 
research setting with the aim of enacting positive change through a series of 
interconnected cycles of analysis, goal-setting, planning, evaluation and change 
(Lewin, 1946). Action research has been used in realist studies as a method of 
evaluating a change in practice within a complex intervention or policy (Westhorp et al., 
2016), but was not appropriate for this research as the aim was to observe how and 
why offloading devices are used in practice, not to make a change in practice.  
Case study approach is a method that aims to make comparisons between multiple 
perspectives rooted in a specific context, or multiple contexts for the multiple case 
study approach (Simons, 2014). Case study design is structured around context(s), 
institution(s) or location(s) where the understanding of the research issue needs to be 
holistic, comprehensive and contextualised (Lewis and McNaughton Nicholls, 2014).  
Interventions are typically implemented simultaneously within different settings and at 
multiple levels. It is, however, not necessarily useful or meaningful to observe this 
happening at all levels, and the relevant level will depend on the assessed intervention 
and the system in which it exists (Pfadenhauer et al., 2017), so was not selected. 
Ethnography is the study of people in their natural environment where the researcher 
participates in the setting in order to collect data and can use a mixture of qualitative 
and quantitative methods (Hammersley and Atkinson, 2007).  Ethnographic research 
typically involves prolonged observation in the field, focusing on the language, 
behaviour and interactions between different parties (Brewer, 2000). Ethnographic 





aspects of the context that cannot easily be measured, such as the culture of an 
organisation (Randell et al., 2014). 
The role of the researcher is to immerse themselves in the lives of the people in the 
setting they are researching to understand their social meanings and ordinary activities. 
The data derived from an ethnographic study is gathered from a mixture of methods, in 
part from observations of naturally occurring phenomena as well as evidence 
generated from enquires and conversations with participants and sources, and 
documentary evidence of various kinds.   
The key purpose of interviews in realist evaluation is to understand people’s reasoning, 
but formal interviews or informal conversations with participants can also provide 
information that might be missed during observations, or that might have happened in 
the past, along with being used to check the researchers understanding of what has 
been observed.  
Ethnography was adopted as triangulating both structured and unstructured 
observations including a review of documentation, along with interviews, across 
different wards, will provide a more complete and accurate account of what is 
happening in practice than they could singularly, deepening our understanding rather 
than just confirming it (Evers and Staa, 2010, Miles et al., 2014a, Greene, 2007). 
Ethnography allowed for testing of the theory alongside identifying new contexts, 
mechanisms, and outcomes through exploring the observable and the unobservable. 
5.3 Summary 
This chapter has presented the methods of data collection and data analysis for Phase 
1: theory elicitation and refinement. Due to the iterative nature of realist evaluation, the 
results of Phase 1 informed the focus of the research and the methods used in Phase 2 
(theory testing). Therefore, a linear presentation in this, and subsequent chapters has 
been used for the benefit of the reader to be able to comprehend the rationale behind 
the research design. The findings from Phase 1 and how the interview data were used 
to modify and refine the original 13 candidate theories into three programme theories 
are presented in Chapters 6-8. The selection of one of these theories for testing 
followed by the methods for the ethnography are presented in Chapter 9 and the 






Chapter 6 Programme theory 1 – Proactive use of offloading 
devices 
6.1 Introduction 
This chapter begins with descriptive results of the TVNS interviews followed by the 
results of the interviews. During the analysis three programme theories emerged that 
encompassed all 13 initial candidate theories. Chapters 6-8 follow the analysis plan 
described in Chapter 5 for the theory elicitation and refinement phase of the realist 
evaluation, with each chapter focussing on one of the three programme theories.  
This chapter will demonstrate how the interview data were used to modify and refine 
candidate theories 1-6 (Table 5-1) into programme theory 1 which examines how 
offloading devices are used proactively in the prevention of heel pressure ulcers.  Each 
of the initial candidate theories are considered in turn, with the contexts presented as 
the subheadings. Then finally all six candidate theories will be summarised and refined 
together into programme theory one.   
6.2 Descriptive results 
6.2.1 Participant recruitment 
Eight TVNSs were recruited and interviewed over a seven-month period between 
January and August 2016. They were all recruited via email through networks identified 
in 5.2.1.3. The average duration of the interviews was 55 minutes (range 42 - 74 
minutes) giving a total of 437 minutes (7.3 hours) of interview data for analysis. 
6.2.2 Participant demographics  
The recruited TVNSs (Table 6-1) were all employed by the NHS and worked across the 
UK; six from England, one from Northern Ireland and one from Wales. Three worked 
solely in acute care, five worked across primary and secondary care settings. For those 
who worked in a combined role, they were asked to discuss experiences in acute care.  
Agenda for Change was introduced into the NHS in 2004 as a statutory framework for 
pay and conditions, with the intention of modernising and replacing the existing Whitley 
scales and clinical grading schemes into a universal banding system. Staff are placed in 
one of nine pay bands, based on their knowledge, responsibility, skills, and effort needed 
for the job (NHS Staff Council, 2019). The TVNSs had a wide range of job roles, 
ranging from band 6 Clinical Nurse Specialists (CNS) to senior TVNS & Lead 





years. The banding of the more senior TVNSs were not recorded and there is no set 
band for the different job titles as this is set by the individual organisation and can 
range from band 7 to 8c. There was also a large variance in the size of the patient 
populations, with the larger trusts likely to be tertiary centres with more specialities and 
therefore a wider variety of patients including maternity and paediatrics. This could lead 
to different contextual factors with regards to experiences of caring for different patient 
types and complexities in different organisations. 
Table 6-1 Participant demographics 
6.2.3 Heel pressure ulcer prevention 
A variety of heel-specific devices and campaigns/training materials for education about 
the prevention of heel pressure ulcers were used by the TVNSs (Table 6-2). The 
“Heels Up” campaign is a catchphrase used amongst TVNSs that they utilise and adapt 
accordingly for use in their areas. The ThinkGlucose programme (NHS Institute for 
Innovation and Improvement, 2011) was designed to improve the management of 
people with diabetes on any hospital ward in the UK and P5 had utilised this to create a 
campaign for their Trust highlighting the risk of wounds including pressure ulcers to the 
feet of diabetic patients.  The variety of different devices and methods utilised to 
promote heel pressure ulcer prevention by the TVNSs highlights that there is no 
general consensus on how and what devices should be used (if any) to prevent heel 












P1 Band 6 CNS 3 1700 beds Acute 
P2 Lead nurse  20 1900 beds Combined 
P3 Band 6 CNS 5 250 beds Combined 
P4 Lead nurse 20 900 beds Combined 
P5 Lead nurse 16 1000 beds Combined 
P6 Band 7 CNS 5 500 beds Acute 
P7 Band 7 CNS 2.5 800 beds Acute 





Table 6-2 Heel pressure ulcer prevention strategies used by the TVNSs 
Participant 
number 
Offloading devices used 
heel pressure ulcer prevention 
policy/strategy/campaign 
P1 
Repose®, PRAFO®, orthotic 
footwear 
Nothing heels specific 
P2 Pillows, Heelift®, Prevalon® Heels up 
P3 Repose wedge®, pillows, soft cast. Nothing heels specific 
P4 Pillows, foam heel lift devices. 
Aide memoir (a flow sheet that they 
follow) 
P5 
Dependent on ward area, no agreed 
criteria for use of heel devices 
ThinkGlucose campaign concentrating 
on the foot, intentional rounding 
P6 
Kerapro® and Aderma®, some 
offloading boots, but used on a single 
patient basis 
Nothing heels specific 
P7 
Offload (Repose® style) and custom-
made troughs 
Heel protection flow chart 
P8 Repose® boots and wedges, Heelpro 
Nothing heels specific – moving over 
to new care plan 
 
6.2.4 Grey literature review 
The grey literature search was conducted on 18/08/2016 and yielded 50 potentially 
relevant articles (Table 6-3). Most of the articles gained from contacting manufacturers 
and searching their websites were conference posters of either case studies or product 
reviews of their offloading devices and did not add anything additional to the theories. 
Twenty-four papers potentially relevant papers were identified that had been previously 
excluded from the systematic review.    
 
Table 6-3 Grey literature search results 
Source Number of papers retrieved 
Open Grey 0 
Systematic review search 24 










6.3 Candidate theory 1  
Healthcare professionals with specialist knowledge of pressure ulcer prevention 
are more likely to appropriately implement an offloading device as a preventative 
measure 
Figure 6-1 Initial theory 1 
 
This theory was initially developed from my personal clinical experience and 
perceptions of how the devices are used and was originally broken down into the CMO 
in Figure 6-1. This theory started as “Healthcare Professionals with advanced 
knowledge of pressure ulcer prevention” as in practice this is not limited to just TVNSs, 
but also includes link nurses (nurses who act as a link between their own clinical area 
and the TVNS team to increase awareness of pressure ulcer prevention, wound care 
issues and motivate staff to improve practice), nurses with an interest and other 
professional groups who use offloading such as physiotherapists and podiatrists. In the 
interviews other healthcare professions were acknowledged and discussed (mainly 
podiatry and physiotherapy) but as the TVNSs largely reflected on their own first-hand 
experiences and specialist knowledge, there was little data about other professionals. 
The link nurses tend to be developed and trained by the TVNSs, so the specialist 
knowledge of the TVNS will have a direct impact upon the knowledge and practice of 
the link nurses, as described by this interviewee:  
 “We have link nurses and we have identified and trained them up to a 
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6.3.1 Dedicated time 
During the interviews, dedicated time was explored as a potential contextual factor. 
TVNSs perceived themselves, when compared to ward staff, to have more dedicated 
time to do a thorough assessment of the patient; being able to take into consideration 
all of the risk factors individual to that patient which could increase susceptibility to heel 
pressure ulcer development. P4 described the dedicated time that they have with 
patients to assess their pressure areas and pressure ulcer risk as a “privilege”, 
because the ward nurses have so many other competing priorities. P1 discusses their 
job role being “focused” on pressure ulcer prevention, which means they are more 
likely to find out more information from patients in a short period of time, but this is 
likely to tie into the specialist knowledge as well as the job role of the TVNS, as 
demonstrated in this quote.  
“ when we go and chat to patients we can very often, and maybe that’s 
because we’re sort of slightly out of the situation, um, and that’s what we’re 
focusing on, that we can find out information from patients within a few 
minutes that is sometimes like, well, you know, why wasn’t someone else 
able to find that out, but I think that it is because we are almost, not 
detached, but we’ve...that’s our focus” (P1, Band 6 CNS).  
It could therefore be argued that having dedicated time and singular focus when 
assessing patients allows for a more thorough assessment of the patient’s pressure 
ulcer risk, and therefore the patients’ requirements in respect to heel offloading.  
The context of dedicated time is not just limited to assessment of patients, but also in 
the investigation, sourcing, and evaluation of devices. P2 discussed working with 
podiatry to look at the different devices:  
“…we really want to sit down [with podiatry] and, you know, get as many 
samples of all the products that are available to try and work out, you know, 
when we use what and where” (P2, lead nurse). 
P3, P4 and P6 discussed that it was their role as TVNSs to test and evaluate devices 
for trust or ward level implementation. Individual wards do not have the time and 
therefore develop a ‘reliance’ on the TVNSs to decide what devices should be used 
and to provide training on how to use them. As demonstrated in Chapter 2, there are 
numerous different devices available on the market for the prevention of heel pressure 
ulcers, with what is available continually changing as new products are introduced or 
old ones adapted. This information is usually gained directly from the supplying 
companies, either through meetings with sales representatives, attending conferences 
or literature from the companies; something that is more frequently targeted to TVNSs 
and that ward staff rarely have access to.  The volume of devices can be problematic 





“I still think that even within my own mind, I do not feel that I know all of the 
devices that are out there, and I do not know, you know, which is best in 
which scenario” (P2, lead nurse). 
There is a potential that the sheer volume of choice could act to confound strategic, 
evidence-based decision making by the TVNS, meaning that the devices selected for 
use within an organisation are those with the best sales team. 
The TVNSs interviewed tended to see it as their responsibility, either as the tissue 
viability service or in conjunction with another speciality like podiatry or procurement, to 
research the different devices available, how they work, figure out if they would be 
suitable for their patients, financial implications and any evidence base behind them, as 
this quote demonstrates:    
“…I think, you know, [ward staff] do rely on us bringing them in and I think 
also finance rely on us bringing them in as well, and the matrons for the 
directorates” (P4, lead nurse). 
There is no set process for how this would take place and would differ between 
organisations. P5 reflected upon not having agreed criteria for the use of heel devices 
in their organisation and had taken it upon themselves as part of their role to develop 
this as this quote shows:   
“At the moment there's nothing sort of… no agreed policy in place, so we 
[TVNSs] have just set up a heel working group of which there is mixed 
clinical area, procurement and podiatry, myself and practice development 
to look at the use of heel devices” (P5, lead nurse). 
Due to the context of dedicated time, the TVNS can become a resource to the patients, 
staff and the organisation in general. Their specialist knowledge, regardless of how 
they develop this, will influence which devices are used, how and where throughout 
their organisation.  From personal experience, on occasion there could be a ward 
manager or link nurse with an interest in heel pressure ulcer prevention, who might 
source a device without the support of the TVNS, but this tends to be the minority 
rather than majority of clinical areas; none of the TVNSs interviewed gave examples of 
this happening in their organisations.  
6.3.2 Pressure ulcer prevention is a priority 
Along with the TVNSs having dedicated time to focus on pressure ulcer prevention, it is 
also seen as a key component of their job role with priorities from their organisation 
seen as an influencing factor.  The NHS is a macro context that influences the 
organisation with pressure ulcer rates being monitored in some organisations in 
England through the Safety Thermometer (Harm Free Care, 2019) and Category 3, 4 
and unstageable pressure ulcers requiring investigating and reporting as a serious 





The reduction of acquired pressure ulcers, (developed whilst the patient was an 
inpatient in a particular hospital or facility) is frequently seen as the responsibility of the 
TVNS, therefore if there is a high incidence of heel pressure ulcers in a clinical area, 
this might influence the implementation of an offloading device to help drive down 
pressure ulcer rates as demonstrated here by P4: 
“When I started writing guidelines it was all about making sure to direct 
resources to where they're needed, and that's normal now that we need to 
do that because we [the TVNS team] are so performance managed. So 
yes, the devices can make a difference” (P4, lead nurse). 
Root cause analysis (RCA) is a systematic process for identifying “root causes” that led 
to a serious incident, and an approach for responding to them to minimise the chance 
of it occurring again. RCAs usually involving a structured documentation review and 
interviews with those involved (which can include the patient) and a meeting to discuss 
the findings and identify learning points. The investigation would normally be conducted 
by the clinical area where the incident occurred, but for pressure ulcer RCAs the TVNS 
would be involved in the meeting and aiding in identifying learning points. This could 
potentially be a method through which clinical environments that might need to 
prioritise pressure ulcer prevention, and where a device could be beneficial are 
identified, which P3 gives an example of:  
 “For example, elderly wards, as well trauma & orthopaedics, they’re so 
twitchy, so they've got stock of offloading devices on their wards, so they're 
very mindful.  They've learned the lessons as well from a few pressure 
ulcers that patients developed on their wards.  They've done root cause 
analysis and that's another thing which basically increases their awareness” 
(P3, Band 6 CNS). 
Along with sharing the lessons learnt from the investigation with the ward staff, if a 
knowledge deficit was identified then this might be addressed through training and 
education or focused work with the ward to resolve this. All of the TVNSs mentioned 
training and education as being a key component of their job role, and felt it was a 
mechanism by which they could successfully implement an offloading device at a ward 
or organisational level to achieve a reduction in pressure ulcer rates.  
6.3.3 Knowledge brokering 
One of the mechanisms by which TVNSs gain their specialist knowledge is through 
networking. In the absence of robust evidence, TVNS utilise the knowledge and 
experiences of other TVNSs, as discussed by P3:  
 “…when I'm having to choose a device I basically go by the manufacturer's 
advice but then trial [evaluate] it, and again with colleagues, see what the 





it…no point if the device fails in another organisation, no point having a go 
in our Trust” (P3, Band 6 CNS). 
TVNSs are the experts in pressure ulcer prevention for their organisation, therefore 
when there is a lack in clinical evidence to make decisions on practice, the TVNSs 
either have to create their own evidence through ‘trialling’ the devices (a product 
evaluation4 that is usually devised and carried out or led by the TVNS team) or search 
for an alternative evidence source to support their decisions.  This could be from other 
specialities or from colleagues outside of their organisation, although this seemed to be 
related to experience, with the more junior TVNS (band 6 or under 5 years of 
experience) opting for this. It could be considered that this does require an element of 
trust by the TVNS though; trust in the rigor of the evaluation process by their 
colleagues along with trust that the context of their organisation is similar enough for 
the results of their evaluation to be transferable (e.g., if the evaluation were performed 
in a small cottage hospital, would it be equally as effective in a large teaching hospital).  
The TVNS might also turn to the distributor of the device for support in implementation 
and training.  Building up a good relationship with the distributor will affect usage which 
P8 gives an example of: 
“our procurement actually monitors the usage of [offloading devices], and 
tells us how many we've got through, so if we feel that we're getting through 
too many we'll get the company in and get them to do training” (P8, Nurse 
Consultant). 
An interesting mechanism identified here by P8 is where an increase in usage of 
devices is assumed to be a sign of inappropriate use, something that is monitored as a 
method of keeping costs down.  However, it could also be that an increase in usage is 
a sign of proactive use or that there is a change in the patient population with more 
patients who require offloading in that clinical area.  
6.3.4 Summary 
The TVNSs have specialist knowledge with regards to the use of offloading devices 
and the different devices available, which is a resource utilised on a meso level by the 
organisation they work in with regards to the reduction in pressure ulcer rates. This 
awareness and knowledge of the resources available is developed in part due to the 
dedicated time that they have to focus on pressure ulcer prevention, which in turn leads 
to a more proactive use of offloading devices. This can be through direct patient care, 
 
4 Where the device is either provided to individual patients or a specific ward, and 
feedback is collected from ward staff and/or the patient about their judgement of 





or through their influential role within their organisations. The TVNS feel they are 
perceived by both ward staff and the wider organisation as being a valuable resource 
for driving forward and influencing the initiation and use of offloading devices through 
training and education along with the development of guidelines and protocols. 
6.4 Candidate theory 2 
Staff working in care environments that frequently care for patients at high risk 
of developing pressure ulcers are more likely to implement an offloading device 
as a preventative measure 
In Chapter 3 it was noted that the majority of RCTs took place in trauma, orthopaedics, 
elderly care, and critical care environments, because these areas are most likely to 
have the patients at highest risk of developing heel pressure ulcers. This candidate 
theory stated that nurses working in clinical areas that frequently care for patients at 
high risk of developing pressure ulcers are more likely to implement an offloading 
device as a preventative measure. Here, pressure ulcer prevention becomes more of a 
clinical priority and staff are more experienced at managing at risk patients, and aware 
of the resources available to them. 
Figure 6-2 Initial theory 2 
  
6.4.1 Culture and ethos of the healthcare setting 
During the interviews, the TVNSs agreed that staff in healthcare settings that care for 
patients at high risk of developing pressure ulcers are more likely to implement an 
offloading device.  Therefore, the factors that influence the culture and ethos of these 
care environments was explored.  
The TVNSs often described viewing it as part of their role to identify these settings and 
to focus their resources to these areas. As discussed in 6.3 some of the TVNSs view 
their roles as being performance managed against the pressure ulcer rates for their 
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organisation, making pressure ulcer prevention a priority. If there are high rates of heel 
pressure ulcers in a clinical area, this might influence the TVNSs resources towards 
that area and therefore more likely to introduce a device to that clinical area as part of 
this.  
P3 discussed how the RCA process increased awareness and the wards became 
mindful of their patient population’s risk, which in turn led to an increase in the use of 
offloading devices, as discussed here:  
 “…they are very cautious about their population, for example elderly 
wards, as well trauma orthopaedics, they’re so twitchy, so they've got stock 
of devices, offloading, Repose® wedges on their wards, so they're very 
mindful... They've learned the lessons as well from a few pressure ulcers 
that patients developed on their wards.  They've done root cause analysis 
and that's another thing which basically increases their awareness” (P3, 
Band 6 CNS).  
The RCA process might act as a mechanism to identify the clinical areas at high risk 
and therefore more likely to require an intervention, subsequently influencing 
implementation. The TVNSs knowledge of their organisation and risk factors is also a 
mechanism through which high risk wards are identified as discussed here:   
“So, for example the diabetic ward and the orthopaedic ward and ICU 
probably are the highest risk areas… but they absolutely get [use of 
offloading devices] drummed into them” (P8, Nurse Consultant). 
This TVNS’s example focuses on the highest risk areas because they will have more 
patients with risk factors for developing a heel pressure ulcer and will therefore have a 
higher incidence of heel pressure ulcers. Using terms like “drummed in” gives the 
impression of repetition as a mechanism for learning.  
If a knowledge deficit was identified during the RCA, then this might be addressed 
through training and education or focused work with the ward. It has been found, with 
regards to pressure ulcer prevention, that nurses with a sounder knowledge base make 
better clinical decisions than those with a poorer knowledge base (Lamond and Farnell, 
1998). All of the TVNS discussed training and education being a large part of their role 
and used it to increase the knowledge of ward staff with regards to risk factors for 
pressure ulcer development, along with heel pressure ulcer prevention strategies.  
Another mechanism to make a change in pressure ulcer rates and to get a device 
implemented, as well as influencing the culture and ethos of a healthcare setting, is 
through good leadership as this TVNS discusses: 
“I think if you have not got good leadership you will not get your pressure 
ulcer rates down.  Our fractured neck of femur ward has an absolutely 
fantastic ward manager.  Obviously, they are an extremely high-risk area… 





for over a year, which I think is an amazing achievement being as it's such 
a high-risk area” (P6, Band 7 CNS).  
Leadership is the ability to influence, inspire confidence and generate support among 
followers for the vision and direction of the leader (McEwen and Wills, 2011). There are 
numerous theories and models with regards to leadership but there is not enough 
evidence from the interviews to inform what it was about the ward manager that 
influenced the change to be able to map it against an existing theory.  
6.4.2 Summary 
The TVNSs discussed care environments such as orthopaedics, critical care, and care 
of the elderly as being areas that frequently care for patients at high risk of developing 
heel pressure ulcers. These were identified through the TVNS knowledge of risk 
factors, their organisation as well as through RCA investigations.  This was reflected in 
Chapter 3 as they were the predominant care environments where the RCTs took 
place. The TVNSs would focus their resources, in the form of time, education, and 
devices towards those areas as this could make the biggest impact and change in 
pressure ulcer rates.  
Following on from the identification of these areas, staff are made more knowledgeable 
of the risk factors for their patient group through shared learning from RCA 
investigations along with focused and repeated training and education. Spaced 
repetition theory is based on the work by Ebbinghaus (2015) that tells us that repeated 
learning over a period of time increases the likelihood of embedding knowledge into 
long term memory. This strategy of repeated teaching could be expected to increase 
the knowledge of heel pressure ulcer risk factors, and theorised that it acts as a 
mechanism to increase the likelihood of devices being implemented and used in their 
clinical area to prevent heel pressure ulcers from occurring. Leadership has also been 
identified as a potential mechanism for influencing pressure ulcer prevention strategies 
including device use and staff engagement.  
6.5 Candidate theory 3 
Nurses are more likely to implement an offloading device if it is easily accessible 
within the care environment 
It was theorised that the easier it is to access a device, the more likely they are going to 
be used in practice, which is supported by Källman and Suserud (2009) who identified 
that nurses’ perceived lack of access to equipment as being a barrier to effective 





Figure 6-3 Initial theory 3 
 
6.5.1 Care environments that stock offloading devices 
Theory 3 does tie in with theory 2, as it is also assumed that care environments that 
are used to caring for patients at risk of developing a heel pressure ulcer are more 
likely to have a stock of offloading devices. This is because if they have identified their 
patient group as being at risk, they are more likely to source a device to reduce this 
risk. The TVNSs perceived that having a device as stock is necessary, but this alone 
will not to lead to a proactive use of devices. A recurring theme from the TVNSs to 
increase offloading device use was through ‘raising awareness’. Mechanisms that raise 
awareness were identified as a robust protocol and/or educational package that 
includes specific risk factors for the heel and the use of offloading devices, which is 
demonstrated here:  
 “…obviously if they’re [the offloading device] there and they know about 
them, they've been educated about them then they’re more likely to use 
them” (P4, Lead Nurse). 
Another possible mechanism through which awareness is gained is through repeated 
use of the offloading devices, which leads to familiarity with the device and becomes 
part of routine practice, as this TVNS describes:  
 “…I think once there was more awareness and I think when more nurses 
see [offloading device] and they know what it does and how to use it, then 
they’re more inclined to initiate it themselves” (P6, Band 7 CNS). 
P7 was part of a regional collective strategy which combined education and access to 
equipment, which they felt to be an effective strategy, as described in this quote.  
“…we were part of the whole 2012 Ambition from the Midlands and East 
and there was a massive drive in education and equipment for the nurses, 
and that's had a huge impact on our numbers of pressure ulcers” (P7, Band 
7 CNS).  
P7 did acknowledge that this initial drive was not followed up and they felt this 
subsequently led to device usage dropping and pressure ulcer rates increasing, 
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although it is not known whether it is the education, the high focused attention from the 
ambition or ‘leadership buy-in’ that was influential, but the TVNS supported repeated 
learning as discussed in 6.4. 
6.5.2 Delays in access  
From clinical experience, if it is decided that a patient requires an offloading device, if it 
is kept on the ward it can potentially be put on the patient immediately, whereas if it 
requires ordering in, regardless of how quick this process is, there will always be a 
delay from the identification of the need to implementation. This was explored during 
the interviews and it was found that this delay varies greatly between organisations 
depending upon how and where they are ordered from and what the ordering process 
entails. Some organisations have a centralised stock which can be accessed within a 
few hours, whilst others order the devices through the NHS supply chain which could 
take several days to be delivered.  
Several of the TVNS discussed how having devices easily accessible does increase 
their usage. There are multiple factors that could affect the ordering of a device, which 
in turn would delay or altogether stop a patient from being given a device. These 
factors included problems with the order process, such as difficulties accessing the 
ordering system or requiring financial approval, or due to competing priorities for the 
ward staff, which P5 gives an example of:  
“in a busy environment, [ordering offloading devices] is just one more thing 
that they [nurses] have to sort out” (P5, Lead Nurse). 
There can be a delay in ordering the device or they might not be ordered at all due to 
“getting lost in transit in terms of communication” (P1, Band 6 CNS)   
This was also reflected in the literature; Campbell et al. (2010) and Spilsbury et al. 
(2008) identified availability of equipment as being a barrier to implementation and 
provision of pressure ulcer preventative care.  
In P5’s organisation, matron level approval was required before anything could be 
ordered which would cause a delay in accessing equipment or make them less likely to 
order due to the extra “hassle” of contacting the matron. This is likely a mechanism 
from managers to monitor and control spending on wards, which ties in with theory 4 
(which follows). 
Some of the TVNSs discussed using pillows to offload the heels in situations where 
wards do not have access to a device or are waiting for a device to be delivered. This 
is something that can in theory be used immediately and all wards should have access 





“the problem we’ve got is that we do not have many pillows, so finding a 
pillow is a real scrabble, so that’s part of a massive problem when it comes 
to using them as a reliable offloading device” (P5, Lead Nurse). 
6.5.3 Summary 
In a busy ward environment where nurses have multiple competing priorities, if the 
device is kept as a stock item it is more likely to be initiated in a timely manner. This 
could be because the offloading device is not kept as stock and therefore easily 
accessible, delays in the supply process and poor communication can lead to a delay 
in the device being initiated or be a barrier to it being used altogether. In the absence of 
devices, alternatives are sought such as pillows, because the need to offload the heels 
has been identified. 
There is little evidence for the use of pillows as an offloading device, but in practice 
pillows are often used under the lower leg (not on the foot) to elevate the heels off the 
bed, as they are easy to access. Tymec et al. (1997) did report difficulties in 
maintaining offloading with a pillow as well as offloading devices over a 24-hour period, 
with the heel moving as the patient moved. Restlessness was reported as making heel 
elevation difficult, if not impossible to maintain, with a pillow.  
6.6 Candidate theory 4 
If patients are moved frequently between different care environments, then 
offloading devices are less likely to be utilised because of cost factors 
Figure 6-4 Initial theory 4 
 
The cost of offloading devices was discussed by most of the TVNS as something that 
does influence their use.  There were differences between organisations in how the 
devices are ordered and who pays for them, but in most cases, they would be paid for 
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out of an individual ward’s budget. For clinical areas that have a high turnover of 
patients, such as A&E or admissions wards, even if the devices could be re-used 
between patients, there could be a reluctance to use the devices in case they leave the 
clinical area with the patient, as this becomes a financial implication and their access to 
the device is lost:  
 “…if we were going to try and implement heel offloading devices at point of 
entry to hospital, if they’re deemed to be at risk, then it means that it could 
be A&E or the medical admissions unit that were constantly buying them, 
even if they were using them for the rest of the stay in hospital” (P5, Lead 
Nurse). 
The TVNSs’ responses suggest that the mechanism in which offloading devices are 
paid for does seem to be an influencing factor, as ward managers and matrons seem 
to be protective of their segment of the budget for their clinical area, therefore costs 
from an organisational context does appear to influence usage of offloading devices. If 
a benefit to the devices could be demonstrated on an organisational level and there 
was evidence that they reduce pressure ulcer incidence, then it would be likely that 
they would be funded. 
P7 gives an example of how the costs influence the ownership of the devices at a ward 
level: 
 “...the ideal would be that the patient would come in and they would get 
given a pair of heel protectors and it would follow them through, but that’s 
not how it works. We’d love to be able to do that, but there’s just not the 
budget for those sorts of things. So, they are ward owned and the wards 
do, when they’re not throwing them away because they think they’re 
disposable, they do keep hold of them” (P7, Band 7 CNS). 
Although the financial implications of the devices appear to be a consideration for the 
TVNSs and managers when making recommendations on what type of devices they 
should use, it remains unclear whether this influences the ward staff, with some of the 
TVNSs thinking that wards became protective over their reusable devices and not 
letting them leave the ward with patients, but others felt that the ward staff would just 
think in terms of what is best for the patient. Some of this could be around the 
perceived “ownership” of the equipment as suggested by this TVNS: 
“I think there’s something there about… it’s almost like the [ward’s] 
ownership of the equipment really rather than, you know, it should be the 
patient’s equipment” (P5, Lead Nurse). 
6.6.1 Summary 
A combination of contextual factors become apparent. The frequency of patient 
movement between care environments becomes an issue when devices are paid for 





usage, which in turn leads to ward staff becoming protective over the devices.  This 
brings about a perceived ownership of the devices being by the ward rather than the 
patient. This closely links in with theory 5 (which follows in section 6.7) as the cost of 
the devices does seem to have an influence on the choice of reusable or single patient 
use devices (as described in Chapter 2). What was less clear was how much influence 
the cost of the devices had on usage at a micro level by the nursing team. 
6.7 Candidate theory 5 
Single patient use offloading devices, versus reusable devices, will be more 
desirable dependent on the care environment and priorities of the ward manager 
Figure 6-5 Initial theory 5 
 
This theory started by looking at whether re-usable (as opposed to single patient use) 
devices were more desirable in particular situations, but it links in with theory 4 with 
regards to the financial implications.  As discussed in 6.6, a key mechanism appears to 
be the perceived ‘ownership’ of the devices being with the patient or the ward.  Single 
patient use devices belong to the patient, so will stay with them throughout their 
inpatient journey whereas reusable devices are owned by the ward. The TVNSs 
described how wards become protective over ‘their’ devices and do not want them to 
be ‘lost’ with the patient during ward transfers, as this TVNS gives an example of:   
” I think some of the issues with the reusable devices has been the fact that 
they have disappeared off with the patient, when the patient has left the 
area, so that can be a cost issue” (P2, Lead Nurse). 
However, if a patient is transferred to another ward without a device then there could 
be a delay until that patient’s heels are offloaded again. Therefore, the financial 
constraints on a meso level and the ownership of the devices can lead to a clinical 
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they are under their care, rather than for the whole of the patient’s journey as this 
TVNS’s example describes:   
“You then have the problem where the ward does not want to transfer [the 
reusable offloading device with the patient] if they belong to the ward and 
they've paid for them. They may not transfer the patient with them, and then 
the patient may not have access to them in the next ward” (P5, Lead 
Nurse). 
However, there is a financial consideration for wards where there are a large proportion 
of patients who are at high risk of developing a heel pressure ulcer that may benefit 
from offloading. Reusable devices can be more desirable as ’what will benefit most of 
their patient population’ is taken into consideration, as discussed in this TVNS’s 
example: 
 “if they’re in ITU for a week post op, they are on inotropes [medication that 
influence how effectively the heart pumps but can alter blood flow to 
peripheries] and everything else, then you know, they’re going to be hugely 
at risk. So, you may want cheap and cheerful but not the long-term single 
patient device. So, it could be that you go down the wedge or something 
that you can re-use for someone else in exactly the same situation the 
following week” (P5, Lead Nurse). 
There is also an element of personal experience, expertise, and preferences of the 
nurse, with regards to the choice of device. The evidence based nursing model 
acknowledges that not only should the available research evidence be taken into 
account, but also clinical expertise allows nurses to be able to balance the benefits and 
risks of the different treatment options available to them for each patient, taking into 
account the patient’s unique clinical circumstances including comorbidities and 
personal preferences (DiCenso et al., 1998). But when there is a lack of evidence and 
knowledge about the potential resources available then the nurse might choose a 
device based on familiarity, as P1 describes:  
 “unless staff recognise which device is suitable for which patient, they 
would still just go for the same one [staff] were comfortable with all of the 
time” (P1, Band 6 CNS) 
6.7.1 Summary 
The type of offloading device available in a clinical area is influenced by the patient 
population and what will cater for their immediate needs. As discussed in candidate 
theory 4 (6.6), patient transfers are a consideration where clinical areas manage 
individual budgets. The perceived ownership of the devices is a key mechanism, with 
single patient use devices being owned by the patient whereas reusable devices are 
owned by the ward. This leads to wards being protective over their stock and not 





long term. There is also a question regarding how to provide the most cost-effective 
care for most patients within a clinical area. If wards regularly care for patients that 
might benefit from offloading, reusable devices could be more financially viable. It 
remains unknown what proportion of usage is single patient versus reusable for 
different clinical environments.    
6.8 Candidate theory 6 
Offloading devices are more effective in patients with reduced consciousness 
Patients cared for in areas such as critical care or stroke wards could be at high risk of 
developing a pressure ulcer due to being bed bound, having reduced consciousness, 
or being sedated and ventilated, and therefore immobile and completely reliant on staff 
for all care including repositioning. These patients are therefore at high risk of 
developing a heel pressure ulcer, not only because of their immobility, but also their 
medical condition and/or medications that can lead to decreased perfusion to the lower 
limb.  It was therefore theorised that this patient group would benefit from offloading 
because of their level of risk, but also it would be more effective because they would be 
less able to remove the device.  
Figure 6-6 Initial theory 6 
 
There was overall agreement with this theory from the TVNSs. There were views that 
this was because this patient group is ‘more compliant’ due to their immobility and 
inability to remove the device as this TVNS describes:  
 “Their patients [ICU] are pretty immobile and easier to manage from that 
respect. So, although they are at higher risk because of inotropes, in fact 
they’re more compliant is probably what they are” (P4, Lead Nurse). 
These patients are more likely to require offloading because they will be higher risk and 
are less likely to remove the device. It could therefore be argued that this is a care 
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 “They’re not moving [the leg] off the pillow or whatever you’re using, so it’s 
easy to reposition them to keep the device in place. I’m not sure whether 
comfort is a case or just immobility and inability to remove it” (P5, Lead 
Nurse). 
Throughout the interviews there were differing opinions with regards to the use of 
pillows and wedges as an offloading device. However, most of the TVNs discussed that 
in this patient group, they would promote the use of a pillow or a wedge in preference 
to an offloading boot. This was because if the lower limb is immobile, then a device that 
is fixed to the foot is not required. This relates to theory 5 (6.7) with regards to reusable 
devices, including pillows, being more suitable and cost effective for a patient group 
that cannot remove the device or complain about it being uncomfortable, as described 
here by P8:  
So, wherever the patients are very high risk, I mean, have really high-risk 
factors and there is a risk that their legs could come off the pillow, then I 
would go for the higher end device. But I do think even for your high-risk 
patients, if they offload satisfactorily on a pillow then there’s a place for 
that” (P8, Nurse Consultant). 
Patients with reduced consciousness or an immobile limb were identified by all the 
TVNSs as being a patient group they consider to be at high risk of developing a heel 
pressure ulcer, so should be proactively offloaded. Generally, it was seen that this 
could be achieved as there are fewer patient factors that will affect device usage, and 
staff should know that all of their patients are at high risk of developing a heel pressure 
ulcer, and hence the importance of offloading for all of their patients. It is also possible 
that this is a patient group where reusable devices such as pillows and wedges could 
be more suitable, giving further evidence to candidate theory 3.  
6.9 Candidate theories 1-6 summary 
These six candidate theories were identified as being part of a larger programme 
theory regarding processes that would lead to a more ‘proactive’ use of offloading 
devices for the prevention of heel pressure ulcers. It was identified that there were 
three contextual levels that were influential. From a macro level the priorities of the 
NHS to reduce pressure ulcer rates influenced the TVNSs as they identified pressure 
ulcer prevention and reduction in pressure ulcer rates within the meso context of their 
organisation as being a significant part of their job role. This was done through 
identifying clinical areas that they knew had a high-risk population, or where patients 
had developed a severe pressure ulcer and shared learning points identified the need 
for offloading through the RCA process.  Within an organisation the TVNSs viewed 
their role as influential in the use of offloading devices, not only by implementing them 





through identifying the clinical need, sourcing the devices, raising staff awareness of 
what is available to them, and providing training and education on how to use them and 
risk factors for heel pressure ulcer development. The TVNSs viewed training and 
education as being a large component of their job role and that this was key for 
influencing the use of these devices. 
The TVNSs felt that they, along with senior nursing managers (ward managers and 
above), were conscious of the cost of devices.  In most of the TVNSs organisations 
offloading devices are paid for out of individual ward budgets. In the micro context of 
individual wards, the choice of reusable or single patient use devices might be 
influenced by what is most cost effective for their patient group. It is unclear if the cost 
of the devices has any impact on how individual ward staff use the devices, or if ward 
staff were even aware of the costs, but it was felt that having offloading devices easily 
accessible to them will increase their usage when in combination with an increased 
awareness of pressure ulcer risk factors.  
In clinical areas where there is a high turnover of patients, where patients are less 
mobile or where offloading devices are not immediately available to them pillows could 
be used as a desirable temporary offloading device.  During the grey literature review 
this advice was reflected by Black (2004), but Campbell et al. (2010) stated the pillow 
should not be seen as a replacement for an offloading device as it does not always 
stay in place, and does not always effectively offload, depending on the thickness of 
the pillow and the weight of the limb. There is also the risk that because a pillow is not 
a device specific to offloading, it can be removed and used elsewhere on the patient or 
for another patient (Gilcreast et al., 2005). 
6.10  Programme theory 1 
NHS and organisational priorities with regards to reduction in pressure ulcer rates are 
influential towards the job role and focus of the TVNS. The TVNSs see themselves as 
central to heel pressure ulcer prevention at a macro, meso and micro level, which can 
be done through the proactive use of offloading devices, thereby acting as both a 
context and a mechanism. TVNSs identify the need for offloading, help to source the 
devices, promote their use through training and education and prescribe them to 
individual patients. Factors that influence their use on a micro level can be the patient 
group, staff knowledge, cost and having a stock of the devices.  This is illustrated in 
Figure 6-7 with the macro context of the NHS and the wider organisation, and how this 
influences the context and mechanism of the role of the TVNS, and in turn how they 





Figure 6-7 Schema for programme theory 1 illustrating the contexts and 
mechanisms that lead to a proactive use of offloading devices 
 
6.11 Summary 
This chapter has presented how candidate theories 1-6 have been refined into 
programme theory 1 regarding the proactive use of offloading devices for the 
prevention of heel pressure ulcers. Chapter 7 will go on to refine candidate theories 7-





Chapter 7 Programme theory 2: Reactive use of offloading 
devices 
7.1 Introduction 
This chapter will demonstrate how the TVNS interview data were used to elicit and 
refine initial candidate theories 7-10 into a programme theory about how offloading 
devices are used ‘reactively’.  When a heel pressure ulcer is already present the 
desired outcome becomes the treatment of the heel pressure ulcer, prevention of a 
pressure ulcer developing on the other heel and prevention of deterioration through 
offloading.  
This theory was developed from personal experience in clinical practice; where it had 
been observed that offloading devices tended to be initiated once there was blanching 
erythema or a heel pressure ulcer of any category had occurred, as a treatment and to 
prevent deterioration, rather than implementing the device in the first instance when 
there were no signs of skin damage. This was explored during the interviews to see if 
this was something that occurs more widely, to try and establish why this happens, and 
if this was viewed as an effective way of utilising offloading devices.  
7.2 Candidate theory 7 
Nurses are more likely to utilise heel offloading devices as a response to 
pressure damage rather than as a preventative measure 
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Offloading following a pressure ulcer developing was often described as a ‘reactive 
response’ and it could be that the skin damage is a visual mechanism that highlights 
the risk that the patient is to develop a heel pressure ulcer as this example illustrates.  
“…even though they have got the [offloading device kept as stock], they 
wouldn’t think to put it there as a preventative, again they would use it, but 
it would be a reactive response, so the advantage it furthers the staff on the 
ward in having the equipment there, is that from their perspective when the 
damage occurs they can put that offloader in place to stop any further 
deterioration, but they wouldn’t think to pro-actively put it in place” (P1, 
Band 6 CNS). 
This reflects candidate theory 3, where it was felt that having a stock of offloading 
devices increases utilisation, although it is acknowledged that this does not happen 
every time and the reasons why are not known.   
7.2.1 At risk patients 
As discussed in Chapter 2, risk assessment is a key component of pressure ulcer 
prevention (NICE, 2014b) by helping the nurse to identify whether the patient is at risk, 
and implement appropriate preventative care. However, how the information from the 
risk assessment is utilised and interpreted is an issue as this TVNS discusses:  
“risk assessment is I think undertaken but I do not think it's interpreted that 
well, certainly not in particular body sites” (P5, Lead Nurse). 
Rather than the context being patients at risk of developing heel pressure ulcers, it is 
the clinical areas without a clear protocol/pathway for heel offloading.  In this context, 
nurses do not tend to think of individual body sites during the risk assessment. The 
focus might be primarily on the buttocks and sacrum, and the heel gets missed as 
washing and cleansing patients, especially if the patient is incontinent, will focus on this 
region. The need for heel offloading is only thought about when skin damage, either as 
erythema or a heel pressure ulcer, becomes a visual prompt that the current 
management strategy is not working, and therefore an additional intervention is 
required. P6 gives an example of this: 
“I think when patients have deep tissue injury and it’s left uncovered, you 
know, there’s no reason to cover that over. I think that heightens nurses’ 
awareness to think, oh that patient is at high risk, they’ve already got a 
deep tissue injury, we need to ensure that we are repositioning. It’s almost 
in their face that they have to do something about it” (P6, Band 7 CNS). 
It could be rationalised that if the skin is assessed as normal, with no signs of pressure 
damage, that the patient is receiving sufficient pressure relief and therefore does not 
require an additional intervention.  There is a balance of assessing the patient’s risk 
and initiating the device as a preventative measure, but this could lead to additional 





pressure ulcer developing, in the form of blanching erythema, and initiating offloading 
at that point could be a viable option, but the danger with the latter is that these first 
signs could be missed, or there is a delay in accessing the device and the additional 
intervention is implemented too late to prevent a heel pressure ulcer.  
There are nationwide campaigns such as React to Red Skin (2019) that aims to teach 
the importance of early recognition of deteriorating pressure areas, where there is 
either blanching or non-blanching erythema, and aims to teach staff to be reactive to 
early signs of pressure damage to prevent it deteriorating to more severe damage. This 
recognition of erythema as a precursor to a pressure ulcer developing is a mechanism 
to alert the nursing team that additional interventions such as offloading devices are 
required. The TVNSs all stated that skin inspection was key for identifying at risk heels, 
however when skin inspections are missed along with signs of deterioration, pressure 
damage more severe than erythema occurs before an offloading device is 
implemented.    
Barriers to skin inspection of the heel were explored; one suggestion, which is reflected 
in clinical practice, is the difficulty in actually accessing and looking at the heel in 
patients that are difficult to reposition or have limited mobility in the lower limb as this 
example illustrates:  
 “The heels are difficult to visualise so to speak, I think sometimes the 
damage gets missed, so until that damage is staring them in the face...the 
minute they see that blistered area, then that would probably trigger 
[implementing an offloading device]” (P1, Band 6 CNS). 
Physical barriers to skin inspection were also discussed, such as bandages, socks, or 
casts, although it was not known why a skin inspection is not done if the physical 
barrier is removable as this TVNS discusses:   
“If a patient's got a four-layer bandage on, of course you're not going to 
take that down and check the heels, but what we would expect and what 
we teach is that they document it… “patient has four-layer bandage and is 
not due for changing until this date, skin will be checked at that time” and 
that's absolutely fine.  What's not okay is when, they've got socks or 
[venous thrombus embolism prevention] stockings and they don't check 
underneath them” (P6, Band 7 CNS). 
There were comments from those TVNSs who tended to work in areas with no heel-
specific campaign, about the heels not being thoroughly inspected during routine skin 
assessments as this TVNS discusses: 
“I’m not convinced that skin inspection is always undertaken thoroughly for 
the heels. I think sacral areas tend to get a big focus and I think people 





It could therefore be that a successful campaign, protocol, or education about the heel 
being a high-risk area could be a mechanism that increases skin inspection at the heel 
which in turn leads to early recognition of deterioration. 
7.2.2 Summary 
The TVNS felt that skin assessments were a mechanism that could highlight early 
signs of deterioration and therefore the need to offload the heel.  This reactive use of 
offloading devices could be effective, through the recognition of early signs of pressure 
damage, highlighting that the current prevention plan is insufficient and therefore an 
additional element like an offloading device is required. When skin inspections are 
missed or deteriorating skin is not recognised, a heel pressure ulcer could develop and 
the opportunity to potentially prevent through offloading has been missed, so the 
offloading device is reactively implemented as a treatment of the heel pressure ulcer 
and to prevent further deterioration. 
7.3 Candidate theories 8 and 9:  
Candidate theory 8: If a powered air mattress is already in use, additional 
preventative methods are less likely to be implemented 
Figure 7-2 Initial theory 8 
  
Candidate theory 9: Repositioning is a key component of pressure ulcer 
prevention but is less likely to take place if devices are being utilised. 
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Very early on in the interviews it became clear that candidate theories 8 and 9 were 
connected, and therefore have been presented together.   
The TVNSs felt that in most cases if a patient was on a dynamic mattress and regularly 
repositioned, then this would be sufficient to prevent heel pressure ulcers, and 
therefore an offloading device would not be required as illustrated by P1:  
 “if you have got a mattress in place that is providing support to relieve 
pressure areas, do you need more than one pressure relieving piece of 
equipment in place? Is it not down to other issues like, if their heels are 
deteriorating, are they actually deteriorating, not because they are not 
getting the pressure relief [from the mattress], but more because they are 
not being repositioned to relieve the pressure?” (P1, Band 6 CNS). 
It is not the mattress alone that is important – but the mattress used in conjunction with 
a repositioning plan; and it is the repositioning that appeared to be the main focus for 
the TVNS.  It was often seen that repositioning was more important than any device, 
therefore linking this theory in with theory 9. 
7.3.1 Care environments that lack capacity to reposition patients 
Because the TVNSs felt that repositioning was the most important component of 
pressure ulcer prevention, it appeared that when repositioning could not be achieved, 
additional devices or interventions would be required. Barriers to repositioning within 
different care environments were explored during the interviews. 
Repositioning is an integral part of pressure ulcer prevention, and as discussed in 
Chapter 2 there is a sound rationale for repositioning, however there is little RCT 
evidence to substantiate this (Gillespie et al., 2014). There was consensus from the 
TVNSs that repositioning is the most important aspect of pressure ulcer prevention and 
would be their main focus, with devices such as mattresses or offloading devices being 
additional requirements for high-risk patients where repositioning alone is insufficient, 
as explained by this TVNS:  
“My first reaction is to increase repositioning…equipment cannot replace 
the need for repositioning” (P3, Band 6 CNS). 
Offloading devices were not viewed as a repositioning aid, but as an additional tool to 
be used when either repositioning could not be achieved or when there was evidence 
of vulnerable skin and used to prevent deterioration. Offloading would be the third line 
choice in pressure ulcer prevention after repositioning and a mattress if these were not 
sufficient to meet the patient’s needs. This could be where a reactive response is 
appropriate; when there are signs of erythema or a heel pressure ulcer, this is a sign 





TVNSs might promote the use of an offloading device proactively in high-risk clinical 
areas they have identified as requiring more than just a mattress and repositioning 
schedule to prevent heel pressure ulcers (as discussed in Chapter 6):  
“Repositioning over anything is the most important aspect of pressure ulcer 
prevention, but if they’re not repositioning for whatever reason or they’re 
not repositioning effectively, if you've got heel devices in protecting the 
heels everyone’s a winner are they not?” (P7, Band 7 CNS). 
But one issue raised here by P7 is whether patients are repositioned ‘effectively’ which 
could include the legs and feet being repositioned, so they are offloaded, or if it is just 
the torso that is moved, and the heels remain in the same position as P1 mentioned: 
“the upper body moves, but the heels stay [in the same place]” (P1, Band 6 
CNS). 
This could be due to patient factors, such as the medical condition of the patient, a 
procedure that means the patient cannot be repositioned or the patient not wanting to 
move. It is in these situations that an offloading device might be useful, as illustrated in 
this example: 
“…when patients either are declining to be repositioned or maybe they can't 
be repositioned.  For example, on the fractured neck of femur ward a lot of 
those patients when they first come back from surgery, they're either in pain 
initially … they find [repositioning] uncomfortable.  A lot of them are very 
elderly, they've got a lot of other co-morbidities, so [offloading devices] are 
an additional aid to repositioning” (P6, Band 7 CNS). 
Where there are patient groups identified where both repositioning and a mattress are 
not sufficient to meet their needs, or they cannot tolerate, this is where the additional 
dimension of care is required, and an offloading device can be used proactively as this 
TVNS discussed:  
 “Where I tend to see it is our respiratory ward where you’ve got a patient 
who, maybe because of breathing difficulties, cannot go on their side and 
they desaturate when you put them on their side, and we’ve had it in 
[critical care] as well you know. I think then in that situation, if you are using 
a heel offloading device, that’s more than justified in that situation” (P6, 
Band 7 CNS). 
This theory links in with theory 6 as ‘effective repositioning’ is dependent on the patient 
maintaining the position that they have been moved to and can therefore be better 
maintained in patients with reduced consciousness. 
7.3.2 Lack of knowledge of the need for repositioning 
As previously discussed, the TVNSs put greatest emphasis on the importance of 
repositioning, therefore repositioning would be central to the TVNSs care planning for a 
patient as well as for education packages delivered to staff. However, when patients 





staff perceive that they can use devices to replace repositioning, or due to a lack of 
resources such as staffing levels.  
Several TVNSs discussed how mattresses had historically been used as a replacement 
for repositioning, but due to ongoing education this misconception was becoming less 
common as discussed here:  
“it was common for the misconception really that if a patient was on a 
dynamic mattress they wouldn't need to be turned, that the mattress was 
doing the job for them.  I think that's probably less so now, you know, it's a 
big part of teaching, big part of discussions around that, so I think that is 
becoming less so” (P5, Lead Nurse). 
If the patient is wearing an offloading device then pressure is removed from the heel, 
but repositioning is still necessary as there is still pressure to other body sites. Although 
using a device (mattress or offloading) as a replacement for repositioning was reported 
as becoming less common, P1 discussed how this was still happening at times in their 
organisation: 
“Based on my experiences of what I see out and about, I would say that if 
they have got a device in situ, that they perceive will provide offloading, 
repositioning support, they are less likely to implement the care because 
they feel that that’s already doing it” (P1, Band 6 CNS). 
7.3.3 Summary 
Theory 8 and 9 were combined because powered air mattresses are not used on their 
own, but in combination with a repositioning schedule as part of the pressure ulcer 
preventative plan of care. Repositioning is viewed by the TVNSs as being the most 
important component of pressure ulcer prevention, and if a patient is repositioned well 
and can maintain that position then the heels should be lifted from the bed. Mattresses 
are a second line choice followed by offloading devices. Offloading devices are 
considered when: 
• Patients are assessed as high risk and another element to prevention is 
required additional to repositioning 
• Patients cannot be repositioned, for example due to medical condition, 
procedure, or surgery 
• Patients cannot maintain the position they have been moved to 
Theories 8 and 9 therefore inform the programme theory of how offloading devices are 
used reactively, because they appear to be a third line choice after repositioning and a 
powered mattress, and it is only when these are no longer sufficient to meet the 
patient’s needs, which could be because their skin is visually deteriorating, that an 





likely to be repositioned if they have a device in situ because the patient has been 
identified as being at high risk of developing a pressure ulcer and so require all 
pressure ulcer preventative interventions available.  
7.4 Candidate theory 10 
The offloading device is a physical reminder for nurses and the patients of their 
risk and therefore more attention is paid to this at-risk body site. 
Figure 7-4 Initial theory 10 
 
It has already been established that devices such as mattresses or offloading are used 
in patients who have been deemed at high risk of developing a pressure ulcer. It was 
theorised that if staff see that a patient has a device in place that this will act as a 
physical reminder of the risk. Some of the TVNSs utilised mattresses as a ‘visual 
trigger’ in their care planning with staff, as illustrated here: 
“a dynamic mattress is a visual trigger to have the SSKIN bundle [a 
resource pack to aid in the assessment and care planning for people at risk 
of pressure ulcers] in place, so I think it goes that if a patient’s on a 
mattress they are more vulnerable and therefore they’re having intentional 
rounding [a structured approach to check patients at set times to assess 
and manage their fundamental care needs]” (P5, Lead Nurse). 
Dynamic mattresses are easy to identify due to the pump at the foot of the bed. 
However, for a patient who is in bed with an offloading device, this could be covered by 
blankets so would only be identified when the covers are pulled back.  It could be that 
this would then be a reminder for staff to check the patient’s heels. In contrast 
offloading devices could also be a barrier to checking the heels as staff might not want 
to remove the device if this is viewed as time consuming, if staff are not sure what the 
offloading device is for or how to reapply them. Little was mentioned about the devices 
raising awareness of heel pressure ulcer risk.  
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7.5 Candidate theories 7-10 summary 
The TVNSs focused on the importance of risk assessments to help identify which 
patients are at risk of developing a heel pressure ulcer, but it was perceived that ward 
nurses do not consider individual body sites during this process, rather the patient as a 
whole. This could lead to risk of heel pressure ulcer development not being identified 
and an offloading device not being implemented until a heel pressure ulcer has 
occurred.    
Skin assessments at the heel could sometimes get missed, for example if repositioning 
is difficult or if there are physical barriers such as bandages, casts, splints or devices, 
including the offloading device itself, which could lead to nurses not recognising early 
signs of pressure damage. Early signs of pressure damage can be a visual indicator 
that the current management plan is insufficient and an additional preventative 
intervention, such as a dynamic mattress or offloading device is required. 
The TVNS perceived repositioning to be the most important component of pressure 
ulcer prevention, followed by implementing a dynamic mattress. When repositioning 
cannot be successfully achieved or the mattress and repositioning is insufficient, 
offloading might then be considered. This can lead to a reactive use of offloading 
devices as they are used only when the other interventions are found not to be working 
and either erythema or a pressure ulcer develops. From the interview data Figure 7-5 
was developed as a proposed model that TVNSs’ use, to illustrate when they would 
consider using an offloading device. This adds more to the algorithm created by NICE 
(2014a) which recommends offloading for patients at high risk of developing a pressure 
ulcer, who are also at risk of developing a heel pressure ulcer. 
Utilising offloading devices in a reactive manner is not necessarily a negative outcome.  
Where repositioning and dynamic mattresses are already in use, in many cases this is 
sufficient to meet the pressure ulcer prevention requirements of the patient, especially 
if the heel is moved and/or lifted off the bed during repositioning.  Early signs of a heel 
pressure ulcer can be a visual prompt that the current plan of care does not meet the 
patients’ need, and it would be these patients that might benefit from an offloading 
device.  
7.6 Programme theory 2 
Programme theory 2 explored factors that could lead to a reactive use of offloading 
devices; where they are used once erythema or pressure damage has already been 






In the micro context of individual patients found to be unable to tolerate or be 
concordant with the repositioning plan or mattress use, an offloading device is supplied 
in response. Another micro context is that if a patient is found to be at high risk of 
developing a heel pressure ulcer, it could be only once the pressure areas start to 
deteriorate that staff recognise the risk and react to the signs of pressure damage by 
initiating a device.  The mechanism through which these patients are identified could 
therefore be viewed as a reactive response. 
7.7 Summary 
This chapter has presented how candidate theories 7-10 have been refined into 
programme theory 2 regarding how offloading devices are used reactively for the 
prevention of heel pressure ulcers when there are early signs of skin changes such as 
erythema, or once a heel pressure ulcer has occurred as a treatment of the heel 
pressure ulcer and to reduce the risk of deterioration.  
Chapter 8 will go on to refine candidate theories 11-13 into a third programme theory. 




Chapter 8 Programme theory 3: Patient factors that influence 
how offloading devices are used 
8.1 Introduction 
Chapters 6 and 7 have presented the first two programme theories, which are focused 
on the prevention and treatment of heel pressure ulcers, as this is a desired outcome 
from the perspective of the TVNSs and clinicians in most situations. However, this 
might not be the desired outcome for patients, where comfort and mobility are of 
importance, or there could be contexts where offloading is not possible or safe. This 
was explored in candidate theories 11-13 and refined into programme theory 3.  
8.2 Candidate theory 11 
Offloading devices are not suitable for use in patients who are at high risk of 
falls as they could become a fall hazard. 
Figure 8-1 Initial theory 11 
 
This theory started from personal clinical experience of caring for patients who are both 
at risk of developing a pressure ulcer and at risk of falling, and how the pressure ulcer 
preventative care is prioritised and delivered. Due to the job role and priorities of a 
TVNS there is an interest and motivation towards preventing pressure ulcers, but also 
insight into the consequences of the care decisions, thereby allowing an informed 
decision to be made with regards to what is perceived to be in the best interest of the 
patient. The interviews therefore explored how decisions are made with regards to the 
use of offloading devices in patients who are also at risk of falling.  
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8.2.1 Patients at high risk of developing a heel pressure ulcer and 
falling 
The grey literature review identified two papers that were looking at devices for patients 
whilst sitting out, Bale et al. (2001) recommended an offloading device whilst sitting out 
and Bateman (2014) used egg-crate foam pads under the feet whilst sitting out. 
Overall, the TVNSs did not feel offloading devices should be used when patients are 
sitting out in a chair, and they should primarily be used on patients nursed in bed, 
especially if the patient has been assessed as at risk of falling as the offloading device 
can become a trip hazard. This could be due to a cognitive impairment that might mean 
the patient does not realise they should not mobilise with an offloading device on, or 
they do not have the ability to mobilise safely as described here:   
 “When the patient is sat in a chair with [offloading device brand] and they 
attempt to walk because either they’re confused or they’re not able to walk 
that well, then they’re at risk of falls” (P2, Lead Nurse). 
These patients might not have the capacity to understand the risks and the 
interventions implemented by the nurses, therefore the nurses must assess what is in 
the best interest for the patients. This could involve balancing the most immediate or 
severest risk for that patient, developing a heel pressure ulcer or falling.  There is also 
a possibility that the patient’s capacity can fluctuate so an intervention might not be 
suitable from one day to the next and therefore requires an ongoing assessment. 
These patients might still need to be offloaded when in bed, and some of the TVNSs 
felt that staff were aware of this risk factor when using the devices as this example 
illustrates. 
“I tend to find that if somebody is up and mobile then the wards would not 
be keen to use any heel devices in the day.  They may use them when the 
patient's in bed but only in bed, they'll not use them in the chair. That's my 
experience” (P5, Lead Nurse). 
There is a difficulty in managing patients who are starting to mobilise but could still be 
at risk of developing a heel pressure ulcer. As most patients at risk of developing a heel 
pressure ulcer tend to be bed bound, the devices are designed accordingly, and if they 
are used in patients out of bed, they could cause the patient to fall. P4 had identified 
this as an issue and was trying to find a device that was suitable for ambulatory 
patients but identified that there was a gap in the market for this. 
“We’re going out to tender in the next few weeks and we’ve actually written 
in our tender spec. that we’re looking for something suitable for ambulatory 
patients. But you and I both know that there probably is not anything out 







Theoretically when a patient is sat in a chair the heel should not be at risk as the 
pressure should be going through the plantar aspect of the heel, where the foot pad is 
designed to take the load. If the patient has poor posture whilst sat out or slides down 
in the chair, or sits with their heels on a footstool, this could lead to the pressure going 
through the posterior heel. This can be rectified with correct positioning or a chair that 
stops the patient from sliding down, so theoretically there should not be many 
circumstances when an offloading device is required in a chair.  
Offloading devices whilst in bed can still be a fall hazard if a patient attempts to get out 
of bed without realising, they are wearing them. 
8.2.2 Falls prevention can be more of a priority 
For the nurses, there are risk assessments to assist in identifying if patients are at risk 
of developing a pressure ulcer, and if they are at risk of falling, but if a patient is at risk 
of both they can be given conflicting advice and so the nurse must assess which is the 
most immediate risk. P3 gave the following example:  
 “On a high/low bed an air mattress is not allowed5, so even the patient with 
Category 4 pressure ulcers to the back or bottom, because they need a 
high/low bed as a priority for risk of climbing out of bed, they have to have a 
high specification foam mattress which is not ideal for the pressure ulcer” 
(P3, Band 6 CNS). 
Some of the TVNSs perceived there to be competing priorities from management 
which could influence how wards prioritised falls prevention and pressure ulcer 
prevention, as this TVNS discusses:  
 “I think falls are high on the agenda which I do not think they should be, but 
they investigate it in the same way as pressure ulcers, as a serious 
untoward incident and they’re being put higher on the agenda than the 
pressure ulcer” (P3, Band 6 CNS). 
This could be personal biases of the TVNSs because pressure ulcer prevention is a 
large component of their job role, or differences between leadership priorities between 
organisations. Overall, there is an interest in finding the safest and best option for the 
patient and identifying what will cause the least harm as illustrated in this example: 
“ ...if they cannot safely offload the heel, so for example if they are using 
pillows or a wedge and they cannot keep the heels free from pressure 
because the patient is agitated or you know, is pretty mobile in the bed, 
then it’s safer to just nurse the heels on the mattress” (P2, Lead Nurse). 
 
5 A high-low bed can be positioned lower than conventional beds, so the patient is 
closer to the floor. There could be issues with entrapment with bedrails, or due to 
the depth of the cells raising up the height of the patient and decreasing the 








In vulnerable patients who might be at risk of both falling and developing a pressure 
ulcer the nurse must assess and care plan according to which is the most immediate or 
severest risk.  The TVNSs felt that offloading devices are best used when the patient is 
in bed as they can become a trip hazard when sat out.  
8.3 Candidate theory 12 
Patients are not always concordant with the use of the devices due to comfort 
factors 
Figure 8-2 Initial theory 12 
 
This theory was initially developed based on the findings of some of the RCTs included 
in the systematic review. Gilcreast et al. (2005) reported that some patients found the 
devices ‘hot & bothersome’ and did not allow free movement in the bed, whilst Donnelly 
et al. (2011) reported that some participants found the boots hot, bulky and restricted 
movement, which they felt ultimately affected compliance in their trial. Different devices 
were used in these trials, so it is not an issue unique to a particular device, but what is 
not known is whether this is the case for all offloading devices; they all tend to be 
padded and bulky as this is what is required in order that the heel is effectively 
offloaded whilst distributing the pressure to the rest of the leg. Some of the TVNSs also 
shared experiences regarding none of the devices being ‘liked’, as illustrated here: 
 “We’ve used Repose®, Prevalon®, Heel-Lift®, and there does not seem to 
be one that [patients] particularly like” (P2, Lead Nurse). 
Comfort of the device is likely to be a high priority for patients; however, it does not 
seem to be a priority to the same extent for the healthcare workers. When selecting an 
offloading device to use in their RCT, Campbell et al. (2010) used a nominal group 
process to prioritise selection criteria, and patient comfort was only ranked fifth out of 
seven in terms of importance, with the device being reusable, cleanable and approved 
by infection prevention as being most important, followed by ease of use and price. It 
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could be that healthcare workers are so focused on doing what is perceived to be best 
for the patient in terms of pressure ulcer prevention, patient comfort is less of a priority 
when selecting an offloading device as this example by P1 shows: 
 “I’ve never thought about it from the device being comfortable actually…I’d 
thought about it more that if the patient is less responsive, quite weak or 
sedated or some other medical condition going on, then they are less likely 
to fidget or kick it off” (P1, Band 6 CNS). 
If a patient is unable to communicate discomfort, they might attempt to remove the 
device through fidgeting and trying to kick it off which could be viewed as the patient 
being ‘awkward’ or ‘agitated’.  This links in with theory 6 as comfort is less of an issue, 
and therefore less of a priority in patients with reduced consciousness, making them 
more ‘compliant’ with offloading as they cannot physically remove the device. The 
context would be that if the patient is unable to make decisions about pressure ulcer 
prevention, the nurse becomes the advocate for the patient, acting in their best 
interests and will deliver pressure ulcer preventative care, possibly including an 
offloading device. 
Patient comfort might also be less of a priority for the TVNS and ward staff as they 
perceive that there is no device available that will be liked by and suitable for all 
patients. Nursing staff instead try and work with the patients to find solutions and 
improve concordance, but this is not always successful and as a result reduces the 
effectiveness of the device, as this TVNS’s example illustrates: 
“The most that we've used are the Repose® boot, and I do get a lot of 
feedback that patients do not find them comfy, they find them hot and 
sweaty.  The nurses then attempted to put a pillowcase over them so 
they're hammocking6, so they have no benefit at all.  Or they wrap them 
with inco[ntinence] sheets, to make them not so hot and sweaty, which 
again negates the sort of benefit of them.  So, I think there's an education 
issue there, but I think the nurses are trying to get the patients to use them, 
so they see the need for them, but not really in the right way when they 
step in to try and improve compliance” (P5, Lead Nurse). 
An individualised assessment that involves the patient might identify patients who 
would not be able to tolerate a device. Some patients ‘on paper’ might seem like they 
would benefit from an offloading device, such as patients with peripheral arterial 
disease who are at high risk of developing a heel pressure ulcer due to decreased 
blood flow to the lower limb, but due to claudication pain (pain and/or cramping in the 
lower leg due to inadequate blood flow to the muscles. By lowering the leg gravity 
 
6 Where the pillowcase creates a sling over the offloading device, so the heel is in 







improves the circulation to the foot, relieving the pain) they might not keep a device on 
as this TVNS discussed:  
“on the vascular ward [the nurses] have the offloading device in place, but 
[the patients] like to dangle the legs off the side of the bed, and of course 
then the device does not work, it slides off in that particular way so when 
they put their legs back up, the device is not there, its somewhere on the 
floor or at the bottom of the bed” (P1, Band 6 CNS). 
This could be viewed as patients being ‘non-compliant’ but through working with the 
patient could lead to a better solution for that patient. Some of the TVNSs and research 
articles discussed ‘patient compliance’ which implies that there should be an element of 
‘obedience’ from patients and that they are passive recipients of their healthcare, as 
this example shows:  
“I mean sometimes it could be the device is not right for that patient, but it 
could be the patient will not be compliant with any device” (P3, Band 6 
CNS). 
It is unclear whether the use of the term ‘compliance’ was intentional or if it was a lack 
of understanding of the term, although it was found to be used more by junior TVNSs 
whilst more senior TVNSs used ‘concordance’, these terms were sometimes used 
interchangeably. Concordance is synonymous with patient centred care where there is 
an agreement between the patient and healthcare professional that respects the beliefs 
and wishes of the patient (Aronson, 2007). In contrast compliance refers to the degree 
in which the patient follows the advice of the healthcare professional (Aronson, 2007). 
There was discussion around how some of the TVNSs worked in partnership with 
patients and relatives as a method of improving device use alongside other pressure 
ulcer preventative interventions as this TVNS reflected upon. 
“…this is not a compliance issue, this is concordance, that we work with the 
patient.  And also, patient centred care, that it needs to be individualised; 
so, we've had a real drive on that generally within the Trust as well.  So, it is 
about working with the patients” (P8, Nurse Consultant). 
P4 also talks about concordance as a method for improving pressure ulcer prevention 
and device use, however there is still a hierarchical element in the description where 
the ultimate aim is for the patient to ‘accept the treatment’ provided by the nurses as 
this quote illustrates:     
 “So, we've just developed a non-concordance checklist and it's to help the 
nurses to understand why the patient's being non concordant.  That's not 
compliance it's concordance.  And it has things in there like, have you 
spoken to the relatives or the carer; have you given them all the information 
involved and why you're doing these things.  And basically, part of it is 
because we want the nurses to not just say, ‘oh the patient is quite 
challenging’, but to say, ‘actually this is what we've gone through to see if 
we can get them to accept the treatment or the options that we're giving 







It could therefore be that, due to the design of these devices, they will never be suitable 
for all patients. However, when the context is patients with capacity to make decisions 
about their care, working in partnership with the patient and explaining the reasoning 
for their use and giving different options leads to a better understanding of their use, 
and the patient would be more likely to adhere with the treatment plan as this TVNS 
gives an example of:  
 “in Wales it's co-production; it's working together in unity with the patient, 
trying to give ownership back to the patient … they have some involvement 
in their management as well and have a responsibility.  And I think it links to 
that and it links to if they have some understanding” (P5, Lead Nurse). 
As discussed previously, offloading appears to be most effective in the immobile limb, 
so as the patient recovers and becomes more mobile offloading might no longer be 
necessary. Campbell et al. (2010) reported that as patients recovered and became 
more mobile, offloading devices would be less likely to stay in place. Gilcreast et al. 
(2005) also reported similar findings; they analysed the Braden subscale for sensory 
perception and saw that as participants became more alert, compliance with offloading 
decreased. What was not reported was whether as these patients became more 
mobile, whether they still required offloading and whether reassessment of risk for heel 
pressure ulcer is undertaken. Theoretically an increase in mobility would mean a 
decrease in risk.  This was reflected in the opinions of the TVNSs as this example 
shows: 
 “So, for example if you’ve come in with a fractured neck of femur you do 
not want to move, and you might actually be very comfortable with your 
[offloading] boot in situ. But once you have had your surgery and you’re 
starting to get a bit more mobile, pain is under control, then you find that the 
boot is actually getting in your way of actually trying to be independent…so 
I think there’s something about use in terms of where in the patient’s 
journey” (P2, Lead Nurse). 
This illustrates that offloading devices are not suitable for all patients at all points in 
time but is a more fluid requirement as the patients’ condition changes. In realist terms 
we should therefore be asking “what works for each patient at which part of their 
journey?” 
This theory started out about patient comfort factors affecting device use, but it has 
developed more about factors that can affect concordance with offloading. The context 
here is the capacity of the patient to make decisions about their care.  Where patients 
are unable to make decisions, the nurse becomes the advocate for the patient and 
prescribes their care, including offloading device use, in the best interests of the 







Due to the nature of the devices, it is unlikely that there will ever be a device that will be 
liked by all patients, but where the patient has capacity to make decisions about their 
care, working in partnership with the patient to help them make decisions about their 
care in turn could improve device use.  
Both the patient’s capacity to make decisions about their care and their heel pressure 
ulcer risk can change throughout their admission, therefore the patient’s offloading 
requirements need to also be reassessed. 
8.4 Candidate theory 13 
Risk assessments that involve the patient and/or carer are more likely to 
highlight specific risk factors/ high risk areas leading to plan of care that is more 
patient specific and the patient will comply with 
Figure 8-3 Initial theory 13 
 
This links with theory 12 as it is focusing on the outcome of increasing compliance with 
device use through concordant working with the patient. From discussions with the 
TVNSs, although the risk assessment did play a part, it was working in concordance 
with patients in the care planning, along with providing them with a sound rationale for 
their treatment that was important.  There are situations where this might not be 
appropriate such as the unconscious patient, or when the patient is acutely unwell, as 
this TVNS’s example illustrates: 
“if I think about a patient who is acutely unwell with sepsis and someone is 
saying “I need to give you these antibiotics and then we need to put this 
line in for these fluids and then we need to offload your heels, and then we 
need to make sure you are eating and drinking well, and then we need to 
be turning you” I think that information is too much at that acute stage, but I 
think what we are not good at doing is once the acute stage has gone, is 
then relooking at the plan that we put in place” (P1, Band 6 CNS). 
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This ties in with “what works for each patient at which part of their journey”. In this 
example the nurse would act as an advocate for the patient and offload the heels, but 
as the patients’ condition improves then the care planning should involve working in 
partnership with the patient. 
8.5 Candidate theories 11-13 summary 
Individual patient preferences and risk factors need to be considered when 
implementing an offloading device.  Certain patient groups have been identified during 
the interviews where offloading is less likely to be used or as effective.  Here it is the 
responsibility of nurses to make a clinical judgement by weighing up which is the most 
immediate, or severest risk for the patient.  
Mobilising is an important part of a patient’s recovery and offloading devices could 
become a hindrance or can even become a trip hazard.  Offloading is primarily used in 
bedbound patients when they are acutely unwell but should be stepped down as 
patients recover. 
Where there are comfort issues for the patient, nurses try to be resourceful and 
collaborate with the patients to improve comfort and in turn concordance, but this can 
lead to the devices being used incorrectly with reduced effectiveness.  
8.5.1 Programme theory 3 
Within the micro context of individual patients, offloading is not suitable for every 
patient, or at every point during the patient’s recovery. Offloading should be viewed as 
a fluid requirement, considering “What works for each patient at which part of their 
journey?”. Individual patient preferences and risk factors need to be considered when 
implementing an offloading device and working with the patient can improve 
concordance (Figure 8-4). 
8.6 Summary 
Chapters 6-8 have presented the findings from interviews with eight TVNSs using the 
teacher-learner interviewing method (Pawson, 1996). All of the theories started out as 
different aspects of care that might influence how offloading devices are used in 
practice but have been refined into three programme theories; factors that lead to a 
proactive or reactive use of offloading devices and patient factors that influence how 
offloading devices are used.  
Offloading devices are not suitable for every patient at every point in their journey, but 







from offloading can lead to a proactive use of the devices. A reactive use of offloading 
devices is not necessarily a negative response but can be an effective use of devices 
where repositioning and a dynamic mattress are not meeting the requirements of the 
patient, or early signs of deteriorating pressure areas are identified and acted upon in a 
timely manner. It was also theorised that care planning in concordance with the patient 
can lead to improved use of devices.  
TVNSs were interviewed during this phase as they would be experienced in prescribing 
offloading devices primarily in the field of pressure ulcer prevention and/or treatment. It 
is important to acknowledge that these devices are brought into an organisation and 
used by other specialities as well as or alongside the TVNS (e.g., all members of the 
nursing team, podiatry, physiotherapy, occupational therapy, orthotics).  
The TVNSs perceive education to be a large part of their role, which has been found in 
previous research into the role of the TVNS (Flanagan, 1996, Ousey et al., 2015) and 
important in the successful implementation and use of offloading devices in practice.  
Education is also numerically measurable, with TVNS being able to provide evidence to 
senior managers of how many members of staff they have educated. However, the 
effectiveness of the education is difficult to evaluate.  
In the absence of robust evidence, the recommendations and care provided by the 
TVNSs were often based on personal preferences which appear to be informed by 
perceptions informed from personal experiences, along with experiences of colleagues 
from within and outside of their organisation.  The findings from these interviews were 
based on the opinions and views of the TVNSs and what they perceive is happening in 
practice in their organisation. It is also based upon their recommendations, however 
the reality of what happens on the wards could be very different.  This is where an 
ethnographic study will add another layer of evidence, going beyond the evidence of 
contexts and outcomes identified during the interviews and making explicit the 
mechanisms that lead to expected or unexpected outcomes. Chapter 9 will describe 
how one of the programme theories was selected for testing in the form of an 
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Chapter 9 Realist Evaluation Phase 2: Ethnography  
9.1 Introduction 
Chapters 6-8 presented how 13 candidate theories were refined into three overarching 
programme theories about how offloading devices are used in clinical practice.   
Chapter 5 described the rationale for choosing ethnography for the testing and 
refinement of a programme theory as part of a realist evaluation. This chapter will 
describe how the methods were developed and the study was conducted to attempt to 
test programme theory 1 (Figure 6-7). Gaining an insight into the interactions, 
processes, and behaviours of nursing staff in clinical practice will aid in the 
understanding of the mechanisms and contexts that lead to the proactive use of 
devices for the prevention of heel pressure ulcers.  
9.2 Methods 
9.2.1 Selection of programme theory for testing 
Three programme theories were developed following the TVNS interviews: 
• Programme theory 1 – How offloading devices are used proactively in the 
prevention of heel pressure ulcers 
• Programme theory 2 – How offloading devices are used reactively for the 
prevention of heel pressure ulcers and as a treatment of heel pressure ulcers 
• Programme theory 3 – Patient factors that can affect compliance with the use of 
offloading devices 
There was not capacity within the confines of the PhD to test all three programme 
theories, therefore programme theory 1 was selected, as it was felt that this would best 
answer the research questions set out in Chapter 4. 
9.2.2 Role of the researcher 
The role of the researcher is paramount to the conduct of the study with regards to both 
the collection and interpretation of the data.  In observations the researcher can adopt 
an overt approach; where the participants know they are being observed or a covert 
approach; where participants are unaware they are being observed.  Gold (1958) first 
described the role of the researcher and the degree in which they participate in 







Table 9-1 Approaches to participant observations and rationale for choice of 
observer as participant method, adapted from (Jones and Smith, 2017, Nicholls 
et al., 2014)  






invisible to the 
participants. 
Observing via a two-way 
mirror or observing a crowd 
in a public place. 
Assumption that the role of 
the researcher will make 
little difference to what is 
being observed. 
Would be ethically difficult 
to conduct in a ward 
setting as removes the 
participants right to 






primary role of the 
researcher, some 
interaction with 




Observing a meeting or 
classroom, engaging in the 
setting for short periods, as 
unobtrusively as possible. 
Researcher is open about 
their purpose and may be 
visibly recording in the 
setting. 
Greater depth in the field 
notes as research is sole 
purpose. Participants are 
aware that they will be 
observed by a nurse, 







integrates self into 
the group/setting, 
whilst observing. 
Working clinically on a 
ward alongside the team 
and patients, but open 
about their purpose as a 
researcher. Assumption 
that the role of the 
researcher within the 
context of the study has 
been acknowledged. 
Would see more from the 
perspective of the team 
being observed, although 
participants are aware that 
they are being observed 
which could change 
practice. Would not be 
able to record as much 







integrated into the 
research setting 
whilst concealing 
role as observer. 
Working clinically on a 
ward alongside the team 
and patients, doing so 
without disclosing purpose 
as a researcher. 
Would be ethically difficult 
to conduct in healthcare as 
removes the participants 
right to consent to 
participation. 
Would see more from the 
perspective of the team 
being observed but would 
not be able to record as 
much detail in the field 
notes in real time. 
 
A covert approach would be desirable as the researcher becomes an ‘insider’ with as 
little contamination as possible to the environment, because participants might change 
their practice if they are aware that they are being observed. However, it could be 
argued that this is ‘ethically untenable’ as it removes the participants’ right to informed 
consent (Angrosino and Rosenberg, 2011). It was decided to take the observer as 







detached from clinical care, as it would allow for a greater depth of field notes as the 
researcher’s focus is primarily on the observation.  
9.2.3 Unit of analysis 
To establish the most effective way to perform the observations, the unit of analysis 
needed to be decided upon. There were several different options that were explored in 
Table 9-2 to help to decide on the unit of analysis for this study.  In order to facilitate a 
more in-depth study, the focus of the research should be on a smaller group of people 
(Hammersley and Atkinson, 2007), and as the research is looking at how healthcare 
staff utilise devices, it was decided that the unit of analysis would be on a team of 
qualified nurses (QNs), student nurses and healthcare assistants (HCA) caring for a 
single bay of patients. Within the hospital, wards usually consist of between 26-30 
patients, and a team will look after between a quarter to half of the ward, depending 
upon acuity of the patients and staffing levels. A bay of patients usually accommodates 
between four and six patients cared for by a single team. 
9.2.4 Sampling 
The site of the study was chosen to exemplify what were theoretically most rich in 
terms of the range of contextual conditions for offloading devices to be used in a 
proactive way in order to trigger the conjectured mechanisms in the theory (Pawson 
and Tilley, 1997b). Ethnographic observations were therefore conducted within 
orthopaedic wards at a large NHS hospital in the North of England, this was in part due 
to this being a patient population with a high proportion of patients who are at risk of 
developing heel pressure ulcers and therefore more likely to require pressure ulcer 
preventative interventions, and because some, but not all these wards keep heel 
offloading devices as a stock item.  There is no standard guidance within the hospital 
regarding the use of offloading devices; whether they should be kept as stock, the 
quantities of stock, which devices should be kept or where they are stored. To try and 
explore the influence of this contextual factor, the selected wards were in the same 
speciality and therefore had access to the same equipment, but how they were 
selected, stocked, and used could differ. As the speciality, patient group and sex of the 
patient were not identified as contextual factors in the theory being tested, variation 
was not sought when selecting wards. Therefore, three orthopaedic wards including 
both male and female patients were selected using purposive sampling, completing 
four observations per ward: twelve observations in total. The contextual influences of 
this Trust and the ward could be studied as the wards would have the same senior 







consistencies across wards could suggest influence from the wider organisation level 
whereas differences might suggest influential factors at the ward level.  
9.2.5 Recruitment Process 
9.2.5.1 Wards 
The researcher contacted the ward manager of potentially suitable wards and provided 
them with information about the study (Appendix E Ward Manager Participant 
Information Sheet) and asked to provide written consent for their ward to participate in 
the study. At this point shift patterns, handover times, ward round times, safety huddle 
times and who is involved, what stock is kept on the ward and where were established. 
A minimum of four observations per ward was agreed with the ward manager, ensuring 
a range of shift patterns, covering different times of the day along with weekdays and 
weekends. The frequency of the observations and times of the day of the visits to the 
field need to be able to provide a representative sample of the events and range of 
activities that occur there.  Nights were not included as it was anticipated that once the 
patients had been settled for bed during the evening, it would be unlikely that any 
pressure ulcer preventative interventions relevant to this theory would take place, other 
than repositioning. It is not possible to record everything that goes on in the field, but 
the aim is to get an overview of the care practices and to be able to distinguish 
between irregular, routine and frequent activities that take place (Brewer, 2000).  
9.2.5.2 Patients 
On the first day of observations on each ward the researcher attended handover and a 
bay of patients was selected to be observed using purposive sampling. The bay would 
be selected either based on the information provided during handover or identified by 
the nurse in charge as having a minimum of one high risk patient with mobility levels 
being either chair or bedfast, either with capacity to consent themselves or having a 
potential consultee present.  By definition, someone who is bedfast or chair fast cannot 
leave their bed or chair due to illness or incapacity, however on an orthopaedic surgical 
ward early mobilisation is a key part of the recovery pathway and therefore mobility 
levels can change on a daily basis. Patients would be recruited on the assumption that 
they met these criteria based on information given by the nursing team. Between one 
and six patient participants would be recruited per observation, with a minimum target 
of twelve patients in total: one per observation. A bay would be excluded if it were 
closed due to infection control reasons or it had been previously observed (defined as 








Table 9-2: Unit of analysis options for observation work, highlighting the chosen option 






Usually between 26-30 
patients, all QNs, student 
nurses and HCAs on shift 
along with other members of 
the multi-disciplinary team 
(MDT). 
Ward could be split 
between 2 and 3 
teams so 9-15 
patients, 1-2 QNs 
and 1-3 HCAs. 
Consists of between 4-
6 patients managed by 
a single team (1-2 QNs 
and 1-3 HCAs). 
Single member of staff 
who would be shadowed 
for the whole 
observation period 
Could select a patient at risk or 
with an offloading device in situ 
Level of 
detail 
Potentially more interactions 
and people to observe.  Can 
see ward dynamics, 
interactions with other 
members of the MDT. Could 
miss some pressure area 
care as cannot watch all 
members of staff at the same 
time. As there are more 
people to observe, overall, 
the observations will be 
lacking in detail  
Team interactions 
and other members 
of MDT can be 
observed. Could be 
more selective of 
who to observe at a 
time depending 
upon their current 
tasks. Overall, there 
will be less detail as 
more people to 
observe 
Team interactions and 
other members of MDT 
can be observed in 
more detail. Could be 
more selective of who 
to observe at a time 
depending upon their 
current tasks.  
Fewer observations of 
pressure ulcer 
preventative care as the 
individual will have lots 
of other duties to 
perform, what is 
observed could be seen 
in more detail 
There might be fewer 
interactions – could go long 
periods without any 
interventions or might only see 
one pressure ulcer preventative 
intervention for the whole 
observation period but would be 
very detailed – would be more 
like a case study. Would be 
issues around 
representativeness & 




Posters on the ward and 
information leaflets, opt out 
process, consent for staff 
interviews 
Posters on the ward 
and information 
leaflets, opt out 
process, consent for 
staff interviews 
Posters on the ward 
and information 
leaflets, opt out 
process, consent for 
staff interviews 
Posters on the ward and 
information leaflets, opt 
out process, consent 
from individual being 
observed for both 
observations and 
interviews 
Posters on the ward and 
information leaflets, opt out 
process, consent from individual 
being observed – could be 
consent issues if the patient 
lacks capacity. Would need to 




Gaining personal consultee assent (9.3.1) could only be done in the presence of 
relatives/visitors, and hence was restricted to visiting time (2-8pm).  This meant that 
observations of people requiring consultee assent were either done for an afternoon 
observation shift by approaching consultee on the day, or for morning observation 
shifts, by seeking out the consultee the previous afternoon.  When this was not 
possible due to the researcher’s clinical commitments, a bay would be selected where 
participants could consent themselves. The nature of the research was explained to the 
patients and/or relatives prior to the start of the observations, a participant information 
sheet (Appendix F Patients Participant Information Sheet) was provided and written 
consent gained, for both the observations and for a review of their medical and nursing 
notes, although no patient identifiable information was collected.  For patients who had 
capacity to give consent but were unable to complete the consent form, witnessed 
verbal consent was completed. Any person in the observed bay who was not eligible 
for inclusion or chose not to participate had no data collected about them, including 
interactions that they might have with those involved in the research project.  
9.2.5.3 Staff 
Following the observation period, a purposive sample of up to four members of staff 
per observation, who had interacted with the observed bay of patients, were invited to 
participate in a short audio recorded interview as close to the period of observation as 
possible. This number was decided based on the anticipated number of staff who 
would be observed working in a single bay (Table 9-2), with a target of at least twelve 
interviews in total, but recruitment stopped once data saturation had been achieved.  A 
participant information sheet (Appendix G Ward Staff Participant Information Sheet) 
was provided and the opportunity to ask any questions about the study given. Full 
written consent was gained. 
9.2.6 Data collection 
In ethnographic research there is no consensus with regards to a suitable sample size 
or number of periods of observations required to provide an adequate overview of 
current practice and to answer the research question (Hammersley and Atkinson, 
2007). It is therefore dependent on the objectives of the study, characteristics of the 
group being observed and the resources available to the researcher (Angrosino, 2007). 
It was therefore decided, due to the limitation of the time and resources of the 
researcher, that four observation periods per ward would take place.  Each observation 






pressure ulcer should be on a minimum of four hourly repositioning (NICE, 2014b), 
therefore they should receive at least one reposition and/or skin assessment / pressure 
ulcer intervention during that period. The observation process is illustrated in   
Figure 9-1.  
Figure 9-1 Observation and data collection process 
 
9.2.6.1 Non-participant observations 
Data were collected in the form of field notes and photographs of non-patient areas. At 
the beginning of each observation period, contextual data were collected in the form of 
photographs and structured field notes. Photographs of the ward stockrooms provided 
evidence of what devices were kept as stock and their accessibility.  Structured field 
notes included a general description of the ward, a map of the ward and bay being 
Gaining access 
•Identify potentially appropriate wards and gain consent to do observations 
from ward manager
•Visit ward the day before the planned observations period, place posters 
around the ward and answer any questions about the project
Observations
•Attend handover at beginning of shift, provide information about the study 
and give the opportunity for staff members to opt out, identify bay of 
patients to observe
•Discuss study with patients/relatives in the selected bay and provide PIS 
and gain written consent to participate in observations and to have their 
medical and nursing notes reviewed
•Observe staff, focusing on patient care and pressure ulcer preventative 
strategies
•Check around the ward for devices and photograph locations of devices
•Answer any questions regarding the research
End of observation 
period
•Data collected from the care plans and medical notes for the patients who 
have consented
•Invite observed staff members to interview, provide PIS and consent, 
where possible hold the interviews as close to the end of the observations






observed, including patient location within the bay and their pressure relieving 
equipment.  
Unstructured field notes (with labels to codify entries) were made, distinguishing 
between what actually happened and feelings about what happened using detailed 
description [DD] of what happened, observers’ comments [OC] for ideas, views or 
theories about what happened, subjective reflections [SR] for personal feelings.  Times 
were recorded throughout to give an accurate timeline of events. Field notes were 
transcribed in full by the researcher as soon as possible following the period of 
observation.  
9.2.6.2 Documentation review 
A documentation review took place at the end of each observation for patients who had 
provided written consent to the study. A structured data collection form was used to 
record whether there were any medical risk factors that could put the patient at risk of 
developing a heel pressure ulcer (e.g., diabetes, peripheral vascular disease, 
neuropathy) along with pressure ulcer risk assessment, presence of any pressure 
ulcers through the skin assessment, and what equipment was prescribed in the 
pressure ulcer prevention care plans and when (i.e., before or after any pressure 
damage might have occurred). No patient identifiable information was collected. 
9.2.6.3 Post observation interviews 
Short audio-recorded interviews took place on the ward as close to the end of the 
observation as possible so that it was still memorable for the staff. The purpose of the 
interviews was to clarify what was observed and to explore the knowledge that 
underpinned the observed behaviours. The interviews were therefore iterative, and the 
questions led by what had been observed. The interviews were also used as an 
opportunity for reflection upon whether the presence of the researcher influenced 
practice in any way. 
It was found during these interviews, respondents reported that the role of the ward 
manager was important, so it was decided to go back and do more in-depth interviews 
with the three ward managers after the observations had finished.  
9.3 Research governance issues 
The University of Leeds was sponsor and responsibilities were delegated as 






through a Research Sponsorship Agreement.  All necessary approvals including NHS 
Permissions and ethical approvals took place prior to the start of recruitment. 
9.3.1 Ethical Considerations 
The main ethical consideration was around the observation of the delivery of patient 
care and interactions between patients and staff. Information about the study was 
displayed around the ward in the form of posters, and the research was explained to all 
staff participants and the opportunity to withdraw given at any time up until three days 
post observation at which point all data would have been transcribed and anonymised. 
Staff were reassured that the intention of the observations was not to assess quality of 
practice, just to observe patient care delivery. The specific focus of the research was 
withheld so as not to influence the care being delivered. 
Although the researcher was present for the observations in a purely research 
capacity, as a registered nurse, as per the guidance from the Nursing and Midwifery 
Council (2019), there was a responsibility to be prepared to intervene if dangerous or 
unsafe care was seen, or if there was a risk of immediate serious harm to an individual.  
If there was no evidence base surrounding the practice being delivered, but it was just 
viewed as poor practice, then there was no need to intervene.  
Minimal ethical issues regarding interviewing NHS staff were foreseen as, due to the 
nature of the interview topic guide, it was unlikely to involve disclosure of sensitive 
information.  
Full written consent was obtained for participants who were observed and to have their 
medical and nursing notes reviewed, although no patient identifiable information was 
collected.  For patients who had capacity but were unable to complete the consent 
form, witnessed verbal consent was completed. 
A large proportion of patients who suffer from pressure ulcers or are at risk of 
developing pressure ulcers have receptive, comprehension or language difficulties. 
They may also have general cognitive impairment affecting their understanding and/or 
dementia (Jaul et al., 2017, Jaul and Meiron, 2017). Cognition impacts upon 
compliance with pressure ulcer preventative care along with the ability to self-care. It 
was important that the research included a cross-section of the normal patient 
population for the included wards; therefore, recruitment procedures facilitated 
consultee or nearest relative/guardian agreement. 
The assessment of capacity related specifically to decisions pertaining to this research 






lacked capacity by assessing the patient’s ability to understand what decisions they 
needed to make and why; the consequences of the decision to participate; their ability 
to understand, use and retain the information related to the decision to participate and 
ability to communicate their decisions effectively (Department of Health, 2005). If there 
were any concerns about capacity the researcher consulted further with other members 
of the attending clinical team and/or relative/carer/friend (as appropriate) and a 
decision made with the relative/carer/friend as to whether the patient was able to 
provide consent. Where the patient was thought not to have capacity to consent, a 
relative, carer or friend who was interested in the patient’s welfare would act as a 
personal consultee. 
The relative/carer/friend was involved in the information and decision-making process 
with the patient and asked to advise the researcher on their presumed wishes and 
feelings and personal consultee assent would be obtained on behalf of the patient.  If 
despite taking all reasonable steps a personal consultee could not be identified and 
contacted, then a nominated consultee would be approached. This person would have 
no connection with the research project and would not be observed. They would be 
nominated by the researcher and would be a member of the medical team directly 
involved in the patients’ care.  
The personal consultee or nominated consultee would be provided with the information 
leaflet describing the research study and the role of the personal/nominated consultee 
would be emphasised; that they were being asked to act on behalf of the participant, 
rather than on any personal views or feelings. 
9.3.2  Data Protection and Confidentiality 
All data collected throughout the study were anonymised and kept strictly confidential. 
The only personal information collected were the names on the consent forms, and 
email addresses or postal addresses should the participant wish to receive copies of 
the research results.  These were stored on a spreadsheet on a password protected 
secure drive at the University of Leeds and would be deleted along with the email trail 
once the results had been sent out. 
Hard copies of any data collected (field notes, consent forms and research journal) 
were stored in a secure lockable place within the School of Healthcare, only accessible 
to the researcher and supervisors.  Once transcribed, the data were stored on a 






Audio recordings were transcribed by a 3rd party external to the research team through 
a University of Leeds trusted transcription service. A confidentiality agreement was 
signed by the transcription service and a secure data exchange programme used. No 
confidential, sensitive, or personally identifiable information was sent to the transcriber. 
9.3.3  Archiving 
Data were securely archived in line with the University of Leeds procedures for a 
minimum of 5 years, following which data will be destroyed in a secure and safe 
manner. 
9.3.4 Ethical approval 
Ethical approval was gained from the Health Research Authority (HRA) on 18th 
September 2018 (Appendix H HRA Ethical Approval (September 2018)). Capability and 
capacity confirmation were required from the hospital to indicate that the speciality had 
capacity for the research to take place.  As this research project was taking place in 
one speciality; orthopaedics, only one capability and capacity form required signing off, 
and permissions from the hospital came through on 22nd October 2018 (Appendix I 
Trust Approval (October 2018)). 
9.4 Data analysis 
In qualitative research there are numerous different possible approaches to data 
analysis, dependent upon the desired output. This could be from providing a detailed 
description of the phenomenon being studied, to developing explanations of the 
patterns seen in the data to constructing more general theories from the data (Spencer 
et al., 2014b). Realist evaluation aims at providing more than just detailed descriptions, 
but to generate theories and conjectures about what works for who in which situations. 
Its fundamental guiding principles require data to be examined in configurations of 
‘mechanisms’ with their triggering ‘contexts’ and ‘resultant outcomes’. Therefore, a 
more deductive approach to data analysis was required in order to test the theory 
generated in the previous chapter in order to develop concepts, categories, themes 
and explanations of the results (Spencer et al., 2014b). 
An iterative approach to data collection and analysis took place to allow for testing, 
explanation, and refinement of the theory, which was then taken into subsequent 
observations for further testing and revisiting the data. Qualitative analysis has two key 
stages; the first involves data management (often referred to as coding) and the 






all interviews, field notes and photographs were inputted into NVIVO 12 (QSR 
International Pty Ltd, 2018) for indexing against the existing theory.  They were coded 
against the three contexts identified in the theory (nodes); the ward, TVNS and the 
organisation/NHS, and additional nodes could be added to allow for open coding as 
new or unexpected findings emerged. Within a node, child nodes were used for each 
mechanism identified in the theory.  Once the data had been grouped into these 
categories a thematic analysis was used to analyse the data, combining elements to 
yield categories that capture conceptual differences in the data and to offer both explicit 
and implicit explanations (Spencer et al., 2014a). Cross-participant (QNs, HCAs and 
student nurses) and cross-site (wards) comparisons added depth and richness to the 
analysis as they identified commonalities or similarities that appeared independent 
(non-causal) or connected (causal) (Maxwell, 2012).  
Because of the limitation of resources available and the time restraints of a PhD, the 
researcher did the data collection and analysis alone, but findings were discussed and 
scrutinised during supervision meetings.  Where possible, the thirteen steps described 
by Miles et al. (2014a) for testing and confirming findings were followed to increase the 
rigour of the data collection and analysis process and findings. How they apply to this 
research is presented in Table 9-3. 
Table 9-3 Tactics for testing and confirming findings in this study using Miles et 
al. (2014a) 
Assessing the 
Quality of the 
data 
Checking for 
representativeness   
When developing findings, how typical and 
representative are they in this context? 
The use of purposive sampling can lead to participants 
being recruited who were not representative of the 
population due to the accessibility of both staff and 
patients.  
The researcher only observed for a limited time therefore 
it is important not to assume what is observed is 
happening when absent. 
Checking for 
researcher effects 
The researcher attempted to minimise biases stemming 
from the researcher’s presence by not disclosing to the 
staff observed the clinical background of the researcher 
or the focus of the research. Staff were invited during the 
interviews to reflect on how the researcher’s presence 
affected practice. 
Avoiding biases stemming from the effects of the site on 
the researcher by attempting to observe and interview a 
wide variety of patients and staff. A reflective diary was 






Triangulation Data were collected during the observations from a range 
of sources: field notes, interviews, medical and nursing 
notes review and photographs of non-clinical areas. 
Corroboration from different data sources can give 
deeper insight and enhance the trustworthiness of the 
findings (Evers and Staa, 2010). Inconsistent and 
conflicting findings were scrutinised.  
Weighting the 
evidence 
The above points will help in assessing the quality of the 
evidence and which data sources are stronger – 





meaning of outliers 
Any exceptions found were explored to test the 




Extreme cases might be from persons with a strong bias 
and exploring these could lead to a more in-depth 
understanding of their reasoning and reactions to the 
available resources  
Following up 
surprises 
Surprises are when something occurred outside of the 
range of expectations. Following up and reflecting upon 
surprise findings can give insight on personal 
expectations and assumptions, but also build upon 
existing theories.  
Looking for 
negative evidence 
Actively searching for data that opposes the researcher’s 
conclusions; if found then an alternative conclusion was 
sought to allow for this evidence 
Testing 
explanations 
Making if-then tests Creating if-then statements can help unpick the contexts 
and mechanisms to help build on the theories 
Ruling out spurious 
relations 
When two variables look correlated or causally 
associated, consider whether there could be a third 
variable that caused, influences, or underlies one or both.   
Replicating a 
finding 
Consider how replicable or transferrable the findings 
would be in a different context 
Could this study be replicated? 
Checking out rival 
explanations 
During final analysis ‘next best’ explanations were 
explored as an alternative to the original theories  
 Getting feedback 
from participants  
As new tentative findings emerged, due to the iterative 
nature of the data collection, new participants were used 
to explore these.  
9.5 Summary 
This chapter has presented the methods used to conduct an ethnographic study to test 
Programme theory 1. The method was designed to be ethically sound and 
reproducible, along with being able to explore the contexts and mechanisms described 





Chapter 10 Testing of programme theory 1 – Proactive use of 
offloading devices 
10.1  Introduction 
Chapter 9 described how programme theory 1 was selected for testing, and the 
methods used to conduct an ethnographic study. This chapter presents descriptive 
results to set the scene of the study, including a description of standard care, the 
patient population observed as well as the ward staff observed and interviewed. The 
findings will then be presented in order to test programme theory 1 which identifies 
factors that influence the proactive use of offloading devices from the micro context of 
the ward, the meso context of the TVNSs and the macro context of the wider 
organisation and NHS. Programme theory 1 was initially made up of six candidate 
theories: 
1. Healthcare professionals with advanced knowledge of pressure ulcer 
prevention are more likely to appropriately implement an offloading device as a 
preventative measure. 
2. Nurses working in clinical areas that frequently care for patients at high risk of 
developing pressure ulcers are more likely to implement an offloading device as 
a preventative measure because pressure ulcer prevention becomes more of a 
clinical priority and staff are more experienced at managing at risk patients and 
aware of the resources available to them. 
3. Nurses are more likely to implement an offloading device if it is easily accessed 
within the care environment. 
4. If patients are moved frequently between different care environments, then 
offloading devices are less likely to be utilised because of cost factors. 
5. Single patient use offloading devices versus reusable devices will be more 
desirable dependent on the care environment and priorities of the ward 
manager. 
6. Offloading devices are more effective in patients with reduced consciousness. 
The contexts and mechanisms identified in Chapter 6 (Figure 6-7) were presented in 
turn, along with any new configurations and theories identified from the research data. 
This chapter includes some discussion of the findings and how they link in with existing 
theory as this will help to test and further refine the theory, but further detail along with 







10.2  Description of standard care 
Standard care across the organisation where the study took place, with regards to 
pressure ulcer prevention and management, included a risk assessment (PURPOSE T) 
completed within 6 hours of admission, which is a national requirement (NICE, 2014b). 
All patients had a high specification foam (HSF) mattress, electric profiling bed and an 
armchair as standard, and if the risk assessment had identified the patient as at risk of 
developing a pressure ulcer, a minimum of four hourly repositioning and SSKIN bundle 
commenced (an intentional-rounding chart). AP and CLP air mattresses and chair 
cushions could be ordered and delivered within four hours, based on clinical judgement 
of patients’ needs. Offloading was recommended in the hospital’s guidelines for 
‘patients at risk of developing a heel pressure ulcer’, based upon international 
guidelines (EPUAP et al., 2019), but no heel-specific devices were specified to be used 
across the organisation as part of standard care.  Any device available through the 
NHS supply chain could be ordered through supplies. Prophylactic dressings were not 
recommended in the hospital’s guidelines as part of standard care. Standard care can 
differ between organisations, and the definition of standard care is often overlooked in 
research papers other than mattress use. Table 10-1 shows what the standard care 
that was delivered to the patient participants during the observations. 







































































































Ward 1 100% (n = 
9/9) 
100% (n = 
9/9) 
33% (n = 
3/9) 
89% (n = 
8/9) 
AP n = 1 
HSF n = 8 
56% (n = 
5/9) 
Ward 2 100% (n = 
11/11) 
91% (n = 
10/11) 
100% (n = 
11/11) 
100% (n = 
11/11) 
AP n = 2 
CLP n = 1 
HSF n = 8 
82% (n = 
9/11) 
Ward 3 100% (n = 
12/12) 
92% (n = 
11-12) 
92% (n = 
11/12) 
100% (n = 
12/12) 
AP n = 1 
HSF n = 11 
83% (n = 
10/12) 
Totals 100% (n = 
32/32) 
 94% (n = 
30/32) 
78% (n = 
25/32) 
97% (n = 
31/32) 
AP 13% (n = 4/32) 
CLP 3% (n = 1/32) 
HSF 84% (n = 27/32) 
75% (n = 
24/32) 
 
During the observations, five patients in total across all three wards (n = 5/32, 15.6%) 
were observed with heel-specific devices in use, however there was no documentary 
evidence in the nursing or medical notes about their use (Table 10-2). Of these five 






reflect the care that was received, as throughout the observations 31/32 patients 
received a minimum of four hourly repositioning. The patient not repositioned was on 
Ward 1, and although they were not turned, they did have their heels checked and 
repositioned, and had an offloading device and a dynamic mattress in place. 
Within the study site at the time of the observations the standard practice for quality 
improvement and monitoring of pressure ulcer rates involved completing a datix 
(incident report form) for all patients with a pressure ulcer to measure incidence, and 
monthly safety thermometer prevalence audits.  Each department would be given an 
annual target specific to their area to reduce acquired pressure ulcer rates, most would 
involve a 5-10% reduction year on year.  A root cause analysis investigation would take 
place for all patients who develop a Category 3, 4 or Unstageable pressure ulcer as an 
inpatient. Following a root cause analysis investigation, an action plan would be 
completed with the aim to gain learning from the incident and minimise the risk of 
another patient developing a pressure ulcer if a similar situation were to arise.    
10.3  Observations and documentary review 
Twelve observations took place on the three wards: four on each ward. A total of 49 
hours and 35 minutes of patient care was observed. This section will describe the 
findings from the observations and documentation review before using this data, along 
with the staff interviews, to test and refine programme theory 1 in section 10.4. 
10.3.1 Wards 
The wards were in the same wing of the hospital but had different numbers of beds and 
layout differed including the locations of the nurses’ station and stock rooms. All the 
wards cared for patients admitted acutely requiring orthopaedic surgery.  
10.3.1.1 Ward 1  
Ward 1 was a 27 bedded ward caring for male patients. It had three bays each with six 
beds, one bay with five beds, and four side rooms. They stocked the Repose® 
reusable offloading boots which were easy to locate in the storeroom that were in a 
clear place that was easy to find. The store room was organised, tidy and the tubes 
were at eye level and, if you know what you are looking for, are easily identified (Figure 






Figure 10-1 Ward 1 stock room, highlighting offloading devices 
 
10.3.1.2 Ward 2 
Ward 2 was a 27 bedded ward caring for female patients. It had four bays each with six 
beds and three side rooms. The Junior Ward Manager stated during their interview that 
they kept the egg-crate heel pads and boots (heel-specific CLP devices) as stock 
items, along with the Repose® offloading boots and wedges. Only 2/6 of other staff 
interviewed were able to identify what items they kept as stock and where, however 
only two Repose® tubes were found on the ward in patient areas, and no other devices 
were found in the stock rooms (Figure 10-2) or observed in use. It is possible that the 
researcher could not locate the devices as the storerooms were cluttered and not well 
organised, or that the ward was out of stock during the observation period. A TVNS 
was observed reviewing patient 5.4 on Ward 2 and they did request offloading as part 
of their plan of care for the patient. The Qualified Nurse did not know how to source the 
offloading device, and it was initiated by the TVNS rather than the ward, which further 









10.3.1.3 Ward 3 
Ward 3 was a 23 bedded ward caring for female patients. It had five bays each with 
four beds and three side rooms. They stocked Repose® offloading boots and wedges 
as well as egg-crate heel pads and boots as stock items which were easy to locate in 
the store room (Figure 10-3), and all staff interviewed knew where they were kept.  
Figure 10-3 Ward 3 stock room showing stock of Repose® offloading devices 
(left) and heel-specific CLP devices – the egg-crate heel pads (right) 
 
 







Due to the large range of heel-specific devices available for the prevention of heel 
pressure ulcers, the research objectives in 4.3 limited the research to any device that 
works by offloading/floating the heel. However, it was not just offloading devices that 
were observed being used, with wards 2 and 3 reporting that they used egg-crate heel 
cups and pads which are heel-specific CLP devices, as well as the Repose® heel 
protectors which are offloading devices. This will be discussed further in 10.4.1.4. 
10.3.3 Patient participants 
10.3.3.1 Screening and consent/assent 
Across the three wards, a total of 65 patients were screened (Figure 10-4) and of those 
32 (49%) consented to be observed and have their medical and nursing notes 
reviewed. Only 5 patients (7.7%) were screened as not eligible to participate due to not 
being at risk of developing a pressure ulcer.  
Twenty-six of the screened patients (40%) lacked capacity which demonstrates the 
importance of being able to recruit this potentially vulnerable patient group. Eight (31%) 
of the patients without capacity were assented by a personal consultee. There was the 
option to assent using a nominated consultee, this had to be a member of the patient’s 
medical team and on each occasion, there was no members of the medical team 
available to be approached for assent. This was a limitation of the research as 17 
patients screened (26%) could not be assented due to the accessibility of personal and 
nominated consultee. The researcher visited the observation wards at different times of 
the day and visited during visiting hours to attempt to access this population and 
ensure that those recruited to the study were representative of the patient population 
across these wards. 
10.3.3.2 Patient characteristics 
Patient characteristics were collected from the nursing and medical notes review. 
Thirty-two patients were recruited with a mean age of 73.9 years, nine were males and 
twenty-three were females. This split is due to observing two female wards and one 
male ward. The patients were given a unique study number denoting the observation 
number followed by the order in which they were consented, for example participant 
7.1 was the first patient recruited during the seventh observation. Table 10-2 gives 






Although the recruitment criteria stated that participants were at risk of developing a 
pressure ulcer due to being bed-bound or chair-bound,13/32 (41%) of patients were 
observed mobilising with assistance (Table 10-2) but all patients observed had reduced 
mobility and were therefore still at risk of developing a pressure ulcer (Coleman et al., 
2013). All participants had a completed risk assessment in their nursing notes and 
were all assessed as at risk of developing a pressure ulcer, apart from participant 4.2 
who had been assessed as not at risk.  The researcher had assessed this patient as 
being at risk because although he was normally fully mobile, during the observations 
he was non weight bearing and bedfast whilst waiting for theatre.  
No patients were seen or documented to have a dressing for prevention. These are 
similar findings to the 14.0% of patients with an adjuvant device or dressing as reported 
in PRESSURE 2, a multi-centre study involving 2029 patients (Nixon et al., 2019). In a 
prevalence study Gunningberg et al. (2011) reported that 11% of patients had a ‘heel 
cushion’, although it is not disclosed what this is. Two offloading devices were 
observed for prevention, two offloading devices for treatment of an existing heel 
pressure ulcer and one CLP device for prevention. 
Six patients (n = 6/32, 18.8%) included in this study had a Category 2 or above 
pressure ulcer, three of which (n = 3/6, 50.0%) were to the heel. One of the limitations 
of the study is that it was not possible to tell whether a patient had their heels offloaded 
with a pillow as their legs would be covered with a blanket. This information would not 
be included separately in the documentation as it would be counted as part of 
repositioning, but this would not guarantee that it would happen every time for every 
patient. 
The most frequent reason for admission (n = 16/32, 50.0%) was following a fractured 
neck of femur (mean age 78.8 years). Of the 16 patients with a fractured neck of femur 
in this study, five (31.3%) had a pressure ulcer, three of which were to the heel (Table 
10-2). Three of the fractured neck of femur patients (n = 3/16, 18.8%) had a heel 
device, two for treatment of a heel pressure ulcer (offloaded) and one for prevention 
(CLP device), this is broken down according to wards in Table 10-3. This patient group 
has been identified as being at high risk of developing pressure ulcers due to pain, 
increased age and the general health status of this population (Houwing et al., 2004, 
Lindholm et al., 2008, Galivanche et al., 2019). Between 2013-2018 the National Hip 
Fracture Database have reported an annual incidence in England, Wales and Northern 
Ireland for Category 2 or above pressure ulcers of 2.8-6% for patients undergoing 






incidence of 3.8% reported by Haleem et al. (2008) over a seventeen year period for 
hip fracture patients, with 44% of all pressure ulcers at the heel.   
 
Figure 10-4 Screening and consent flow diagram 
 
  
Total Screened  
n = 65  
Ward 1 n = 24 
Ward 2 n = 22 
Ward 3 n = 19 
Personal 
Consultee Assent 
n = 8 (25%)  
Consented Self  
n = 24 (75%) 
Not Consented  
n = 33 (51%) 
Reasons 
Not eligible n = 5 
Refused n = 9 
No consultee available n = 17 
Patient asleep n = 1 
Previously observed n = 1 
Total 
Consented  
n = 32 (49%) 
Ward 1 n = 9 
Ward 2 n = 11 
Ward 3 n = 12 
Ward 1 n = 5 
Ward 2 n = 8 
Ward 3 n = 11 
Ward 1 n = 4 
Ward 2 n = 3 





















1 1.1 M 90 22.6 Fractured left acetabulum 
Can mobilise but spends 
majority of time in bed 
PVD, 
diabetes 
No No  
1 1.2 M 90 
Not 
measured 
Fractured pubic rami, left 







1 2.1 M 81 23.6 




No No No  
1 2.2 M 56 
Not 
measured 
Right 4th and 5th toe 
amputation 
Can mobilise but spends 
majority of time in bed 
PVD, 
diabetes 
No No  
1 3.1 M 80 26.4 
Fractured left neck of 
femur 
Chair-fast, can reposition 
self 
No No No  
1 3.2 M 88 
Not 
measured 
Fractured right neck of 
femur 
Chair-fast, can reposition 
self 
No No No  
1 3.3 M 40 
Not 
measured 
Fractured left ankle, tibia, 
and fibula 
Chair-fast, can reposition 
self 
No No No  
1 4.1 M 80 22 








1 4.2 M 50 25.1 Fractured right ankle 
Chair-fast, can reposition 
self 
No No No  
2 5.1 F 86 
Not 
measured 
Fractured left neck of 
femur 
Can mobilise but spends 
majority of time in chair 
No No No  
 






















2 5.2 F 69 
Not 
measured 
Fractured left neck of 
femur 
Can mobilise but spends 
majority of time in bed 
No No No  
2 5.3 F 43 23.4 
Pubic fusion and bilateral 
screw insertion 
Bedfast, can reposition self No No No  
2 5.4 F 80 22.3 





Category U left 
heel, Category 2 
right heel 
No  
2 6.1 F 94 
Not 
measured 
Necrotic right 2nd toe 
Can mobilise but spends 
majority of time in bed 
PAD No No  
2 6.2 F 83 25 










2 7.1 F 89 17.8 








2 7.2 F 90 24.7 




No No No  
2 8.1 F 83 
Not 
measured 










2 8.2 F 70 
Not 
measured 
Left leg Ischaemic ulcers 
and vomiting 
Can mobilise but spends 
majority of time in bed 
PAD No No  
2 8.3 F 58 
Not 
measured 
Fractured right femoral 
shaft and pelvis 
Bedfast, required 
repositioning 
No No No  
3 9.1 F 55 41 
Fractured left tibia, fibula, 
and patella 



























3 9.2 F 60 35.7 




No No No  
3 9.3 F 89 20 
Fractured right neck of 
femur 
Can mobilise but spends 
majority of time in chair 
No No No  
3 10.1 F 86 22.7 Septic arthritis right wrist 
Can mobilise but spends 
majority of time in chair 
No No No  
3 10.2 F 90 23.2 Fractured pubic rami 
Can mobilise but spends 
majority of time in chair 
IHD, pre-
diabetic 
No No  
3 10.3 F 56 25.5 




Diabetes No No  
3 10.4 F 81 30.9 
Fractured right neck of 
femur 
Can mobilise but spends 
majority of time in chair 
No 
Category U to 
buttock 
No  
3 11.1 F 62 27.4 








3 11.2 F 61 19.3 
Fractured tibia, Illisarov 
frame, infected pin sites 
Can mobilise but spends 
majority of time in chair 
Diabetes No No  
3 11.3 F 84 18.3 
Fractured left neck of 
femur 
Can mobilise but spends 
majority of time in chair 
Diabetes No No  
3 12.1 F 93 20.6 





Category 2 to 
buttocks 
No  
3 12.2 F 48 38.6 
Fractured right ankle, left 
wrist, C5/6 
Can mobilise but spends 
majority of time in chair 





Table 10-3 Summary of patients with pressure ulcers and how heel-specific 
























Ward 1 33.3% (n = 
3/9) 
22.2% (n = 
2/9) 
0% (n = 0/9) 0% (n = 0/0)  0% (n = 0/0) 
Ward 2 63.6% (n = 
7/11) 
0% (n = 
0/11),  
36.4% (n = 
4/11) 
75% (n = 3/4)  66.7% (n = 
2/3) 
Ward 3 50% (n = 
6/12)  
8.3% (n = 
1/12) 
16.7% (n = 
2/12) 
0% (n = 0/2)  0% (n = 0/0) 
Totals 50% (n = 
16/32) 
9.4% (n = 
3/32) 
18.8% (n = 
6/32) 
50% (n = 3/6) 66.7% (n = 
2/3) 
10.3.4 Ward staff  
The nursing team was made up of several different job roles, bands, and level of 
qualification. When starting the observations, it was sometimes difficult to identify the 
different job roles whilst getting familiar with the different uniforms, as not only were 
there numerous different uniforms specific to the hospital, but there were also different 
uniforms for agency staff.  To try and understand the roles of the nursing team with 
regards to pressure ulcer prevention, they were separated into Qualified Nurses (QNs), 
Healthcare Assistants (HCAs) and nursing students (Table 10-4).  The Nursing 
Associate role is new, with the first cohort qualifying and registering with the Nursing 
and Midwifery Council during the observation period.  The Nursing Associate role 
contributes to most aspects of nursing care, including delivery and monitoring, but the 
Registered Nurse leads on assessment, planning and evaluation, as well as managing 
and coordinating care (Nursing and Midwifery Council, 2018). Although the job roles 
differ at ward management level, the day-to-day care observed in the bay was similar, 
so a post observation decision was made to group Registered Nurses and Nursing 
Associates together as QNs. 
10.3.4.1 Handover 
One handover was observed on each ward to get an overview of what was 
communicated about pressure ulcer prevention. Ward 1 and 3 did not discuss pressure 
ulcer risk or repositioning plans, whilst Ward 2 did. All the wards included whether the 
patients had a pressure ulcer on the handover sheet. Devices were not discussed at 





Table 10-4 Job roles that make up the nursing team 






Nurse (Ward Manager) 












Nursing Associate   
 
10.3.4.2 Staff and patient interactions 
Times that staff entered and left the bay, along with all interactions between the patient 
participants and all staff on the ward (i.e., Doctors, Physiotherapists, Occupational 
Therapists etc.) were recorded in the field notes, including verbal interactions and 
direct patient care.  Most of the interactions between the patients and ward staff were 
with members of the nursing team (Table 10-5).  During 49 hours and 35 minutes of 
observations, a total of 305 interactions were observed lasting 16 hours and 49 
minutes. During each observation period the participants had a mean of 2.9 QN 
interactions and 0.7 student nurse interactions compared with 4.8 interactions with 
HCAs (Table 10-5). The interactions with the HCAs also tended to be longer, averaging 
at 15 minutes per participant compared with an average of 8.7 minutes spent with the 
QNs and 2.5 minutes with student nurses.  The majority of QN time spent in the bay 
was doing medication rounds and documentation. Only documentation that was 
completed at the bedside during an interaction with the patient was recorded in the 
fieldnotes, but in most cases documentation was completed away from the bedside 
with the care plans being taken out of the bay or completed without a conversation or 
interaction with the patient. The HCAs were doing most of the direct patient care such 
as performing observations, assisting patients with hygiene needs, skin assessments, 
mobilising, and repositioning patients. This is similar to the findings by Sving et al. 
(2012) who reported that QNs delegated most of the pressure ulcer preventative care 
to HCAs. The Nursing students observed functioned at a level between the QN and 
HCA role, assisting on medication rounds and dressings, but also performing direct 
patient care.  
 






Along with more patient interactions, the HCAs were present in the observed bays 
more than QNs. This is in part due to a protocol in some of the bays that were 
designated “falls bays” where patients at high risk of falls are all placed in the same bay 
and a member of staff would need to be always in the bay to try and prevent patients 
mobilising or climbing out of bed unaided; a duty that was primarily undertaken by the 
HCA.  
Ward 3 saw more QN interactions and time spent with the participants, but this was 
mainly from medication rounds. There is a potential reporting bias here though, as due 
to the iterative nature of the research project, Ward 3 was observed after Wards 1 and 
2 had been analysed, so what was being observed and reported was more focused 
and the interactions between the patients and staff were more comprehensively 
documented in the field notes.  
The HCAs performing most of the pressure ulcer preventative care is an important 
finding, as the majority of the initial theories did focus on QNs, but the focus of the 
theory needs to be changed to include all staff in a QN led team when providing direct 
care. Two physiotherapists were also observed completing skin assessments so there 
is evidence of an MDT approach to pressure ulcer prevention starting to take place 
within this organisation. Theory development therefore needs to consider the whole 
MDT.  
10.3.4.3 Staff interactions 
Overall, of the observations, only 20 interactions between QNs and HCAs were 
observed in the bay, mainly to discuss the results of vital signs observations. A total of 
four short interactions, lasting less than 1 minute each, between QNs and HCAs about 
pressure ulcer prevention were observed and three occasions where HCA staff were 
observed discussing amongst themselves repositioning plans or pressure ulcer 
prevention care needs of patients. When the Nursing Students worked alongside the 
QNs the work was aligned to the activities of the QN for example medication rounds 
and completing a referral to occupational therapy. When the Nursing Students were 
working alongside the HCAs, they would align to the HCA role. There were no 










Table 10-5 Staff and participant interactions per observation period  
Participant 
number 





















Number of other staff 
interactions 
1.1  07.15-11.30 12 4 22 4 0 0 0 0 
1.2 07.15-11.30 11 4 7 6 0 0 9 1 Physiotherapist (physio) 
2.1 14.50-18.15 6 4 9 3 0 0 1 1 Speech and language 
therapist (SALT) 
2.2 14.50-18.15 1 1 5 4 15 1 10 1 Doctor 
3.1 14.10-18.30 2 2 31 12 0 0 0 0 
3.1 18.00-22.10 4 2 5 5 0 0 0 0 
3.2 14.10-18.30 1 1 9 5 0 0 0 0 
3.3 14.10-18.30 4 1 16 3 0 0 0 0 
4.1 18.00-22.10 6 2 17 4 0 0 0 0 
4.2 18.00-22.10 0 0 1 1 0 0 4 1 Trauma co-ordinator 
Totals  47 21 122 47 15 1 24 4 
Means (Ward 
1): 


































Number of other staff 
interactions 
5.1 07.15-12.00 5 2 33 7 0 0 0 0 
5.2 07.15-12.00 5 2 20 3 0 0 17 1 Occupational therapist (OT), 
1 Physio, 
5.3 07.15-12.00 9 5 60 5 0 0 3 1 OT, 1 Physio, 1 Doctor 
5.4 07.15-12.00 32 7 14 3 9 1 25 1 Physio, 1 Medical 
Illustration, 1 TVNS 
6.1 10.00-14.00 0 0 10 9 6 3 0 0 
6.2 10.00-14.00 3 2 26 14 7 6 9 1 Physio, 1 Physiotherapy 
assistant (PA) 
7.1 14.15-18.20 6 3 4 3 0 0 0 0 
7.2 14.15-18.20 7 3 22 4 0 0 0 0 
8.1 18.00-22.05 5 4 12 6 0 0 28 1 Student Doctor 
8.2 18.00-22.05 17 8 2 2 0 0 0 0 
8.3 18.00-22.05 7 4 21 3 0 0 0 0 
Totals  96 40 224 59 24 10 82 11 
Means (Ward 
2): 

































Number of other staff 
interactions 
9.1 07.15-11.30 13 4 11 3 22 3 9 3 Doctors 
9.2 07.15-11.30 10 4 23 4 11 3 9 1 doctor, 1 PA 
9.3 07.15-11.30 2 2 2 2 1 1 19 1 Physio, 1 PA, 1 doctor 
10.1 10.15-14.20 8 5 1 1 0 0 4 1 Doctor 
10.2 10.15-14.20 12 3 17 7 0 0 0 0 
10.3 10.15-14.20 38 4 14 5 0 0 5 2 Doctors 
10.4 10.15-14.20 6 3 24 7 0 0 0 0 
11.1 14.20-18.40 7 2 16 2 7 2 0 0 
11.2 14.20-18.40 10 3 12 5 2 1 0 0 
11.3 14.20-18.40 12 3 12 6 0 0 3 1 British Red Cross 
12.1 18.15-22.05 12 3 14 7 0 0 0 0 
12.2 18.15-22.05 5 1 4 3 1 1 0 0 
Totals  132 37 150 52 44 11 49 12 
Means  
(Ward 3): 
  11.3 3.1 12.5 4.3 3.7 9.2 4.1 1.0 
Totals for all 
observations 
 275 98 496 158 83 22 155 27 
Means for all 
observations 





One limitation of this study was that the observations all took place in a bay, therefore 
there could have been more interactions and conversations between staff at the 
nurses’ station or elsewhere on the ward. Previous studies have demonstrated that 
crucial informal communication often occurs in hallways, break rooms and around 
nursing stations (Ellingson, 2003). The nurses’ station does seem to be a central 
location where interactions and discussions about patients would happen; during two 
observations, on different wards, the nurses’ station could be seen from the bay and 
QNs, HCAs and Nursing Students would be seen to congregate during quieter periods. 
Without being able to hear the conversations, some of the discussions appeared to be 
about the patients, but some were also social conversations. Having a central space 
where the nursing team can communicate with one another along with other members 
of the MDT is important for not only work-related conversations, but also provides an 
opportunity for important relational, mentoring, teaching, and learning interactions (Real 
et al., 2017). It has however also been found that a centralised nursing station leads to 
higher walking distances for the nursing team (Real et al., 2019), which has been 
associated with reduced patient care activities and communication with the family 
(Ulrich et al., 2008).  
At this hospital the medical and nursing notes were partially electronic and partially 
paper. The nurses would tend to sit at the nurses’ station to complete all care plans 
and documentation, rather than at the bedside, even though there were mobile 
computer workstations that could be moved into the bay. This is likely to be one of the 
reasons why the QNs were observed in the bays for less time and were observed 
being involved in fewer patient interactions compared with the HCAs, as discussed in 
10.3.4.2.  
10.3.4.4 Staff Interviews 
A total of 19 ward staff (Table 10-6) were approached immediately after the 
observations and recruited to participate in a short interview; each lasting between 5-10 
minutes. All staff who were approached agreed to be interviewed, although not all staff 
observed could be approached as they might have finished their shift or were no longer 
on the ward. This is a limitation to this research as the number of staff not available 
was not recorded, and their accessibility could be connected to differences in their 
workload which could affect the representativeness of those recruited. On reflection, 
although it was not intentional, it is possible that staff who were easiest to access could 
have been more likely to be recruited leading to a selection bias. 
Each interviewee was assigned a unique participant number, the number relates to the 




participant 3b was the second staff member recruited during the third observation.  
Eleven of the interviewed staff were HCAs (n = 11/19, 57.9%), reflecting the staff 
observed delivering most of the direct patient care (Table 10-6). 
Table 10-6 Job roles of interviewees 
Ward 1 Ward 2 Ward 3 
Participant 
Number 
Job Role Participant 
Number 
Job Role Participant 
Number 
Job Role 
1a HCA 5a HCA 9a QN 
1b HCA 5b QN 9b HCA 
1c QN 6a Agency HCA 9c HCA 
2a QN 6b Agency HCA 10a Junior Sister 
2b HCA 6c Apprentice HCA 10b Nursing 
Associate 
3a HCA 6d Trainee Nursing 
Associate 
11a Junior Sister 




    
 
During the interviews it became apparent that the role of the Ward Manager could be 
significant, and therefore due to the iterative nature of the research, it was decided to 
do three additional in-depth interviews with the Ward Managers (WM) for the three 
observed wards, each lasting approximately 30 minutes. The Ward Manager for Ward 
2 was not available for interviewing, therefore one of the Junior Sisters was interviewed 
instead, taking the total number of staff interviews to 22.  
It needs to be acknowledged that although the nursing team were mostly unaware of 
my job role as a TVNS during the observations, they were made aware before the 
interviews which could have influenced their responses. 
The interviews tended to confirm my interpretation of the observations, and no major 
disparities in the answers was noted between the different job roles, although due to 
the depth of the ward manager interviews, these did provide greater depth. 
10.4 Testing of programme theory 1 
Based on the programme schema developed following the TVNS interviews for 




under the contexts of the ward, TVNS and organisation/NHS with the mechanisms as 
sub headings, as per Figure 6-7. 
10.4.1 Ward context 
During the TVNS interviews, there were four mechanisms identified within the context 
of the ward that influenced the use of offloading devices for the prevention of heel 
pressure ulcers: Staff awareness and knowledge, stock and supply of devices, 
identification of a suitable patient group and leadership/management. The TVNS all felt 
that knowledge & awareness was key for the proactive use of offloading devices, so 
they ensured that imparting knowledge and raising awareness was a key part of what 
they did. 
10.4.1.1 Staff awareness and knowledge  
10.4.1.1.1 Training and education 
No direct training or education with regards to pressure ulcer prevention was witnessed 
between any staff members during the observations. There was one opportunity, with a 
TVNS being observed reviewing a patient’s heel pressure ulcer.  A nursing student was 
present during the assessment, so it was possible that observational learning occurred, 
and it is also possible that teaching about the patient assessment was delivered once 
they had left the bay instead of doing it in front of the patient.   
During the staff interviews a wide range of sources of training and education were 
described, from formal teaching at induction to informal teaching on the ward by the 
clinical educators, other members of staff, link practitioners and the Ward Manager, 
along with shadowing the TVNS.  
Within the organisation all members of the nursing team were required to undertake 
pressure ulcer prevention training every 2 years as a minimum, but none of the 
interviewed members of staff could recall this training. Three of the interviewed 
members of staff were new to the hospital (within the previous four months) so had 
undergone pressure ulcer prevention training during this time as part of their induction; 
where all new staff receive as much of their mandatory and priority training required for 
their role within the first four weeks of employment.  None of the new members of staff 
could recall any of the training being about offloading or heel pressure ulcer prevention, 





Only one member of staff identified that they had received training that was specifically 
about the prevention of heel pressure ulcers or the use of offloading devices, delivered 
by the Ward Manager on Ward 1: 
“[I’ve had] more [education] about the pressure on the heels on here with 
[the Ward Manager], she loves the boots” (Participant 1C, QN, Ward 1) 
Learning theories describe a process that leads to a change in an individual’s 
understanding, which ultimately changes the way in which they perform a task or skill 
(Wills and McEwen, 2011).  For example, most staff interviewed knew that offloading 
devices could reduce the risk of their patients developing a heel pressure ulcer, but it 
could be argued that only once this has become incorporated into routine practice that 
learning has occurred.  
10.4.1.1.2 Staff knowledge 
From the observations no evidence of formal training and education on the use of 
offloading devices was witnessed. On Wards 1 and 3 there was evidence of knowledge 
about what devices were available and when to use them, with staff using collective 
terms like “we” to illustrate something they all do as a team; potentially learning and 
working as a community of practice, as this example illustrates:   
“if we find that their heels are quite red on admission, we’d straight away 
put them on repose® boots” (Participant 2a, QN, Ward 1) 
From the interviews with staff, it does appear that staff have gained their knowledge 
through tenacity, authority and a priori (Kerlinger and Lee, 1986). The Ward Manager 
for Ward 1 gives an example of how knowing through authority is supplemented by 
evidence and a priori:  
“I’m sure if someone said ‘if you run round the ward with an orange bag on 
your head it would prevent this, that and the other’ [knowledge through 
evidence], we’d probably go along with that if it made sense! So, if it makes 
sense and it’s understandable [knowledge through a priori] then your staff 
are more likely to follow your lead [knowledge through authority]. (Ward 
Manager, Ward 1) 
Knowledge through authority will be discussed further in 10.4.1.2 as this was seen to 
be an important element of leadership. As well as knowledge through authority, staff on 
Ward 1 were also able to demonstrate knowledge through a priori by demonstrating 
reasoning behind why they were offloading fractured neck of patients, as this HCA can 
evidence:  
“we deal with a lot of hip problems, like broken hips, so with them being 
less mobile we tend to concentrate on the heels, it’s one of the things that 




There is also an element of experience required to gain knowledge through tenacity 
and a priori. Something that is illustrated by this HCA who has identified that they have 
little experience in pressure ulcer prevention: 
“I wouldn’t say I was massively confident anyway with like pressure ulcer 
prevention care, I haven’t seen that much to be fair, I just kind of follow 
what other people are doing, but if I’ve seen breakdown of skin, I’d let the 
nurse know and then just do whatever they told me to do”. (Participant 6b, 
agency HCA, Ward 2) 
This does also give further evidence to the importance of communication between staff, 
but also how inexperienced staff can look to colleagues to gain knowledge through 
communities of practice(Andrew et al., 2008, Wenger, 2010).  
10.4.1.1.3 Visual awareness 
Another mechanism whereby offloading devices increase awareness for staff is by 
being a visual reminder that the patient’s heel is at risk and therefore they will put in 
extra measures to offload the heel even though they already have a device in place, 
which was part of candidate theory 10 discussed in Chapter 7, as this quote gives an 
example of: 
“when we actually ran out of [heel devices] we had slightly more [Category 
1 pressure ulcers] because people, if you put the eggshell thing in [CLP 
device], people will actually [profile the bed at the feet] to offload but if you 
don’t have it, they’ll forget” (Ward Manager, Ward 3) 
This is a perception of the Ward Manager and junior sister on Ward 3 and was not 
something that was evident during the observations. Only one patient on Ward 3 was 
observed with a heel-specific CLP device, and the foot of the bed was not profiled, and 
they were not repositioned any more frequently than any of the other patients. This 
does link in with the stock and supply of devices (10.4.1.4) as if access to devices is 
not maintained, it could contribute to a heel pressure ulcer not just because they do not 
have a device, but they do not have the additional interventions that the Ward Manager 
and Junior Sister on Ward 3 believed happened. No research evidence could be found 
about whether visual cues such as mattresses or offloading devices prompt more 
interventions.  
10.4.1.2 Leadership and management 
During the interviews, leadership with regards to the Ward Managers’ influence on 
pressure ulcer prevention and the use of offloading devices was explored. This links in 
with the theory by Kerlinger and Lee (1986) about gaining knowledge through authority, 




“every fractured neck of femur patient on here should really have Repose® 
boots given to them, that’s what the manager likes to have on here, as like 
a protocol” (Participant 1a, HCA, Ward 1) 
Staff on Ward 3 were also able to give examples of leadership having an impact on 
offloading device use, as something that has been embedded into ward practice as this 
quote illustrates.  
“we've got quite a focus on pressure ulcers on here, and our sisters are 
quite hot on it, and it's just been instilled in us to always offload someone’s 
heels” (Participant 9a, QN, Ward 3) 
In contrast, none of the staff on Ward 2 discussed the preferences or opinions of the 
current Ward Manager and there appeared to be a lack of focus on heel pressure ulcer 
prevention, which does seem to influence practice by omission.  
A staff member on Ward 2 suggested that a former Ward Manager had influenced 
pressure ulcer prevention practice, but this was then over-ruled by Senior Managers 
due to financial costs. Although this staff member talks about the use of mattresses it 
gives a generic example of how ward leadership can impact upon practice.  
“it was a manager that I [previously] worked for and they basically wanted 
all patients with neck of femur fractures to be put on Nimbus® mattresses 
[AP mattress], at least for the first few days until they started sitting out, but 
[Matron and Head of Nursing] stopped us doing it because we were doing 
that, we were ordering mattresses and cushions for everybody but then 
they were kept on the mattresses far too long” (Participant 5b, QN, Ward 2) 
Leadership appears to be influential on device use, as staff on both Ward 1 and 3 
discussed the preferences of the Ward Manager and how this impacted upon their use 
of devices Gunningberg et al. (2010) concluded that it is the nursing managements’ 
responsibility to stimulate collaboration amongst the nursing team as well as the wider 
MDT to embed pressure ulcer prevention in daily practice. Leadership seems to be an 
important mechanism for the proactive use of offloading devices within the ward 
context. However, what was discussed by staff was not witnessed during the 
observations, with only one patient with a fractured neck of femur on Ward 3, had a 
heel-specific device proactively for prevention.  
10.4.1.2.1 Protocol 
On Wards 1 and 3 there was evidence of an informal protocol for when offloading 
devices should be used, which was developed and/or initiated and maintained by the 
ward leadership teams. The preferences and opinions of the Ward Manager on Ward 1 





 “The protocol normally is that if someone’s been admitted with a fractured 
[neck of femur] we tend to put the Repose® boots on as soon as” 
(Participant 2a, QN, Ward 1) 
From the evidence provided during the interviews, staff on Ward 1 perceived 
themselves to be proactive in the use of offloading devices for the prevention of heel 
pressure ulcers, although no patients were observed pre- or immediately post-
operatively with a device to support this. 
Ward 2 had no protocol in place for the use of offloading devices, which the Junior 
Sister did reflect upon and did seem keen on developing and initiating. Here the Junior 
Sister has provided some insight into why they think the protocol helps in that it gives 
ward staff a rationale behind their practice.  
 “I think you do need a protocol; I think if you give a protocol then [the 
nursing team] have got something to concentrate on, they’ve actually got a 
rationale of why we’re doing it. I don’t think a lot of staff understanding the 
reasoning why they actually are doing a task, because it’s literally just a tick 
box sometimes, … if they understand the rationale why you’re doing it, and 
I think you’d have a better response from it, so having a protocol in place 
and saying this is the research behind it, now it’s in place you’ve got to do 
it, you’ll have better success” (Junior Sister, Ward 2) 
The staff on Ward 3 said their protocol was initiated as part of the fractured neck of 
femur pathway; a national quality improvement project designed to improve the care of 
vulnerable patients admitted to hospital in the UK with hip fractures (Royal College of 
Physicians, 2019). Pressure ulcer rates in orthopaedic units are monitored on the 
National Hip Fracture Database (Royal College of Physicians, 2019), but no written 
evidence or guidance could be found locally or nationally about the use of offloading 
devices. Through informal conversations with a Clinical Educator and the Fracture and 
Fragility Nurse Specialist, it was discovered that the heel-specific CLP devices were 
brought in a couple of years previously by the Fracture and Fragility Nurse Specialist 
along with one of the Matrons within orthopaedics for use in this patient group, but only 
Ward 3 appeared to continue to use them.   
Although it was apparent that staff on Ward 1 and Ward 3 knew more about the heel-
specific devices available to them and when they should be used, this was not evident 
from the observations. No clear difference was seen between the patients or the wards 
in terms of when a device would be used proactively, and it appeared that device use 
was on an ad-hoc basis, although these observations provide only a snapshot of 






10.4.1.3 Identification of a suitable patient group 
There appeared to be consensus across all the observed wards with regards to the 
vulnerability of fractured neck of femur patients, with Wards 1 and 3 having an informal 
protocol to provide these patients a heel-specific device on admission. A total of 
sixteen patients (50%) were observed who had been admitted with fractured neck of 
femurs (highlighted in Table 10-2), of which three (n= 3/16, 18.8%) had a heel-specific 
device, two to treat a pre-existing heel pressure ulcer (n = 2/16, 12.5%), and one (n = 
1/16, 6.3%) as prevention. 
One of the benefits of ethnography is its ability to allow you to view a snapshot of what 
is really going on in the real world, compared to interviews that give an individual’s 
accounts and beliefs about what is happening.  For example, in the interviews staff 
were able to demonstrate their knowledge with regards to the protocols and processes 
in place for the use of heel-specific devices, whereas the observations demonstrate the 
application (or not) of this knowledge. The mechanism demonstrated through the 
interviews is that knowledge and awareness of the vulnerability of patients with a 
fractured neck of femur should trigger the implementation of a device, but the 
observations can help to unpick the contextual factors that means it only happened for 
one patient. 
10.4.1.4 Stock and Supply of Devices 
During the TVNS interviews it was theorised that in the context of a ward that 
frequently cares for patients at high risk of developing heel pressure ulcers, and where 
staff are knowledgeable about the risk factors for their patients, nurses are more likely 
to use offloading devices especially if they are readily available to them. From the 
observations, Wards 1 and 3 had a stock of offloading devices (10.3.1), but this did not 
appear to lead to more patients being offloaded during the period of observation. 
There was not a consistent approach to the type of device used within the context of 
the orthopaedics department, and the reasoning behind this seemed to be down to 
personal preferences of individual wards. There was also little differentiation made by 
staff between heel cushioning devices and offloading devices which is important to 
acknowledge because the initial theories focused on offloading devices. From the 
systematic review, it is unknown whether the offloading or the cushioning devices are 
more effective, but in the absence of this evidence, the outcome is that ward staff are 
attempting to reduce risk through the implementation of a heel-specific device, 




With regards to knowledge about the devices themselves, Ward 1 only had access to a 
single type of offloading device, so their knowledge and responses were limited to just 
this device, but there was evidence that they knew when the device should be used 
and for which patients. There was no clarity from the staff interviewed on Ward 2 over 
which devices they stocked or used and when, and there appeared to be no set 
process for stocking and using the devices. Two patients had an offloading device for 
treatment, but none of the staff knew if they had been ordered in or were ward stock. 
Staff on Ward 3 had access to both an offloading device (Repose® offloading boot) 
and a heel-specific CLP device (egg-crate heel pads and boots). Some staff described 
using the heel-specific CLP devices for prevention and offloading for treatment as this 
example illustrates.   
“I think we tend to do use the [offloading device] when a pressure [ulcer] 
has occurred, not more as a preventer, I think the [heel-specific CLP 
devices] are more of a preventer, whereas the [offloading device] are just, I 
think they are more for once the pressure damage is already there” 
(Participant 9b, HCA, Ward 3)  
This was discussed with the Ward Manager for Ward 3 to try and establish why they 
were used in this manner, however the Ward Manager viewed the offloading devices 
as being for high-risk patients, but the CLP devices being for patients at medium risk, 
as this quote demonstrates:  
“If we’ve got a patient that is medium risk [of developing a pressure ulcer] 
it’s [heel-specific CLP device] fine, but if we’ve got a patient with higher risk 
that hasn’t got a pressure ulcer people are less likely to switch and upgrade 
[to Repose] because they still haven’t got [a pressure ulcer] …. I would 
say [Repose] would take a higher risk but we would only go to the 
complete offload boots that you get from Orthotics if somebody actually did 
have [a pressure ulcer]” (Ward Manager, Ward 3) 
There is a differentiation between two different offloading device types, the Repose 
re-usable device and the ‘complete offload boots that you get from orthotics’ which are 
single patient use padded offloading devices that are fixed to the limb. This does imply 
that the Ward Manager made a distinction, based on clinical judgement, between being 
at risk and having a pressure ulcer and viewing the single patient use offloading 
devices as being required for patients who have a heel pressure ulcer. Therefore, not 
only are the heel-specific CLP devices and offloading devices not viewed as having 
equal benefits, but not all offloading devices are viewed equally.  
The Junior Ward Manager for Ward 2, where no devices were observed in the stock 
room, thought that a more consistent approach with regards to stock of a heel-specific 
device across the speciality could influence their use, but this idea was not shared with 




of heel-specific devices into practice, that shared practice from similar wards could aid 
with this, as this quote demonstrates: 
“There’s that many different types [of heel-specific device] you’d lose focus 
of which one’s best, which one’s not. If it was [standardised] to [your 
department] it should be easier, and actually it’s only one thing for staff to 
go to for your patients” (Junior Ward Manager, Ward 2) 
Another finding was that staff have a belief about the effectiveness of the devices and 
have associated patients developing a heel pressure ulcer due to the device not being 
available. Both a Junior Sister and the Ward Manager on Ward 3 discussed patients 
developing a heel pressure ulcer when they ran out of heel-specific devices; 
demonstrating tenacity in the belief of the effectiveness of the devices from senior 
members of the nursing team, which could have an impact on the wider nursing team, 
as this quote illustrates: 
“… we did see a patient develop a pressure ulcer to the heel, and that was 
because we did run out of the [heel-specific CLP devices]” (Participant 10a, 
junior sister, Ward 3) 
10.4.1.5 Summary 
Leadership of the ward emerged as an important mechanism to raise staff awareness 
regarding the proactive use of heel-specific devices. There was evidence of the ward 
leaders influencing practice through developing and maintaining an informal protocol to 
give clarity to staff about when the devices should be used that was specific to their 
patient population. There was also evidence of staff gaining more knowledge about the 
devices through authority, tenacity, and a community of practice within the ward rather 
than through formal teachings. This is in keeping with other research that has reported 
perceptions that clinical areas with strong leadership and role modelling does have an 
impact on the delivery of good pressure ulcer preventative care (Spilsbury et al., 2008).  
Heel-specific devices were only observed being used sporadically, not as part of 
standard care for the prevention of heel pressure ulcers, either for the general 
orthopaedic population or for the fractured neck of femur patients. Leadership and 
protocols appear to be influential over raising the awareness for nursing staff regarding 
proactive use of devices. Having a stock of the devices was important to the nursing 
staff, however the specific mechanism with regards to how this knowledge and 
awareness leads to the device being used, remains unclear. It is possible that devices 
were being used pre and immediately post-operatively, but as it was not documented 
or observed it could not be evidenced. It is also possible that there could have been 
specific patient factors that were not explored, that meant these devices were not 




10.4.2 TVNS context  
Chapters 6-8 established that the TVNSs felt that they were influential in the sourcing 
and implementation of heel-specific devices, developing education packages, 
guidelines, and campaigns across their organisation for pressure ulcer prevention and 
the use of offloading devices as well as prescribing the devices through direct patient 
care, which was attempted to be tested through the ethnographic study. 
10.4.2.1 Training and education 
During the TVNS interviews, training and education was discussed by all as being a 
large and important component of their job role; influential on a macro contextual level 
of their organisation by developing educational packages, protocols, guidelines, and 
campaigns, as well as at a micro contextual level of the ward through direct delivery of 
the training and education. The pressure ulcer prevention guidelines for this 
organisation specifies that patients at risk of developing a heel pressure ulcer should 
be offloaded but does not recommend device type.  There was no evidence of the 
TVNS team for this organisation being directly involved in the development, 
implementation, or ongoing monitoring of the informal protocols in place on Wards 1 
and 3. 
As previously discussed in 10.4.1.1.1 in the organisation where the study took place, 
pressure ulcer prevention training is a priority training requirement across the 
organisation for all members of the nursing team to complete every two years. The 
TVNS team identifies what needs to be included in the training and education 
packages and develop the resources for the whole organisation.  From the context of 
the TVNSs they would appear to have an indirect influence on the pressure ulcer 
prevention practices of ward staff by developing the training and education, but due to 
the size of the organisation to deliver the competencies they require the assistance 
from designated members of staff. It was not possible in this study to identify the 
success of these education packages on changing practice or influencing the proactive 
use of heel-specific devices, although none of the interviewed members of staff could 
recall having any formal teaching about heel pressure ulcer prevention.  
10.4.2.2 Knowledge and personal preferences 
The knowledge of the TVNS team were viewed as a resource for the wards to access. 
The TVNS is seen as an expert on pressure ulcer prevention due to their experience, 
knowledge of research evidence and different devices and products; but this 
knowledge should be used in conjunction with the knowledge of the ward staff, as they 




“The tissue viability team are very important as they see a lot of reps don’t 
they, and they see a lot of equipment coming through, see a lot of research 
bits what are happening, so actually [the TVNS] probably can tell us which 
[device is] better, but actually from our client group, our patient group that’s 
when the ward staff need to have a little bit of an influence.” (Junior Ward 
Manager, Ward 2) 
It was suggested that the knowledge of the TVNS should be used in collaboration with 
the knowledge of the ward staff. The ward staff need to have ownership of pressure 
ulcer prevention practice in their clinical area, as this nurse discusses:  
 “but I think the ward staff do need to own [pressure ulcer prevention 
practice] because we are asking [TVNS] for advice … we don’t expect 
[TVNS] to take over with it, so I still think we need the courage of our own” 
(Ward Manager, Ward 3)  
One of the members of staff discussed working directly with the TVNS team by 
shadowing them, another example of how ward staff can access the resource of the 
TVNS knowledge. Although this had a direct influence on their interests, it is not 
possible to demonstrate if or how this acquired knowledge changed their practice.  
“When I first started this course, I worked with the TVNS for a week…I did 
learn a lot with the TVNS and it made me interested to do my dissertation 
on [pressure ulcer prevention]” (Participant 6d, Trainee Nurse Associate, 
Ward 2) 
This does however link in with the theory by Kerlinger and Lee (1986) showing how the 
nursing team acquire pressure ulcer prevention knowledge through authority from both 
the Ward Manager and the TVNS, but this is not necessarily through training and 
education, and what remains unknown is the mechanism through which this knowledge 
is used leading to a change in practice.  
10.4.2.3 Campaigns and protocols 
Within the study organisation there were no campaigns or protocols evident for the use 
of heel-specific devices that were developed or implemented by the TVNS team. 
10.4.2.4 Direct patient care 
One TVNS was observed on Ward 2 visiting a patient with a heel pressure ulcer 
present on admission. It was evident during the interviews that ward staff wanted more 
input from the TVNSs on the management of their patients, as they were seen as a 
valued resource by the ward staff, however the TVNS team at the study site did not 
seem able to meet the demand from the wards. The direct patient care delivered by the 
TVNS was viewed by some of the ward staff as being more reactive to damage that 
has already happened rather than being proactive and being a mechanism for initiating 




“If we develop a pressure area and it’s [reported] they come, they look, they 
either say “yes it is, no it isn’t, do [an investigation], get medical 
photography, whatever and they just dictate but they don’t…there isn’t 
enough of them to be able to sit and do other interventions, teachings and 
things” (Ward Manager, Ward 1) 
10.4.2.5 Summary 
Within this theory the TVNSs were initially seen as a context, however it is emerging 
that within the context of the ward the TVNSs are also a mechanism, with their 
knowledge about pressure ulcer prevention and best practice being a resource 
accessed and valued by the ward staff as well as a resource to advise about the care 
of individual patients. From the context of the TVNS, it was theorised that the 
knowledge of the TVNS team about pressure ulcer prevention and the different 
products available is a mechanism to bring devices into the organisation and identify 
clinical areas that they might be relevant for, although this was not evident during these 
observations.  The ward-based nursing team are the experts on their patient population 
therefore using this in conjunction with the TVNSs knowledge of devices and pressure 
ulcer prevention could lead to the development of a successful protocol.  
10.4.3 Organisation context  
The context of how the wider organisation influences an individual ward was difficult to 
establish through the observations. The Ward Manager interviews were therefore used 
to further explore this context. 
10.4.3.1 Leadership and management 
All three wards were managed by the same Senior Managers (Matron and Head of 
Nursing). The Ward Managers felt that there was little influence from their managers 
and the wider organisation with regards to pressure ulcer prevention and the use of 
heel-specific devices. It could be because for Wards 1 and 3 they already had heel-
specific devices available that they perceived themselves to be using and therefore 
there was no need for the Matron or Head of Nursing to become involved, or there was 
no perceived need to intervene.   
The Ward Managers did feel that the practice of senior management was more 
reactive, and it was only when an incident occurred like a patient developing a severe 
pressure ulcer, that they became involved through the root cause analysis process 
(10.4.3.4). Ward Manager 1 felt that their managers focused on ‘mistakes’ rather than 
‘incidents’, which seem to be attributable to people rather than processes on the ward, 




“They’re [Senior Managers] not around, they’re not visible, so they don’t 
really influence an awful lot unless somebody’s made a mistake 
somewhere then they’re likely to be more visible and share that experience 
with everybody and get people to learn from a mistake that somewhere 
else has made” (Ward Manager, Ward 1) 
The role of Senior Managers is more focused on finances, serious incidents, wider 
organisational issues such as monitoring incident rates, patient throughput as well as 
staff management. This does position them further away from clinical practice, but the 
Junior Sister for Ward 2 felt that because the Senior Managers are further away from 
direct patient care, they have less insight on what works directly on the ward for that 
patient group, as this quote shows: 
“I’m going to say this but actually it sounds really, really bad, but [Senior 
Managers] they’re not aware of the challenges that we have on the ward, 
because I suppose the higher up you get in chain of command, the less 
clinical you are. You don’t actually see how much of a struggle we have on 
the ward every day, so whether or not it might be patient acuity, or might 
just be your generally deteriorating patients or you might have difficulties 
with Doctors who don’t see [every patient] – all they do is come back and 
say, “your pressure ulcer numbers have increased, you’ve had a fall this 
day, this has increased” (Junior Sister, Ward 2). 
This could be why, from the perspective of the nursing team, that the organisational 
context appears to have little influence on pressure ulcer prevention practices and the 
use of devices. During the observations, one Senior Manager was seen once on Ward 
3, and that was at the nurses’ station for a total of 4 minutes talking to the nurse in 
charge. At no point did they enter the bay or were seen interacting with patients, 
although the observations are only a snapshot of the day-to-day running of the wards.   
10.4.3.2 Finance 
The cost of the devices does not appear to be a mechanism that has a direct influence 
over ward staff and how they use heel-specific devices. No members of ward staff 
discussed the financial cost of heel-specific devices, but does seem to be a more 
important factor from a senior management and organisational context as this example 
shows: 
“I suppose for your Matron from that level, I suppose a lot of budgeting and 
costs [of devices] is a massive influence” Junior Ward Manager Ward 2 
One of the QNs felt that when senior management influenced the way in which they 
used mattresses due to financial implications and that this did have a direct impact 
upon their heel pressure ulcer rates as this quote illustrates.  
 “in our unit we were using [the highest numbers of alternating air] 
mattresses and spending the most money on mattresses so they [senior 
management] decided, the [high specification foam] as they’re a high-risk 




saying leave them on an [the high specification foam] unless they started 
portraying signs of pressure damage.  But we found since we stopped 
[using alternating air mattresses] that heel damage has increased” 
(Participant 5b, QN, Ward 2) 
Although there is no actual evidence that there was an increase in heel pressure ulcers 
or if this was directly related to the change in mattresses, this does give some insight 
into how the QNs might perceive the importance of mattresses and other devices in 
pressure ulcer prevention. It is also possible that if a patient develops a pressure ulcer 
because the mattresses were taken away, then the nursing staff can attribute 
responsibility on someone/ something else.  
10.4.3.3 Priorities and targets 
Prevention of avoidable harms such as pressure ulcers, infections and falls is a 
nationwide priority as well as within the study site (Harm Free Care, 2019). It had been 
theorised that targets set by the organisation such as a reduction in pressure ulcer 
rates could be a mechanism by which devices are initiated, aimed at reducing heel 
pressure ulcer rates.  
The only evidence during the observations of organisational priorities and targets was a 
patient safety board seen on Ward 1 showing that the ward had been 253 days without 
a hospital acquired pressure ulcer, although this number was not updated throughout 
the observations. It is likely that Ward 2 and 3 had this information on display but it was 
not noted during the observations, this could be because they were not in as noticeable 
place, or because Ward 1’s poster gained my attention due to the high number. These 
numerical targets can lead to a sense of pride for wards that are doing well, but equally 
could lower morale for struggling wards, as this Ward Manager gives an example of: 
“it’s about getting your staff to be engaged and being proud, you know, 414 
days, over a year without any [pressure ulcers] being developed. Pretty 
damn good and we were very pleased. But that wasn’t, oh that’s a target for 
the [hospital], that was because we were doing it for our patients on our 
ward because they belong to us, it kind of comes to belonging to us and 
owning that responsibility” (Ward Manager, Ward 1) 
Numerical targets set by the organisation do not appear to have a direct influence over 
the nursing team, but awareness of patient safety and reduction in harms is important 
to staff as this quote demonstrates. 
 “… [nursing staff] are trying to prevent harm to patients, it’s probably of 
more importance than saying that we have to reduce by 10% I would say… 
because 10%, 10% of what? It’s quite difficult, numbers are numbers, and 




Although the wider organisation does not seem to have a direct influence on the 
implementation of heel-specific devices, the use of targets such as pressure ulcer free 
days is a management priority and target which seems to have influenced awareness. 
10.4.3.4 Identifying practice that needs improving through RCA 
investigations 
From personal experience, documentation is often a focus during root cause analysis 
investigations because, whilst good record keeping is a professional and legal 
requirement of nurses, it is believed that poor record keeping is linked to poor practice 
(Andrews and St Aubyn, 2015). Documentation is also something that can be a 
measurable outcome that can be audited to demonstrate an improvement in practice.  
On discussion with the Ward Managers, it was established that Ward 1 had the lowest 
acquired pressure ulcer rate, going above 414 days, but had less documentary 
evidence in the care plans about the pressure ulcer preventative care received 
compared to the other wards. There was therefore no link seen here between the 
quality of the documentation and pressure ulcer development. One theory behind this 
could be because Ward 1 had not had an acquired pressure ulcer, and therefore a root 
cause analysis investigation, for over one year, so there was less of a focus on their 
documentation.  
Within the context of the organisation, root cause analysis investigations were viewed 
as a reactive response to incidents that had occurred. The Ward Managers disclosed 
that Senior Managers shared learning from root cause analysis investigations across 
all wards within the speciality, but not all the Ward Managers saw this as a good thing 
especially if they felt it was not relevant to the practice on their ward, as this quote 
demonstrates. 
“so, we’ve now got a competency so that’s now being taught to avoid the 
pressure areas that we’ve had from the traction. So again, it’s a kneejerk, 
it’s not a proactive, it’s a kneejerk, this has happened, we must do 
something about it, which we are doing” (Ward Manager, Ward 1) 
The root cause analysis process was a potential mechanism by which the devices were 
first initiated on Ward 3, which was associated with a positive outcome on the 
perceived reduction in the number of patients subsequently developing heel pressure 
ulcers, as discussed: 
“So, the decisions have come off the back of [root cause analysis] 
meetings… I presume it came through the Education Team for the [egg-
crate heel pads] but I can’t remember. I think it was a trial we started off the 
back of heel pressure ulcers that were [not caused by a cast or a device], 
so we’ve had a massive reduction [in heel pressure ulcers] using those” 





The ward nurses perceived that the wider context of the organisation was less 
influential on the nursing team’s day-to-day pressure ulcer prevention practices and the 
use of devices, compared to the influence of the Ward Manager. However, through 
lessons learnt from root cause analysis investigations, devices might be implemented 
reactively. During the TVNS interviews, it was felt that the TVNS team might introduce 
a heel-specific device to meet organisational targets for reducing heel pressure ulcer 
rates, but this was not evident during the ethnographic study.  
10.5  Other findings 
Programme theory three discussed how heel-specific devices are not suitable for all 
patients, at all points in their recovery journey, and there was agreement from the 
TVNSs that they were not suitable for patients whilst sitting out as they could become a 
fall hazard. Patient 6.2 initially had the offloading boots in place when she was sat out, 
but the staff were observed discussing concerns about patient 6.2 being a fall risk with 
the physiotherapists as she was sliding down in her chair, and when the 
physiotherapists repositioned her into a better sitting posture, they removed the 
offloading boots and placed them on the bedside table. Patient 11.1 had an egg-crate 
heel pad in bed, but when she was transferred to the chair this was also moved to the 
bedside table by the HCA.  As this theory was not the focus of the ethnography this 
was not explored further during the interviews.  
Patients 6.1 and 8.2 were also examples of where heel devices were not suitable for all 
patients; as even though they both had PAD and were therefore very high risk for 
developing a heel pressure ulcer, patient 6.1 was agitated and confused and kept 
trying to climb out of her bed, so would have either kicked the device off or it could 
have become a fall hazard. Patient 8.2 had ischaemic leg ulcers but was independently 
mobile and was observed repositioning her legs frequently. 
10.6  Chapter summary 
This chapter has presented the findings from data collected from the ethnographic 
study conducted on three orthopaedic wards through observations, case notes review 
and interviews. The programme theory developed from the interviews with TVNS in 
Chapter 6 about the proactive use of offloading devices was tested using the data 
collected.  
Due to the large range of heel devices available, to increase the depth of the research 




offloading/floating the heel. However, during the observations several different ‘heel-
specific’ devices were observed in use, and although they work differently staff referred 
to them all as ‘offloading devices’. There is no evidence that one is better than the 
other, therefore if they are being implemented it is felt that they are having a positive 
impact in preventing heel pressure ulcers, then all devices should be considered. The 
theory has been further developed from ‘offloading devices’ to ‘heel-specific devices’ to 
include any device that either offloads or reduces pressure to the heel.  
For the context of the ward, nursing staff perceived leadership from the Ward Manager 
to be a key mechanism for the proactive use of heel-specific devices. This was done 
through the development of a protocol specific for their ward and patient population, as 
well as influencing the practice of their staff through authority, as well as being 
conducive to a community of practice. Alongside the staffs’ knowledge, the stock and 
supply of devices and awareness of what was available to them was perceived to have 
a positive impact on device use. Ward 1 and Ward 3 had both identified fractured neck 
of femur patients as being a high-risk patient group that should be proactively 
offloaded, however this was not observed on any of the wards. The context of the ward 
was felt to have the most significant impact on the proactive use of devices, so the 
diagrammatic representation of this programme theory originally presented in Figure 
6-7 was adjusted accordingly to emphasise the ward context by making it a darker 
colour and therefore the focal point of the diagram (Figure 10-5). 
Within the context of the TVNS, the mechanism of training and education was difficult 
to test, and none of the staff interviewed could recall any training and education from 
the TVNS team that consciously influenced their practice with regards to heel pressure 
ulcer prevention. There was no evidence of any heel related protocols or campaigns 
initiated by the TVNSs. Direct patient care from one TVNS was observed on one 
occasion, but this was reactive, reviewing a patient who was admitted with a heel 
pressure ulcer, but they did recommend an offloading device, something that the ward 
had not initiated.  As well as the TVNS being a context, they were also identified as a 
mechanism within the context of the ward, with the nursing team seeing their specialist 
knowledge as a valuable resource that they would access. The context of the TVNS 
was also a link between the ward and the wider organisation, and therefore the second 
most significant context that influences the proactive use of offloading devices, 
therefore it is placed in the diagrammatic representation between the ward and 
organisational context, with a lighter colour than the ward, but a darker colour than the 




The macro context of the NHS and the organisation is more influential over the practice 
of the TVNS team and Senior Managers through National and organisational targets to 
reduce avoidable harms to patients, which has led to the root cause analysis process 
identifying practice that requires improvement, such as initiating a heel-specific device 
to reduce the risk of heel pressure ulcers.  
Figure 10-5 Diagrammatic representation of how theory has developed for the 
proactive use of heel-specific devices, highlighting the most influential context 






Chapter 11 Discussion 
11.1 Introduction 
The results of the systematic review, along with its strengths and limitations, are 
presented at the end of Chapter 3, as this influenced the development of the research 
question and choice of realist evaluation for the remainder of the research. This 
Chapter will discuss the results of the realist evaluation in relation to the study aims set 
out in Chapter 4. It will provide a critical appraisal of the study methods and results 
along with the strengths and weaknesses of the realist evaluation. It will finally present 
personal reflections of being a practitioner researcher.  
11.2  What factors influence the implementation of a heel-
specific device in clinical practice? 
During the TVNS interviews it was identified that priorities set by the macro context of 
the wider organisation, along with investigations into serious pressure ulcers, would 
lead the TVNS to identify clinical areas that require heel-specific devices. The TVNS 
were a meso context being influenced by the wider organisation, but also influential on 
device use through identifying the need for offloading, identifying which devices should 
be used, promoting their use through training and education, and prescribing them for 
individual patients. Several mechanisms were identified that appeared to be influential 
over the implementation of heel-specific devices at the micro context of individual 
wards, which were explored further in the ethnographic study. 
11.2.1 Influence of the TVNS  
The TVNSs perceived themselves to be key in the implementation of devices, in part 
due to the dedicated time they have to focus on pressure ulcer prevention, through 
their influential role within their organisation or direct patient care. The TVNSs felt they 
are perceived by both ward staff and the wider organisation as being a valuable 
resource for driving forward and influencing the initiation and use of heel-specific 
devices through training and education along with the development of guidelines and 
protocols.  
11.2.2 Staff awareness and knowledge 
None of the ward staff interviewed during the ethnographic study discussed research 
evidence informing practice. A reliable body of empirical evidence should guide 
practice and could influence implementation, but in a constantly changing healthcare 




adapting (Van Achterberg et al., 2008). There is an expectation that healthcare workers 
need to adapt accordingly, which can be difficult based on the volume and quality of 
the evidence. For heel pressure ulcer prevention, evidence is informing and guiding, 
rather than being the basis for practice.   
In the context of the wards observed, staff gained their knowledge of the devices, 
awareness of what was expected of them and when to implement them, through an 
informal protocol and guidance from ward leaders.  
11.2.3 Leadership and management  
The TVNSs identified strong leadership to be influential in pressure ulcer prevention, 
which was also seen during the ethnography. Previous research has identified 
leadership as being influential in pressure ulcer prevention through providing guidance 
and clear expectations for their staff, as well as through personal preferences 
influencing practice. Spilsbury et al. (2008) interviewed research nurses about their 
experiences of working on a clinical trial related to pressure ulcer prevention and 
reported that leadership and role-modelling were important in influencing good 
pressure ulcer preventative care. In a review of the literature, Wurster (2007) 
concluded that nurse leaders must shape the environment of care through providing 
guidance and clear expectations. 
11.2.4 Stock and supply of devices 
The TVNSs suggested that if a device is kept as a stock item and therefore easily 
accessible to ward staff, it is more likely to be initiated in a timely manner. This could 
be because delays in the supply process or poor communication can lead to a delay in 
the device being initiated or be a barrier to it being used altogether. 
Despite being in the same department, the three observed wards all kept different 
devices and levels of stock, with one ward having no evidence of any devices in their 
stock rooms. There appeared to be a connection between stocking the devices, and 
staff being aware of what they had access to and when they should be used, although 
there was no evidence that this increased usage.  
11.2.5 Identification of patients most at risk 
Recognition of a patient group at high risk of developing a heel pressure ulcer, where 
the majority would benefit from a heel-specific device could potentially influence 
implementation. Fractured neck of femur patients were highlighted in both the TVNS 




heel pressure ulcer development, and therefore all should have a device implemented 
on admission.   
There was no explicit awareness in any of the ward staff interviewed of conditions like 
diabetes or PAD/PVD being a risk factor for heel pressure ulcers (Coleman et al., 
2013), and there was no evidence of proactive use of devices for these patients. It 
could be that fractured neck of femur is the primary condition and reason for admission, 
and therefore is discussed more and regularly highlighted during handovers, ward 
rounds and care planning.  Therefore, more opportunities for this risk factor to be 
identified and if missed by the admitting nursing team, identified by someone else and 
a device initiated. In contrast diabetes and PAD/PVD are secondary morbidities, and 
therefore less likely to be picked up on as a requirement for a device without 
knowledge about these being a risk factor for heel pressure ulcer development.  
Despite staff being aware of the need for fractured neck of femur patients to have a 
heel-specific device, this was not routinely observed in practice. There are two possible 
reasons for this discrepancy: 
1. Most of the fractured neck of femur patients observed were later in their post-
operative recovery journey: it may be that a device had been used when the 
patients were first admitted, but was no longer required at the time of 
observation, hence heel-specific devices had been used and subsequently 
discontinued.  This could not be explored further as patient length of stay was 
not recorded as part of the documentation review. Furthermore, the use of heel-
specific devices was not documented in the medical or nursing notes for any of 
the patients on any of the wards, despite there being a section in the pressure 
ulcer prevention care plan.  
2. Despite there being an informal protocol in place, knowledge about when to use 
them and a stock and supply of the devices, there is a missing mechanism that 
meant devices were not implemented every time.   
There is a vast amount of literature looking at implementation in health care including 
theories surrounding implementation science such as adoption and diffusion (Institute 
of Health Economics, 2015), normalisation process theory (Murray et al., 2010) and 
diffusion of innovations theory (Rogers, 2003). There is also a Cochrane group that 
focuses on interventions designed to improve professional practice and the 
organisation of health care service (Cochrane Effective Practice and Organisation of 
Care (EPOC), 2017). It is therefore not possible to explore all the existing literature, but 
an overview of some of the relevant literature that could help to identify this missing 




The Institute of Health Economics (2015) looked at factors affecting the adoption and 
diffusion of medical devices. There was evidence that some of the wards had adopted 
and diffused heel-specific devices as the decision had been made to accept the need 
for the intervention and communicated amongst ward staff. However, adoption and 
diffusion does not necessarily ensure its utilisation; the process of putting the decision 
to adopt the device into practice is implementation (Rye and Kimberly, 2007).   
A number of theories surrounding implementation science in nursing focus on the 
evidence base (Van Achterberg et al., 2008). The actual level of evidence behind an 
intervention could hinder implementation if there are doubts about its need and benefits 
(Grol and Grimshaw, 2003, Van Achterberg et al., 2008). This is not the case here, as 
despite there being insufficient good quality research evidence to inform the use of 
heel-specific devices for the prevention (Chapter 3) or treatment (McGinnis and 
Stubbs, 2014) of heel pressure ulcers, it was known to the researcher that these 
devices were widely used in clinical practice, and the ethnographic study demonstrated 
that the devices are being used sporadically. This is in keeping with other wound care 
and prevention devices that are routinely used in clinical practice despite a poor 
evidence base. For example alternating pressure mattresses are used on 
approximately 10-20% of hospital beds without the evidence to support their use 
(McInnes et al., 2015, Nixon et al., 2019) and negative pressure wound therapy is 
widely used for the treatment of complex wounds, also without any robust evidence 
(Arundel et al., 2016, Dumville et al., 2015). 
Van Achterberg et al. (2008) identified a contextual factor where the integration of a 
protocol into wider structures and processes within an organisation, can improve 
implementation. In the context of the orthopaedics department observed, this could 
involve embedding the devices into the admission pathway for fractured neck of femur 
patients. For this to be effective this would require all members of the MDT involved in 
this pathway to be on board.  
11.3  How are heel-specific devices used/not used in clinical 
practice? 
During the TVNS interviews, it was identified that heel-specific devices are used in 
clinical practice proactively or reactively. The previous section (11.2) covers the 
proactive use of devices. The reactive use of devices is to prevent deterioration of early 





The TVNSs viewed offloading devices as being a third line approach to pressure ulcer 
prevention, following repositioning and dynamic mattress use. Only if these were not 
meeting the needs of the patient, or they were unable to tolerate or be concordant with 
the repositioning plan or mattress use would they consider the addition of a heel-
specific device, in a reactive manner.  
Chapter 8 surmised that offloading devices are not suitable for all patients, at every 
point in their inpatient journey; mainly being useful during the acute phase when 
patients are unwell and bedbound, and becoming less effective during the rehabilitation 
phase as patients start to mobilise.  Fractured neck of femur patients are an example of 
this, with ward staff describing how they would use a device when the patient is 
admitted and immediately post operatively.   
Heel-specific devices were also identified during the TVNS interviews as not being 
suitable for patients who were sitting out and a falls risk, something that was observed, 
with two patients with heel devices having them removed when sitting out. 
There is evidence of the devices being perceived by patients as hot, uncomfortable, 
and restricting movement (Gilcreast et al., 2005, Donnelly et al., 2011, Bååth et al., 
2016), and this was acknowledged by the TVNSs. Examples were given of nurses 
attempting to improve comfort and therefore compliance, through using items like 
pillowcases to line the devices, so the skin was not in direct contact with the device. 
This reduces the effectiveness of the devices, but we do not know by how much. 
During the ethnographic interviews it was found that staff referred to all heel-specific 
devices as ‘offloading’, although they were not all viewed equally.  Despite there being 
no evidence of effect for offloading versus CLP devices, there appeared to be a 
preference for offloading boots for ‘higher risk’ patients, or those already with a 
pressure ulcer over CLP for ‘medium risk’ patients.  
11.4  Strengths of the research 
The strengths and limitations of the systematic review are presented at the end of 
Chapter 3. Additionally it should be acknowledged that a thorough knowledge of 
existing research, especially that gained through systematic reviews, should be used to 
design future studies (Liberati et al., 2009), which was the basis for this thesis. 
Realist evaluation is a relatively new methodology which originated in social policy in 
the 1990s, but more recently is being used more to evaluate healthcare systems. This 
methodology was selected as it was acknowledged that my own knowledge and clinical 
experience was relevant and needed to be included. Research needs to reflect the 




Not many examples have been found regarding the use of realist methodology to 
evaluate pressure ulcer preventative strategies; Teo et al. (2019) used a realist case 
study approach to explore nursing staff’s pressure ulcer preventative strategies but little 
was mentioned about the use of devices and nothing was discussed regarding heel 
pressure ulcer prevention. Harris et al. (2019) looked at intentional-rounding strategies 
as a method to improve engagement between nurses and patients, which included but 
did not focus on pressure ulcer prevention strategies. This is the first realist evaluation 
to focus on the use of devices in pressure ulcer prevention or that focused on the 
prevention of heel pressure ulcers.  
The first part of the realist evaluation involved interviews with TVNSs who were 
recruited purposefully through personal and national Tissue Viability Networks. This 
allowed for timely recruitment of TVNSs from across the UK and the recruitment target 
was easily met. It was felt that interviewing over the telephone did not diminish the 
quality of the interviews and was more time and cost efficient than travelling to conduct 
face to face interviews. The TVNS interviews provided a rationale behind their use of 
offloading devices, as professional knowledge is often implicit and intuitive, especially 
in the absence of robust research evidence.  
During the ethnographic study consent was obtained though written, witnessed verbal 
consent or consultee agreement. This allowed inclusion of all patients at risk of 
developing a heel pressure ulcer including those with receptive, comprehension, 
language difficulties, general cognitive impairment affecting their understanding and/or 
dementia (Jaul et al., 2017, Jaul and Meiron, 2017), in a way that is both meaningful 
and ethically sound. 
The unit of observation was debated in Table 9-2 and it was decided to observe the 
bay. This gave more insight into the patient experience along with allowing for a wide 
range of job roles to be observed.  If an individual member of staff had been the unit of 
analysis more information might have been gained about staff interactions and 
communication, but the importance of the HCA role in pressure ulcer prevention might 
not have been identified, along with the emergence of an MDT approach to pressure 
ulcer prevention; with physiotherapists being observed performing and documenting 
skin assessments.   
Other than evaluations into the effectiveness of the devices for the prevention of heel 
pressure ulcers, there is little research about how heel-specific devices are used (and 
not used) in clinical practice, and little evidence has been found regarding their use as 
part of standard pressure ulcer preventative care. Only two observational studies were 




included heel pressure ulcer prevention (Hoviattalab et al., 2015, Özdemir and 
Karadag, 2008) and are summarised in Table 11-1.  
Table 11-1 Summary of standard care in observation studies 









This thesis Orthopaedics 
in England 
100% 84.4% 15.6% 15.6% 
Hoviattalab 











86.7% Unknown Unknown 53.3% ‘lifting 
heels’ 
 
Neither study stated how the heels were lifted, demonstrating that this something that 
is seldom reported on and is therefore new knowledge. This thesis also gives a 
detailed description of what standard care looks like. 
Leadership of the ward emerged as an important mechanism to raise staff awareness 
regarding the proactive use of heel-specific devices. There was evidence of the ward 
leaders influencing practice through developing and maintaining an informal protocol to 
give clarity to staff about when the devices should be used that was specific to their 
patient population. There was also evidence of staff gaining more knowledge about the 
devices through authority, tenacity, and a community of practice within the ward rather 
than through formal teaching. This is not new knowledge but is in keeping with other 
research and supplements a small body of evidence that clinical areas with strong 
leadership, a positive attitude towards pressure ulcer prevention and role modelling is 
essential for staff to work effectively and delivery of good pressure ulcer preventative 
care (Hommel et al., 2017, Spilsbury et al., 2008). 
11.5  Limitations of the research 
This was the researcher’s first time conducting and analysing qualitative research 
interviews. There would be times during the analysis where it would be noted that one 
of the TVNSs had said something relevant, which should have been followed up on, 
but was missed.  This is likely due to inexperience and concentrating on the next 
questions, rather than actively listening to the responses of the participants; something 




As described in Chapter 5, due to the iterative nature of realist evaluation a preliminary 
analysis of each interview was performed before the next would take place. Due to the 
timescale of the interviews, only a basic analysis was performed, and a full analysis at 
the end. A more thorough analysis between each interview might have also given 
greater depth in the latter interviews.  
In the TVNS interviews, the use of a heel-specific campaign was highlighted as a 
method of improving device use. However, the wards in the observed hospital had no 
heel-specific pressure ulcer prevention campaign led by the TVNSs, just what the Ward 
Managers had devised or led upon. If a different hospital was observed that did have a 
heel-specific campaign it might have been possible to compare and contrast whether 
there was any link to device use, staff knowledge and the influence of the TVNS on 
device use.   
The observations took place on three orthopaedic wards in one hospital, and the 
generalisability of the findings need to be taken into consideration. The identification of 
a specific patient group that could benefit from a heel-specific device, as the fractured 
neck of femur patients were identified in orthopaedics, could be transferable to different 
specialities. The research was also limited to acute care as this was where most of the 
research evidence, along with the experience of the researcher sits.  Heel-specific 
devices are also used in community care settings, but they are likely to be used 
differently, primarily using single patient use devices as they will likely be used more 
long-term for treatment of existing pressure ulcers or for permanently immobile and/or 
individuals at constant high risk of developing a heel pressure ulcer.  
Another limitation of the research is that more patients might have had a device at the 
beginning of their admission and had since been discontinued, but no patients were 
observed pre-operative and the number of days post-operative was not recorded. 
Although there was space in the care plans, no participants had heel-specific devices 
documented to be able to find out if they had been used previously.  Data on the length 
of stay and acuity of the patients would have given a better picture of the acuity of the 
wards, where the patients were on the recovery journey along with whether they would 
have benefitted from a heel-specific device. Sixteen patients with a fractured neck of 
femur were observed, if they were all immediately post op then this would have 
evidenced that devices were not being used proactively and therefore the informal 
protocol was ineffective. However, if the patients were further along the recovery, they 
might not have needed the devices anymore. On reflection, non-leading questions 




previously, providing more data on “what devices work for this patient group at which 
stage of their journey”. 
It was decided not to interview patients for this study, as it was felt that there was 
already data in the literature about patients’ experiences of using offloading devices, 
but there was an omission of literature surrounding how nurses use, and their thoughts 
on, the devices.  The inclusion of patients was limited to observations and record 
review, and although useful insights of the interactions between patients and staff were 
gained, if the patients had been interviewed, they might have been able to recall 
whether they had heel-specific devices previously, or if this had been discussed. Also, 
as the observations were just in the bay, and care that took place behind the curtains 
were not observed made it difficult to tell if the heels had been repositioned. It was not 
possible to tell if the patients had a device in place, or if the heels were offloaded with a 
pillow when the legs were covered with a blanket, so the assumption was made that 
unless a device was seen in use, then they were not in place. Involving the patients in 
the observations could also have given insight into whether the patients perceived the 
nurses to care for the heels differently when the device was in place, for example if 
they felt the ward staff repositioned them more due to the device, or opinions and 
perceptions ward staff might have disclosed to the patients or other members of staff 
about the devices. 
There could be a possible selection bias due to the observed bays being selected 
based on which patients could be consented. As many different bays as possible were 
observed across the observation period, however if patients did not have relatives or 
carers visiting, they were more difficult to recruit. Although there was an option to 
assent via nominated consultee, it was difficult to find members of the medical team as 
they were not easily identified on the wards, or if they were seen they were busy with 
ward rounds or patient care. It was considered whether the ward nurses could have 
been a nominated consultee, but this was identified as being a potential conflict of 
interests as they were being observed, along with other members of the MDT.  
11.6  Personal reflections 
11.6.1 Reflections on being a practitioner researcher 
During the PhD I have maintained my clinical practice as a TVNS and developed my 
role as a clinical academic, trying to blend the separate communities of academia and 
clinical practice. This is a vital role that can act as a bridge and influence how we 
develop research that is relevant to clinical practice and can also be influential on the 




As a TVNS the topic for this thesis came about through clinical practice. Whilst going to 
conferences and meeting with representatives from manufacturers it became clear that 
there were numerous different devices available promoted for the prevention of heel 
pressure ulcers, but with little good quality clinical evidence to help inform practitioners. 
Whilst my experience in clinical practice informed the research question and design, a 
balance was required between using this knowledge to develop the research and not 
letting my own opinions cloud my judgement. The choice of realist methodology 
acknowledged my knowledge and experience as a valid part of the research.   
For the key stakeholder interviews, I was able to recruit TVNSs from across the UK due 
to my knowledge of various networks. The interviews were focused and relevant to 
those being interviewed, and by being a fellow practitioner I was able to develop a 
rapport as being one of them, it also meant they were able to describe their practice 
using language familiar to me, such as trade names for equipment, models of practice 
and standardised assessments. This enabled a flow of conversation during interviews 
as I rarely needed to interrupt to ask the TVNS to explain a term or phrase.  
When analysing the TVNS interviews, because at times they would be reflecting my 
own practice and experiences, it would sometimes feel like I would be writing about 
something that feels obvious to me, but to the non-clinician this is not always known 
and therefore could be relevant, giving a picture of standard care practices.  
I feel that being a practitioner researcher, along with experience of sitting on the School 
research ethics committee as a student representative, made the ethics process 
easier.  My clinical knowledge of organisational structures and how wards work was 
beneficial, allowing me to plan for the data collection to be done in an ethically sound 
way that would minimise impact on staff and their treatment of patients.  
During the ethnography I was concerned about the Hawthorne effect and the possibility 
of my presence influencing practice.  This has been evident in previous healthcare 
observation studies such as in a study of hand-washing among medical staff, where 
compliance in hand-washing was 55% greater when staff knew they were being 
watched, compared to when they were not (Eckmanns et al., 2006). I tried not to 
disclose my role until after the observations had finished, dressing in non-uniform 
clothing, and introduced myself as a ‘nurse researcher’. When staff were observed on 
multiple occasions, and therefore had become aware of my job role and research 
focus, no differences were seen in their practice between observations. During the staff 
interviews my presence and whether it had consciously altered practice was explored, 
and overall staff felt that it had not, although some of the more junior members of the 




I was also conscious of observer bias during the ethnography. If there is subjective 
judgement as part of the observation, different observers could get variable results 
which could lead to bias (Catalogue of Bias Collaboration, 2017). I tried to minimise this 
through recording in the field notes as factually as possible, but also writing reflections 
to try and acknowledge some of my personal thoughts and feelings.  I did at times find 
myself having a bias towards Ward 1 as they seemed to be using offloading in a way 
that is desirable to support my programme theory, and there was evidence that this did 
work as they appeared to have fewer pressure ulcers than the other two wards, 
although this was only speculative. However, the aim was to seek to understand the 
perspectives of others, rather than to judge their behaviours to be correct or incorrect, 
something that could potentially have been easier to achieve as a non-practitioner 
researcher. 
During one of the observations, I witnessed a trainee nursing associate do an 
unobserved medication round.  As I had recently returned from maternity leave and 
was not familiar with this role due to it being relatively new, it was only when I 
investigated afterwards that I discovered that this was a professional misconduct issue 
on the part of the nurse who had not supervised the trainee nursing associate, 
requiring me to report it to senior management. If I had not been a practitioner 
researcher, it would have been less likely that this might not have been identified.  
Being a practitioner researcher has not only shaped the construction of the research 
question and the design of the study, but my knowledge and understanding of acute 
care and pressure ulcer prevention did influence how the results were interpreted. I 
would not have been able to immediately step into the interviews and observations 
without the understanding of the job roles and the routines of the wards I already had. 
Throughout the thesis I have been explicit about how my dual role as a practitioner 
researcher has influenced the study design and conduct, along with identifying and 
addressing any potential biases.   
11.6.2 Experiences of the publication process 
The systematic review was written according the Cochrane collaboration format and 
publication standards (Higgins, J.P. and Green, S., 2011) by Cochrane. A protocol was 
written, accepted and published on 14th March 2014 (Greenwood et al., 2014). The 
review was conducted according to the protocol and submitted for editorial review on 
12th August 2015. Following a thorough and lengthy editorial and peer review process 
over a period of 20 months, including an updated search in April 2016, the systematic 
review was not accepted for publication. Feedback included concerns about the 




of the whole trial population in some cases, where heel pressure ulcer data were 
extracted from trials of whole-body devices. It was felt that this approach threatened 
the validity of randomisation as well as reducing power. The planned analysis was 
included in the protocol, accepted and published by Cochrane, and these issues were 
not identified during the publication of the protocol (Greenwood et al., 2014), but the 
developing standards for publication have resulted in this being now tailored for an 
alternative publication.   
It is important to establish if whole body devices such as mattresses and overlays 
prevented pressure ulcers from developing at the heel. Clinical staff often see 
mattresses as a first line choice for pressure ulcer prevention, and it would be more 
efficient and cost effective to use a single device if it prevents pressure ulcers equally 
to all body sites.  Therefore, by establishing whether whole body devices prevent heel 
pressure ulcers can inform whether, if, and when additional interventions such as heel-
specific devices are required. However, no mattress trials were identified that looked 
specifically at just heel pressure ulcers, therefore 18 trials that reported heel pressure 
ulcer incidence were included. This is an outcome-based subgroup which there are 
concerns that their use can lead to misleading results if a particular treatment effect 
influences classification to the subgroup. This can mask whether the outcome is a true 
effect of treatment or the result of inherent patient characteristics that led to a particular 
response (Hirji and Fagerland, 2009).  
One of the issues with performing this outcome-based subgroup analysis is that the 
power to detect clinically meaningful effects is reduced considerably as only heel 
pressure ulcers were included. This is problematic especially when several of the 
included studies had a moderate or small sample size to start with. All that were 
randomised were included in the analysis as per ITT, although assumptions were made 
that baseline confounding would account for participants with amputations and 
repositioning or offloading of the heels would be equal in both groups. To be able to 
perform a meaningful subgroup analysis for this outcome, the guidelines on subgroup 
analysis by Wang et al. (2007) should have been applied (Hirji and Fagerland, 2009), 
although this would likely require the support of a statistician.  
This was a very frustrating and upsetting experience as a great deal of work and time 
was invested into the preparation for the review to be published by the Cochrane 
Library. Professional rejection is a frequent experience in academia with the most 
prestigious journals and grant applications having low acceptance rates (DeCastro et 
al., 2013). Fostering resilience and persistence is something that many academics 




systematic review for heel-specific devices in an alternative journal, with an updated 
protocol published on PROSPERO (Greenwood et al., 2019). The review of whole-
body devices will be revisited in the future following consultation with a statistician.  
11.6.3 Unexpected /additional findings 
The word ‘trial’ was used with interchangeable meanings during the interviews.  Three 
of the TVNSs along with two members of nursing staff during the ethnographic study 
used ‘trial’ to describe an approach to understanding the effectiveness of a product 
through a product evaluation, whilst the researcher used ‘trial’ to discuss empirical 
research. An interpretation of this could be that nurses are not as exposed to the 
research process, or where there is no research evidence, nurses are attempting to 
develop their own evidence in a process they believe to be fair and impartial, hence 
calling it a ‘trial’. 
Another unexpected finding was that in the absence of clinical evidence a mechanism 
through which TVNSs gain knowledge is through networking and seeking the opinions 
and advice of their peers from outside of their organisation. This could be because the 
TVNSs are the experts in pressure ulcer prevention for their organisation, therefore 






Chapter 12 Summary and recommendations 
12.1  Introduction 
This chapter will summarise the key findings for this research, the systematic review 
followed by the two phases of the realist evaluation: theory elicitation and testing. It will 
then go on to provide recommendations of further research along with the implications 
for clinical practice.  
12.2  Summary of findings 
12.2.1 Systematic review 
The aim of this thesis, set out at the end of Chapter 2, was to explore the use of 
devices in the prevention of heel pressure ulcers, both in terms of their clinical 
effectiveness but also how they are actually used and perceived in clinical practice. 
The clinical effectiveness of the devices was explored by conducting a systematic 
review to meticulously search and summarise the current evidence base.  
The primary outcomes of the systematic review are summarised in Table 12-1. Twenty-
nine RCTs were identified that provided separate heel pressure ulcer data. Due to the 
wide range of device types investigated, fifteen different comparisons and a total of 
eight meta-analyses were performed. A maximum of three RCTs were included in each 
meta-analysis, and they often had low numbers of participants and were 
underpowered, which along with the poor quality of most of the included trials, reduced 
the certainty of the results. Comparisons between heel-specific offloading devices and 
standard care found a significant difference in favour of offloading for all Categories of 
heel pressure ulcer, although the quality of evidence was low according to GRADE for 
≥Category 1 pressure ulcers, and moderate for ≥Category 2 pressure ulcers. 
Secondary outcomes of interest included time-to-heel pressure ulcer development, 
acceptability of the intervention and cost. These were infrequently reported, and for 
those trials which did report these outcomes there was insufficient data to be able to 
combine data. Adverse events were seldom reported. This could be because the 
outcome of interest is an adverse event itself, however other adverse events that could 
be attributed to the devices in question need to be reported.  
Evidence of effectiveness is not a requirement prior to product marketing for medical 
devices (Department of Health and Social Care, 2002) therefore a full RCT rarely 
happens. For the heel-specific device trials included in the systematic review, there 




the mechanical properties of heel-specific devices, variables that can influence how 
and why they are utilised in practice do not appear to be considered in the included 
trials.  
12.2.2 Realist evaluation phase 1 – Theory elicitation 
Realist evaluation was selected as it is a methodology that allows for an exploration of 
the effectiveness of an intervention, through gaining an understanding of how the 
causal mechanisms are influenced by both human decisions and actions; asking what 
works for whom in which situations (Pawson and Tilley, 1997f). 
Due to the wide range of devices used in numerous different clinical settings, and the 
limitations of the thesis, the research was limited to offloading devices in an acute care 
setting because this was the area where there seemed to be some evidence of 
effectiveness, but problems with compliance. 
The first phase of the realist evaluation consisted of developing candidate theories 
about the use of offloading devices in acute care. Thirteen theories were developed 
informed by the systematic review, in combination with personal experiences of clinical 
practice. These focused-on factors that influence the implementation and use of 
offloading devices in practice to address the first two research questions. These 
theories were then refined and added to using interviews with key stakeholders: TVNSs 
from across the UK. The thirteen candidate theories were refined into three over-
arching programme theories.  
12.2.2.1 Programme theory one 
This theory focused on the proactive use of offloading devices for the prevention of 
heel pressure ulcers. The TVNSs viewed their role as being central to pressure ulcer 
prevention and the implementation of offloading devices, providing a link between the 
contextual levels of the NHS and wider organisation and individual wards. The analysis 
suggested that the macro context of the organisation and NHS influences the TVNSs 
through the monitoring of pressure ulcer rates and investigations into severe pressure 
ulcers, acting as a mechanism for the TVNSs to identify clinical areas or patient 
populations that would benefit from the proactive use of offloading devices. 
Subsequently, the TVNSs would source the devices, considering costs and usability, 
and promote device use in the meso context of the ward through training and 
education, along with recommending devices for individual patients they would review. 
The TVNSs focused on training and education as being a large part of their job role, 
however it remains uncertain whether education can prevent pressure ulcers, or affects 




al., 2018). Other factors that were felt to be influential included accessibility of the 
devices for ward staff, and leadership. 
12.2.2.2 Programme theory two 
Programme theory two explored how offloading devices are used reactively, either as a 
response to signs of early pressure damage to reduce the chance of deterioration, or to 
treat a pre-existing heel pressure ulcer.  Initially it appeared that using offloading 
reactively was a negative response, in that it was only once a heel pressure ulcer had 
developed that a device would be implemented, which could be viewed as being ‘too 
late’ to prevent the pressure ulcer. However, if the skin to the heel is monitored and 
early signs of pressure damage are recognised, such as blanching or non-blanching 
erythema, then initiating a device at this point to prevent deterioration could be an 
effective way of using the device. This is supported in the study by Vanderwee et al. 
(2007a) where they saw no difference in pressure ulcer rates when preventative 
interventions were initiated as a response to non-blanching erythema in comparison to 
interventions being initiated based on the results of a risk assessment. More research 
is needed into this as the results seen by Vanderwee et al. (2007a) could be the result 
of a type II error, and there is also a reliance on correct and timely skin assessments, 
and ability of staff to recognise the early signs of pressure damage.  
Studies into the ability of nursing staff to be able to recognise Category 1 pressure 
ulcers has been variable, with Sterner et al. (2011) finding visualisation of the skin and 
using the finger to press the skin to identify blanching erythema was unreliable, 
whereas Vanderwee et al. (2006) found that interrater reliability to recognise non-
blanching erythema was high, with agreement rates for the finger method of 92.1% and 
91.7% when using a transparent disk pressed to the skin. There are numerous 
variables that could lead to the differences seen here such as trial settings, patient 
types, sample size or the education received by the nursing staff prior to trial. It also 
reflects the difficulties in assessment and diagnostic uncertainty of pressure ulcers. 
Vanderwee et al. (2006) did however find skin assessments to be less reliable at the 
heel compared to the sacrum, which they theorise could be because patients would 
primarily be in the supine position when assessed, making visualisation of the skin at 
the heels more difficult. It is also possible that the thicker epidermis of the heel can 
mask the capillary blood flow and reperfusion in the dermis. Neither of these studies 
included participants with darker skin tones, in which blanching and non-blanching 
erythema can be more difficult to detect due to the higher concentration of melanin in 








Table 12-1 Summary of systematic review findings 
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Downgraded once for design & execution due to attrition bias 
although there was also poor reporting within these studies; 
downgraded once for imprecision due to small sample size and 
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and lack of blinding, downgraded once for imprecision due to 
small sample size and wide 95% CI that crossed no effect 
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to pool  
 One trial reported total number of heel pressure ulcers rather 
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 Interventions were clinically heterogenous therefore not pooled 
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145 (2 RCTs) Not 
possible 
to pool 
 One trial reported total number of heel pressure ulcers rather 
than participants with a heel pressure ulcer 
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297 (1 RCT) Unknown  Reported total number of heel pressure ulcers rather than 
participants with a heel pressure ulcer 
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Higher prevalence rates have been reported in people with darker skin tones 
(VanGilder et al., 2010, VanGilder et al., 2008), which could be due to a failure to 
identify early signs of pressure damage, leading to a delay in the implementation of 
preventative care. Therefore, as well as being able to recognise non-blanching 
erythema, healthcare staff need to be aware of the indicators of early pressure damage 
in individuals with darker skin, which includes localised heat, oedema and a change in 
the consistency of tissues in relation to surrounding area (EPUAP et al., 2019). This is 
important for the successful use of offloading devices reactively in clinical practice, with 
the discriminant ability of staff to be able to recognise early signs of skin damage in all 
patients in a timely manner essential.   
12.2.2.3 Programme theory three 
This theory explored patient factors that could influence how offloading devices are 
used or not used. It was established that offloading is not suitable for every patient who 
is at risk of developing a heel pressure ulcer, nor is it suitable at all time points during a 
patient’s journey, so the question is “What works for each patient at which part of their 
journey”.   Individual patient preferences, and risk factors need to be taken into account 
when implementing an offloading device and working with the patient can improve 
concordance. 
Patients at risk of falling were discussed as a patient group potentially unsuitable for 
offloading.  Only six trials included in the systematic review reported adverse events 
(3.2.3.3), and only Donnelly et al. (2011) reported falls; both groups experienced falls 
and none were attributed to a device. Despite the lack of evidence, it is recognised that 
they could become a trip hazard in ambulatory patients, however it was agreed that 
offloading should be primarily used when patients are in bed and removed as patients 
recover and become more mobile.  
Comfort issues were reported by the TVNSs as a major factor affecting patient 
concordance, likewise Donnelly et al. (2011) reported 88 protocol violations related to 
patients not wearing the device for comfort reasons. Bååth et al. (2016) reported 
comfort issues such as the device being “sweaty”, not being comfortable when side 
lying, and saw more patient withdrawals in the intervention group than the control but 
did not give a reason. The TVNSs reported that ward staff would try to be resourceful 
and collaborate with the patients to improve comfort of the device, and in turn 
concordance.  This would involve things like lining the device with a pillowcase, but this 




12.2.3 Realist evaluation phase 2 – Theory testing 
Programme theory 1 was selected to be tested, as it would best answer the research 
questions set out in Chapter 4. Although patient factors are important when looking at 
withdrawals and protocol violations, there had already been an attempt to identify these 
issues, and general feedback was that patients found the devices bulky, hot and 
restricted movement (Bååth et al., 2016, Campbell et al., 2010, Donnelly et al., 2011). 
Without changing the design of the devices, the perceptions of the patients cannot be 
altered, but the contexts and mechanisms through which the devices are implemented, 
used, and how the nursing staff work with the patients to deal with concordance could 
help inform practice and future clinical trials.  
The ethnographic study took place across three orthopaedic wards within a single 
hospital in the North of England. Orthopaedics was selected due to having a large 
proportion of patients at risk of developing a heel pressure ulcer and being a known 
user of offloading devices.  
During the TVNS interviews, training and education was highlighted as being a large 
part of their job role, and they felt that this was an important mechanism in the 
proactive use of heel-specific devices.  However, within the context of the observed 
wards and the staff interviews, no formal training and education from the TVNSs was 
evidenced with regards to heel pressure ulcer prevention or the use of heel-specific 
devices, and no heel-specific campaign was used within the observed hospital. None of 
the interviewed members of staff could recall receiving any education about heel 
pressure ulcer prevention.  
Personal preferences of the Ward Manager, along with strong leadership appear to be 
influential on heel-specific device availability and use. This manifested as an informal 
verbal protocol to identify which patients required a heel-specific device and when. On 
two of the wards, patients were identified according to reason for admission, rather 
than based on individual risk assessments, with fractured neck of femur patients 
identified as requiring offloading on admission.  This informal protocol driven by the 
Ward Manager and senior members of the nursing team, along with a stock of heel-
specific devices, led to staff perceiving themselves to be using the devices proactively. 
In contrast one participating ward had no devices identified as stock, leadership was 
not identified through the interviews as influential on device use and there was no 
protocol in place. Despite this, little difference was observed across the three wards in 
the use of devices for the prevention of heel pressure ulcers. This is an important 
finding in this study; the discrepancy between what should have happened, what staff 




discrepancy between what members of the nursing team are saying they are doing and 
what actually happens has been observed in other areas of nursing practice, with Dihle 
et al. (2006) seeing this during post-operative pain management and (Bolster and 
Manias, 2010)reported nurses perceived themselves to be conducting medication 
activities using a person centred approach which was not always observed. One of the 
possible reasons for the discrepancy suggested by Dihle et al. (2006) was due to an 
inadequate transfer of knowledge into practice, due to superficial or inadequate 
knowledge by staff; although it was not possible to establish the level and depth of 
knowledge with regards to heel pressure ulcer prevention amongst the observed staff.  
Although the focus of the realist evaluation was on the use of offloading devices, it was 
found that both offloading, and heel-specific CLP devices were being used in this 
hospital. The mechanisms through which the devices prevent a heel pressure ulcer 
differs; offloading devices aim to completely remove the pressure to the heel whereas 
CLP devices reduce the magnitude of the pressure by increasing surface area for 
contact between the heel and the support surface. Despite this, some members of staff 
referred to all heel-specific devices as ‘offloading devices’, therefore not differentiating 
between the mechanistic properties of the devices and would use them in the same 
manner.  However, some members of staff viewed the offloading devices as being 
‘better’ and therefore should be used for higher risk patients and those already with a 
heel pressure ulcer.  The theory changed accordingly to include ‘heel-specific’ devices, 
although this does not include dressings or low friction devices as they were not 
observed in use. 
12.3  Recommendations for further research 
12.3.1 Future intervention comparisons 
The systematic review and meta-analyses summarised a series of mostly poor-quality 
studies in which patient compliance, methodological quality and low event rates were 
prevalent. It appeared to conclude that offloading devices, when compared to standard 
care, were more effective at preventing Category 1 or above (RR 0.20, CI(0.05 to 
0.80)) and Category 2 or above heel pressure ulcers (RR 0.08, CI(0.01 to 0.67)), 
however precision and risk of bias means that this result is likely to need revision in the 
face of the quality of the research evidence. #.  It also remains uncertain whether any 
of the following prevent heel pressure ulcers: 
• Offloading devices when compared to heel-specific CLP devices 
• Heel-specific CLP devices, including dressings, compared to standard care  




• AP mattresses or CLP mattresses when compared to standard care 
A key priority for future mattress trials should be a requirement to report pressure ulcer 
incidence by body site. If a mattress is found to reduce the risk of developing a heel 
pressure ulcer, additional devices might not be required.  
The next logical step in developing evidence for heel specific devices, is therefore to 
strengthen the existing evidence base through high quality, appropriately powered RCT 
comparing offloading devices and standard care. It could be argued that an RCT with 
sufficient power that is designed following the CONSORT statement (Begg et al., 1996) 
would be time consuming, resource heavy and costly. However, the alternative of 
continuing to use devices in clinical practice without evidence could also be costly if 
they are ineffective or could be potentially causing harm, such as increasing the risk of 
pressure ulcers developing to other body sites.  
For the generalisability of any future clinical trial, it is important to establish what 
standard care looks like across all sites: what support surfaces are used, frequency of 
repositioning including how the feet are repositioned, and the use of pillows to offload 
the heels,.  None of the heel-specific trials included in the systematic review included 
data regarding mattress type or repositioning frequency in their publications. This 
research found that devices could act as a visual reminder of the patient’s pressure 
ulcer risk and trigger other interventions. This was something that one TVNS 
encouraged, using mattresses as a visual trigger that the patient required an 
intervention care plan bundle. One of the Ward Managers felt that if patients had a 
heel-specific device in place, staff were more likely to profile the foot of the bed, further 
relieving pressure to the heels.  However, this was not observed in practice, although 
when patients were in bed with a blanket it was not always possible to tell if there was 
a device in situ or if the heels were offloaded with a pillow.  As it would not be possible 
to blind the participants or staff to the intervention, if the devices do act as a visual 
reminder of the patient’s risk and therefore increase other pressure ulcer preventative 
interventions this needs to be considered as a potential confounding variable. A 
pragmatic trial design would consider this in the sum of total effects of the intervention 
but would not disentangle them or identify the relevance of these factors. 
Standard care in some clinical areas included using pillows to reposition or offload the 
heels. However, as heel-specific devices are used as a replacement, it is unlikely that 
pillows would be used in both arms, so they could be an intervention if used routinely in 
the control arm. It is not known if pillows prevent heel pressure ulcers, therefore if a 




implications, as well as staff not wanting to recruit if they believe this could increase the 
risk of the control group developing a heel pressure ulcer.   
12.3.2 Implications for research design 
Although the focus of this research was on heel-specific devices for the prevention of 
heel pressure ulcers, this thesis has demonstrated the benefits of performing a realist 
evaluation prior to performing a clinical trial, a method that could be transferrable to 
other device trials. Increasing our understanding of the mechanisms that influence 
device use in different contexts will inform trial design, which in turn could improve trial 
compliance. Other researchers have successfully used realist evaluation as part of a 
feasibility study to inform trial design (Fletcher et al., 2016, Randell et al., 2020). How 
this thesis will influence the design of future heel-specific device trials will be discussed 
further. 
This research identified that heel-specific devices are viewed as a third line 
intervention, following repositioning and mattress use. The context of different care 
environments, patient factors and dynamics of the nursing teams could also be 
influential on the utilisation and effectiveness of the intervention. A realist RCT would 
aim to determine if it were the intervention itself, or a combination of factors that 
implemented the change, whilst a pragmatic trial design would be beneficial to mimic 
usual practice, with the mattress and repositioning needing to be considered alongside 
a heel-specific device, which could be done in the form of a pragmatic realist RCT. 
The second phase of the PhD used realist evaluation prior to a potential clinical trial to 
try and inform the trial question, trial development, intervention compliance and 
feasibility. Although the focus was on offloading devices, it was identified that nurses 
used heel-specific CLP devices, CLP foam pads and offloading devices 
interchangeably. This research suggests that heel-specific CLP devices might be more 
frequently used in practice due to their lower costs, usability by patients and nursing 
staff along with both patient and nursing preferences. A pragmatic two arm intervention 
trial comparing offloading to heel-specific CLP devices could therefore be more 
beneficial to reflect clinical practice and address patient and healthcare professional 
usability as well as cost effectiveness. 
12.3.2.1 Clinical equipoise 
Grebel & Wilfer 2010 looked at technology adoption and reported that clinicians behave 
according to preferences that are formed through experience and the influence of 
champions. Clinical equipoise demands that there should be no rational basis 




clinical trial virtually no information should be available on an intervention under 
investigation (Olsen, 2000). However, if a trial is conducted for an intervention that is 
already used in practice, clinicians will have already developed their own opinions and 
preferences with regards to the effectiveness of the device, and if it is viewed that this 
device is necessary for their patient they will not want to randomise to a control or a 
device that they view as inferior. Ward leadership opinion rather than evidence of 
effectiveness was a key feature in the perceived utilisation of these devices in practice. 
This suggests that undertaking a trial to compare an offloading or CLP device against 
standard care may be problematic as nursing teams are not in equipoise. The TVNSs 
interviewed already had strong opinions on the devices used in their organisations.  
Clinical equipoise in heel-specific device trials could be difficult to achieve when they 
are already in routine use. One solution would be conducting a trial in an area where 
there could be clinical equipoise due to not being familiar with the devices, although as 
these devices are already widely in use this would be difficult. The solution could be to 
compare two interventions, rather than an intervention and control, along with engaging 
with the TVNSs and ward leaders during trial design and set up to address any biases 
towards an intervention.  
12.3.2.2 Gatekeepers 
TVNSs view themselves as central for training and education, implementation of 
devices and a resource for ward nurses. Although the TVNSs were not seen to have 
much of an impact upon day-to-day ward practice during the observations, they are a 
resource for wards and often evaluate and introduce new devices. Ward level 
leadership is also an important consideration for trial design and set up, as it has been 
previously acknowledged that engaging clinical leaders and senior staff facilitates in the 
cooperation of all staff during a clinical trial (Spilsbury et al., 2008). 
However, what the TVNSs and ward staff think they do, and what they were observed 
doing were not the same. There is a perception from most of the interviewed TVNSs 
and ward staff on two of the observed wards that heel-specific devices are in common 
use, but, they were not. This needs to be considered during trial set up as a potential 
gatekeeper issue, as there could be compliance issues with device use, as well as 
contamination issues in a standard care arm.  
12.3.2.3 Patient population 
To ensure high external validity within a trial, there needs to be a representative 
sample of the patient population with a broad inclusion criterion, and minimal exclusion 




therefore assent using a personal consultee was demonstrated as a viable option. 
Including nurses as well as medical staff as a nominated consultee would widen 
recruitment further, as demonstrated by Nixon et al. (2019). Two of the RCTs included 
in the systematic review discussed using next of kin or ‘surrogates’ to consent patients, 
(Gilcreast et al., 2005, Tymec et al., 1997) but none of the trials discussed capacity. 
Consideration is needed into whether a patient without capacity would be likely to keep 
the device on, and whether the device could be a trip or fall hazard. 
Immobile patients or those with reduced consciousness would be a suitable patient 
group to study as they are at high risk of pressure ulcers and would lead to fewer 
withdrawals and attritions as they would not be able to remove the device, therefore 
comfort would not be an issue, although there are more ethical implications.  
12.3.2.4 Patient and public involvement 
Some of the trials included in the systematic review provided anecdotal data about 
patients’ perceptions of offloading devices.  Involving patients and public who have 
experience of heel pressure ulcers, wearing, or using heel-specific devices, as part of a 
priority setting methodology, might help to identify the key priority questions patients 
have with regards to heel pressure ulcer prevention, and to aid in the selection of which 
devices should be tested.  
12.3.2.5 Protocol compliance 
Heel-specific devices are more likely to stay in place when a patient is bed bound or 
immobile, therefore a trial should aim to recruit earlier during this ‘acute phase’ of 
illness, when the patient is more likely to be immobile. For example, during the 
ethnography it was theorised that for fractured neck of femur patients, heel-specific 
devices are more beneficial either pre, or immediately post operatively. 
Ease of access to the devices was found to be an important factor limiting their use and 
having devices available at recruitment could lead to fewer protocol deviations due to 
incorrect intervention. None of the trials included in the systematic review reported 
problems with implementation of the heel-specific device (Bååth et al., 2016, Cadue et 
al., 2008, Campbell et al., 2010, Donnelly et al., 2011, Gilcreast et al., 2005, Tymec et 
al., 1997). It is assumed that the device was supplied at the point of randomisation in 
these trials as offloading devices are small enough to be carried and supplied by the 
researcher, although only Bååth et al. (2016) confirmed this in the methods.  This 
contrasts with mattress trials where the research nurse cannot supply the mattresses 
due to size, so it is the responsibility of ward staff to ensure that the patient is placed on 




10%-17.7% of randomised participants did not receive the allocated intervention (Nixon 
et al., 2019, Nixon et al., 2006b) which has an impact on intervention fidelity.  
This research also showed that most of the direct patient care relating to pressure ulcer 
prevention was done by HCAs, and therefore including them in the research during trial 
set up could help to improve compliance with any trial by both the ward and the patient. 
12.3.2.6 Safety 
There are potential safety implications with the use of heel-specific devices, such as 
the increased risk of trips and falls so it is important to be aware of these and to 
monitor. 
12.4  Recommendations for clinical practice 
No recommendations for practice can be given following the systematic review for heel-
specific devices due to the quality of the evidence. Heel offloading devices probably 
decrease the incidence of Category 2 or above heel pressure ulcers when compared to 
standard care alone, however this is based on evidence of moderate quality.  
This thesis, along with an updated version of the systematic review for publication 
(Greenwood et al., 2020) found no significant difference in the effectiveness of 
prophylactic dressings for heel pressure ulcer prevention. The systematic review by 
Moore and Webster (2018) found that there was a low level of certainty in the use of 
silicone dressing for the prevention of all pressure ulcers. However, findings from 
individual studies are being pushed by manufacturers recommending prophylactic 
dressing for the prevention of heel pressure ulcers (Smith and Nephew, 2020, 
Mölnlycke, 2020) and recommendations in the EPUAP et al. (2019) guidelines and by 
Ramundo et al. (2018) are that dressings should be used as an adjunct to heel 
offloading and other heel pressure ulcer prevention strategies, something not 
supported by the evidence in this thesis.  
No recommendations can be made with regards to the use of support surfaces for the 
prevention of heel pressure ulcers due to the sparsity and poor quality of the evidence. 
A risk assessment should be undertaken to assess the risk of using heel-specific 
devices when a patient is not in bed, as they could become a fall or trip hazard.  
Heel-specific devices can be used proactively in high-risk patient groups, such as the 
fractured neck of femur patient, or in patients who do not tolerate a dynamic mattress 
or repositioning plan. They can also be used reactively in patients with early signs of 
pressure damage, such as blanching erythema to prevent further skin damage, but 




patients with multiple co-morbidities, or early signs of skin damage could be missed in 
patients with darker skin.  
Proactive device use can be influenced by having the devices easily accessible, staff 
being knowledgeable about which patients they are suitable for through an informal 
protocol initiated and supported by senior members of the ward team. Therefore, when 
introducing a device to a clinical area, engagement from ward leaders is important and 
staff knowing when to use the devices could improve device use. It is also important to 
acknowledge that the majority of pressure ulcer preventative care observed was 
delivered by the HCAs, therefore even though care planning is the responsibility of the 
QN, any pressure ulcer prevention improvement interventions should focus on the 
whole ward.  
This thesis has demonstrated that leadership has been found to be a significant 
influential factor in the use of devices, or other pressure ulcer prevention intervention. 
Strong leadership gives staff clear expectations of what they should be doing and 
when. Leadership was also influential in how staff gain their knowledge, through 
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Appendix A Search Strategy 
The following search strategy was used for Ovid Medline and was then adapted 
accordingly to the other databases searched.  
1.exp Beds/ 
2.(bed or beds or frame*) 
3.(mattress* or cushion* or pillow*) 
4.(foam*1 or cutfoam or overlay*) 





10.low pressure support* 
11.((constant or alternat*) adj pressure*) 
12.((air or water) adj suspension*) 
13.(sheepskin* or sheep skin*) 
14.foot waffle 
15.air bag* 
16.(elevat* adj2 device*) 
17.static air 
18.exp Shoes/ 
19.(shoe*1 or boot*1 or booties or cup*1) 
20.(footwear or foot wear) 
21.exp Orthotic Devices/ 
22.(orthotic adj (device* or therapy)) 
23.(orthos* or insole*) 
24.((contact or walk*) adj cast*1) 
25.(aircast or scotchcast) 
26.((foot or feet) adj2 pressure) 
27.((foot or feet) adj2 protect*) 
28.((foot or feet) adj2 device*) 
29.(heel* adj2 pressure*) 




31.((foot or feet) adj2 device*) 
32.(heel* adj2 (lift* or float* or splint* or glove* or suspension or elevat*)) 
33.(trough* adj2 (leg* or foot or feet or heel*)) 
34.or/1-33 
35.exppressure ulcer/ 
36.(pressure adj (ulcer* or sore* or injur*)) 
37.(decubitus adj (ulcer* or sore* or injur*)) 
38.(bedsore* or bed sore*) 
39.or/35-38 
40.34 and 39 
41.randomized controlled trial.pt. 
42.controlled clinical trial.pt. 
43.randomi?ed.ab. 
44.placebo.ab. 




49.exp animals/ not humans.sh. 
50.48 not 49 





Appendix B Risk of bias tables 
Bååth et al. (2016) 
Bias Authors’ 
judgement 




Low risk "Computer generated block randomisation that 
divided interventions and controls amongst the 




Low risk Sealed envelopes removed by the Research Nurse 





Unclear risk  Does not discuss blinding of participants or 
personnel 
Blinding of outcome 
assessment 
(detection bias) 
High risk Data collected by 5 research nurses who had 
training in pressure ulcer grading, but does not 
appear that they were blinded to the intervention or 
that there was any inter-rater reliability testing 
Incomplete outcome 
data (attrition bias) 
Unclear risk 405 participants were randomised in the 
ambulance prior to consent, but only 183 
participants were included in the analysis as a 
large proportion of participants were not admitted 
to hospital or one of the wards involved in the trial. 
This is unlikely to lead to bias as the intended 
effect of the intervention is dependent on the 
participant being admitted to hospital, which cannot 
be influenced by the randomised allocation 
Selective reporting 
(reporting bias) 
Low risk All pre-specified outcomes reported 
Other bias - were 
groups similar at 
baseline regarding 
the most important 
prognostic 
indicators? 
Low risk No significant differences between the 2 groups in 
terms of age, sex and level of risk. There was a 
difference in the average length of stay between 
the 2 groups - 7.9 days in the intervention group 
and 10.4 days in the control 
 
Berthe et al. (2007) 
Bias Authors’ 
judgement 




High risk Unknown method of randomisation; "when a 
patient was admitted to any of these departments, 
a mattress was randomly assigned". 
Randomisation ratio was changed during the trial; 
"an interim analysis after 3 months showed that 
participants with the worst Ek scores were more 
often assigned to a Kliniplot mattress. Therefore, 






Support for judgement 
the standard mattress by using a 1:2 allocation 









Unclear risk "The patient and the nurse were not explicitly 
informed of the type of mattress used" It is unclear 
if the mattresses could be differentiated  
Blinding of outcome 
assessment 
(detection bias) 
Unclear risk No information given regarding the outcome 
assessors 
Incomplete outcome 
data (attrition bias) 




Low risk All pre-specified outcomes reported 
Other bias - were 
groups similar at 
baseline regarding 
the most important 
prognostic 
indicators? 
High risk Allocation ratio was changed to ensure there was 
a match at baseline of modified Ek's scale (they 
were only interested in the mobility variable). No 
other baseline comparisons were reported 
 
 
Cadue et al. (2008) 
Bias Authors’ 
judgement 




Low risk “Two groups drawn at random using a 




Low risk “The distribution being determined following a 
patient's inclusion by a pre-sealed sequentially 






High risk Participants would have been unaware of the 
intervention as they were sedated, it was not 
possible to blind personnel 
Blinding of outcome 
assessment 
(detection bias) 
Unclear risk "Every day, a physiotherapist and a nurse 
evaluated the extent of lesions on the heels, the 
sacrum and the calves in accordance with a scale 
ranging from lesion absence (stage 0) to bone 
visibility (stage 5)". There is no discussion of 
whether the physiotherapist and nurse were 
blinded to the intervention. No inter-rater reliability 
testing discussed. Appearance of interventions 






Support for judgement 
Incomplete outcome 
data (attrition bias) 




Low risk All the study's pre-specified outcomes have been 
reported 
Other bias - were 
groups similar at 
baseline regarding 
the most important 
prognostic 
indicators? 
Low risk No clear difference between the 2 groups in age, 
gender, Waterlow scores, weight, BMI, smoking 
status, DM, arteritis of the lower limbs, sedatives, 
ventilation, curarization, haemo-filtration and 
catecholamines. The only significant difference 
between the 2 groups was in the simplified severity 
scale II, which was higher in the experimental 
group 
 
Campbell et al. (2010) 
Bias Authors’  
judgement 




Low risk which of the three devices that the patient received 










High risk Not possible to blind the intervention to the 
participants and personnel 
Blinding of outcome 
assessment 
(detection bias) 
High risk A single "Heel pressure ulcer champion" carried 
out the study, no interrater reliability testing 




Low risk 72 subjects randomised and pressure ulcer 
incidence of all 72 participants reported 
Selective reporting 
(reporting bias) 
Low risk All outcomes appear to be reported 
Other bias - were 
groups similar at 
baseline regarding 
the most important 
prognostic 
indicators? 








Cavicchioli and Carella (2007) 
Bias Authors’ 
judgement 




Unclear risk Control group not randomised therefore excluded 
from analysis - treatment arms were randomised 









Unclear risk Not discussed 
Blinding of outcome 
assessment 
(detection bias) 
Low risk "As there is no visible difference between these 2 
modes, the external observer was blinded as to 
which one was in use" 
Incomplete outcome 
data (attrition bias) 




Low risk All relevant pre-specified outcomes reported 
Other bias - were 
groups similar at 
baseline regarding 
the most important 
prognostic 
indicators? 
Low risk Similar in terms of male to female ratio, age and 
Braden score at the beginning and end of the trial 
 
Conine et al. (1990)  
Bias Authors’ 
judgement 






Only information given: "a modified sequential 
clinical trial as described by Pocock (1981) was 
used to assign subjects randomly to one of the two 











High risk "Although disguising the equipment was 
impossible, care was taken to control bias by 
separating the responsibilities for subject selection 
and assignment and for taking the measures. 







Support for judgement 





"The research assistant, a professional nurse with 
tissue trauma experience, was responsible for the 
assessment of all outcome measures. She was not 
associated with the institution and was not 
informed about the study" Does not discuss if 
participants were blinded 
Incomplete outcome 
data (attrition bias) 




Low risk All relevant pre-specified outcomes reported 
Other bias - were 
groups similar at 
baseline regarding 
the most important 
prognostic indicators? 
Low risk No clear difference between the 2 groups in age, 
gender, Norton scores, weight, diagnoses, years 
diagnosed, years of wheelchair use, previous 
bedsores, sensory loss, spasticity/shearing, 
incontinence and anaemia 
 
Daechsel and Conine (1985) 
Bias Authors’ 
judgement 




Unclear risk Method of randomisation not reported: “All 
qualified subjects were entered into the trial for a 
period of three months and all were randomly 









Unclear risk Not reported 
Blinding of outcome 
assessment 
(detection bias) 
Unclear risk Not reported 
Incomplete outcome 
data (attrition bias) 




Low risk All pre-specified outcomes reported 
Other bias - were 
groups similar at 
baseline regarding 
the most important 
prognostic indicators? 
Low risk “Statistical tests of significance indicated that the 
groups were comparable on the factors that are 
considered to be associated with the 
development of decubitus ulcers”. However, 
states “additional preventive aids, such as heel 
and ankle protectors were used as typically 
directed by the occupational therapist” for both 
groups, but we do not know how many heel and 
ankle protectors were used and how they were 




(Demarre et al., 2012) 
Bias Authors’ 
judgement 




Low risk Random allocation sequence was based on a 




Low risk When the participant was eligible, and a study 
mattress was available, they were assigned to one 
of the mattresses by contacting the researcher (24-
hour telephone accessibility). The ward nurse 





High risk both mattresses were covered with an identical 
mattress cover...The study could not be blinded 
because of the visible differences of the external 
control unit of the study mattresses". "No information 
was provided to the ward nurses about the 
differences between the experimental and control 
study device, both were presented as alternating 
pressure air mattresses". No discussion about 





High risk Daily skin assessment and the risk assessments 
were performed by the ward nurses. No inter-rater 








Low risk All the study's pre-specified outcomes of interest in 
the review have been reported in the pre-specified 
way 
Other bias - were 
groups similar at 
baseline regarding 
the most important 
prognostic 
indicators? 
Low risk Experimental and control group were comparable for 
all baseline characteristics which included age, 
weight, height, BMI, Braden score and maximum 
time sitting and/or transport 
 












Low risk Randomisation schedule was held and managed 
by a senior research nurse manager not directly 












High risk “It was not possible to blind the participants as the 
intervention was very distinctive. Ward nurses 
were not blinded and "for pragmatic reasons, 
mattress type was determined by ward nurses 
according to perceived need" 
Blinding of outcome 
assessment 
(detection bias) 
High risk “It was not possible to blind the investigator as the 
intervention was very distinctive, however there 
was a blinded inter-rater reliability test; "an 
experienced tissue viability nurse who was blinded 
to the subject's history, the investigators 
assessment of the skin and the group to which the 
subject had been assigned, viewed photographs 
of suspected pressure damage, as well as intact 
pressure points" 
Incomplete outcome 
data (attrition bias) 




Low risk All the study's pre-specified outcomes of interest 
have been reported in the pre-specified way 
Other bias - were 
groups similar at 
baseline regarding 
the most important 
prognostic 
indicators? 
Low risk Both groups were comparable at baseline in terms 
of co-morbidities and the length of time spent lying 
on a hard surface prior to study enrolment. 
Subjects in the intervention group had a shorter 
wait from injury time to theatre, but spent longer in 
theatre than the control group 
 
Ferrer Sola et al. (2013) 
Bias Authors’ 
judgement 













High risk Blinding of participants is not stated due to 
differences in the interventions 
Blinding of outcome 
assessment 
(detection bias) 
Unclear risk Not reported 
Incomplete outcome 
data (attrition bias) 
Unclear risk Not reported 
Selective reporting 
(reporting bias) 




Other bias - were 
groups similar at 
baseline regarding 
the most important 
prognostic 
indicators? 
Low risk Both groups were comparable at baseline in terms 
of demographic and clinical characteristics, 
including age, sex, Braden score, dementia, 
diabetes, infection, and other ulcers 
 
Gilcreast et al. (2005) 
Bias Authors’ 
judgement 




Low risk “A set of 21 cards were prepared in advance, 7 
with each intervention on them. These were 
placed in identical envelopes and shuffled 3 
times. The first card was taken from the box once 




High risk Assignment envelopes were not sequentially 
numbered. Does not state who kept the cards or 





High risk Due to the nature of the intervention, it is likely 
that it would not be possible to blind the 
participants or personnel 
Blinding of outcome 
assessment 
(detection bias) 
High risk “The 1 nurse was performing all research tasks 
and was not blinded to the device to which the 
participant was assigned”. "Interrater reliability for 
assessment and staging of pressure ulcers was 
obtained by the concurrent assessment of 10 
patients' by the 2 RNs" 
Incomplete outcome 
data (attrition bias) 
High risk “53 subjects were eliminated from the analysis 
because they did not wear the devices for at least 
48 hours. 24 of these subjects were eliminated 
because of early discharge from the hospital and 
only 24 hours in the study. The others were 
dropped because either they did not want to wear 
the devices, or the devices were not replaced by 
family members or staff after patient-care 
activities as requested".  338 subjects 
randomised, 240 had complete data and included 
in the analysis, it is unclear how many participants 
were initially randomised to each group and 
therefore which arms the dropouts came from. No 
ITT analysis done 
Selective reporting 
(reporting bias) 
Low risk All pre-specified outcomes reported 
Other bias - were 
groups similar at 
baseline regarding 





The distribution of gender was not equal between 





Gray and Smith (2000) 
Bias Authors’ 
judgement 






Method of randomisation unknown: "Individuals 
who met the entry criteria were randomised to a 





High risk Randomised using an opaque envelope; but 
unclear who performed the randomisation, where 
the envelopes were stored and if they were 







Does not discuss whether the participants and 
personnel were blinded to the intervention 
Blinding of outcome 
assessment 
(detection bias) 
Low risk The two mattresses had similar covers and 
"tissue damage was assessed by staff who were 
unaware of which mattress the subject was using" 
Incomplete outcome 
data (attrition bias) 
Low risk Two subjects from the control group were 
withdrawn from the trial due to the mattress 
covers being torn. ITT analysis performed 
Selective reporting 
(reporting bias) 
Low risk All pre-specified outcomes reported 
Other bias - were 
groups similar at 
baseline regarding 
the most important 
prognostic indicators? 
Low risk States that the groups were comparable in terms 
of age, sex, risk (Waterlow score) and length of 
time spent in bed 
 
Gunningberg et al. (2000) 
Bias Authors’ 
judgement 




Unclear risk “on arrival in A&E patients with a suspected hip 
fracture were randomised to an experimental or 










High risk It is assumed that due to the nature of the 
intervention the participants were not blinded but 
this is not discussed. "Although the nurses knew 
which study group the patient belonged to, there 
is no reason to suspect that there were any 
differences in the documentation procedure 
between them" 
Blinding of outcome 
assessment 
(detection bias) 
Unclear risk Main outcome not blinded, but 25pressure ulcers 
in 13 participants were photographed and inter-





data (attrition bias) 
Unclear risk 18 participants were excluded from the study, but 
it is unclear which arm they were randomised to 
or at what point they were excluded; "The study 
included 119 patients.... 18 were excluded 
because they died (2), did not have a skin 
assessment documented on arrival (3) were 
admitted with a pressure ulcer (13). Of the 
remaining 101 patients, 48 and 53 were allocated 




Low risk All pre-specified outcomes reported 
Other bias - were 
groups similar at 
baseline regarding 
the most important 
prognostic 
indicators? 
Low risk “No significant differences were found between 
the groups in terms of gender, age, modified 
Norton scores, waiting time for surgery, time in 
the operating theatre and other inclusion 
characteristics" 
 
Hofman et al. (1994) 
Bias Authors’ 
judgement 






Each group of 6 consecutively admitted 
participants were randomly divided into 3 
participants nursed on control and 3 on 












High risk  It was not possible to blind in respect to the 
observer or the nurse...because “making the 
Decube mattress unrecognisable would influence 
its effectiveness”. It is not discussed if the 
participants were blinded 
Blinding of outcome 
assessment 
(detection bias) 
Low risk Outcome assessment not blind to treatment 
group. Participants were examined 1 and 2 weeks 
after surgery by 2 physicians independently; 
disagreement resolved by a 3rd observer 
Incomplete outcome 
data (attrition bias) 
High risk Of the 46 participants randomised, 2 were 
excluded due to the randomisation not being 
performed correctly (no further details) both in the 
intervention group. By week 1, 1 participant had 
left each group (1 death, 1 discharge). By week 2, 
a further 3 participants in each group had been 
discharged or died. It appears that only those 
remaining were included in the 2-week analysis (n 
= 17 in cubed foam mattress group and n = 19 in 







Low risk Main outcome of interest was occurrence of 
pressure ulcers and this was recorded 
Other bias - were 
groups similar at 
baseline regarding 




Age and length of hospital stay were similarly 
matched. Sex and fracture type were not similar 
at baseline 
 
Matsui et al. (2001) 
Bias Authors’ 
judgement 




Unclear risk "All subjects were randomly divided into 3 









Unclear risk Not reported 
Blinding of outcome 
assessment 
(detection bias) 
Unclear risk Three people were trained relating to all data 
measurements and 2 people would check, does 
not mention if they were blinded to the 
intervention 
Incomplete outcome 
data (attrition bias) 
High risk 107 participants randomised, 1 participant 
dropped out of the single layer group due to 
discomfort and 1 person in the 2-layer group who 
developed a pressure ulcer (does not specify 
severity of pressure ulcer) due to the mattress not 
being plugged in. It does not appear that these 
participants were included in any analysis 
Selective reporting 
(reporting bias) 
Low risk All pre-specified outcomes appear to have been 
reported 
Other bias - were 
groups similar at 
baseline regarding 
the most important 
prognostic indicators? 
Low risk All groups were comparable in terms of average 
age, sex, and diagnosis. There was a significant 
difference between the groups in CRP results, but 
it is uncertain how significant this would be 
 
McGowan et al. (2000) 
Bias Authors’ 
judgement 




Unclear risk Stated, “patients were randomly allocated 
(using sealed envelopes) by research nurses to 













High risk It was not possible to blind either the participant 
or the investigator as the intervention was very 
distinctive and participants could not be moved 
from their beds for skin assessments 
Blinding of outcome 
assessment 
(detection bias) 
High risk Two registered nurses were employed as 
research nurses who undertook all the 
assessments. One of the investigators 
undertook regular inter-rater reliability 
comparisons 
Incomplete outcome 
data (attrition bias) 
Low risk “Data collection for patients up until the time of 
withdrawal has been included in the analysis 
with the exception of 5 controls and 2 from 
experimental group for whom study participation 
time was not available", ITT analysis performed 
Selective reporting 
(reporting bias) 
Low risk All pre-specified outcomes reported 
Other bias - were 
groups similar at 
baseline regarding 
the most important 
prognostic 
indicators? 
High risk More males and more knee replacement 
surgeries in the experimental group. Other 
baseline comparisons were similar between the 
two groups 
 
Nixon et al. (1998) 
Bias Authors’ 
judgement 




Low risk Randomisation was stratified by centre (Leeds or 
Hartlepool) and by age (55 - 69 and ≥ 70). "A 
telephone randomisation schedule was developed 
within random permuted blocks of 6, with a run in 
of 8, and managed by the Northern and Yorkshire 




Low risk Randomisation schedule held by centre external to 
the data collectors. "The record pertaining to the 
intra-operative randomised mattress allocation 
remained separate from the main data collection 





Low risk "All pre- and intra-operative data were recorded by 
the research nurse, and post-operative data 
recorded by recovery and ward staff who were 
blind to the intra-operative mattress allocation". 
Does not discuss if the participants were blinded to 
which intervention they received, but they would 







Support for judgement 
Blinding of outcome 
assessment 
(detection bias) 
Low risk “All pre- and intra-operative data were recorded by 
the research nurse, and post-operative data 
recorded by recovery and ward staff who were 
blind to the intra-operative mattress allocation” 
Incomplete outcome 
data (attrition bias) 
Low risk The main endpoint was determined for 416 
participants, with incomplete data for 30 
participants. A sensitivity analysis was carried out 
assuming that the participants with missing 
endpoints were in fact failures and reported that the 
effects of the 2 mattresses were "in the same 




Low risk All pre-specified outcomes reported 
Other bias - were 
groups similar at 
baseline regarding 
the most important 
prognostic 
indicators? 
Low risk Standard mattress group: longer length of 
operation, longer preoperative stay, more time in 
hypotensive state than dry polymer pad group. 
Adjusted analysis was performed to consider these 
differences 
 
Nixon et al. (2006b) 
Bias Authors’ 
judgement 




Low risk "Randomisation was through an independent, 
secure, 24-hour randomisation automated 
telephone system, ensuring allocation 





Low risk Randomisation was through an independent, 
secure, 24-hour randomisation automated 





High risk "It was not possible to mask the randomised 
intervention to the patients participating in the trial, 
ward nursing staff or clinical research nurses 
conducting the skin assessments...To minimise the 
potential for bias it was planned that qualified ward-
based nursing staff would record daily skin 
assessments and clinical research nurses would 
undertake assessments twice weekly to validate 







Support for judgement 
Blinding of outcome 
assessment 
(detection bias) 
Low risk "the main limitation of our trial was the lack of 
blinded outcome assessment". Inter-rater reliability 
assessments and data quality monitoring identified 
problems associated with the accuracy and 
completeness of the ward-based nurses 
records....it was therefore recommended that the 
clinical research nurse assessments were used for 
the trial analysis but neither the clinical research 
nurses not the ward nurses were informed of this 
decision 
Incomplete outcome 
data (attrition bias) 
Low risk ITT analysis conducted 
Selective reporting 
(reporting bias) 
Low risk All pre-specified outcomes reported 
Other bias - were 
groups similar at 
baseline regarding 
the most important 
prognostic 
indicators? 
Low risk Groups were comparable at baseline, no concerns 
 
Ozyurek and Yavuz (2015) 
Bias Authors’ 
judgement 




Low risk Randomisation was performed through an 
independent, secure, 24-hour randomisation 
automated telephone system. "We used 




Low risk Secure and independent automated telephone 





High risk Nurses were not blind to participant assignments. 
Does not discuss blinding of participants 
Blinding of outcome 
assessment 
(detection bias) 
High risk "The main limitation of this trial was the lack of 
blinded outcome assessments; it was difficult to 
mask viscoelastic support surfaces and it would be 
unethical to frequently move critically ill participants 
from bed to bed" 
Incomplete outcome 
data (attrition bias) 
High risk Randomised n = 357, however only 105 were 
included in the analysis. Reasons for loss include 
hospitalised for less than 7 days (n = 245), lost to 
follow up (n = 29), without risk/no limitation of 
movement minimum 3 days after surgery (n = 6) 
and discontinued intervention (n = 1). Does not 






Support for judgement 
Selective reporting 
(reporting bias) 
Low risk All pre-specified outcomes reported 
Other bias - were 
groups similar at 
baseline regarding 
the most important 
prognostic 
indicators? 
High risk Viscoelastic foam 2 had significantly lower GCS 
scores, and viscoelastic foam 1 had significantly 
more participants with a higher Braden score (15 - 
18) 
 
Ricci et al. (2013) 
Bias Authors’ 
judgement 




Low risk Randomised according to a computer generated 






Unknown if the envelopes were opaque, 







Does not discuss 





Does not discuss 
Incomplete outcome 
data (attrition bias) 




Low risk All pre-specified outcomes addressed 
Other bias - were 
groups similar at 
baseline regarding 
the most important 
prognostic 
indicators? 
Low risk Participants were comparable in terms of age, 
gender, and other demographic and clinical 
characteristics with no significant differences 
between the two groups 
 
Russell et al. (2000) 
Bias Authors’ 
judgement 










Low risk “Randomisation was done blindly using a sealed 














Does not discuss 





Does not discuss 
Incomplete outcome 
data (attrition bias) 
High risk Stated that they did ITT, but is inaccurate: "ITT 
sample included all patients who signed consent 
forms and who were placed on either (mattress) 




Low risk The pre-specified outcomes of interest have been 
reported 
Other bias - were 
groups similar at 
baseline regarding 
the most important 
prognostic 
indicators? 
Low risk Baseline characteristics were comparable in terms 
of major physiological and demographic 
characteristics 
 
Sanada et al. (2003) 
Bias Authors’ 
judgement 














High risk The subjects were blinded to which surface they 
were receiving; the participating nurses could not 
be blinded because they needed to change and 
inspect the bedding. The nurses were unaware of 
the efficiency of the support surfaces used 
Blinding of outcome 
assessment 
(detection bias) 
Unclear risk Does not discuss if the outcome assessors are 
blinded to the intervention or if anything was done 
to attempt to minimise this bias 
Incomplete outcome 
data (attrition bias) 
High risk "A total of 123 patients were recruited to this 
study, of which 41 patients withdrew before 
completion. Reasons for withdrawal included 
some patients not requiring head elevation, some 
patients refusing to accept head elevation as part 
of their treatment, and others asking to be 
withdrawn." 15 were excluded before 







Support for judgement 
Selective reporting 
(reporting bias) 
Low risk The pre-specified outcomes of interest have been 
reported 
Other bias - were 
groups similar at 
baseline regarding 
the most important 
prognostic 
indicators? 
Low risk No clear difference on prognostic indicators at 
baseline between groups 
 
Santamaria et al. (2013) 
Bias Authors’ 
judgement 




Low risk "Retrieving the next envelope in a pre-prepared 
series of envelopes that had been randomised 
using a computer-generated set of random 




Low risk "The randomisation of participants was 
undertaken by an ED research nurse when the 
patient was admitted to the ED and following 
screening to determine if they met the inclusion 
criteria, they would then determine group 
allocation by retrieving randomisation envelope". 
These envelopes were sequentially numbered 





High risk Participants were likely to be unaware of the 
intervention, however the data collectors and staff 
caring for the participants could not be blinded to 
the nature of the treatment interventions. 
Blinding of outcome 
assessment 
(detection bias) 
High risk The only data collectors who assessed the 
participants daily were members of the study 
team and each had undergone inter-rater testing 
for staging pressure ulcers prior to the 
commencement of the study, but does not state if 
they were blinded 
Incomplete outcome 
data (attrition bias) 
Unclear risk States that “the analysis was based on ITT where 
all patients randomised to the intervention were 
analysed regardless of protocol violations". 
However, there were several patients who were 
randomised but didn't go to ICU, and patients who 
went to ICU but were discharged prior to first 
pressure ulcer assessment, who were not 
included in the analysis 
Selective reporting 
(reporting bias) 








Support for judgement 
Other bias - were 
groups similar at 
baseline regarding 
the most important 
prognostic 
indicators? 
Low risk Baseline characteristics were comparable in terms 
of major physiological and demographic 
characteristic 
 
Takala et al. (1996) 
Bias Authors’ 
judgement 






"Only 2 patients could be studied simultaneously, 
consecutive eligible patients were randomised to 
one of the two study mattresses..." The 
participants were randomised in blocks of four. 
When two participants were on the special 





Low risk Opaque sealed envelopes were used, and the 
randomisation was done by a person not involved 





High risk “Type of mattress could not be blinded" 
Blinding of outcome 
assessment 
(detection bias) 
High risk "This study was not blinded since the severity of 
the illness of the patients precluded their transfer 
for evaluation of the skin condition by a blinded 
reviewer. There is some evidence that there was 
an attempt to blind some of the outcome 
assessments as it states "All sore areas were 
measured and photographed for independent 
verification of severity" 
Incomplete outcome 
data (attrition bias) 
Low risk All 40 participants recruited were included in the 
ITT analysis, however numerous withdrawals were 
reported: "10 patients were randomised but not 
treated due to either early discharge or death, and 
so were included in the ITT analysis. 6 patients 
randomised on the pressure relieving mattress 
were included only in the ITT analysis, since the 
start of treatment was delayed due to mattress 
non-availability due to delayed discharge of 
patients already in the study. Accordingly, 40 
patients were included in the ITT analysis and 24 











Support for judgement 
Other bias - were 
groups similar at 
baseline regarding 
the most important 
prognostic 
indicators? 
Low risk Treatment groups similar at baseline, however, not 
compared for degree of pressure ulcer risk 
 
Torra i Bou et al. (2002) 
Bias Authors’ 
judgement 






Participants were allocated using a list of random 
numbers. It is not clear how the random number 



















Does not mention who the outcome assessors 
were and if any measures were taken to minimise 
bias 
Incomplete outcome 
data (attrition bias) 
High risk 130 participants included in the study (65 in each 
arm) but only 111 completed. 1 person not 
accounted for "6 people from the bandage group 
died and 8 left the study ... which left 50 still in the 
group at the end of the study". Four deaths were 
reported in the dressings group leaving 61 




Low risk The pre-specified outcomes of interest have been 
reported 
Other bias - were 
groups similar at 
baseline regarding 





The two groups were comparable at baseline 










Tymec et al. (1997) 
Bias Authors’ 
judgement 




Low risk Assignment to either pillow or Foot Waffle was 
undertaken "...using a block randomised list" and 
the participant’s position order “...was determined 









Unclear risk Not reported 
Blinding of outcome 
assessment 
(detection bias) 
Unclear risk Does not mention who the outcome assessors 
were and if any measures were taken to minimise 
this bias 
Incomplete outcome 
data (attrition bias) 
Unclear risk 52 participants (23 women and 29 men) in the 
study, but nowhere was the number in each group 
reported. 8/52 participants developed a pressure 
ulcer, which was a completion criterion of the 




Low risk Pressure ulcer occurrence mean survival time 
(i.e., time until one occurred), and mean interface 
pressures were reported. These are all meaningful 
outcomes 
Other bias - were 
groups similar at 
baseline regarding 
the most important 
prognostic 
indicators? 
Unclear risk No participant characteristics provided 
 
Van Leen et al. (2011) 
Bias Authors’ 
judgement 












Randomisation was performed using numbered 













Support for judgement 





"A weekly inspection of the skin ... was done by an 
independent nurse" but it does not state if this 
person was blinded to the intervention 
Incomplete outcome 
data (attrition bias) 
Low risk 9 participants died during the trial; all were included 
in the statistical analysis 
Selective reporting 
(reporting bias) 
Low risk All pre-specified outcomes appear to have been 
reported 
Other bias - were 
groups similar at 
baseline regarding 
the most important 
prognostic 
indicators? 
Low risk "More patients in the static air group had a very low 
Norton score…further relevant differences were 
encountered between both groups" 
 
Van Leen et al. (2013) 
Bias Authors’ 
judgement 








Unclear risk Randomisation was performed using numbered 





Unclear risk Not reported 
Blinding of outcome 
assessment 
(detection bias) 
Unclear risk Not reported 
Incomplete outcome 
data (attrition bias) 
Low risk In total 5 participants died during the study period, 
3 in the first 6-month period. Participants who died 




Low risk The pre-specified outcomes of interest have been 
reported 
Other bias - were 
groups similar at 
baseline regarding 
the most important 
prognostic 
indicators? 
Low risk Due to the crossover nature of the trial each 
participant serves as his or her own control, but 
there could have been a "carry-over" effect 
between both interventions which may have 
confounded the estimates of the intervention 
effects, this has been taken into account by only 







Vanderwee et al. (2005) 
Bias Authors’ 
judgement 




Low risk “...randomisation tables generated with the SPSS 




Low risk "Serially numbered, closed envelopes were made 
for each participating area. The envelope with the 






High risk There was not really an easy option to blind or 
camouflage the type of mattress, therefore the 
ward nurse, data nurse and researcher were not 
blinded to the intervention. Does not discuss if the 
participants were blinded to the intervention 
Blinding of outcome 
assessment 
(detection bias) 
Low risk Skin inspections would be done daily by the ward 
nurses. "A random sample of patients was 
observed at unexpected moments by both the 
researcher and the data nurse". The inter-rater 
reliability for the classification of pressure ulcers 
between researcher, nursing staff, and data nurse 
ranged from κ=0.88 (95% CI 0.78–0.97) to κ=0.94 
(95% CI 0.91–0.97) 
Incomplete outcome 
data (attrition bias) 
Low risk No dropouts/withdrawals reported. Flow chart 
showed 447 participants enrolled in total, 297 
assessed by Braden and 150 by non-blanchable 
erythema. Numbers in the results match these 
Selective reporting 
(reporting bias) 
Low risk Published reports include all pre-specified and 
expected outcomes 
Other bias - were 
groups similar at 
baseline regarding 
the most important 
prognostic 
indicators? 
Low risk Participants well balanced at baseline.... "Since the 
groups were similar in all characteristics except 






 School of Healthcare Studies 
Appendix C Participant information sheet 
An exploration of the use of offloading devices for the prevention of heel 
pressure ulcers 
You are being invited to take part in a research project looking at how offloading 
devices are used in secondary care for the prevention of heel pressure ulcers. Before 
you decide whether or not to take part it is important for you to understand why the 
research is being done and what it will involve.  
Please take time to read the following information carefully and discuss it with others if 
you wish. Ask me if there is anything that is not clear or if you would like more 
information. Take time to decide whether or not you wish to take part.  
What is the purpose of this study? 
The aim of this research project is to explore how offloading devices are used in clinical 
practice in the prevention of heel pressure ulcers, both in terms of their clinical 
effectiveness but also how they are actually used and perceived in clinical practice 
when individual patient preferences, nursing knowledge, resources and care 
environment are taken into account.  This research will aim to inform practice with 
regards to the use of heel offloading devices when individual patient factors and 
nursing preferences are taken into account. 
Who is doing the study?  
The interviews will be conducted by Clare Greenwood, a Clinical Nurse Specialist in 
Tissue Viability at Leeds Teaching Hospitals.  This study will become part of her PhD 
thesis being conducted at the University of Leeds.  This study is being overseen by her 
PhD supervisors: Prof Andrea Nelson, Prof Jane Nixon, Dr Elizabeth McGinnis and Dr 
Rebecca Randell. 
Who is being asked to participate?  
I am looking to recruit Tissue Viability Nurses who primarily work in a secondary care 
environment as they will have experience of caring for a wide variety of patients at risk 
of developing pressure ulcers.  You have been invited to participate as you will have 
experience of assessing and implementing a plan of care for patients at risk of 
developing a heel pressure ulcer, which might or might not include the utilisation of an 
offloading device.  
What will be involved if I take part in this study? 
You will be invited to participate in a single telephone interview that will be anticipated 
to last no more than 60 minutes.  These will be arranged at a date and time convenient 
to you. The interviews will be audio recorded. 




What are the advantages and disadvantages of taking part? 
The main disadvantage to participating will be the time commitment that will be 
required of you. Whilst no immediate benefits or advantages can be anticipated for 
those people participating in the project, it is hoped that this work will lead to an 
improved understanding of how and why offloading devices are used (and not used) in 
clinical practice for the prevention of heel pressure ulcers and will lead to a series of 
evidence based practical recommendations. 
Can I withdraw from the study at any time?  
You are free to withdraw from the study before, during or up to the point of transcription 
which will take place shortly after the interview (within 48 hours), at which point all data 
will be anonymised. You do not have to give a reason for withdrawing.  If you chose to 
withdraw during this period, any data collected will be destroyed.   
Will the information obtained in the study be confidential?  
All participants will be assigned a study ID number and will be referred to by this 
number throughout the study and in future publications in order to protect the identity of 
the individual participants.  Any identifiable details (e.g., place of work) will not be 
included in any publication.  
All data collected will only be accessible by the researcher and supervisors named on 
this information sheet. All data collected as part of this research will be stored in a 
password protected drive of the University computer system and will be kept for at least 
3 years after completion of the PhD or publication, whichever is longer.  All data 
handling procedures are in accordance with the Data Protection Act 1998. 
What will happen to the results of the study? 
The main output of this research will be part of a PhD thesis.  
Study participants will each be provided with a summary of the findings at the end of 
this stage of the research.  The overall results of the PhD will be disseminated through 
journal publications and conference presentations. 
Who has reviewed this study? 
Ethical approval has been granted by the School of Healthcare Research Ethics 
Committee (HREC15-014, October 2015). 
 
If you agree to take part, would like more information or have any questions or 
concerns about the study please contact Clare Greenwood via email within the 
next 3 days on c.e.greenwood12@leeds.ac.uk 
 




















Appendix E Ward Manager Participant Information Sheet 
An exploration of the use of offloading devices for the prevention of heel pressure 
ulcers – an observation study 
You are being invited to take part in a research project looking at how offloading 
devices are used (and not used) in secondary care for the prevention of heel pressure 
ulcers. Before you decide whether or not to participate it is important for you to 
understand why the research is being done and what it will involve.  
Please take time to read the following information carefully and discuss it with others if 
you wish. Ask me if there is anything that is not clear or if you would like more 
information. Take time to decide whether or not you wish to take part.  
What is the purpose of this study? 
There are numerous different devices available on the market designed for the 
prevention of heel pressure ulcers; however, the evidence base for these devices is 
sparse. The aim of this research project is to explore the use of devices in the 
prevention of heel pressure ulcers, specifically with regards to how they are actually 
used and perceived in clinical practice when individual patient preferences, nursing 
knowledge, resources and care environment are taken into account.   
Who is doing the study?  
The research will be conducted by Clare Greenwood, a Clinical Nurse Specialist in 
Tissue Viability at Leeds Teaching Hospitals.  This study will become part of her PhD 
thesis being conducted at the University of Leeds.  This study is being overseen by her 
PhD supervisors; Prof Andrea Nelson, Prof Jane Nixon, Dr Elizabeth McGinnis and Dr 
Rebecca Randell. 
Who is being asked to participate?  
I am looking to recruit wards within Trauma & Orthopaedics and Acute Medicine CSUs 
who keep a stock of offloading devices and therefore have these devices easily 
accessible to your staff.  You have been invited to participate as your ward routinely 
cares for patients at risk of developing a heel pressure ulcer, which might or might not 
include the utilisation of a device.  
What will be involved if I take part in this study? 
You will be consenting to an observation study of pressure ulcer preventative care 
practices to take place on your ward, and therefore consenting to any staff member 
working on your ward to being observed including patients, nurses, CSWs and wider 
members of the MDT.  




There will be a minimum of 4 separate observation periods that will take place over 
different shift times including evenings and weekends, which will be arranged at a date 
and time convenient to you and your team. The observations will primarily take place 
within a bay of patients which has at least one patient at high risk of developing a 
pressure ulcer, which will be determined by the patient being either bed-fast or chair-
fast, but the observations will also include ward handovers/safety huddles/board 
rounds.  The layout of the ward will also be observed including photography of the 
storerooms. At each separate observation period a different bay of patients will be 
observed each time, or the same bay if a minimum of 50% of the patients have 
changed between observations. All patients in the observed bay will be verbally 
consented to be observed and those at risk of developing a pressure ulcer will be 
consented, either personally or through consultee agreement as applicable, to have a 
review of their medical and nursing notes following the period of observation.  
All patients in the observed bay will be verbally consented to be observed and those at 
risk of developing a pressure ulcer will be consented, either personally or through 
consultee agreement as applicable, to have a review of their medical and nursing notes 
following the period of observation. 
All patients and members of staff involved in the observations will be provided with 
information about the study and given the opportunity to opt out at any point.  Staff and 
patients will be informed that this is an observational study of care, but the specific 
focus of the research will not be disclosed so as not to influence practice.  You will 
therefore be asked not to disclose to staff the specific focus of the study for this reason.  
1-3 members of ward staff who have been working in the observed bay will be invited 
to participate in a short audio-recorded interview, anticipated to last 15-30 minutes. The 
interviews will take place as close to the end of the period of observations as possible. 
The interviews will seek to gather the thought processes behind the implementation of 
the plan of care and choice of equipment in use and when it was implemented.  
The only personal information that will be collected during the study will be email 
addresses if participants decide that they would like to receive copies of the results 
once the study has been completed. This information will be stored on the University of 
Leeds M: drive which is password protected and only accessible to the principal 
investigator. 
The only anticipated risk that can be foreseen if you choose to take part could be if 
poor or dangerous practice is observed or disclosed during the interviews. If there is 
any immediate danger to patients or staff, then I will intervene during the observations. 
Anything I perceive to be bad practice will be fed back to yourself at the end of the 
observation period.  The intention is not to assess the practice that is being delivered, 
just to observe what is actually happening. 
What are the advantages and disadvantages of taking part? 
The main disadvantage associated with taking part will be the time required of your 
staff. However, we have chosen data collection methods, such as observation, that 
seek to minimise this burden. The researcher will aim to not get in the way during the 
observations and will minimise any disruption by scheduling interviews at times 
convenient to both the member of staff and the ward, and observation periods can be 




Whilst no immediate benefits or advantages can be anticipated for those people 
participating in the project, it is hoped that this work will lead to an improved 
understanding of how and why offloading devices are used (and not used) in clinical 
practice for the prevention of heel pressure ulcers. A summary of the research findings 
will be made available to all participants if requested. 
Can I withdraw from the study at any time?  
You are free to withdraw your ward from the study before, during or up to the point of 
transcription of the field notes which will take place shortly after the observation (within 
3 days), at which point all data will be anonymised. You do not have to give a reason 
for withdrawing.  If you chose to withdraw during this period, any data collected will be 
destroyed.  Individual members of staff will also have the option to withdraw at any 
point up until the point of transcription. 
Will the information obtained in the study be confidential?  
All participating wards will be assigned a study ID number and will be referred to by this 
number throughout the study and in future publications in order to protect the identity of 
the individual participants.  Any identifiable details will not be included in any 
publication.  
Data of any sort (field notes, interview tapes, consent forms and research journal) will 
be stored in a secure lockable place within the School of Healthcare and will only be 
accessible to the researcher and supervisors.  Once they have been transcribed, the 
data will be stored on a password protected secure drive at the University of Leeds for 
5 years after completion of the PhD or publication, whichever is longer.  All data 
handling procedures are in accordance with the Data Protection Act 2018. 
The University of Leeds is the sponsor for this study based in the United Kingdom. We 
will be using information from your patients in order to undertake this study and will act 
as the data controller for this study. This means that we are responsible for looking 
after your information and using it properly. The University of Leeds will keep 
identifiable information about you for 5 years after the study has finished. 
Your rights to access change or move your information are limited, as we need to 
manage your information in specific ways in order for the research to be reliable and 
accurate. If you withdraw from the study, we will keep the information about you that 
we have already obtained. To safeguard your rights, we will use the minimum 
personally identifiable information possible. 
You can find out more about how we use your information at 
http://www.leeds.ac.uk/secretariat/data_protection.html. 
What will happen to the results of the study? 
The main output of this research will be part of a PhD thesis. Study participants will 
each be offered a summary of the findings at the end of this stage of the research. An 
email address will be collected in order to disseminate the results. These will be stored 
on a spreadsheet in a password protected drive of the University of Leeds computer 
system and will not be shared with anyone.  Once the results have been sent out this 




The overall results of the PhD will be disseminated through journal publications and 
conference presentations. 
What if I have a complaint about the research? 
If you have a concern about any aspect of this study, you should ask to speak to the 
researchers and they will do their best to answer your questions, their contact details 
are at the end of this leaflet. Or you can contact Patient Advice and Liaison Service 
(PALS) on (0113) 2066261 or patientexperience.leedsth@nhs.net. 
Who has reviewed this study? 
This study is sponsored by the University of Leeds and Ethical approval has been 
granted by the NHS Research Ethics Committee (8/YH/0272 18/09/2018). 
If you agree to take part, would like more information or have any questions or 
concerns about the study please contact Clare Greenwood via email on 
c.e.greenwood12@leeds.ac.uk or Rebecca Randell (PhD supervisor) on 
R.Randell@leeds.ac.uk 
 








Appendix F Patients Participant Information Sheet 
An exploration of the use of offloading devices for the prevention of heel pressure 
ulcers – an observation study 
A large-print version of this sheet is available on 
request   
You are being invited to take part in a research project looking at how different 
products are used in hospital to prevent heel pressure ulcers. Before you decide 
whether or not to participate it is important for you to understand why the research is 
being done and what it will involve.  
Please take time to read the following information carefully and discuss it with others if 
you wish. Ask me if there is anything that is not clear or if you would like more 
information. Take time to decide whether or not you wish to take part.  
What is the purpose of this study? 
Pressure ulcers (also known as pressure sores or bedsores) are injuries to the skin and 
tissues beneath, mainly caused by long periods of lying or sitting.  They can happen to 
anyone, but usually affect people who are unwell and spend a long time in bed or sit in 
a chair or wheelchair for long periods of time. 
There are lots of different products available to nurses that are designed to prevent 
pressure ulcers to the heel; however, there isn’t much information available about 
which are the best and how and when they should be used. The aim of this research 
project is to explore how nurses prevent pressure ulcers to the heel, and how patients 
react to the care given. 
Who is doing the study?  
The research will be conducted by Clare Greenwood, a Clinical Nurse Specialist in 
Tissue Viability at Leeds Teaching Hospitals.  This study will become part of her PhD 
thesis being conducted at the University of Leeds.  This study is being overseen by her 
PhD supervisors; Prof Andrea Nelson, Prof Jane Nixon, Dr Elizabeth McGinnis and Dr 
Rebecca Randell. 
Who is being asked to participate?  
You are being invited to participate because you may be at risk of developing a 
pressure ulcer due to your stay in hospital and longer times spent in the bed and/or 
chair. It does not mean that you will develop one and staff will be trying to reduce your 
risk, and this is what is being studied.  




What will be involved if I take part in this study? 
You are being asked to consent to having your medical and nursing records reviewed 
by the researcher.  All data collected will be anonymous and therefore won’t be 
identifiable to you. The researcher will be looking at how the nurses and doctors have 
planned and cared for you with regards to preventing you from developing a pressure 
ulcer, or how they have treated your pressure ulcer if you have one.  
What are the advantages and disadvantages of taking part? 
Whilst there are no immediate benefits or advantages to taking part, it is hoped that this 
work will lead to an improved understanding of how and why products are used (and 
not used) for the prevention of heel pressure ulcers and could lead to better practice in 
the future. 
No disadvantages to taking part can be foreseen.  
Can I withdraw from the study at any time?  
You do not have to take part in this study.  If you choose to consent to having your 
medical and nursing notes reviewed, you are free to change your mind and pull out of 
the study up to 3 days after. Your care will not be affected should you chose to 
withdraw.   
What will happen to the results of the study? 
The main output of this research will be part of a PhD thesis.  
If you are interested a copy of the study findings can be sent to you as a lay summary. 
An email address or your home address will be collected in order to send this 
information to you.  The overall results of the PhD will be shared through journal 
publications and conference presentations. 
Will the information obtained in the study be confidential?  
You will be assigned a study ID number by the researcher and will be referred to by 
this number throughout the study and in future publications in order to protect your 
identity. The only personal details that will be collected is your name on the consent 
form and email address and/or personal address should you wish to receive a copy of 
the results. The email address and/or personal address will be stored on a spreadsheet 
in a password protected drive of the University of Leeds computer system and will not 
be shared with anyone.  Once the results have been sent out this spreadsheet will be 
destroyed, and the email will be deleted from the sent items folder.  
The University of Leeds is the sponsor for this study based in the United Kingdom. We 
will be using information from your medical records in order to undertake this study and 
will act as the data controller for this study. This means that we are responsible for 
looking after your information and using it properly. The University of Leeds will keep 
identifiable information about you for 5 years after the study has finished. 
The researcher may use your name and contact details to contact you about the 
research study, and make sure that relevant information about the study is recorded for 
your care, and to oversee the quality of the study. Individuals from the University of 
Leeds and regulatory organisations may look at your medical and research records to 
check the accuracy of the research study. The researcher will pass these details to The 




only people at the University of Leeds who will have access to information that 
identifies you will be people who need to audit the data collection process. The people 
who analyse the information will not be able to identify you and will not be able to find 
out your name or contact details. 
All data collected as part of this research will be stored in a password protected drive of 
the University computer system and will be kept for 5 years after completion of the PhD 
or publication, whichever is longer.  All data handling procedures are in accordance 
with the Data Protection Act 2018. 
Your rights to access change or move your information are limited, as we need to 
manage your information in specific ways in order for the research to be reliable and 
accurate. If you withdraw from the study, we will keep the information about you that 
we have already obtained. To safeguard your rights, we will use the minimum 
personally identifiable information possible. 
You can find out more about how we use your information at 
http://www.leeds.ac.uk/secretariat/data_protection.html. 
What if something goes wrong? 
If you have a concern about any aspect of this study, you should ask to speak to the 
researchers, and they will do their best to answer your questions. Clare Greenwood is 
leading the research and her contact details are given at the end of this information 
sheet. If you remain unhappy and wish to complain formally, you can do this by 
contacting Dr Rebecca Randell on R.Randell@leeds.ac.uk. Or you can contact Patient 
Advice and Liaison Service (PALS) on (0113) 2066261 or 
patientexperience.leedsth@nhs.net. 
Who has reviewed this study? 
This study is sponsored by the University of Leeds and Ethical approval has been 
granted by the NHS Research Ethics Committee (8/YH/0272 18/09/2018). 
If you agree to take part, would like more information or have any questions or 
concerns about the study please contact Clare Greenwood via email on 
c.e.greenwood12@leeds.ac.uk or I can be contacted on the ward during the 
observation period. 
 








Appendix G Ward Staff Participant Information Sheet 
An exploration of the use of offloading devices for the prevention of heel pressure 
ulcers – an observation study 
You are being invited to take part in a research project looking at how offloading 
devices are used in secondary care for the prevention of heel pressure ulcers. Before 
you decide whether or not to participate it is important for you to understand why the 
research is being done and what it will involve.  
Please take time to read the following information carefully and discuss it with others if 
you wish. Ask me if there is anything that is not clear or if you would like more 
information. Take time to decide whether or not you wish to take part.  
What is the purpose of this study? 
There are numerous different devices available on the market designed for the 
prevention of heel pressure ulcers; however, the evidence base for these devices is 
sparse. The aim of this research project is to explore the use of devices in the 
prevention of heel pressure ulcers, specifically with regards to how they are actually 
used and perceived in clinical practice when individual patient preferences, nursing 
knowledge, resources and care environment are taken into account.   
Who is doing the study?  
The research will be conducted by Clare Greenwood, a Clinical Nurse Specialist in 
Tissue Viability at Leeds Teaching Hospitals.  This study will become part of her PhD 
thesis being conducted at the University of Leeds.  This study is being overseen by her 
PhD supervisors, Prof Andrea Nelson, Prof Jane Nixon, Dr Elizabeth McGinnis and Dr 
Rebecca Randell. 
Who is being asked to participate?  
All members of ward staff working in the observed bays on the days that the 
observations take place will be invited to participate. 
What will be involved if I take part in this study? 
You are being invited to participate in a short audio-recorded interview, anticipated to 
last 15-30 minutes. The interviews will take place as close to the end of the period of 
observations as possible. The interviews will seek to gather the thought processes 
behind the implementation of the plan of care and choice of equipment in use and 
when it was implemented.  
The only anticipated risk that can be foreseen if you choose to take part could be if 
poor or dangerous practice is disclosed during the interviews. Anything perceived by 
the researcher to be bad or dangerous practice will be fed back to the ward manager.  




What are the advantages and disadvantages of taking part? 
The main disadvantage to participating in the interviews will be the time commitment 
that will be required of you. Whilst no immediate benefits or advantages can be 
anticipated by participating in the project, it is hoped that this work will lead to an 
improved understanding of how and why offloading devices are used in clinical practice 
for the prevention of heel pressure ulcers and might lead to better care in the future. 
Can I withdraw from the study at any time?  
If you choose to participate in the interviews, you are free to withdraw from the study 
before, during or up to the point of transcription of the interviews which will take place 
shortly after (within 3 days), at which point all data will be transcribed and anonymised.  
What will happen to the results of the study? 
The main output of this research will be part of a PhD thesis.  
Study participants will be offered a summary of the findings at the end of this stage of 
the research via email.  The overall results of the PhD will be disseminated through 
journal publications and conference presentations. 
Will the information obtained in the study be confidential?  
All participants will be assigned a study ID number and will be referred to by this 
number throughout the study and in future publications in order to protect your identity.  
Any identifiable details will not be included in any publication. The only personal details 
that will be collected is your name on the consent form and email address should you 
wish to receive a copy of the results. The email address will be stored on a 
spreadsheet in a password protected drive of the University of Leeds computer system 
and will not be shared with anyone.  Once the results have been sent out this 
spreadsheet will be destroyed, and the email will be deleted from the sent items folder.  
Audio recordings may be transcribed by a 3rd party external to the research team. This 
will be through a University of Leeds trusted transcription service. A confidentiality 
agreement will be signed by the transcription service and a secure data exchange 
programme will be used. No confidential, sensitive or personally identifiable information 
will be sent to the transcriber. 
The University of Leeds is the sponsor for this study based in the United Kingdom. We 
will be using information from you in order to undertake this study and will act as the 
data controller for this study. This means that we are responsible for looking after your 
information and using it properly. The University of Leeds will keep identifiable 
information about you for 5 years after the study has finished. 
The researcher may use your name and contact details to contact you about the 
research study, and make sure that relevant information about the study is recorded for 
your care, and to oversee the quality of the study. Individuals from the University of 
Leeds and regulatory organisations may look at your interview transcripts to check the 
accuracy of the research study. The researcher will pass these details to the University 
of Leeds. The only people at the University of Leeds who will have access to 
information that identifies you will be people who need to contact you to audit the data 
collection process. The people who analyse the information will not be able to identify 




All data collected as part of this research will be stored in a password protected drive of 
the University computer system and will be kept for 5 years after completion of the PhD 
or publication, whichever is longer.  All data handling procedures are in accordance 
with the Data Protection Act 2018. 
Your rights to access change or move your information are limited, as we need to 
manage your information in specific ways in order for the research to be reliable and 
accurate. If you withdraw from the study, we will keep the information about you that 
we have already obtained. To safeguard your rights, we will use the minimum 
personally identifiable information possible. 
You can find out more about how we use your information at 
http://www.leeds.ac.uk/secretariat/data_protection.html. 
What if I have a complaint about the research? 
If you have a concern about any aspect of this study, you should ask to speak to the 
researchers and they will do their best to answer your questions, their contact details 
are at the end of this leaflet. Or you can contact Patient Advice and Liaison Service 
(PALS) on (0113) 2066261 or patientexperience.leedsth@nhs.net. 
Who has reviewed this study? 
This study is sponsored by the University of Leeds and Ethical approval has been 
granted by the NHS Research Ethics Committee (8/YH/0272 18/09/2018). 
If you agree to take part, would like more information or have any questions or 
concerns about the study please contact Clare Greenwood via email on 
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